data_2cpd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2cpd _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.7 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.898 0.38 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.7 p -122.48 132.99 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.51 116.85 18.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 63.2 mt -147.9 145.32 18.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.551 HD13 ' CE1' ' A' ' 273' ' ' PHE . 88.4 mt -133.26 109.21 9.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -91.71 133.28 35.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 23.1 t -114.58 137.44 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.106 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.0 ttp85 -129.78 156.13 44.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 73.83 44.28 0.28 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 25.0 mt -93.69 131.61 38.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 10.6 mmt -67.16 123.3 19.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 26.0 mt -48.27 -32.01 6.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 9.5 t -66.72 -35.75 80.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.453 HG23 ' N ' ' A' ' 243' ' ' SER . 39.2 m -59.62 141.72 54.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.135 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.453 ' N ' HG23 ' A' ' 242' ' ' THR . 4.3 m -110.61 166.15 11.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 247' ' ' ILE . 29.7 mt-10 -52.27 -52.03 55.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -41.49 -43.52 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 21.2 mmm -63.99 -36.25 83.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 244' ' ' GLU . 43.0 mt -74.8 -38.31 44.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.123 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -71.13 -43.97 66.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 16.4 ptmt -63.89 -47.88 78.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.473 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 31.7 mm-40 -58.29 -46.95 85.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.42 ' CE2' HG23 ' A' ' 271' ' ' VAL . 8.2 m-85 -72.57 -34.05 67.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.926 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -69.03 -32.22 71.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -47.02 -29.98 2.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.437 HD11 ' CB ' ' A' ' 285' ' ' ALA . 25.0 mm -68.2 -53.28 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -143.78 137.31 14.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.554 0.692 . . . . 0.0 110.936 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 126.24 13.11 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.682 2.255 . . . . 0.0 112.388 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 60.9 39.5 97.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.512 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -101.08 -45.13 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.24 109.93 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.14 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -61.37 -57.68 11.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -153.34 158.05 40.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 91.1 t -132.41 115.89 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -110.31 106.95 16.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . 0.416 ' HD3' ' CD1' ' A' ' 247' ' ' ILE . 14.7 tptm -79.51 148.56 31.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.572 HD11 ' CD2' ' A' ' 268' ' ' TYR . 6.1 mt -137.36 172.19 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.161 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.464 ' C ' ' O ' ' A' ' 265' ' ' ILE . 20.1 mmt180 -31.86 -70.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.29 17.76 6.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.592 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.2 OUTLIER -146.08 177.93 8.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -170.14 165.02 9.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.109 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -127.59 142.18 51.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.42 HG23 ' CE2' ' A' ' 251' ' ' PHE . 21.5 t -127.38 123.44 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.143 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -99.96 157.59 16.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.551 ' CE1' HD13 ' A' ' 233' ' ' LEU . 41.3 m-85 -135.0 170.83 15.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.4 t -84.3 -34.24 23.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -138.67 144.66 39.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 -55.07 -42.51 72.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -46.49 -55.26 7.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -60.32 -51.31 70.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -51.17 -42.48 60.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 91.8 t -61.54 -48.57 88.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.13 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -58.33 -55.58 33.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.69 -26.72 64.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.078 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 51.2 ttp -65.5 -60.24 3.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 285' ' ' ALA . 6.1 mtmp? -65.26 -55.21 19.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.907 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.437 ' CB ' HD11 ' A' ' 254' ' ' ILE . . . -36.4 -47.85 0.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.091 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 287' ' ' ASN . 34.3 mt -84.46 -39.71 18.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.9 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 286' ' ' LEU . 31.9 t30 -37.1 104.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 98.97 38.24 3.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.478 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -114.35 159.17 20.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.786 0.327 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 294' ' ' SER . 98.8 t -121.51 97.4 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.127 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 293' ' ' GLY . 60.4 mt -92.99 153.15 18.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 291' ' ' LEU . 23.7 m-20 37.73 28.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.828 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 74.0 44.61 29.54 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.493 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.448 ' N ' HG12 ' A' ' 290' ' ' VAL . 8.2 t -155.02 134.7 7.96 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.669 0.747 . . . . 0.0 110.81 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 102.08 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.367 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.8 pt -93.89 144.37 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -116.66 154.71 30.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.8 t -141.26 119.4 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.162 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 76.9 p -137.88 169.44 17.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.151 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 8.0 mt -83.78 108.49 16.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -66.1 140.75 58.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.625 0.726 . . . . 0.0 110.882 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.914 0.387 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.93 134.85 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.2 116.58 17.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 37.6 mt -147.89 131.98 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 15.7 mt -117.46 111.16 18.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -91.31 122.53 34.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.968 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.423 HG11 ' CG ' ' A' ' 238' ' ' LEU . 21.9 t -102.23 128.87 54.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.116 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 15.9 ttp85 -122.4 160.5 25.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.463 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 32.8 t-20 65.8 53.32 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.423 ' CG ' HG11 ' A' ' 235' ' ' VAL . 89.6 mt -106.16 131.31 53.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.9 mmt -66.33 136.99 56.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 72.3 mt -56.4 -24.2 43.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.935 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 11.4 t -75.1 -26.4 59.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 243' ' ' SER . 49.3 m -68.15 139.48 56.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.1 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.434 ' N ' HG22 ' A' ' 242' ' ' THR . 37.0 m -115.36 170.46 8.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.857 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 247' ' ' ILE . 48.8 mt-10 -50.95 -54.22 26.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -40.85 -48.06 3.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 2.9 mmt -55.98 -36.13 67.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 244' ' ' GLU . 40.6 mt -78.55 -46.72 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.115 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -60.22 -37.5 80.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 5.8 ptmt -73.47 -47.2 43.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.481 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 49.6 mm-40 -65.19 -22.78 66.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.531 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 7.3 m-85 -94.51 -26.32 16.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.44 ' OD1' ' CG2' ' A' ' 259' ' ' VAL . 78.6 m-20 -84.66 -18.99 33.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -59.6 -23.3 62.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 13.7 mm -75.7 -56.03 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -139.52 134.61 16.41 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.524 0.678 . . . . 0.0 110.923 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 138.09 37.09 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.679 2.253 . . . . 0.0 112.359 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 56.08 41.09 84.82 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -105.07 -53.06 2.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 111.073 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.44 ' CG2' ' OD1' ' A' ' 252' ' ' ASN . 96.9 t -61.15 114.61 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.154 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -72.02 -62.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.926 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -149.07 151.45 34.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.86 151.71 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -141.47 116.2 9.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . 0.417 ' NZ ' ' HB ' ' A' ' 242' ' ' THR . 30.1 tptt -84.88 145.94 27.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.573 ' CD1' ' CD2' ' A' ' 268' ' ' TYR . 5.3 mt -133.88 172.18 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.467 ' C ' ' O ' ' A' ' 265' ' ' ILE . 14.4 mmm180 -31.51 -72.04 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -126.88 19.13 7.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.2 OUTLIER -148.4 177.85 9.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -163.98 170.55 16.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -133.35 146.24 51.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.451 HG21 ' CE2' ' A' ' 251' ' ' PHE . 16.6 t -133.55 134.2 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.136 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -112.41 152.34 28.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -129.2 -177.82 4.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 41.8 t -95.45 -22.01 17.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.45 151.4 31.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -62.44 -37.39 85.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -48.24 -63.49 1.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.92 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -44.88 94.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.847 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.98 -47.15 61.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.87 -42.67 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -60.87 -49.26 78.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.829 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.0 -29.93 71.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.125 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 53.6 ttp -70.42 -50.37 39.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -69.97 -30.09 67.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.59 -45.1 84.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.531 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 41.5 mt -87.28 -27.6 22.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . 0.436 ' OD1' ' C ' ' A' ' 287' ' ' ASN . 23.4 t-20 -48.8 108.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 97.62 33.74 5.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.505 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -113.95 151.13 32.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.932 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 86.3 t -110.05 103.47 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.162 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.441 HD12 ' CD1' ' A' ' 296' ' ' ILE . 25.1 mt -102.4 147.11 27.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 44.97 24.96 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.847 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 77.97 41.31 18.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.49 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 3.0 t -153.81 135.16 8.71 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.681 0.753 . . . . 0.0 110.836 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.463 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 54.3 Cg_endo -69.72 93.94 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.441 ' CD1' HD12 ' A' ' 291' ' ' LEU . 11.4 pt -76.64 146.51 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.12 135.11 54.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.908 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.79 118.21 54.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 18.9 p -132.45 166.29 22.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.153 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.2 mt -83.77 102.87 12.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -71.16 157.33 38.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.115 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 121.586 0.708 . . . . 0.0 110.908 179.957 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.935 0.397 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.2 p -113.68 132.03 63.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.45 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -133.95 117.03 16.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 98.6 mt -147.73 139.14 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 12.1 mt -121.09 107.63 12.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.751 ' CD1' ' CE1' ' A' ' 270' ' ' PHE . 33.3 t80 -91.46 121.32 33.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.19 132.23 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -119.69 155.78 31.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.41 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 38.6 t-20 70.68 52.62 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.23 126.62 52.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 22.8 mtt -71.49 139.98 49.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 39.9 mt -55.96 -18.74 9.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.3 t -75.89 -28.59 58.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 42.8 m -64.5 146.66 54.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 44.1 m -120.63 165.71 14.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.805 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.5 -16.37 62.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -69.59 -64.02 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.408 ' HA ' ' CD ' ' A' ' 249' ' ' LYS . 13.0 ptp -54.7 -30.87 56.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.854 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 73.1 mt -69.81 -45.13 78.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -65.53 -53.56 40.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.468 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 0.7 OUTLIER -53.32 -49.48 66.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.468 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 61.4 mm-40 -52.92 -53.46 49.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.503 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 5.8 m-85 -61.83 -58.49 7.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 253' ' ' ASN . 2.3 m120 -47.12 -49.1 22.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.952 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 252' ' ' ASN . 29.8 m-20 -36.65 -46.77 0.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.905 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.464 HD13 ' CB ' ' A' ' 285' ' ' ALA . 43.1 mm -51.64 -56.79 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.124 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.462 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 0.1 OUTLIER -143.95 137.06 13.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.548 0.689 . . . . 0.0 110.932 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.462 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 53.0 Cg_endo -69.82 136.75 33.64 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.63 2.22 . . . . 0.0 112.309 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 60.12 36.42 90.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -99.43 -39.15 8.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 111.13 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.5 t -90.99 132.99 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.171 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.424 ' OE1' ' N ' ' A' ' 260' ' ' GLU . 0.7 OUTLIER -94.37 -52.17 4.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . 0.478 ' HD3' ' N ' ' A' ' 262' ' ' VAL . 0.1 OUTLIER -151.23 161.75 42.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.478 ' N ' ' HD3' ' A' ' 261' ' ' ARG . 32.5 t -131.63 138.89 51.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.154 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 6.6 tppt? -123.99 113.6 18.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.9 tptp -87.66 143.31 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.56 HD11 ' CD2' ' A' ' 268' ' ' TYR . 6.7 mt -133.61 172.93 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.13 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.476 ' C ' ' O ' ' A' ' 265' ' ' ILE . 20.4 mmt180 -30.66 -73.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.99 15.92 7.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -142.49 172.39 12.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.943 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -159.28 165.54 33.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.08 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.751 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 86.8 m-85 -128.35 149.6 50.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 19.8 t -132.56 123.78 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.115 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -97.15 144.24 27.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.835 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -120.4 177.52 5.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 33.4 t -90.86 -33.4 15.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.84 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -143.15 161.38 38.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 277' ' ' GLU . 11.1 ttp180 -64.49 -61.77 2.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 276' ' ' ARG . 16.1 mt-10 -35.99 -49.11 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -64.19 -50.73 66.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -53.4 -47.3 69.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 83.5 t -59.69 -43.12 90.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.84 -56.39 17.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.09 -38.24 67.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.124 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 65.0 ttp -60.32 -47.71 84.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.872 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -70.08 -37.6 75.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.464 ' CB ' HD13 ' A' ' 254' ' ' ILE . . . -55.19 -47.96 74.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.091 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.503 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 64.8 mt -84.6 -36.65 21.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 286' ' ' LEU . 11.3 t30 -36.74 93.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 113.03 33.82 1.93 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.475 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -110.79 157.88 19.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.458 HG11 ' N ' ' A' ' 294' ' ' SER . 91.3 t -119.8 96.13 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 31.3 mt -92.9 147.29 22.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.4 ' OD1' ' SD ' ' A' ' 246' ' ' MET . 3.2 m-20 46.64 30.47 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 69.91 43.05 67.4 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.459 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.458 ' N ' HG11 ' A' ' 290' ' ' VAL . 1.9 m -155.05 137.35 9.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.693 0.759 . . . . 0.0 110.856 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.41 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.3 Cg_endo -69.79 108.74 2.15 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.627 2.218 . . . . 0.0 112.365 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 10.1 pt -97.54 141.72 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -112.34 143.9 42.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.847 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.07 117.84 51.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 10.5 p -132.84 167.57 19.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.209 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 9.3 mt -85.91 113.18 21.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -66.23 139.01 58.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.125 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.586 0.708 . . . . 0.0 110.872 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.91 0.386 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -116.25 132.69 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.112 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.417 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -130.72 116.9 18.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 68.5 mt -147.91 136.42 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.129 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 23.4 mt -118.57 110.16 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.402 ' CD1' ' CE1' ' A' ' 270' ' ' PHE . 28.2 t80 -93.47 125.74 38.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.3 t -108.83 142.52 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.089 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 7.3 ttt-85 -134.87 157.23 47.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 295' ' ' PRO . 12.2 t30 71.92 47.95 0.3 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 31.0 mt -100.99 125.34 47.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 14.3 mtt -63.75 125.73 25.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.836 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 20.3 mt -50.93 -23.95 3.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.934 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 7.2 m -68.87 -33.32 73.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 24.9 m -63.56 144.9 56.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.196 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.6 m -112.17 165.81 11.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.855 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.57 -46.69 80.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -45.17 -36.65 3.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 27.5 mtt -69.53 -42.02 75.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.879 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 46.0 mt -68.89 -39.92 80.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.452 ' OE1' ' CG2' ' A' ' 262' ' ' VAL . 4.3 tp10 -64.69 -43.79 92.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.864 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 1.7 ptmm? -72.54 -46.27 55.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 62.3 mm-40 -56.82 -33.51 66.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.915 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.631 ' CD1' ' CD1' ' A' ' 286' ' ' LEU . 8.0 m-85 -87.93 -30.61 19.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -76.42 -26.91 55.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -52.72 -23.84 7.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 16.0 mm -78.19 -52.82 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -144.14 134.0 11.76 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.587 0.708 . . . . 0.0 110.924 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 142.53 48.28 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 0.0 112.348 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 55.13 26.23 41.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.519 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -90.52 -53.72 4.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.333 . . . . 0.0 111.08 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.5 t -62.25 114.42 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -73.98 -60.02 2.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -150.2 146.2 26.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.87 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.452 ' CG2' ' OE1' ' A' ' 248' ' ' GLU . 61.3 t -116.92 128.84 74.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.13 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -115.63 108.41 16.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -85.22 142.17 29.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.565 HD11 ' CD2' ' A' ' 268' ' ' TYR . 6.7 mt -133.86 172.41 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.472 ' C ' ' O ' ' A' ' 265' ' ' ILE . 15.6 mmt180 -31.11 -72.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.82 15.84 8.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.85 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -143.37 175.27 10.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -163.79 160.32 22.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.052 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.402 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 86.4 m-85 -124.56 138.15 54.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.12 129.58 74.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.11 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -106.69 151.74 24.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.865 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -129.73 174.62 9.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 25.4 t -80.96 -38.41 27.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.878 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -144.28 153.31 41.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 277' ' ' GLU . 21.5 ttt180 -50.87 -56.17 13.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.876 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 276' ' ' ARG . 4.9 mm-40 -35.76 -54.76 0.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -59.63 -49.93 75.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.813 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -53.05 -50.18 64.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 48.9 t -53.75 -48.9 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -59.01 -59.93 4.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.844 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.28 -18.64 6.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 56.9 ttp -78.01 -57.67 3.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -66.89 -29.56 69.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -62.42 -56.99 12.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.095 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.631 ' CD1' ' CD1' ' A' ' 251' ' ' PHE . 55.2 mt -76.71 -40.19 49.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.945 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -39.87 121.14 1.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 90.63 27.33 20.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.525 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -110.37 161.78 15.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.419 HG11 ' C ' ' A' ' 294' ' ' SER . 72.9 t -123.85 95.11 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.078 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.409 HD23 ' CD ' ' A' ' 250' ' ' GLU . 33.1 mt -87.07 148.01 25.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 40.6 t0 41.47 41.54 1.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.902 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 59.58 45.85 94.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.419 ' C ' HG11 ' A' ' 290' ' ' VAL . 2.0 t -154.62 136.59 9.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.683 0.754 . . . . 0.0 110.883 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.425 ' O ' ' ND2' ' A' ' 237' ' ' ASN . 53.6 Cg_endo -69.76 110.9 2.67 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.712 2.275 . . . . 0.0 112.306 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 10.8 pt -101.33 144.38 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.176 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -115.45 151.79 34.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 8.8 t -140.43 113.52 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 51.2 p -134.35 167.65 20.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.163 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 10.9 mt -81.54 108.87 15.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.92 137.41 53.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 94.6 p . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.928 0.394 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.19 136.5 51.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.112 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.457 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -137.61 116.88 12.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 77.0 mt -147.91 140.29 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.055 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.461 HD11 ' CE1' ' A' ' 273' ' ' PHE . 11.4 mt -120.83 111.87 18.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.921 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 236' ' ' ARG . 16.2 t80 -92.08 129.72 37.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.469 HG13 ' CG ' ' A' ' 238' ' ' LEU . 17.4 t -115.18 133.82 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.505 ' HB2' ' CE2' ' A' ' 234' ' ' TYR . 30.3 ttp85 -129.31 161.17 30.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 71.26 35.84 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.469 ' CG ' HG13 ' A' ' 235' ' ' VAL . 11.5 mt -91.76 122.6 34.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' MET . . . . . 0.496 ' CB ' ' OD2' ' A' ' 292' ' ' ASP . 4.7 mmt -57.43 139.66 52.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.495 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 40.4 mt -63.34 -7.66 6.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.885 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 37.6 m -97.44 16.64 19.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.459 HG22 ' N ' ' A' ' 243' ' ' SER . 49.2 m -99.02 145.33 27.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.459 ' N ' HG22 ' A' ' 242' ' ' THR . 2.3 m -119.05 155.07 32.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -56.1 -15.04 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.835 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -72.58 -66.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 13.2 ptp -55.64 -29.08 58.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 63.4 mt -75.77 -45.84 37.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.134 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.411 ' HG2' ' ND2' ' A' ' 252' ' ' ASN . 17.9 tt0 -63.1 -44.28 96.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 16.2 ptmt -64.61 -47.58 78.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.472 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 21.6 mm-40 -57.25 -34.72 68.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -81.89 -32.16 31.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.411 ' ND2' ' HG2' ' A' ' 248' ' ' GLU . 59.2 m-20 -79.86 -14.6 58.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -60.17 -18.48 48.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 10.0 mm -79.86 -60.21 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -136.67 135.32 20.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.556 0.693 . . . . 0.0 110.959 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 137.45 35.56 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.727 2.285 . . . . 0.0 112.317 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.57 40.43 94.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.511 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -102.56 -56.41 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 111.112 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.432 HG11 ' N ' ' A' ' 260' ' ' GLU . 97.2 t -59.76 136.13 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.432 ' N ' HG11 ' A' ' 259' ' ' VAL . 28.5 mm-40 -93.91 -55.77 3.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -152.74 149.32 28.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 19.2 t -122.41 137.85 54.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -128.31 109.1 11.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -80.35 140.62 36.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.954 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.57 HD12 ' CD2' ' A' ' 268' ' ' TYR . 6.2 mt -130.82 173.33 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.083 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.504 ' C ' ' O ' ' A' ' 265' ' ' ILE . 22.0 mmt180 -28.66 -75.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.879 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -125.0 14.26 8.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -140.58 171.67 13.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.944 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -157.87 154.88 28.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -116.07 146.06 42.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.892 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 18.1 t -134.49 125.35 46.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.145 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -98.9 154.68 17.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.889 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.461 ' CE1' HD11 ' A' ' 233' ' ' LEU . 18.6 m-85 -131.85 167.88 18.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.6 t -77.18 -33.78 56.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -146.63 153.13 39.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 277' ' ' GLU . 5.8 ttt-85 -54.04 -55.95 22.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 276' ' ' ARG . 77.8 mt-10 -34.91 -59.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.885 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -56.84 -49.11 76.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.83 -53.33 33.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.66 -37.0 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.159 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -65.41 -49.4 69.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.97 -21.17 65.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 51.2 ttp -71.3 -58.45 3.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -66.16 -30.02 70.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -60.66 -55.67 30.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 42.8 mt -79.49 -31.29 42.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -40.65 115.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 93.08 32.92 7.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -109.83 157.46 19.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.802 0.334 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 76.5 t -118.79 96.19 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.152 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 30.6 mt -95.0 152.81 18.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.496 ' OD2' ' CB ' ' A' ' 239' ' ' MET . 34.2 t70 41.86 26.51 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.83 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.7 43.84 34.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.516 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 2.0 m -154.39 137.88 10.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.62 0.724 . . . . 0.0 110.897 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 91.93 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.685 2.257 . . . . 0.0 112.352 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 17.2 pt -78.35 144.97 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -120.44 140.06 51.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.91 134.61 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 41.0 p -147.32 176.43 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 15.5 mt -95.64 105.78 17.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -71.78 145.01 48.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 19.7 pttm . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.582 0.706 . . . . 0.0 110.886 179.973 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.906 0.384 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.42 130.5 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.116 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.405 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -131.32 116.85 18.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 40.6 mt -148.05 136.5 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.114 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 36.0 mt -124.04 108.57 12.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.416 ' HB2' ' CB ' ' A' ' 301' ' ' ALA . 22.8 t80 -92.02 126.27 37.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.873 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 24.3 t -108.0 144.49 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.134 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -136.98 157.81 45.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 295' ' ' PRO . 15.1 t30 72.9 53.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 14.8 mt -111.14 134.46 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 3.8 mtt -70.51 137.47 50.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 70.3 mt -53.95 -18.65 3.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 36.7 m -75.09 -31.36 61.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 50.6 m -67.5 127.27 32.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.151 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.1 t -107.08 157.4 17.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -43.34 -28.04 0.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -60.55 -42.55 96.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.3 mmt -63.82 -42.47 97.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 69.1 mt -67.12 -36.9 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.439 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 19.3 tt0 -70.34 -49.12 52.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 4.8 ptmt -63.23 -46.77 85.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.471 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 27.7 mm-40 -59.79 -56.29 23.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.865 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.495 ' CD2' HG13 ' A' ' 271' ' ' VAL . 7.4 m-85 -62.33 -41.77 98.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.439 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 5.8 m-20 -62.03 -42.35 99.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -38.49 -42.62 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 44.2 mm -53.99 -58.95 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.437 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 26.6 tptt -141.05 136.81 16.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.538 0.685 . . . . 0.0 110.909 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.437 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 53.4 Cg_endo -69.77 131.28 20.89 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.677 2.251 . . . . 0.0 112.325 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 62.82 39.52 98.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.509 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -103.94 -45.11 4.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 0.0 111.069 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.409 ' CG2' ' OD1' ' A' ' 252' ' ' ASN . 93.8 t -71.62 117.89 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.64 -60.32 2.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -145.52 152.96 40.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.2 t -127.8 130.74 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -118.94 109.65 16.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -86.66 143.61 27.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.902 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.486 ' O ' ' C ' ' A' ' 266' ' ' ARG . 5.5 mt -133.95 172.65 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.486 ' C ' ' O ' ' A' ' 265' ' ' ILE . 22.7 mmt180 -30.89 -70.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -125.62 -1.11 7.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.641 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -124.45 177.54 5.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.96 164.94 16.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.101 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.484 ' CE2' HD11 ' A' ' 265' ' ' ILE . 97.8 m-85 -127.21 142.81 51.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.495 HG13 ' CD2' ' A' ' 251' ' ' PHE . 5.2 t -129.99 122.65 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -105.74 133.38 50.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.817 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.431 ' CZ ' ' CB ' ' A' ' 282' ' ' ALA . 30.9 m-85 -108.02 175.71 5.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.449 ' O ' ' ND2' ' A' ' 275' ' ' ASN . 17.3 t -86.5 -28.46 23.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 274' ' ' SER . 5.3 m120 -146.92 149.52 33.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -52.48 -49.19 65.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 278' ' ' ASP . 13.8 pt-20 -44.35 -51.85 8.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.411 ' N ' ' HG3' ' A' ' 277' ' ' GLU . 2.5 m-20 -60.62 -50.53 73.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.844 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -52.44 -49.79 63.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.06 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 77.9 t -53.77 -54.97 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -53.56 -59.83 4.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.431 ' CB ' ' CZ ' ' A' ' 273' ' ' PHE . . . -54.33 -29.36 47.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 62.2 ttp -68.84 -57.14 5.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -63.67 -51.62 64.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -45.12 -51.97 9.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.074 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.431 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 81.4 mt -79.13 -29.15 42.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.914 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . 0.402 ' O ' ' ND2' ' A' ' 287' ' ' ASN . 2.7 t30 -49.52 91.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 115.88 31.49 1.91 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.458 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -106.5 163.2 13.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 110.931 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 51.9 t -125.53 96.59 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.106 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 294' ' ' SER . 72.0 mt -89.92 152.67 21.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.899 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 291' ' ' LEU . 1.6 m-20 34.94 36.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 66.62 46.99 71.51 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.477 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 291' ' ' LEU . 5.2 t -154.77 136.25 9.22 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.667 0.746 . . . . 0.0 110.86 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.448 ' O ' ' ND2' ' A' ' 237' ' ' ASN . 54.1 Cg_endo -69.68 106.05 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.719 2.279 . . . . 0.0 112.367 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.9 pt -94.09 145.28 8.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.16 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -118.6 146.83 44.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.0 117.81 39.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 33.9 p -135.67 170.31 16.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 22.3 mt -86.89 102.2 14.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.934 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.416 ' CB ' ' HB2' ' A' ' 234' ' ' TYR . . . -72.41 114.16 10.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 121.537 0.684 . . . . 0.0 110.894 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.877 0.37 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.88 133.11 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.139 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.34 116.84 19.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.418 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 20.0 mt -147.95 130.93 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.09 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 15.2 mt -117.49 112.49 20.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.914 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -91.85 128.99 37.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.09 128.74 73.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.127 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -125.23 159.55 31.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 7.0 t30 71.88 51.23 0.23 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 41.5 mt -107.83 119.09 38.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 7.0 mmt -54.3 125.39 19.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.1 mt -44.44 -30.17 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 36.0 t -59.92 -40.53 89.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.443 ' HA ' ' CE ' ' A' ' 246' ' ' MET . 30.9 m -60.56 155.16 19.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.153 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 43.2 m -134.64 168.28 19.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.838 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 245' ' ' GLU . 54.3 mt-10 -47.43 -57.74 4.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 244' ' ' GLU . 38.0 tt0 -35.68 -59.73 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.443 ' CE ' ' HA ' ' A' ' 242' ' ' THR . 6.9 mtt -47.52 -51.66 19.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.0 -34.02 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.118 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -64.66 -51.38 62.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.454 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 1.6 ptpp? -65.81 -44.34 85.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.888 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.497 ' O ' ' ND2' ' A' ' 253' ' ' ASN . 52.0 mm-40 -61.0 -28.8 69.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.466 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 7.2 m-85 -95.24 -23.19 17.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.77 -35.7 32.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 250' ' ' GLU . 0.6 OUTLIER -42.56 -29.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 15.5 mm -68.76 -66.79 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -131.35 131.96 23.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.519 0.676 . . . . 0.0 110.887 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 121.83 8.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 72.9 33.25 60.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.522 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -101.34 -39.71 7.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 78.8 t -73.16 113.75 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.061 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -66.84 -65.0 0.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.907 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . 0.463 ' CD ' ' HB2' ' A' ' 272' ' ' HIS . 0.0 OUTLIER -146.86 162.62 38.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.877 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 48.1 t -133.53 137.57 52.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.419 ' C ' ' HD3' ' A' ' 263' ' ' LYS . 9.4 tmtm? -127.06 105.2 8.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . 0.406 ' HB2' ' CG ' ' A' ' 244' ' ' GLU . 11.4 tptp -79.67 145.17 33.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.56 HD12 ' CD2' ' A' ' 268' ' ' TYR . 6.8 mt -133.6 172.05 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.148 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.467 ' C ' ' O ' ' A' ' 265' ' ' ILE . 51.9 mtt85 -32.01 -71.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.64 15.57 7.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -142.56 177.37 8.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -167.6 164.74 14.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.075 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -130.94 142.9 50.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.47 125.51 70.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.107 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . 0.463 ' HB2' ' CD ' ' A' ' 261' ' ' ARG . 3.5 m-70 -105.3 137.55 42.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -117.03 -177.51 3.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.83 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.3 t -99.45 -24.99 14.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -144.78 144.17 31.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.865 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 277' ' ' GLU . 9.6 ttp180 -54.4 -54.17 44.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 276' ' ' ARG . 4.8 mm-40 -35.64 -54.64 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.42 -51.72 67.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -46.48 -46.88 19.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.057 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.428 ' CG1' ' HD2' ' A' ' 284' ' ' LYS . 51.6 t -65.69 -54.47 27.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.084 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -50.13 -47.61 54.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.49 -31.37 68.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 67.6 ttp -66.82 -53.58 31.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.428 ' HD2' ' CG1' ' A' ' 280' ' ' VAL . 30.0 mtpt -65.92 -39.75 90.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -53.85 -53.83 47.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.466 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 35.2 mt -77.06 -35.49 56.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -41.15 95.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 114.83 32.53 1.87 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.524 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -113.66 160.35 18.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 0.0 110.863 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 294' ' ' SER . 95.8 t -123.23 103.59 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 293' ' ' GLY . 22.4 mt -95.64 150.85 19.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 41.92 24.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 77.32 38.17 29.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.472 ' N ' HG13 ' A' ' 290' ' ' VAL . 23.6 p -145.59 135.68 11.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 110.908 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 102.41 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.7 2.267 . . . . 0.0 112.328 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.3 pt -90.43 147.2 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.11 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -122.96 140.69 52.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.24 122.33 65.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 81.9 p -137.84 172.79 12.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.122 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 11.4 mt -90.22 110.02 21.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.418 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -71.43 153.42 42.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.105 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.578 0.704 . . . . 0.0 110.893 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.943 0.402 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.54 131.98 62.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.138 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.21 116.83 17.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 21.9 mt -147.94 140.77 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.567 HD13 ' CE1' ' A' ' 273' ' ' PHE . 39.5 mt -126.28 106.89 9.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.514 ' CE2' ' HG3' ' A' ' 236' ' ' ARG . 38.9 t80 -91.38 123.95 35.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.96 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 20.8 t -104.45 148.36 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.514 ' HG3' ' CE2' ' A' ' 234' ' ' TYR . 24.0 mtp180 -138.72 160.31 39.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.453 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 26.7 t-20 67.72 53.03 0.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 27.0 mt -109.46 120.63 43.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 8.4 mmt -54.97 133.64 48.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.849 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.489 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 54.4 mt -51.91 -25.01 7.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 61.5 m -70.79 -32.3 69.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 93.9 m -65.82 139.95 58.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.1 t -121.11 164.11 17.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.83 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -47.92 -22.04 0.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -65.69 -45.3 83.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 2.3 mmt -67.59 -44.53 77.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 79.2 mt -65.97 -37.65 80.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.442 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 13.9 tt0 -71.62 -57.75 4.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 5.8 ptmt -49.34 -45.98 46.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.473 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 23.6 mm-40 -61.99 -58.21 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.531 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 6.0 m-85 -54.57 -27.53 39.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 16.2 m120 -71.77 -44.57 63.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.955 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -38.78 -40.76 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 17.0 mm -56.47 -64.24 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -139.48 131.75 15.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.58 0.705 . . . . 0.0 110.908 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 136.67 33.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.617 2.211 . . . . 0.0 112.39 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 63.37 33.32 86.93 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.445 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -100.75 -51.04 3.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.353 . . . . 0.0 111.108 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 260' ' ' GLU . 69.5 t -60.73 135.9 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.123 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . 0.401 ' N ' HG13 ' A' ' 259' ' ' VAL . 18.1 mt-10 -96.89 -64.33 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.885 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -146.06 142.41 28.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 263' ' ' LYS . 66.6 t -120.92 136.55 57.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.419 ' N ' HG12 ' A' ' 262' ' ' VAL . 68.2 tttt -129.66 110.13 11.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' A' ' 265' ' ' ILE . 23.4 tptp -79.49 144.63 33.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.547 HD11 ' CD2' ' A' ' 268' ' ' TYR . 6.5 mt -132.3 173.1 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.141 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 265' ' ' ILE . 20.3 mmm180 -29.4 -68.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -132.42 15.08 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.2 OUTLIER -142.86 173.38 11.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.928 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -162.18 158.98 25.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.086 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 95.3 m-85 -118.62 148.86 42.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.81 124.43 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -100.68 146.82 26.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.567 ' CE1' HD13 ' A' ' 233' ' ' LEU . 22.7 m-85 -126.84 167.59 15.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.887 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 45.8 m -74.79 -39.17 61.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -142.87 153.34 43.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.443 ' O ' ' C ' ' A' ' 277' ' ' GLU . 10.0 ttt85 -54.4 -57.7 10.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 276' ' ' ARG . 4.6 mp0 -34.36 -50.25 0.41 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -63.67 -53.65 48.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -51.86 -53.31 41.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.405 HG13 ' NZ ' ' A' ' 284' ' ' LYS . 56.1 t -52.74 -44.8 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.173 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.62 -51.83 67.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.15 -14.57 63.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.107 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -76.6 -60.8 2.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.405 ' NZ ' HG13 ' A' ' 280' ' ' VAL . 19.0 mtmm -64.22 -37.48 87.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -51.46 -54.7 24.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.111 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.531 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 50.5 mt -76.08 -40.16 53.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 286' ' ' LEU . 2.0 t30 -36.29 97.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 109.51 33.91 2.58 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.522 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -114.86 164.2 14.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.769 0.318 . . . . 0.0 110.953 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 56.8 t -124.64 110.79 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.114 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 293' ' ' GLY . 26.9 mt -102.96 146.38 28.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 39.62 29.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.59 47.55 12.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.469 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.8 m -154.52 134.68 8.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.678 0.751 . . . . 0.0 110.852 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.453 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.4 Cg_endo -69.76 94.78 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 10.1 pt -83.61 148.31 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 298' ' ' VAL . 4.5 tp10 -122.79 148.41 45.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.423 ' N ' ' HG3' ' A' ' 297' ' ' GLU . 4.2 t -130.97 117.88 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.156 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 24.7 p -134.78 160.57 37.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.175 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 8.8 mt -83.88 100.61 11.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -66.73 124.52 23.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.069 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.583 0.706 . . . . 0.0 110.918 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.932 0.396 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -106.83 131.02 57.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.131 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.64 116.42 18.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 80.9 mt -147.9 142.66 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.139 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.546 HD11 ' CE1' ' A' ' 273' ' ' PHE . 81.7 mt -128.94 106.0 8.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.575 ' CD1' ' CE1' ' A' ' 270' ' ' PHE . 32.6 t80 -91.31 128.52 37.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.9 t -109.56 150.64 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.149 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -138.81 157.98 45.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 71.8 54.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 23.6 mt -107.04 113.14 26.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' MET . . . . . 0.45 ' CG ' ' OD2' ' A' ' 292' ' ' ASP . 13.4 mmt -53.89 128.15 28.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.443 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 25.7 mt -49.09 -30.38 6.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.906 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 97.8 p -64.49 -33.36 75.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.445 ' O ' ' NZ ' ' A' ' 264' ' ' LYS . 7.8 m -58.96 150.05 25.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.146 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 3.4 m -118.02 159.79 22.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -54.19 -41.62 68.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -54.84 -32.34 60.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.6 mtt -70.74 -37.25 73.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 25.9 mt -74.72 -39.81 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.156 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -68.81 -45.97 69.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.476 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 0.0 OUTLIER -62.35 -48.38 80.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.907 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.476 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 52.8 mm-40 -56.35 -50.11 72.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.457 ' CD2' HG12 ' A' ' 271' ' ' VAL . 7.2 m-85 -65.74 -23.56 66.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -75.49 -41.38 55.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -37.37 -46.96 0.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 49.7 mm -49.59 -63.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -141.17 129.38 12.29 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.596 0.712 . . . . 0.0 110.934 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 114.96 3.88 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.672 2.248 . . . . 0.0 112.324 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 90.36 38.23 6.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -114.35 -43.62 3.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 111.084 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.61 118.4 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -80.25 -67.99 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -144.76 150.92 38.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 93.7 t -127.22 130.1 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.12 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -115.54 106.26 13.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . 0.445 ' NZ ' ' O ' ' A' ' 242' ' ' THR . 15.6 tptm -80.09 140.94 36.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.571 HD13 ' CD2' ' A' ' 268' ' ' TYR . 5.1 mt -132.26 172.42 16.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.465 ' C ' ' O ' ' A' ' 265' ' ' ILE . 30.7 mmt180 -31.78 -72.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 7.7 p-10 -126.51 17.48 7.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.2 OUTLIER -146.25 178.01 8.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -169.22 165.78 10.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.104 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.575 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 96.3 m-85 -126.89 145.4 50.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.457 HG12 ' CD2' ' A' ' 251' ' ' PHE . 66.6 t -129.79 134.54 62.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.117 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -113.99 156.29 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.546 ' CE1' HD11 ' A' ' 233' ' ' LEU . 44.9 m-85 -134.37 179.95 5.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 62.5 p -83.26 -34.68 25.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -147.49 153.18 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.872 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 277' ' ' GLU . 8.5 ttt85 -53.79 -54.57 36.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 276' ' ' ARG . 44.7 mt-10 -34.48 -56.52 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.81 -50.78 72.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.05 -54.23 21.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.038 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 71.6 t -53.39 -47.89 57.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.088 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -56.0 -58.45 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.19 -30.87 51.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.091 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 63.6 ttp -68.07 -55.74 11.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -68.6 -14.94 63.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -79.29 -52.73 7.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.082 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 287' ' ' ASN . 59.5 mt -82.69 -35.16 27.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 286' ' ' LEU . 2.3 t-20 -38.28 99.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 107.68 34.37 2.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.504 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -113.59 159.66 19.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.824 0.345 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 86.7 t -121.32 93.6 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.173 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 293' ' ' GLY . 27.7 mt -92.08 153.86 19.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.45 ' OD2' ' CG ' ' A' ' 239' ' ' MET . 3.2 p-10 42.15 25.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.1 38.29 40.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.51 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 291' ' ' LEU . 68.1 p -147.05 134.9 10.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.637 0.732 . . . . 0.0 110.887 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 92.0 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.629 2.22 . . . . 0.0 112.323 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.5 pt -82.85 148.38 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -125.87 143.71 50.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.409 ' C ' HG21 ' A' ' 299' ' ' THR . 4.6 t -123.86 127.22 73.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' THR . . . . . 0.409 HG21 ' C ' ' A' ' 298' ' ' VAL . 25.7 p -137.43 171.76 13.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 5.4 mt -94.74 100.15 12.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -65.5 151.72 45.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 17.0 mmtm . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 121.596 0.713 . . . . 0.0 110.897 179.949 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.91 0.386 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.15 137.68 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.466 ' HE2' ' CA ' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -136.71 116.99 13.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.923 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.461 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 70.2 mt -147.95 137.05 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.174 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 10.7 mt -122.07 110.96 16.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.922 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 236' ' ' ARG . 22.5 t80 -91.43 132.92 35.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.441 HG13 ' CD1' ' A' ' 238' ' ' LEU . 16.5 t -120.08 133.08 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.089 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 234' ' ' TYR . 9.7 ptm180 -129.59 161.98 29.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.418 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 35.2 t-20 71.79 38.79 0.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.441 ' CD1' HG13 ' A' ' 235' ' ' VAL . 26.2 mt -96.71 126.95 42.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 14.6 mmt -59.0 131.92 52.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.477 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 53.5 mt -51.35 -38.16 51.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 29.8 t -59.03 -24.43 62.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.874 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 30.9 m -60.38 157.09 14.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.177 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 64.9 m -134.6 153.89 51.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.845 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -44.94 -50.62 10.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -43.91 -41.71 5.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 9.5 mtt -65.7 -38.14 88.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 72.0 mt -72.42 -34.08 47.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 24.5 tt0 -75.32 -48.5 22.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 14.3 ptmt -57.96 -48.07 81.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.97 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.459 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 26.1 mm-40 -62.34 -59.48 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -59.15 -23.83 62.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.448 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 6.8 m-20 -80.99 -37.63 28.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -45.12 -45.11 11.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 42.8 mm -50.72 -63.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -134.87 127.07 18.18 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.527 0.68 . . . . 0.0 110.943 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 125.35 12.07 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.672 2.248 . . . . 0.0 112.341 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 75.84 33.7 50.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.487 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -105.17 -45.33 4.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 51.5 t -69.24 118.65 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.75 -60.7 2.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -146.78 154.56 41.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 94.4 t -126.58 142.69 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -134.85 109.61 8.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -82.71 146.68 28.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.563 HD13 ' CD2' ' A' ' 268' ' ' TYR . 6.8 mt -135.44 172.19 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.092 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.477 ' O ' ' CD2' ' A' ' 240' ' ' LEU . 21.4 mmt85 -31.71 -72.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.82 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.73 15.41 7.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -142.27 176.72 8.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.13 166.91 16.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.113 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -130.6 144.26 51.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 18.3 t -129.85 117.26 40.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -93.4 154.75 17.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -130.86 179.7 5.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.418 ' O ' ' ND2' ' A' ' 275' ' ' ASN . 3.8 m -102.28 -23.09 14.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.845 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.466 ' CA ' ' HE2' ' A' ' 231' ' ' LYS . 1.7 m120 -142.33 133.35 25.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.41 ' N ' ' CE ' ' A' ' 231' ' ' LYS . 6.0 ttp-105 -49.87 -46.58 51.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -46.99 -48.84 21.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.89 -57.63 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -48.59 -49.47 36.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.077 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 64.6 t -55.74 -52.98 42.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.137 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -57.81 -47.84 81.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.91 -26.69 68.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 9.6 tmm? -72.14 -50.13 30.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -70.38 -35.25 73.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -57.2 -57.96 10.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.108 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 47.9 mt -74.24 -32.81 63.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -41.93 99.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 109.3 29.9 3.8 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -109.14 161.19 15.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 0.0 110.873 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 294' ' ' SER . 71.8 t -123.59 93.87 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.105 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 294' ' ' SER . 31.8 mt -87.11 153.43 21.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 291' ' ' LEU . 3.9 p30 35.43 34.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 68.12 46.39 65.69 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.479 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 291' ' ' LEU . 5.6 t -155.07 133.65 7.16 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.651 0.738 . . . . 0.0 110.852 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.418 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.9 Cg_endo -69.75 101.27 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.682 2.254 . . . . 0.0 112.363 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.5 pt -89.44 145.37 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -120.92 137.64 54.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.42 ' C ' HG21 ' A' ' 299' ' ' THR . 3.7 t -123.52 122.26 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.072 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' THR . . . . . 0.42 HG21 ' C ' ' A' ' 298' ' ' VAL . 69.5 p -140.46 163.35 33.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.4 mt -77.61 114.15 16.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.461 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -68.42 155.77 39.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.086 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.554 0.693 . . . . 0.0 110.919 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 93.1 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.927 0.394 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.75 135.38 50.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.116 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.93 116.78 17.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.7 mt -147.96 138.2 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 34.6 mt -123.85 110.63 15.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -92.56 127.76 38.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 51.5 t -110.39 139.88 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.087 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -135.34 162.97 31.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.407 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 35.0 t-20 67.56 47.45 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 64.9 mt -104.45 137.42 42.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.1 mmt -69.51 129.9 40.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 27.5 mt -50.28 -35.63 28.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.0 t -63.39 -26.92 68.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 93.5 m -64.83 140.44 58.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.8 m -113.94 167.68 10.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.872 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 247' ' ' ILE . 5.4 mp0 -53.17 -50.08 65.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.857 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -41.27 -42.29 2.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 3.1 mmt -65.81 -34.62 78.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 244' ' ' GLU . 21.6 mt -75.58 -40.69 41.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -65.45 -45.21 84.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.496 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 2.3 ptmm? -64.93 -49.15 71.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.892 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.496 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 44.4 mm-40 -56.9 -35.09 68.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.456 ' CD2' HG12 ' A' ' 271' ' ' VAL . 5.4 m-85 -87.85 -21.5 24.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -88.83 -8.7 53.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -75.6 -18.22 59.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.28 -52.58 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -140.39 129.32 13.13 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.56 0.695 . . . . 0.0 110.877 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 123.27 9.93 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.695 2.263 . . . . 0.0 112.343 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 73.18 39.35 52.96 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -104.0 -43.44 5.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 111.112 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 24.2 t -72.5 121.9 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -82.84 -58.65 2.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -145.56 151.67 38.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 97.9 t -126.11 135.43 63.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -127.25 106.04 8.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -79.56 146.24 32.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.564 HD13 ' CD2' ' A' ' 268' ' ' TYR . 6.9 mt -137.28 172.46 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.48 ' C ' ' O ' ' A' ' 265' ' ' ILE . 30.5 mmt180 -30.77 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -127.0 20.2 6.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.564 ' CD2' HD13 ' A' ' 265' ' ' ILE . 0.3 OUTLIER -148.81 175.93 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.03 168.86 18.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -130.57 137.81 49.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' A' ' 251' ' ' PHE . 18.0 t -127.56 122.69 59.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.134 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -98.85 155.72 17.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -129.43 179.58 5.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.3 t -98.69 -19.05 17.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.809 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.449 ' OD1' ' CG ' ' A' ' 278' ' ' ASP . 47.2 p30 -154.25 142.1 20.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -51.0 -47.39 61.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -41.02 -65.31 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.449 ' CG ' ' OD1' ' A' ' 275' ' ' ASN . 72.1 m-20 -52.5 -50.2 63.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.23 -44.6 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.447 ' CG1' ' HE3' ' A' ' 284' ' ' LYS . 54.2 t -60.97 -47.82 91.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -59.82 -60.98 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -53.2 -28.08 24.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.111 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.486 ' O ' ' CB ' ' A' ' 287' ' ' ASN . 65.9 ttp -68.18 -54.39 18.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.447 ' HE3' ' CG1' ' A' ' 280' ' ' VAL . 6.4 mtmp? -78.86 -15.62 58.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.02 -29.95 60.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 46.6 mt -111.95 -28.6 7.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.915 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 283' ' ' MET . 9.2 t-20 -55.99 106.12 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 114.26 4.57 22.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.464 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 289' ' ' LYS . 12.7 mptt -98.35 153.76 18.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 110.89 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 59.0 t -107.09 96.97 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.467 ' CD1' ' HG3' ' A' ' 250' ' ' GLU . 22.1 mt -83.64 146.62 28.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 292' ' ' ASP . 26.3 t70 36.3 40.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.839 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 65.19 44.56 93.71 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 291' ' ' LEU . 8.4 t -154.32 132.01 6.36 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.624 0.726 . . . . 0.0 110.886 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.407 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.6 Cg_endo -69.79 105.79 1.55 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.637 2.225 . . . . 0.0 112.348 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 19.3 pt -95.76 140.64 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -117.15 134.44 54.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.28 112.79 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.138 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 58.6 p -128.28 165.34 20.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 16.7 mt -82.59 102.47 11.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -66.88 141.6 57.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.572 0.701 . . . . 0.0 110.873 -179.996 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.931 0.396 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.41 129.24 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.148 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.414 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -130.92 116.68 18.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 75.1 mt -147.91 132.89 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.107 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.452 HD12 ' CE1' ' A' ' 273' ' ' PHE . 10.8 mt -117.17 109.28 16.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -91.67 132.71 36.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.26 140.53 41.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.123 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -137.63 166.71 23.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.833 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 38.5 t30 69.15 44.62 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 26.2 mt -101.52 154.34 18.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 4.4 mtt -83.38 133.96 34.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 63.9 mt -56.53 -13.91 2.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.947 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 2.0 m -90.14 9.03 29.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.419 HG21 ' N ' ' A' ' 243' ' ' SER . 98.6 m -100.88 135.16 42.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.419 ' N ' HG21 ' A' ' 242' ' ' THR . 21.4 p -106.57 171.21 7.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -64.61 -18.67 65.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -69.52 -44.2 71.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.888 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 9.7 mtt -64.96 -39.05 92.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.872 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 35.8 mt -70.97 -40.04 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -68.0 -50.77 53.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 2.4 ptmm? -56.81 -47.35 80.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.499 ' O ' ' ND2' ' A' ' 253' ' ' ASN . 54.0 mm-40 -56.87 -65.55 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.541 ' CD1' HD13 ' A' ' 286' ' ' LEU . 8.0 m-85 -52.43 -22.48 4.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.886 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -79.84 -43.73 21.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 250' ' ' GLU . 0.7 OUTLIER -46.82 -28.91 1.71 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 14.8 mm -74.8 -51.04 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -139.16 112.16 7.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.557 0.694 . . . . 0.0 110.9 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 125.93 12.7 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.685 2.256 . . . . 0.0 112.335 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 74.96 28.86 61.75 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.492 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -106.97 -48.03 3.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 111.093 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.3 131.63 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.159 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -89.78 -62.64 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -147.76 158.46 44.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.1 t -137.93 142.83 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.2 116.01 19.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -81.53 139.52 35.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.569 HD12 ' CD2' ' A' ' 268' ' ' TYR . 5.2 mt -129.13 172.41 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.151 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.476 ' C ' ' O ' ' A' ' 265' ' ' ILE . 18.2 mmm180 -31.32 -75.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.63 19.45 8.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.577 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.2 OUTLIER -146.79 174.9 11.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.81 167.37 18.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.111 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -126.67 151.09 48.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.03 117.46 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.074 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -94.76 158.15 15.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.452 ' CE1' HD12 ' A' ' 233' ' ' LEU . 28.5 m-85 -133.45 178.69 6.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 85.7 p -95.45 -14.95 23.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.865 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -160.0 145.85 15.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 18.4 ttt-85 -55.22 -41.69 72.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -45.67 -58.39 3.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -60.95 -46.44 90.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.58 -51.21 50.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.101 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 66.2 t -58.53 -49.83 81.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.167 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -55.4 -57.3 12.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.66 -33.96 61.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.102 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 53.5 ttp -59.87 -68.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -61.29 -20.28 62.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -67.0 -56.97 7.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.541 HD13 ' CD1' ' A' ' 251' ' ' PHE . 26.4 mt -79.93 -30.37 39.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -40.55 112.3 0.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 95.4 32.3 7.07 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.471 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -109.74 158.94 17.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 83.1 t -118.79 96.26 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.12 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 294' ' ' SER . 38.0 mt -92.72 153.47 18.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 61.7 t0 40.96 28.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 72.97 41.46 48.48 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.446 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 291' ' ' LEU . 1.8 m -154.3 138.7 11.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.674 0.749 . . . . 0.0 110.908 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 105.99 1.58 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 0.0 112.381 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 9.8 pt -93.54 151.36 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -123.22 148.38 45.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 11.1 t -133.36 124.72 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.108 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 67.7 p -141.06 165.02 28.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 6.9 mt -81.48 106.63 13.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -71.24 139.81 50.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.106 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.577 0.704 . . . . 0.0 110.887 -179.999 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 97.5 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.938 0.399 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.09 131.33 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.56 116.83 19.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.406 HG23 ' N ' ' A' ' 233' ' ' LEU . 66.3 mt -148.07 138.82 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.139 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.516 HD13 ' CE1' ' A' ' 273' ' ' PHE . 76.8 mt -126.9 111.09 13.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -93.34 128.46 39.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.969 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 16.8 t -112.02 129.06 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.112 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.473 ' HG3' ' N ' ' A' ' 237' ' ' ASN . 13.5 tpt180 -120.57 161.3 21.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.473 ' N ' ' HG3' ' A' ' 236' ' ' ARG . 9.0 t30 74.87 35.22 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 42.2 mt -85.24 124.82 32.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.858 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 3.6 mmt -62.82 133.6 54.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 58.2 mt -59.46 -12.74 6.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 20.7 m -98.2 15.56 24.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 38.8 m -102.62 129.88 49.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.133 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.0 m -97.16 145.86 25.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 247' ' ' ILE . 45.7 mt-10 -42.03 -48.29 4.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.886 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -42.14 -38.77 1.8 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 10.8 mtt -66.05 -39.56 90.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 244' ' ' GLU . 44.9 mt -72.64 -34.97 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.454 ' HG2' ' ND2' ' A' ' 252' ' ' ASN . 25.9 tt0 -73.75 -46.62 44.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 13.7 ptmt -60.54 -45.14 94.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.472 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 25.3 mm-40 -61.76 -58.26 8.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.546 ' CE1' HD13 ' A' ' 286' ' ' LEU . 7.6 m-85 -55.81 -46.42 78.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.454 ' ND2' ' HG2' ' A' ' 248' ' ' GLU . 79.6 m-20 -66.02 -23.42 66.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.845 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -51.98 -37.31 52.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 14.5 mm -65.71 -52.57 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -142.71 133.48 12.58 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.609 0.719 . . . . 0.0 110.885 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 137.78 36.21 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.257 . . . . 0.0 112.32 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.93 41.04 96.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.534 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -106.63 -45.62 4.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 111.11 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 76.5 t -68.26 126.24 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -83.3 -60.59 2.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -147.85 150.15 33.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.824 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 85.7 t -127.68 110.82 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.16 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -100.78 110.07 22.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 265' ' ' ILE . 15.9 tptp -79.49 147.86 32.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.531 HD11 ' CD2' ' A' ' 268' ' ' TYR . 6.0 mt -137.1 172.11 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.103 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.469 ' C ' ' O ' ' A' ' 265' ' ' ILE . 23.5 mmt180 -31.32 -71.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.45 ' OD1' ' C ' ' A' ' 266' ' ' ARG . 1.0 OUTLIER -127.86 16.52 6.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -143.59 176.32 9.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.42 158.33 13.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.061 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.446 ' CE2' HD12 ' A' ' 265' ' ' ILE . 98.3 m-85 -117.86 146.61 43.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.544 HG22 ' CE2' ' A' ' 251' ' ' PHE . 21.0 t -130.41 119.64 46.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -98.2 147.51 24.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.516 ' CE1' HD13 ' A' ' 233' ' ' LEU . 38.5 m-85 -126.15 171.74 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.4 ' C ' ' OD1' ' A' ' 275' ' ' ASN . 13.2 t -79.13 -41.58 28.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.403 ' O ' ' OD1' ' A' ' 278' ' ' ASP . 5.9 m-20 -135.48 170.25 16.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.902 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -74.36 -36.05 63.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 278' ' ' ASP . 12.1 pt-20 -53.04 -52.5 58.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 278' ' ' ASP . 7.4 p-10 -70.07 -47.32 62.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -51.14 -49.67 60.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.122 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.45 -52.93 45.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.093 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -47.19 -41.69 18.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.834 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.46 -40.05 77.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.0 ttp -50.37 -54.2 23.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -68.45 -42.1 79.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.883 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -51.18 -54.38 26.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.064 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.546 HD13 ' CE1' ' A' ' 251' ' ' PHE . 42.1 mt -78.4 -41.53 32.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 286' ' ' LEU . 9.5 t30 -35.99 109.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 98.15 34.26 5.44 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 38.3 mmtt -112.63 147.33 36.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 89.6 t -114.39 97.92 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 41.6 mt -96.06 153.72 17.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.2 t0 42.97 24.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 75.66 38.0 38.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 33.1 p -146.43 133.93 10.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.659 0.742 . . . . 0.0 110.877 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 92.78 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 6.9 pt -81.32 146.2 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.121 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -112.19 156.59 22.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 20.8 t -143.77 115.1 2.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.12 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 29.4 p -138.5 172.94 12.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 6.8 mt -88.88 100.34 13.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.61 137.68 50.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.109 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.584 0.707 . . . . 0.0 110.921 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 42.0 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.917 0.389 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.22 129.62 62.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.156 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.452 ' HD3' ' N ' ' A' ' 276' ' ' ARG . 1.6 pttm -131.35 116.79 18.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 96.8 mt -147.92 142.32 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.149 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.559 HD12 ' CE1' ' A' ' 273' ' ' PHE . 92.3 mt -127.08 111.72 14.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -91.98 132.36 36.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.6 t -116.24 142.39 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.136 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -132.35 170.34 15.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 295' ' ' PRO . 28.1 t-20 62.31 49.21 4.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 39.4 mt -102.95 115.39 30.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.93 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 6.2 mtt -56.67 122.91 13.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.438 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 38.6 mt -45.16 -33.12 2.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.939 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 13.3 t -63.22 -39.27 94.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.842 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.415 ' O ' ' NZ ' ' A' ' 264' ' ' LYS . 52.1 m -58.46 142.47 48.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.166 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 49.8 m -111.71 168.0 9.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.852 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.453 ' OE1' ' N ' ' A' ' 244' ' ' GLU . 1.2 mp0 -56.25 -46.87 79.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.911 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -43.31 -37.09 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.5 mmt -70.37 -45.03 66.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.856 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 48.9 mt -65.02 -40.18 88.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -67.51 -60.91 2.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 8.1 ptpt -45.85 -46.23 15.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 23.0 mm-40 -59.38 -69.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.46 ' CD2' HG11 ' A' ' 271' ' ' VAL . 16.1 m-85 -49.34 -24.19 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 253' ' ' ASN . 3.6 m-20 -73.3 -44.82 58.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 249' ' ' LYS . 6.8 m120 -36.36 -49.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.913 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 45.2 mm -47.95 -62.43 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -139.51 135.02 16.63 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.539 0.685 . . . . 0.0 110.934 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 127.44 14.63 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.684 2.256 . . . . 0.0 112.386 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 67.23 38.89 92.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.52 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -104.04 -43.67 5.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 251' ' ' PHE . 21.7 t -72.62 112.57 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -70.55 -64.61 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 262' ' ' VAL . 0.5 OUTLIER -140.83 165.05 28.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.447 ' N ' ' HD2' ' A' ' 261' ' ' ARG . 40.3 t -140.2 113.98 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -101.53 107.4 18.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . 0.415 ' NZ ' ' O ' ' A' ' 242' ' ' THR . 16.0 tptm -79.83 143.28 34.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.558 HD12 ' CD2' ' A' ' 268' ' ' TYR . 5.3 mt -133.97 172.41 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.476 ' C ' ' O ' ' A' ' 265' ' ' ILE . 12.7 mmm180 -31.34 -73.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -125.36 18.8 8.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.558 ' CD2' HD12 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -148.03 177.75 9.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.72 174.05 9.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.116 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -130.69 143.6 50.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.46 HG11 ' CD2' ' A' ' 251' ' ' PHE . 70.0 t -127.07 123.03 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -102.47 155.42 18.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.559 ' CE1' HD12 ' A' ' 233' ' ' LEU . 37.8 m-85 -132.65 177.67 7.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.408 ' C ' ' HE3' ' A' ' 231' ' ' LYS . 78.8 p -89.11 -14.14 36.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.822 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.418 ' N ' ' HD2' ' A' ' 231' ' ' LYS . 11.1 p30 -162.03 147.19 12.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.452 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 27.5 ttt180 -55.25 -45.83 76.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.889 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -40.82 -56.29 2.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -63.78 -48.32 77.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -48.25 -45.52 34.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.2 -59.1 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -46.74 -43.91 18.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.0 -34.56 73.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 59.4 ttp -53.33 -66.4 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -62.61 -37.76 87.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -46.47 -55.85 6.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.06 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 287' ' ' ASN . 46.7 mt -80.61 -36.61 32.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 286' ' ' LEU . 22.9 t-20 -36.88 103.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 104.91 31.33 4.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -111.79 156.65 21.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.836 0.35 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . 0.418 HG13 ' N ' ' A' ' 294' ' ' SER . 55.9 t -120.09 96.36 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.139 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 294' ' ' SER . 32.2 mt -90.33 153.96 20.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 291' ' ' LEU . 7.7 t70 37.48 39.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.868 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 61.98 43.97 98.45 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.493 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.418 ' N ' HG13 ' A' ' 290' ' ' VAL . 1.8 m -152.42 138.26 11.6 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.661 0.743 . . . . 0.0 110.841 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.401 ' O ' ' OD1' ' A' ' 237' ' ' ASN . 53.4 Cg_endo -69.8 100.78 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 8.3 pt -93.62 145.46 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -117.79 157.27 26.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 6.3 t -146.05 121.77 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 82.6 p -144.05 175.27 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 8.7 mt -87.11 102.6 14.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.954 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -66.27 138.61 57.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.072 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 24.1 tttm . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.613 0.72 . . . . 0.0 110.902 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 57.3 m . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.939 0.399 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.54 132.55 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.417 ' HD3' ' C ' ' A' ' 275' ' ' ASN . 0.1 OUTLIER -131.22 116.91 18.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 233' ' ' LEU . 55.0 mt -147.86 141.33 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.098 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.564 HD12 ' CE1' ' A' ' 273' ' ' PHE . 15.4 mt -124.25 105.09 9.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.472 ' HB2' ' CE2' ' A' ' 270' ' ' PHE . 6.5 t80 -91.21 125.12 35.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 23.4 t -106.35 135.75 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.091 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -128.66 170.88 12.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.543 ' ND2' ' HG ' ' A' ' 294' ' ' SER . 6.9 t30 62.84 43.46 7.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 15.3 mt -100.83 140.81 34.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' MET . . . . . 0.411 ' CE ' ' HB2' ' A' ' 294' ' ' SER . 20.3 mmt -80.14 141.07 36.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 37.1 mt -53.72 -28.54 34.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.4 m -66.88 -25.31 66.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.441 HG21 ' N ' ' A' ' 243' ' ' SER . 39.6 m -65.82 144.11 57.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.106 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.441 ' N ' HG21 ' A' ' 242' ' ' THR . 1.3 t -128.77 150.92 50.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -46.89 -20.82 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -66.7 -68.77 0.35 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.468 ' HA ' ' CD ' ' A' ' 249' ' ' LYS . 20.2 ptm -53.12 -37.08 61.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 77.8 mt -61.44 -50.87 78.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.112 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.464 ' HG2' ' ND2' ' A' ' 252' ' ' ASN . 3.4 tt0 -59.37 -64.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 13.9 pttt -39.47 -46.09 1.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.473 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 33.6 mm-40 -57.82 -51.81 68.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.862 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.684 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 4.8 m-85 -61.76 -56.12 22.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.464 ' ND2' ' HG2' ' A' ' 248' ' ' GLU . 5.7 m-80 -54.32 -40.07 67.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -48.04 -31.35 5.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 29.2 mm -68.76 -54.24 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.157 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -142.27 120.3 7.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.58 0.705 . . . . 0.0 110.894 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 121.91 8.61 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.367 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 84.25 37.82 10.68 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -118.13 -43.84 2.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.336 . . . . 0.0 111.05 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 41.5 t -74.73 136.65 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.153 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -100.08 -62.02 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . 0.461 ' CD ' ' HB2' ' A' ' 272' ' ' HIS . 0.1 OUTLIER -143.67 153.59 42.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 263' ' ' LYS . 89.9 t -122.65 147.35 26.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . 0.403 ' N ' HG12 ' A' ' 262' ' ' VAL . 18.4 tptm -136.18 110.74 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.919 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' A' ' 265' ' ' ILE . 11.0 tptm -87.58 144.8 26.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.574 HD12 ' CD2' ' A' ' 268' ' ' TYR . 6.7 mt -136.12 172.35 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.148 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.471 ' C ' ' O ' ' A' ' 265' ' ' ILE . 18.9 mmt180 -31.55 -72.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.08 14.13 7.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -140.82 176.88 8.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.14 179.1 7.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.11 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 234' ' ' TYR . 95.7 m-85 -144.29 148.94 35.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.558 HG22 ' CE2' ' A' ' 251' ' ' PHE . 3.1 t -135.54 123.12 36.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.141 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . 0.461 ' HB2' ' CD ' ' A' ' 261' ' ' ARG . 3.9 m-70 -97.8 150.74 20.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.564 ' CE1' HD12 ' A' ' 233' ' ' LEU . 19.3 m-85 -126.92 176.87 6.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.895 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.8 t -97.52 -25.93 14.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.417 ' C ' ' HD3' ' A' ' 231' ' ' LYS . 7.6 m-80 -144.83 135.19 24.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 277' ' ' GLU . 14.0 ttt180 -45.53 -54.33 7.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 276' ' ' ARG . 62.9 mm-40 -37.01 -56.03 0.9 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.51 -47.89 83.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.94 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -54.86 -40.59 69.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.58 -42.99 90.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -65.39 -51.52 59.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.84 -38.72 79.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.075 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 47.4 ttp -52.23 -66.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.412 ' HA ' ' CB ' ' A' ' 287' ' ' ASN . 40.1 mtmt -58.79 -48.75 80.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 284' ' ' LYS . . . -36.53 -52.65 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.684 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 73.4 mt -85.75 -29.24 24.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . 0.412 ' CB ' ' HA ' ' A' ' 284' ' ' LYS . 19.1 t-20 -42.53 95.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 112.08 29.63 3.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.494 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -108.52 155.9 20.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.828 0.347 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 75.5 t -118.02 109.59 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 26.9 mt -106.54 153.24 22.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 42.53 29.16 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 71.99 42.55 51.75 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.506 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.543 ' HG ' ' ND2' ' A' ' 237' ' ' ASN . 10.9 t -153.78 140.03 12.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.626 0.727 . . . . 0.0 110.866 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.491 ' O ' ' ND2' ' A' ' 237' ' ' ASN . 53.6 Cg_endo -69.78 98.56 0.7 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.727 2.285 . . . . 0.0 112.306 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 8.1 pt -86.14 147.45 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.126 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -121.77 153.33 38.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 8.4 t -135.32 119.2 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.174 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 16.3 p -137.8 168.11 20.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 11.1 mt -83.87 100.1 10.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.408 ' CB ' ' HB2' ' A' ' 234' ' ' TYR . . . -71.11 138.45 49.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.079 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 15.5 pttm . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.596 0.712 . . . . 0.0 110.891 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.949 0.404 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.1 132.39 60.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.131 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.41 ' CD ' ' C ' ' A' ' 275' ' ' ASN . 4.3 pttm -131.49 117.02 18.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 92.2 mt -147.93 138.88 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.149 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 68.6 mt -122.8 108.93 13.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -92.37 124.22 36.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.98 143.29 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.123 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -134.6 165.62 24.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 72.16 39.97 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.7 mt -99.15 115.87 30.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.4 mtt -56.21 130.78 45.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 46.1 mt -44.68 -39.05 4.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 30.9 m -56.98 -36.77 70.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 24.6 m -60.86 137.4 58.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.177 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.7 m -113.9 170.39 8.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.834 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 247' ' ' ILE . 25.8 mt-10 -53.68 -52.59 59.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -40.03 -47.83 2.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.4 mtt -60.24 -37.94 81.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 244' ' ' GLU . 55.7 mt -73.75 -36.43 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.11 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.498 ' O ' ' ND2' ' A' ' 252' ' ' ASN . 16.8 tt0 -70.66 -46.77 62.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.477 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 4.6 ptmm? -62.91 -47.98 80.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.917 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.477 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 25.8 mm-40 -56.08 -54.8 40.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.546 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 10.2 m-85 -63.28 -47.47 82.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 248' ' ' GLU . 1.1 m-80 -54.73 -46.9 74.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -38.1 -48.35 1.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.861 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.2 mm -48.35 -57.95 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.121 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -141.06 128.19 11.87 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.564 0.697 . . . . 0.0 110.902 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 120.19 7.01 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.717 2.278 . . . . 0.0 112.311 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 76.39 34.54 45.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.515 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -104.32 -34.23 8.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 0.0 111.102 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.452 HG21 ' ND2' ' A' ' 252' ' ' ASN . 74.4 t -80.75 149.04 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -106.42 -59.21 1.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . 0.424 ' CZ ' ' HB3' ' A' ' 261' ' ' ARG . 4.8 ptp180 -151.73 155.62 38.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.879 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.21 152.28 37.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.106 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -140.78 109.79 6.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 11.4 tptp -79.68 141.76 36.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.571 HD11 ' CD2' ' A' ' 268' ' ' TYR . 6.5 mt -132.33 172.52 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.115 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' A' ' 265' ' ' ILE . 13.9 mmm180 -31.39 -72.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 0.5 OUTLIER -126.8 17.26 7.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.571 ' CD2' HD11 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -145.14 176.13 9.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -165.87 158.95 15.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.135 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -117.57 151.53 36.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 57.8 t -139.44 134.4 39.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.121 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -113.57 157.99 21.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.824 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -132.86 173.37 11.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.403 ' O ' ' ND2' ' A' ' 275' ' ' ASN . 43.4 t -81.49 -18.4 45.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.825 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.41 ' C ' ' CD ' ' A' ' 231' ' ' LYS . 4.8 m120 -157.12 159.4 37.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -61.73 -48.31 81.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -48.21 -44.25 32.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -65.28 -51.42 60.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -56.04 -39.02 71.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.087 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.443 ' CG1' ' HE3' ' A' ' 284' ' ' LYS . 77.8 t -67.87 -47.94 77.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -59.08 -48.12 82.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.0 -34.82 76.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.2 ttp -60.38 -58.92 6.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.443 ' HE3' ' CG1' ' A' ' 280' ' ' VAL . 84.4 mttt -63.62 -28.35 69.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.59 68.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.546 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 55.1 mt -85.21 -17.48 36.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.957 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -57.01 109.55 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 97.32 32.79 6.21 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.523 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -112.0 154.81 24.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.909 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 87.4 t -117.81 96.61 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 293' ' ' GLY . 25.3 mt -92.73 152.0 19.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 41.77 25.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.21 43.52 25.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.499 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.1 t -154.75 137.62 10.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.692 0.758 . . . . 0.0 110.852 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 97.45 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.699 2.266 . . . . 0.0 112.329 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.9 pt -85.96 144.07 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.152 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -115.59 141.95 47.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.1 t -128.92 111.3 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 63.8 p -132.92 178.97 6.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 10.2 mt -95.79 110.22 22.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -65.79 145.78 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 121.566 0.698 . . . . 0.0 110.916 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 93.4 p . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.899 0.381 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.1 130.46 68.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.135 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.412 ' HD2' ' CA ' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -130.47 116.64 18.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.915 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 56.8 mt -147.9 125.19 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.177 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 16.1 mt -115.6 112.09 21.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.419 ' CE2' ' HB2' ' A' ' 236' ' ' ARG . 51.3 t80 -91.88 121.45 33.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.3 t -108.67 121.9 62.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.163 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.419 ' HB2' ' CE2' ' A' ' 234' ' ' TYR . 28.3 ttt180 -115.64 160.31 20.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.418 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 28.8 t-20 71.55 48.35 0.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 19.8 mt -102.08 124.32 47.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 8.0 mmt -60.17 141.5 55.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 26.3 mt -65.55 -24.09 67.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 34.2 m -82.99 16.0 2.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 23.0 m -102.83 141.36 35.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.124 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 67.7 m -111.11 147.68 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -43.52 -46.75 7.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -39.88 -46.24 1.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 12.1 mtt -62.6 -43.45 98.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 59.2 mt -64.52 -36.76 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.143 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -68.49 -57.29 6.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.911 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 18.6 pttt -52.33 -46.86 66.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.51 ' O ' ' ND2' ' A' ' 253' ' ' ASN . 19.3 mm-40 -55.99 -51.29 68.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.889 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.544 ' CE2' HG22 ' A' ' 271' ' ' VAL . 8.2 m-85 -72.7 -20.3 61.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -90.65 -11.03 41.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 250' ' ' GLU . 16.9 p30 -72.47 -17.92 61.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.434 ' N ' ' OD1' ' A' ' 253' ' ' ASN . 4.9 mp -79.47 -55.9 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.108 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -143.56 125.66 8.5 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.538 0.685 . . . . 0.0 110.903 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 120.23 7.05 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 87.09 33.41 12.11 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.423 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -108.74 -54.95 2.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 111.081 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.57 142.42 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -102.94 -61.79 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -144.92 152.99 41.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.68 127.85 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -119.08 104.7 10.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 265' ' ' ILE . 9.9 tptp -79.4 145.14 33.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.569 HD13 ' CD2' ' A' ' 268' ' ' TYR . 5.3 mt -135.86 172.43 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.158 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.471 ' C ' ' O ' ' A' ' 265' ' ' ILE . 39.9 mmm-85 -31.34 -74.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 8.4 p-10 -125.36 22.25 7.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.569 ' CD2' HD13 ' A' ' 265' ' ' ILE . 0.4 OUTLIER -151.52 177.01 10.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.9 171.37 14.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.093 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -135.58 134.51 39.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.891 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.544 HG22 ' CE2' ' A' ' 251' ' ' PHE . 39.4 t -120.16 129.82 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -104.85 155.34 19.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.4 ' C ' ' HG3' ' A' ' 231' ' ' LYS . 43.7 m-85 -136.41 -176.02 4.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.924 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 30.8 t -88.89 -31.86 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.412 ' CA ' ' HD2' ' A' ' 231' ' ' LYS . 2.7 m120 -152.17 144.65 24.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.501 ' O ' ' CG2' ' A' ' 280' ' ' VAL . 0.0 OUTLIER -50.07 -29.46 8.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -54.42 -62.7 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -59.77 -39.11 83.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -64.11 -35.89 82.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.102 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 276' ' ' ARG . 97.2 t -68.55 -39.59 80.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.194 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -68.46 -51.4 43.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.7 -40.48 72.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.09 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.1 ttp -60.8 -45.78 93.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -75.02 -19.26 60.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -78.39 -39.15 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 41.3 mt -95.82 -21.27 18.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -48.67 96.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 113.79 30.84 2.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.444 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -107.48 160.16 15.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.809 0.338 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 58.6 t -123.46 107.92 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.107 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 294' ' ' SER . 34.7 mt -102.86 153.25 20.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 41.83 26.62 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.76 38.52 49.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.476 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 291' ' ' LEU . 23.7 p -146.4 137.39 12.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.687 0.756 . . . . 0.0 110.833 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . 0.418 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.5 Cg_endo -69.8 101.79 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.718 2.279 . . . . 0.0 112.323 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 12.0 pt -90.65 147.75 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.36 133.42 52.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 28.2 t -115.36 116.77 53.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.111 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 28.7 p -131.16 169.23 16.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 10.9 mt -88.71 99.98 12.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.98 137.49 53.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 23.9 pttt . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 121.546 0.688 . . . . 0.0 110.913 179.974 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 79.3 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.945 0.402 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.5 p -110.8 137.91 41.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.164 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.449 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -135.14 116.88 15.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 36.0 mt -147.98 136.55 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.121 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 11.5 mt -120.64 108.11 13.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -91.18 129.04 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.2 135.76 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.128 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -129.26 163.04 26.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.834 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 7.9 t30 70.91 48.07 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.427 ' CD1' ' HB3' ' A' ' 269' ' ' ALA . 21.2 mt -103.28 123.09 46.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.1 mmt -60.88 123.33 17.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.45 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 38.1 mt -45.73 -29.03 1.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 9.9 t -65.21 -37.6 87.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 35.1 m -58.82 156.35 11.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.127 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 58.3 m -128.8 167.9 16.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 247' ' ' ILE . 7.5 mp0 -54.42 -54.26 43.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 244' ' ' GLU . 41.6 tp10 -37.95 -39.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 5.8 mtt -71.18 -40.39 71.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 244' ' ' GLU . 44.3 mt -68.05 -40.46 83.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.122 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 18.8 tt0 -70.27 -56.23 7.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.471 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 0.0 OUTLIER -49.21 -46.55 45.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.904 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 39.2 mm-40 -60.74 -51.35 69.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 5.3 m-85 -65.86 -25.46 67.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 22.6 m120 -70.06 -46.47 64.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.868 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 252' ' ' ASN . 74.8 m-20 -36.2 -41.87 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.436 HD12 ' CB ' ' A' ' 285' ' ' ALA . 26.0 mm -56.44 -63.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.474 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 4.2 tppt? -141.89 136.42 15.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.6 0.714 . . . . 0.0 110.898 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.474 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 53.6 Cg_endo -69.78 132.56 23.55 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.715 2.277 . . . . 0.0 112.326 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 61.83 37.02 93.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.52 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -99.16 -43.72 6.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.838 0.351 . . . . 0.0 111.162 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.6 t -70.14 118.33 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.108 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -78.53 -57.58 3.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -144.14 149.45 36.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 69.0 t -133.13 111.57 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.125 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -107.32 117.63 34.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -86.53 142.19 28.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.569 HD12 ' CD2' ' A' ' 268' ' ' TYR . 6.5 mt -131.12 172.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.492 ' C ' ' O ' ' A' ' 265' ' ' ILE . 70.9 mtm-85 -30.1 -73.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.82 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.48 0.15 8.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -124.25 176.47 6.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.427 ' HB3' ' CD1' ' A' ' 238' ' ' LEU . . . -160.52 172.99 16.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.18 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.568 ' CE2' HD13 ' A' ' 265' ' ' ILE . 68.1 m-85 -136.37 135.4 38.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.1 t -130.16 126.08 61.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -103.36 159.3 15.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -133.53 168.18 19.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.826 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.1 t -75.72 -39.2 57.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.467 ' N ' ' OD1' ' A' ' 275' ' ' ASN . 4.6 p-10 -139.58 149.07 43.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.938 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' A' ' 277' ' ' GLU . 15.2 ttt180 -51.35 -55.14 20.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.848 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 276' ' ' ARG . 5.8 mp0 -35.12 -60.28 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -55.75 -52.53 63.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -48.28 -45.62 34.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.094 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.21 -51.83 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.25 -54.1 41.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.89 -30.86 68.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' MET . . . . . 0.445 ' O ' ' CB ' ' A' ' 287' ' ' ASN . 66.0 ttp -65.78 -57.33 8.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -68.78 -32.68 72.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.436 ' CB ' HD12 ' A' ' 254' ' ' ILE . . . -62.08 -56.51 18.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.084 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.633 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 35.0 mt -76.17 -35.83 58.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 283' ' ' MET . 6.1 t-20 -41.81 106.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 100.59 37.5 3.72 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.473 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -114.17 153.19 30.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.856 0.36 . . . . 0.0 110.893 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 81.9 t -117.93 94.51 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.144 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 294' ' ' SER . 37.9 mt -94.46 153.59 17.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 41.88 25.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.84 38.51 36.16 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.542 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 291' ' ' LEU . 31.8 p -146.34 133.12 9.89 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.661 0.744 . . . . 0.0 110.821 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 86.19 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.687 2.258 . . . . 0.0 112.333 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 6.9 pt -72.95 149.63 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.141 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -118.82 156.43 29.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 20.2 t -143.6 118.51 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 60.6 p -143.55 162.79 34.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.187 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 9.3 mt -77.39 100.05 5.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -67.66 112.86 5.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.077 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 27.1 mttp . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 121.621 0.724 . . . . 0.0 110.923 179.963 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 96.0 p . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.931 0.396 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.473 ' O ' ' CD ' ' A' ' 276' ' ' ARG . 0.9 OUTLIER -119.68 139.8 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.123 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.449 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -133.56 116.73 16.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.4 mt -147.94 132.35 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.106 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 12.2 mt -115.48 109.13 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.888 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.525 ' CE2' ' HB3' ' A' ' 236' ' ' ARG . 12.9 t80 -91.49 134.12 34.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 22.7 t -120.91 131.07 73.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.18 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.525 ' HB3' ' CE2' ' A' ' 234' ' ' TYR . 14.6 ptt180 -123.47 163.39 20.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 69.84 50.79 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 11.8 mt -108.52 121.54 45.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.944 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 24.2 mtt -60.2 134.86 57.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.5 mt -53.94 -26.84 27.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 64.0 p -65.03 -40.31 94.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.441 ' O ' ' NZ ' ' A' ' 264' ' ' LYS . 52.1 m -59.46 147.9 34.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 59.5 m -121.17 164.19 17.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 247' ' ' ILE . 35.2 mt-10 -52.95 -54.38 35.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 244' ' ' GLU . 27.3 tt0 -36.81 -43.42 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.418 ' HA ' ' NZ ' ' A' ' 249' ' ' LYS . 9.5 mtp -63.63 -45.93 88.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 244' ' ' GLU . 28.4 mt -64.07 -29.39 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.149 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -71.27 -54.4 11.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 4.4 ptpp? -58.29 -41.82 85.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.474 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 17.4 mm-40 -61.94 -54.0 47.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -68.21 -28.27 67.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . 0.42 ' OD1' ' CG2' ' A' ' 259' ' ' VAL . 4.6 m-20 -81.76 -23.9 36.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -59.97 -31.44 69.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.463 HD13 ' CB ' ' A' ' 285' ' ' ALA . 13.2 mm -66.44 -56.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.146 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -142.84 131.88 11.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.549 0.69 . . . . 0.0 110.934 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 133.65 26.07 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.717 2.278 . . . . 0.0 112.306 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 65.61 39.83 95.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.475 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -110.72 -27.04 9.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.756 0.312 . . . . 0.0 111.048 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.42 ' CG2' ' OD1' ' A' ' 252' ' ' ASN . 75.8 t -91.77 128.75 43.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.134 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -89.23 -54.66 4.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 30.5 ptt85 -151.11 150.74 31.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.87 138.44 54.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 33.4 tttp -132.95 115.96 15.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . 0.441 ' NZ ' ' O ' ' A' ' 242' ' ' THR . 17.0 tptm -86.48 146.73 26.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.563 HD13 ' CD2' ' A' ' 268' ' ' TYR . 5.7 mt -134.28 172.08 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.142 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.464 ' C ' ' O ' ' A' ' 265' ' ' ILE . 21.7 mmm180 -31.96 -72.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -125.82 15.71 8.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.606 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -143.33 177.75 8.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.95 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -165.14 167.05 18.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.062 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . 0.466 ' CD2' HD11 ' A' ' 265' ' ' ILE . 89.9 m-85 -130.6 143.68 50.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 40.5 t -135.11 126.61 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -102.24 153.89 19.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -125.83 -177.66 4.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.0 t -91.89 -31.62 15.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.869 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -144.51 156.51 44.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.473 ' CD ' ' O ' ' A' ' 230' ' ' VAL . 1.5 tpp85 -52.62 -67.06 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 276' ' ' ARG . 67.7 mm-40 -35.6 -57.84 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -47.93 -52.23 20.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -58.98 -46.67 87.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.99 -48.49 84.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.113 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.44 -53.51 57.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.63 -31.97 71.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 58.2 ttp -59.59 -53.96 51.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 285' ' ' ALA . 85.5 mttt -68.68 -53.23 23.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.463 ' CB ' HD13 ' A' ' 254' ' ' ILE . . . -36.55 -43.53 0.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.106 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.428 ' O ' ' C ' ' A' ' 287' ' ' ASN . 49.0 mt -90.56 -39.95 12.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.859 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 286' ' ' LEU . 20.7 t-20 -36.3 113.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 93.28 33.62 7.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.476 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -109.95 160.79 16.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 25.3 t -122.42 101.73 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.074 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.456 HD11 ' CD1' ' A' ' 296' ' ' ILE . 29.8 mt -99.1 154.2 18.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.8 p30 39.59 28.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 71.98 40.85 56.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.486 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 291' ' ' LEU . 1.9 m -149.23 137.5 11.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.681 0.753 . . . . 0.0 110.877 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 99.19 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.456 ' CD1' HD11 ' A' ' 291' ' ' LEU . 7.2 pt -90.69 147.85 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -118.62 155.89 30.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.1 119.54 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.169 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 80.4 p -139.85 174.63 10.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.83 118.28 26.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.46 151.69 39.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 16.0 pttp . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.586 0.708 . . . . 0.0 110.86 -179.973 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.86 0.362 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.457 ' O ' ' CD ' ' A' ' 276' ' ' ARG . 1.1 p -121.72 132.72 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.147 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 116.9 18.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 69.9 mt -147.92 151.23 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.166 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.563 HD11 ' CE1' ' A' ' 273' ' ' PHE . 85.9 mt -136.8 110.12 7.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.523 ' CE2' ' HB3' ' A' ' 236' ' ' ARG . 23.9 t80 -91.18 129.42 37.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.1 126.96 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.11 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.523 ' HB3' ' CE2' ' A' ' 234' ' ' TYR . 23.6 ptt85 -120.17 169.72 9.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 63.94 47.77 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 64.3 mt -104.43 131.93 51.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' MET . . . . . 0.494 ' CB ' ' OD2' ' A' ' 292' ' ' ASP . 8.7 mmt -71.25 132.09 44.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.443 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 62.8 mt -50.27 -29.11 8.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.951 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 72.7 m -63.71 -33.26 75.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.86 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' THR . . . . . 0.438 HG21 ' N ' ' A' ' 243' ' ' SER . 87.4 m -66.5 138.04 57.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.103 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.438 ' N ' HG21 ' A' ' 242' ' ' THR . 6.2 m -117.77 164.77 14.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.825 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 245' ' ' GLU . 17.4 mt-10 -44.49 -60.47 1.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 244' ' ' GLU . 30.7 tt0 -34.86 -62.23 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 25.9 mmm -40.33 -56.96 1.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 250' ' ' GLU . 36.8 mt -62.94 -65.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -39.55 -34.4 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.835 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -77.99 -38.94 43.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 247' ' ' ILE . 21.4 mm-40 -66.08 -48.5 70.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.465 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 15.1 m-85 -67.24 -42.13 84.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -61.88 -40.67 96.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -42.74 -42.17 3.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 31.9 mm -55.64 -58.7 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.416 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 10.6 tppt? -142.82 135.03 13.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.585 0.707 . . . . 0.0 110.889 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.416 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 54.3 Cg_endo -69.73 133.64 26.1 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.673 2.249 . . . . 0.0 112.354 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 65.9 39.02 94.8 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.507 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -103.33 -55.23 2.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.855 0.36 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 251' ' ' PHE . 58.0 t -69.6 114.98 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.085 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -74.2 -55.97 5.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -150.61 144.22 25.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.2 t -121.84 119.41 58.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -105.77 108.87 20.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -79.42 143.44 35.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.566 HD13 ' CD2' ' A' ' 268' ' ' TYR . 5.7 mt -135.66 172.8 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.117 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.49 ' C ' ' O ' ' A' ' 265' ' ' ILE . 21.1 mmt180 -30.17 -72.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 4.4 p-10 -128.29 20.35 6.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' TYR . . . . . 0.566 ' CD2' HD13 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -148.37 173.08 13.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -160.92 163.09 32.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.81 136.42 54.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.868 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 42.3 t -123.13 129.04 75.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.098 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -102.43 159.21 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.563 ' CE1' HD11 ' A' ' 233' ' ' LEU . 29.7 m-85 -137.19 -178.62 5.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.7 m -98.65 -28.28 13.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.841 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -145.95 147.68 31.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.891 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.457 ' CD ' ' O ' ' A' ' 230' ' ' VAL . 1.3 tpt180 -50.52 -61.72 2.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 276' ' ' ARG . 27.8 mt-10 -36.62 -50.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.83 -57.83 10.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -54.83 -37.6 66.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.43 ' CG1' ' HE2' ' A' ' 284' ' ' LYS . 76.7 t -65.77 -47.26 86.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.171 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.21 -50.4 73.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.26 -26.2 68.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.081 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.0 ttp -64.01 -67.64 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.43 ' HE2' ' CG1' ' A' ' 280' ' ' VAL . 26.7 mtmt -59.79 -29.29 68.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -56.31 -55.67 30.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.085 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.465 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 60.7 mt -81.54 -30.64 33.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -40.31 104.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 105.52 20.54 9.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -97.48 154.9 17.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.339 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 98.3 t -122.09 98.17 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.104 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 294' ' ' SER . 32.1 mt -94.57 153.69 17.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.494 ' OD2' ' CB ' ' A' ' 239' ' ' MET . 25.0 t0 42.33 26.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.33 38.21 53.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.484 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 291' ' ' LEU . 22.4 p -146.34 134.04 10.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.63 0.729 . . . . 0.0 110.856 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 102.35 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 2.237 . . . . 0.0 112.38 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 11.4 pt -89.49 148.22 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -121.87 136.1 54.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.4 t -119.09 121.92 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.124 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 68.4 p -139.73 168.34 20.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.112 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.92 101.89 13.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.25 161.63 16.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.061 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' LYS . . . . . 0.407 ' HD2' ' C ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 121.569 0.699 . . . . 0.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 20.0 m -76.08 156.86 33.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.4 m -43.46 -50.34 7.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 108.68 -77.73 0.23 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.45 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 1.2 t -123.02 134.01 54.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 110.852 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 27.4 t -87.69 -34.5 18.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 89.46 87.69 1.27 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.491 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -174.97 173.78 2.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.717 0.294 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -130.06 108.07 9.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -76.14 -50.29 15.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 5.6 m -124.09 104.23 8.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.147 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 12.3 ptp -65.73 -34.01 77.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 2.8 m -108.82 85.34 2.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.7 p -93.59 110.27 21.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.866 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.7 p -122.48 132.99 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.51 116.85 18.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 63.2 mt -147.9 145.32 18.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.551 HD13 ' CE1' ' A' ' 273' ' ' PHE . 88.4 mt -133.26 109.21 9.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -91.71 133.28 35.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 23.1 t -114.58 137.44 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.106 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.0 ttp85 -129.78 156.13 44.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 73.83 44.28 0.28 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 25.0 mt -93.69 131.61 38.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 10.6 mmt -67.16 123.3 19.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 26.0 mt -48.27 -32.01 6.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 9.5 t -66.72 -35.75 80.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.453 HG23 ' N ' ' A' ' 243' ' ' SER . 39.2 m -59.62 141.72 54.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.135 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.453 ' N ' HG23 ' A' ' 242' ' ' THR . 4.3 m -110.61 166.15 11.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 247' ' ' ILE . 29.7 mt-10 -52.27 -52.03 55.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -41.49 -43.52 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 21.2 mmm -63.99 -36.25 83.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 244' ' ' GLU . 43.0 mt -74.8 -38.31 44.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.123 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -71.13 -43.97 66.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 16.4 ptmt -63.89 -47.88 78.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.473 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 31.7 mm-40 -58.29 -46.95 85.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.42 ' CE2' HG23 ' A' ' 271' ' ' VAL . 8.2 m-85 -72.57 -34.05 67.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.926 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -69.03 -32.22 71.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -47.02 -29.98 2.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.437 HD11 ' CB ' ' A' ' 285' ' ' ALA . 25.0 mm -68.2 -53.28 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -143.78 137.31 14.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.554 0.692 . . . . 0.0 110.936 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 126.24 13.11 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.682 2.255 . . . . 0.0 112.388 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 60.9 39.5 97.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.512 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -101.08 -45.13 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.24 109.93 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.14 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -61.37 -57.68 11.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -153.34 158.05 40.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 91.1 t -132.41 115.89 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -110.31 106.95 16.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.416 ' HD3' ' CD1' ' A' ' 247' ' ' ILE . 14.7 tptm -79.51 148.56 31.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.572 HD11 ' CD2' ' A' ' 268' ' ' TYR . 6.1 mt -137.36 172.19 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.161 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.464 ' C ' ' O ' ' A' ' 265' ' ' ILE . 20.1 mmt180 -31.86 -70.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.29 17.76 6.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.592 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.2 OUTLIER -146.08 177.93 8.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -170.14 165.02 9.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.109 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -127.59 142.18 51.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.42 HG23 ' CE2' ' A' ' 251' ' ' PHE . 21.5 t -127.38 123.44 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.143 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -99.96 157.59 16.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.551 ' CE1' HD13 ' A' ' 233' ' ' LEU . 41.3 m-85 -135.0 170.83 15.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.4 t -84.3 -34.24 23.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -138.67 144.66 39.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 -55.07 -42.51 72.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -46.49 -55.26 7.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -60.32 -51.31 70.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -51.17 -42.48 60.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 91.8 t -61.54 -48.57 88.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.13 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -58.33 -55.58 33.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.69 -26.72 64.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.078 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 51.2 ttp -65.5 -60.24 3.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 285' ' ' ALA . 6.1 mtmp? -65.26 -55.21 19.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.907 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.437 ' CB ' HD11 ' A' ' 254' ' ' ILE . . . -36.4 -47.85 0.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.091 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 287' ' ' ASN . 34.3 mt -84.46 -39.71 18.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.9 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 286' ' ' LEU . 31.9 t30 -37.1 104.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 98.97 38.24 3.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.478 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -114.35 159.17 20.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.786 0.327 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 294' ' ' SER . 98.8 t -121.51 97.4 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.127 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 293' ' ' GLY . 60.4 mt -92.99 153.15 18.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 291' ' ' LEU . 23.7 m-20 37.73 28.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.828 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 74.0 44.61 29.54 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.493 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.448 ' N ' HG12 ' A' ' 290' ' ' VAL . 8.2 t -155.02 134.7 7.96 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.669 0.747 . . . . 0.0 110.81 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 102.08 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.367 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.8 pt -93.89 144.37 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -116.66 154.71 30.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.8 t -141.26 119.4 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.162 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 76.9 p -137.88 169.44 17.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.151 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 8.0 mt -83.78 108.49 16.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -66.1 140.75 58.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.35 90.55 7.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.625 0.726 . . . . 0.0 110.882 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 140.67 43.04 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.34 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.14 138.3 21.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.14 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -163.66 162.33 24.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.912 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -135.29 131.83 37.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -40.92 115.54 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 39.7 p -60.81 141.17 57.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 28.4 p -96.2 129.04 43.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -153.09 -172.56 21.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.483 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 114.72 3.8 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.717 2.278 . . . . 0.0 112.348 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 3.3 t -56.83 -50.3 72.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.852 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 66.1 m -96.03 88.24 4.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.886 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.458 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 68.5 m -90.29 169.65 10.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.909 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 25.2 t -91.82 -56.6 3.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.874 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 142.74 60.96 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.465 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 67.9 m -142.88 114.3 7.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 110.875 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 74.2 m -66.53 -34.77 78.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 66.89 150.59 0.15 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.498 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 43.56 41.93 3.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.317 . . . . 0.0 110.846 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -58.16 102.94 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -148.69 161.4 41.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 32.9 p -123.04 43.72 2.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.146 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 42.1 ttp -80.71 -50.35 10.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 3.2 m -164.76 148.14 8.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.876 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 50.9 m -71.55 98.57 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.851 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.93 134.85 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.2 116.58 17.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 37.6 mt -147.89 131.98 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 15.7 mt -117.46 111.16 18.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -91.31 122.53 34.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.968 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.423 HG11 ' CG ' ' A' ' 238' ' ' LEU . 21.9 t -102.23 128.87 54.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.116 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 15.9 ttp85 -122.4 160.5 25.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.463 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 32.8 t-20 65.8 53.32 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.423 ' CG ' HG11 ' A' ' 235' ' ' VAL . 89.6 mt -106.16 131.31 53.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.9 mmt -66.33 136.99 56.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 72.3 mt -56.4 -24.2 43.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.935 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 11.4 t -75.1 -26.4 59.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 243' ' ' SER . 49.3 m -68.15 139.48 56.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.1 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.434 ' N ' HG22 ' A' ' 242' ' ' THR . 37.0 m -115.36 170.46 8.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.857 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 247' ' ' ILE . 48.8 mt-10 -50.95 -54.22 26.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -40.85 -48.06 3.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 2.9 mmt -55.98 -36.13 67.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 244' ' ' GLU . 40.6 mt -78.55 -46.72 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.115 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -60.22 -37.5 80.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 5.8 ptmt -73.47 -47.2 43.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.481 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 49.6 mm-40 -65.19 -22.78 66.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.531 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 7.3 m-85 -94.51 -26.32 16.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.44 ' OD1' ' CG2' ' A' ' 259' ' ' VAL . 78.6 m-20 -84.66 -18.99 33.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -59.6 -23.3 62.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 13.7 mm -75.7 -56.03 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -139.52 134.61 16.41 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.524 0.678 . . . . 0.0 110.923 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 138.09 37.09 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.679 2.253 . . . . 0.0 112.359 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 56.08 41.09 84.82 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -105.07 -53.06 2.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 111.073 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.44 ' CG2' ' OD1' ' A' ' 252' ' ' ASN . 96.9 t -61.15 114.61 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.154 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -72.02 -62.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.926 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -149.07 151.45 34.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.86 151.71 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -141.47 116.2 9.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.417 ' NZ ' ' HB ' ' A' ' 242' ' ' THR . 30.1 tptt -84.88 145.94 27.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.573 ' CD1' ' CD2' ' A' ' 268' ' ' TYR . 5.3 mt -133.88 172.18 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.467 ' C ' ' O ' ' A' ' 265' ' ' ILE . 14.4 mmm180 -31.51 -72.04 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -126.88 19.13 7.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.2 OUTLIER -148.4 177.85 9.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -163.98 170.55 16.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -133.35 146.24 51.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.451 HG21 ' CE2' ' A' ' 251' ' ' PHE . 16.6 t -133.55 134.2 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.136 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -112.41 152.34 28.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -129.2 -177.82 4.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 41.8 t -95.45 -22.01 17.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.45 151.4 31.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -62.44 -37.39 85.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -48.24 -63.49 1.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.92 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -44.88 94.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.847 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.98 -47.15 61.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.87 -42.67 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -60.87 -49.26 78.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.829 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.0 -29.93 71.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.125 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 53.6 ttp -70.42 -50.37 39.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -69.97 -30.09 67.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.59 -45.1 84.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.531 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 41.5 mt -87.28 -27.6 22.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.436 ' OD1' ' C ' ' A' ' 287' ' ' ASN . 23.4 t-20 -48.8 108.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 97.62 33.74 5.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.505 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -113.95 151.13 32.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.932 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 86.3 t -110.05 103.47 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.162 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.441 HD12 ' CD1' ' A' ' 296' ' ' ILE . 25.1 mt -102.4 147.11 27.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 44.97 24.96 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.847 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 77.97 41.31 18.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.49 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 3.0 t -153.81 135.16 8.71 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.681 0.753 . . . . 0.0 110.836 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.463 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 54.3 Cg_endo -69.72 93.94 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.441 ' CD1' HD12 ' A' ' 291' ' ' LEU . 11.4 pt -76.64 146.51 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.12 135.11 54.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.908 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.79 118.21 54.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 18.9 p -132.45 166.29 22.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.153 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.2 mt -83.77 102.87 12.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -71.16 157.33 38.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.115 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -106.71 140.93 21.83 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.586 0.708 . . . . 0.0 110.908 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 143.55 51.27 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.678 2.252 . . . . 0.0 112.34 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 90.8 t -108.85 110.42 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -156.54 134.58 11.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.76 135.22 33.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.911 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -59.2 105.22 0.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 4.6 m -73.97 154.94 39.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 59.0 p -95.45 -44.77 7.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 125.24 146.75 6.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 136.14 32.1 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.661 2.241 . . . . 0.0 112.345 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 34.0 p -71.78 -58.65 3.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 1.8 t 66.84 42.22 2.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 37.3 p -83.48 101.04 11.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.861 0.362 . . . . 0.0 110.851 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 45.6 m -88.69 -45.69 9.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 121.87 142.08 6.23 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 51.9 p -88.9 138.29 31.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 16.9 m -80.56 -29.34 37.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 101.8 -94.28 1.2 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -115.22 130.7 56.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.787 0.327 . . . . 0.0 110.896 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.44 ' N ' ' CD ' ' A' ' 224' ' ' GLU . 1.4 pm0 -142.53 174.17 10.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -128.27 102.27 6.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 82.6 p -83.34 45.3 1.02 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.76 -48.24 5.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 96.6 p -148.8 126.99 12.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.855 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 43.7 m -86.91 102.56 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.843 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.2 p -113.68 132.03 63.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.45 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -133.95 117.03 16.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 98.6 mt -147.73 139.14 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 12.1 mt -121.09 107.63 12.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.751 ' CD1' ' CE1' ' A' ' 270' ' ' PHE . 33.3 t80 -91.46 121.32 33.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.19 132.23 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -119.69 155.78 31.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.41 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 38.6 t-20 70.68 52.62 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.23 126.62 52.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 22.8 mtt -71.49 139.98 49.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 39.9 mt -55.96 -18.74 9.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.3 t -75.89 -28.59 58.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 42.8 m -64.5 146.66 54.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 44.1 m -120.63 165.71 14.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.805 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -64.5 -16.37 62.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -69.59 -64.02 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.408 ' HA ' ' CD ' ' A' ' 249' ' ' LYS . 13.0 ptp -54.7 -30.87 56.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.854 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 73.1 mt -69.81 -45.13 78.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -65.53 -53.56 40.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.468 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 0.7 OUTLIER -53.32 -49.48 66.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.468 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 61.4 mm-40 -52.92 -53.46 49.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.503 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 5.8 m-85 -61.83 -58.49 7.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 253' ' ' ASN . 2.3 m120 -47.12 -49.1 22.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.952 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 252' ' ' ASN . 29.8 m-20 -36.65 -46.77 0.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.905 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.464 HD13 ' CB ' ' A' ' 285' ' ' ALA . 43.1 mm -51.64 -56.79 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.124 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.462 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 0.1 OUTLIER -143.95 137.06 13.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.548 0.689 . . . . 0.0 110.932 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.462 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 53.0 Cg_endo -69.82 136.75 33.64 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.63 2.22 . . . . 0.0 112.309 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 60.12 36.42 90.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -99.43 -39.15 8.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 111.13 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.5 t -90.99 132.99 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.171 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.424 ' OE1' ' N ' ' A' ' 260' ' ' GLU . 0.7 OUTLIER -94.37 -52.17 4.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . 0.478 ' HD3' ' N ' ' A' ' 262' ' ' VAL . 0.1 OUTLIER -151.23 161.75 42.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.478 ' N ' ' HD3' ' A' ' 261' ' ' ARG . 32.5 t -131.63 138.89 51.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.154 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 6.6 tppt? -123.99 113.6 18.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.9 tptp -87.66 143.31 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.56 HD11 ' CD2' ' A' ' 268' ' ' TYR . 6.7 mt -133.61 172.93 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.13 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.476 ' C ' ' O ' ' A' ' 265' ' ' ILE . 20.4 mmt180 -30.66 -73.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.99 15.92 7.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -142.49 172.39 12.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.943 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -159.28 165.54 33.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.08 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.751 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 86.8 m-85 -128.35 149.6 50.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 19.8 t -132.56 123.78 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.115 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -97.15 144.24 27.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.835 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -120.4 177.52 5.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 33.4 t -90.86 -33.4 15.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.84 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -143.15 161.38 38.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 277' ' ' GLU . 11.1 ttp180 -64.49 -61.77 2.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 276' ' ' ARG . 16.1 mt-10 -35.99 -49.11 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -64.19 -50.73 66.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -53.4 -47.3 69.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 83.5 t -59.69 -43.12 90.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.84 -56.39 17.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.09 -38.24 67.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.124 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 65.0 ttp -60.32 -47.71 84.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.872 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -70.08 -37.6 75.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.464 ' CB ' HD13 ' A' ' 254' ' ' ILE . . . -55.19 -47.96 74.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.091 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.503 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 64.8 mt -84.6 -36.65 21.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 286' ' ' LEU . 11.3 t30 -36.74 93.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 113.03 33.82 1.93 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.475 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -110.79 157.88 19.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.458 HG11 ' N ' ' A' ' 294' ' ' SER . 91.3 t -119.8 96.13 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 31.3 mt -92.9 147.29 22.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.4 ' OD1' ' SD ' ' A' ' 246' ' ' MET . 3.2 m-20 46.64 30.47 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 69.91 43.05 67.4 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.459 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.458 ' N ' HG11 ' A' ' 290' ' ' VAL . 1.9 m -155.05 137.35 9.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.693 0.759 . . . . 0.0 110.856 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.41 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.3 Cg_endo -69.79 108.74 2.15 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.627 2.218 . . . . 0.0 112.365 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 10.1 pt -97.54 141.72 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -112.34 143.9 42.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.847 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.07 117.84 51.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 10.5 p -132.84 167.57 19.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.209 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 9.3 mt -85.91 113.18 21.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -66.23 139.01 58.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.125 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.0 141.77 59.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.586 0.708 . . . . 0.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 141.7 45.69 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.701 2.267 . . . . 0.0 112.297 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 91.4 t -104.32 99.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -82.3 51.24 1.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.83 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -44.17 117.42 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.92 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -62.81 134.59 56.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 60.2 p -107.92 132.63 53.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.874 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 2.7 m -115.55 136.52 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 114.79 148.21 9.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.487 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 91.61 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.656 2.237 . . . . 0.0 112.352 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 7.4 t -156.93 125.2 5.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.862 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 3.5 m -58.08 176.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.907 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.526 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.3 m -101.05 97.73 8.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.844 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 18.2 p -126.28 161.07 28.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.847 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 104.87 40.78 2.08 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.509 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 96.6 p -116.33 149.83 38.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.881 0.372 . . . . 0.0 110.87 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 43.9 m -101.0 -35.15 9.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 156.39 -156.1 26.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.509 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.38 118.96 33.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.748 0.309 . . . . 0.0 110.902 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -78.81 85.25 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.92 167.01 8.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 9.4 t -164.08 158.93 19.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.117 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 11.0 mmt -75.37 -51.77 12.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.936 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 24.4 m -83.17 93.18 7.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 80.1 p -109.62 107.75 17.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -116.25 132.69 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.112 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.417 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -130.72 116.9 18.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 68.5 mt -147.91 136.42 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.129 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 23.4 mt -118.57 110.16 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.402 ' CD1' ' CE1' ' A' ' 270' ' ' PHE . 28.2 t80 -93.47 125.74 38.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.3 t -108.83 142.52 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.089 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 7.3 ttt-85 -134.87 157.23 47.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 295' ' ' PRO . 12.2 t30 71.92 47.95 0.3 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 31.0 mt -100.99 125.34 47.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 14.3 mtt -63.75 125.73 25.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.836 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 20.3 mt -50.93 -23.95 3.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.934 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 7.2 m -68.87 -33.32 73.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 24.9 m -63.56 144.9 56.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.196 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.6 m -112.17 165.81 11.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.855 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.57 -46.69 80.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -45.17 -36.65 3.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 27.5 mtt -69.53 -42.02 75.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.879 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 46.0 mt -68.89 -39.92 80.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.452 ' OE1' ' CG2' ' A' ' 262' ' ' VAL . 4.3 tp10 -64.69 -43.79 92.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.864 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 1.7 ptmm? -72.54 -46.27 55.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 62.3 mm-40 -56.82 -33.51 66.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.915 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.631 ' CD1' ' CD1' ' A' ' 286' ' ' LEU . 8.0 m-85 -87.93 -30.61 19.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -76.42 -26.91 55.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -52.72 -23.84 7.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 16.0 mm -78.19 -52.82 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -144.14 134.0 11.76 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.587 0.708 . . . . 0.0 110.924 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 142.53 48.28 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 0.0 112.348 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 55.13 26.23 41.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.519 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -90.52 -53.72 4.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.333 . . . . 0.0 111.08 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.5 t -62.25 114.42 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -73.98 -60.02 2.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -150.2 146.2 26.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.87 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.452 ' CG2' ' OE1' ' A' ' 248' ' ' GLU . 61.3 t -116.92 128.84 74.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.13 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -115.63 108.41 16.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -85.22 142.17 29.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.565 HD11 ' CD2' ' A' ' 268' ' ' TYR . 6.7 mt -133.86 172.41 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.472 ' C ' ' O ' ' A' ' 265' ' ' ILE . 15.6 mmt180 -31.11 -72.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.82 15.84 8.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.85 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -143.37 175.27 10.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -163.79 160.32 22.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.052 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.402 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 86.4 m-85 -124.56 138.15 54.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.12 129.58 74.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.11 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -106.69 151.74 24.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.865 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -129.73 174.62 9.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 25.4 t -80.96 -38.41 27.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.878 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -144.28 153.31 41.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 277' ' ' GLU . 21.5 ttt180 -50.87 -56.17 13.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.876 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 276' ' ' ARG . 4.9 mm-40 -35.76 -54.76 0.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -59.63 -49.93 75.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.813 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -53.05 -50.18 64.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 48.9 t -53.75 -48.9 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -59.01 -59.93 4.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.844 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.28 -18.64 6.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 56.9 ttp -78.01 -57.67 3.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -66.89 -29.56 69.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -62.42 -56.99 12.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.095 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.631 ' CD1' ' CD1' ' A' ' 251' ' ' PHE . 55.2 mt -76.71 -40.19 49.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.945 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -39.87 121.14 1.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 90.63 27.33 20.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.525 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -110.37 161.78 15.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.419 HG11 ' C ' ' A' ' 294' ' ' SER . 72.9 t -123.85 95.11 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.078 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.409 HD23 ' CD ' ' A' ' 250' ' ' GLU . 33.1 mt -87.07 148.01 25.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 40.6 t0 41.47 41.54 1.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.902 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 59.58 45.85 94.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.419 ' C ' HG11 ' A' ' 290' ' ' VAL . 2.0 t -154.62 136.59 9.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.683 0.754 . . . . 0.0 110.883 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.425 ' O ' ' ND2' ' A' ' 237' ' ' ASN . 53.6 Cg_endo -69.76 110.9 2.67 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.712 2.275 . . . . 0.0 112.306 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 10.8 pt -101.33 144.38 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.176 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -115.45 151.79 34.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 8.8 t -140.43 113.52 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 51.2 p -134.35 167.65 20.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.163 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 10.9 mt -81.54 108.87 15.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.92 137.41 53.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.42 90.49 5.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 0.0 110.942 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 133.41 25.54 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.661 2.241 . . . . 0.0 112.384 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 29.1 m -82.96 143.2 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.141 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -158.81 111.46 2.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.28 -44.06 53.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -50.54 110.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 309' ' ' SER . 11.2 t -72.19 120.94 18.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 308' ' ' SER . 47.3 p -37.32 108.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.836 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -174.18 83.85 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.514 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 163.88 36.59 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.656 2.237 . . . . 0.0 112.352 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 68.9 m -70.0 167.25 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 51.2 m -58.86 168.92 1.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.886 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.508 -179.926 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 39.7 t -68.24 -54.49 17.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.378 . . . . 0.0 110.877 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 2.7 t -46.74 153.14 0.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -168.87 -66.6 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 43.1 m -82.95 145.69 29.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 110.863 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 t -62.7 -14.79 48.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.832 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 122.55 -101.81 0.75 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.509 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -135.69 124.88 24.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 110.828 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -119.4 -45.82 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 6.5 t70 57.34 30.84 19.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 9.9 t -68.61 137.94 54.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.094 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 3.9 ttp -72.87 -30.26 63.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 30.2 t -81.79 110.13 16.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 94.6 p -70.29 105.77 3.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.19 136.5 51.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.112 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.457 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -137.61 116.88 12.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 77.0 mt -147.91 140.29 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.055 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.461 HD11 ' CE1' ' A' ' 273' ' ' PHE . 11.4 mt -120.83 111.87 18.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.921 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 236' ' ' ARG . 16.2 t80 -92.08 129.72 37.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.469 HG13 ' CG ' ' A' ' 238' ' ' LEU . 17.4 t -115.18 133.82 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.505 ' HB2' ' CE2' ' A' ' 234' ' ' TYR . 30.3 ttp85 -129.31 161.17 30.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 71.26 35.84 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.469 ' CG ' HG13 ' A' ' 235' ' ' VAL . 11.5 mt -91.76 122.6 34.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.496 ' CB ' ' OD2' ' A' ' 292' ' ' ASP . 4.7 mmt -57.43 139.66 52.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.495 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 40.4 mt -63.34 -7.66 6.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.885 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 37.6 m -97.44 16.64 19.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.459 HG22 ' N ' ' A' ' 243' ' ' SER . 49.2 m -99.02 145.33 27.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.459 ' N ' HG22 ' A' ' 242' ' ' THR . 2.3 m -119.05 155.07 32.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -56.1 -15.04 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.835 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -72.58 -66.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 13.2 ptp -55.64 -29.08 58.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 63.4 mt -75.77 -45.84 37.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.134 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.411 ' HG2' ' ND2' ' A' ' 252' ' ' ASN . 17.9 tt0 -63.1 -44.28 96.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 16.2 ptmt -64.61 -47.58 78.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.472 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 21.6 mm-40 -57.25 -34.72 68.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -81.89 -32.16 31.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.411 ' ND2' ' HG2' ' A' ' 248' ' ' GLU . 59.2 m-20 -79.86 -14.6 58.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -60.17 -18.48 48.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 10.0 mm -79.86 -60.21 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -136.67 135.32 20.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.556 0.693 . . . . 0.0 110.959 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 137.45 35.56 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.727 2.285 . . . . 0.0 112.317 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.57 40.43 94.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.511 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -102.56 -56.41 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 111.112 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.432 HG11 ' N ' ' A' ' 260' ' ' GLU . 97.2 t -59.76 136.13 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.432 ' N ' HG11 ' A' ' 259' ' ' VAL . 28.5 mm-40 -93.91 -55.77 3.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -152.74 149.32 28.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 19.2 t -122.41 137.85 54.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -128.31 109.1 11.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -80.35 140.62 36.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.954 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.57 HD12 ' CD2' ' A' ' 268' ' ' TYR . 6.2 mt -130.82 173.33 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.083 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.504 ' C ' ' O ' ' A' ' 265' ' ' ILE . 22.0 mmt180 -28.66 -75.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.879 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -125.0 14.26 8.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -140.58 171.67 13.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.944 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -157.87 154.88 28.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -116.07 146.06 42.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.892 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 18.1 t -134.49 125.35 46.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.145 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -98.9 154.68 17.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.889 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.461 ' CE1' HD11 ' A' ' 233' ' ' LEU . 18.6 m-85 -131.85 167.88 18.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.6 t -77.18 -33.78 56.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -146.63 153.13 39.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 277' ' ' GLU . 5.8 ttt-85 -54.04 -55.95 22.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 276' ' ' ARG . 77.8 mt-10 -34.91 -59.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.885 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -56.84 -49.11 76.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.83 -53.33 33.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.66 -37.0 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.159 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -65.41 -49.4 69.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.97 -21.17 65.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 51.2 ttp -71.3 -58.45 3.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -66.16 -30.02 70.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -60.66 -55.67 30.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 42.8 mt -79.49 -31.29 42.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -40.65 115.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 93.08 32.92 7.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -109.83 157.46 19.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.802 0.334 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 76.5 t -118.79 96.19 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.152 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 30.6 mt -95.0 152.81 18.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.496 ' OD2' ' CB ' ' A' ' 239' ' ' MET . 34.2 t70 41.86 26.51 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.83 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.7 43.84 34.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.516 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 2.0 m -154.39 137.88 10.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.62 0.724 . . . . 0.0 110.897 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 91.93 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.685 2.257 . . . . 0.0 112.352 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 17.2 pt -78.35 144.97 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -120.44 140.06 51.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.91 134.61 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 41.0 p -147.32 176.43 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 15.5 mt -95.64 105.78 17.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -71.78 145.01 48.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -94.65 143.97 27.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.582 0.706 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 150.78 68.59 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.717 2.278 . . . . 0.0 112.32 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 304' ' ' VAL . 9.3 p -90.29 121.24 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.13 147.31 35.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.822 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -133.51 136.27 44.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -72.65 84.98 1.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 8.5 t -59.09 127.28 31.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.839 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 18.2 m -123.3 164.82 18.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.884 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 105.31 83.03 1.63 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.429 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 159.13 54.54 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.665 2.244 . . . . 0.0 112.375 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 22.1 p -139.58 138.68 36.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 40.0 t -55.75 124.66 18.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.7 t -131.91 167.57 19.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.87 0.367 . . . . 0.0 110.876 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 31.3 t -85.6 136.1 33.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 86.12 51.64 3.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.491 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 88.1 p -138.84 121.73 16.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.382 . . . . 0.0 110.86 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.4 t -116.94 -34.69 4.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.895 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -166.63 84.71 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -92.31 140.5 29.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.745 0.307 . . . . 0.0 110.851 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -119.64 86.45 2.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.891 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 46.86 39.81 8.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 10.1 t -104.46 116.14 31.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.134 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 17.4 ptm -96.41 -45.37 6.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 87.8 p -79.36 129.93 34.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 69.0 m -61.75 103.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.859 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.42 130.5 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.116 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.405 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -131.32 116.85 18.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 40.6 mt -148.05 136.5 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.114 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 36.0 mt -124.04 108.57 12.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.416 ' HB2' ' CB ' ' A' ' 301' ' ' ALA . 22.8 t80 -92.02 126.27 37.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.873 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 24.3 t -108.0 144.49 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.134 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -136.98 157.81 45.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 295' ' ' PRO . 15.1 t30 72.9 53.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 14.8 mt -111.14 134.46 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 3.8 mtt -70.51 137.47 50.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 70.3 mt -53.95 -18.65 3.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 36.7 m -75.09 -31.36 61.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 50.6 m -67.5 127.27 32.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.151 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.1 t -107.08 157.4 17.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -43.34 -28.04 0.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -60.55 -42.55 96.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.3 mmt -63.82 -42.47 97.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 69.1 mt -67.12 -36.9 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.439 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 19.3 tt0 -70.34 -49.12 52.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 4.8 ptmt -63.23 -46.77 85.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.471 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 27.7 mm-40 -59.79 -56.29 23.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.865 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.495 ' CD2' HG13 ' A' ' 271' ' ' VAL . 7.4 m-85 -62.33 -41.77 98.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.439 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 5.8 m-20 -62.03 -42.35 99.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -38.49 -42.62 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 44.2 mm -53.99 -58.95 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.437 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 26.6 tptt -141.05 136.81 16.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.538 0.685 . . . . 0.0 110.909 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.437 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 53.4 Cg_endo -69.77 131.28 20.89 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.677 2.251 . . . . 0.0 112.325 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 62.82 39.52 98.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.509 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -103.94 -45.11 4.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 0.0 111.069 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.409 ' CG2' ' OD1' ' A' ' 252' ' ' ASN . 93.8 t -71.62 117.89 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.64 -60.32 2.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -145.52 152.96 40.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.2 t -127.8 130.74 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -118.94 109.65 16.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -86.66 143.61 27.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.902 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.486 ' O ' ' C ' ' A' ' 266' ' ' ARG . 5.5 mt -133.95 172.65 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.486 ' C ' ' O ' ' A' ' 265' ' ' ILE . 22.7 mmt180 -30.89 -70.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -125.62 -1.11 7.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.641 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -124.45 177.54 5.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.96 164.94 16.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.101 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.484 ' CE2' HD11 ' A' ' 265' ' ' ILE . 97.8 m-85 -127.21 142.81 51.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.495 HG13 ' CD2' ' A' ' 251' ' ' PHE . 5.2 t -129.99 122.65 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -105.74 133.38 50.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.817 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.431 ' CZ ' ' CB ' ' A' ' 282' ' ' ALA . 30.9 m-85 -108.02 175.71 5.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.449 ' O ' ' ND2' ' A' ' 275' ' ' ASN . 17.3 t -86.5 -28.46 23.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 274' ' ' SER . 5.3 m120 -146.92 149.52 33.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -52.48 -49.19 65.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 278' ' ' ASP . 13.8 pt-20 -44.35 -51.85 8.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.411 ' N ' ' HG3' ' A' ' 277' ' ' GLU . 2.5 m-20 -60.62 -50.53 73.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.844 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -52.44 -49.79 63.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.06 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 77.9 t -53.77 -54.97 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -53.56 -59.83 4.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.431 ' CB ' ' CZ ' ' A' ' 273' ' ' PHE . . . -54.33 -29.36 47.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 62.2 ttp -68.84 -57.14 5.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -63.67 -51.62 64.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -45.12 -51.97 9.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.074 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.431 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 81.4 mt -79.13 -29.15 42.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.914 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.402 ' O ' ' ND2' ' A' ' 287' ' ' ASN . 2.7 t30 -49.52 91.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 115.88 31.49 1.91 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.458 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -106.5 163.2 13.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 110.931 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 51.9 t -125.53 96.59 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.106 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 294' ' ' SER . 72.0 mt -89.92 152.67 21.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.899 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 291' ' ' LEU . 1.6 m-20 34.94 36.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 66.62 46.99 71.51 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.477 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 291' ' ' LEU . 5.2 t -154.77 136.25 9.22 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.667 0.746 . . . . 0.0 110.86 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.448 ' O ' ' ND2' ' A' ' 237' ' ' ASN . 54.1 Cg_endo -69.68 106.05 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.719 2.279 . . . . 0.0 112.367 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.9 pt -94.09 145.28 8.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.16 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -118.6 146.83 44.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.0 117.81 39.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 33.9 p -135.67 170.31 16.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 22.3 mt -86.89 102.2 14.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.934 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.416 ' CB ' ' HB2' ' A' ' 234' ' ' TYR . . . -72.41 114.16 10.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -79.31 143.99 61.35 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.537 0.684 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 141.48 45.41 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.67 2.247 . . . . 0.0 112.334 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 91.6 t -103.22 97.28 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.129 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -139.5 135.67 33.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -63.64 153.58 35.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.35 123.92 23.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 21.9 p -82.31 155.31 24.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 60.3 p -100.06 151.92 20.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.866 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 178.72 -178.15 48.64 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.493 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 135.69 31.25 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.707 2.272 . . . . 0.0 112.321 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 70.6 m -96.28 -55.71 2.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.86 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 1.9 t -112.39 107.38 16.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.836 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.479 -179.982 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 7.3 t 52.25 41.53 30.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 110.831 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 31.5 t -109.76 103.24 12.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 109.97 57.21 0.52 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.473 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 93.4 p -114.5 42.26 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.875 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.3 t -112.25 -34.5 5.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 80.68 -100.96 1.99 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.458 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -50.01 104.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.766 0.317 . . . . 0.0 110.838 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.21 94.47 2.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -55.97 -47.11 78.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 42.1 p 40.1 41.1 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 33.8 mtt -95.4 -46.06 6.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 42.9 m -159.41 148.73 18.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.9 m -65.66 99.35 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.884 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.88 133.11 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.139 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.34 116.84 19.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.418 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 20.0 mt -147.95 130.93 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.09 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 15.2 mt -117.49 112.49 20.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.914 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -91.85 128.99 37.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.09 128.74 73.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.127 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -125.23 159.55 31.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 7.0 t30 71.88 51.23 0.23 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 41.5 mt -107.83 119.09 38.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 7.0 mmt -54.3 125.39 19.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 65.1 mt -44.44 -30.17 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 36.0 t -59.92 -40.53 89.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.443 ' HA ' ' CE ' ' A' ' 246' ' ' MET . 30.9 m -60.56 155.16 19.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.153 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 43.2 m -134.64 168.28 19.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.838 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 245' ' ' GLU . 54.3 mt-10 -47.43 -57.74 4.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 244' ' ' GLU . 38.0 tt0 -35.68 -59.73 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.443 ' CE ' ' HA ' ' A' ' 242' ' ' THR . 6.9 mtt -47.52 -51.66 19.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.0 -34.02 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.118 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -64.66 -51.38 62.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.454 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 1.6 ptpp? -65.81 -44.34 85.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.888 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.497 ' O ' ' ND2' ' A' ' 253' ' ' ASN . 52.0 mm-40 -61.0 -28.8 69.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.466 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 7.2 m-85 -95.24 -23.19 17.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.77 -35.7 32.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 250' ' ' GLU . 0.6 OUTLIER -42.56 -29.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 15.5 mm -68.76 -66.79 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -131.35 131.96 23.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.519 0.676 . . . . 0.0 110.887 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 121.83 8.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 72.9 33.25 60.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.522 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -101.34 -39.71 7.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 78.8 t -73.16 113.75 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.061 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -66.84 -65.0 0.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.907 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . 0.463 ' CD ' ' HB2' ' A' ' 272' ' ' HIS . 0.0 OUTLIER -146.86 162.62 38.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.877 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 48.1 t -133.53 137.57 52.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.419 ' C ' ' HD3' ' A' ' 263' ' ' LYS . 9.4 tmtm? -127.06 105.2 8.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.406 ' HB2' ' CG ' ' A' ' 244' ' ' GLU . 11.4 tptp -79.67 145.17 33.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.56 HD12 ' CD2' ' A' ' 268' ' ' TYR . 6.8 mt -133.6 172.05 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.148 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.467 ' C ' ' O ' ' A' ' 265' ' ' ILE . 51.9 mtt85 -32.01 -71.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.64 15.57 7.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -142.56 177.37 8.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -167.6 164.74 14.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.075 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -130.94 142.9 50.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.47 125.51 70.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.107 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . 0.463 ' HB2' ' CD ' ' A' ' 261' ' ' ARG . 3.5 m-70 -105.3 137.55 42.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -117.03 -177.51 3.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.83 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.3 t -99.45 -24.99 14.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -144.78 144.17 31.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.865 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 277' ' ' GLU . 9.6 ttp180 -54.4 -54.17 44.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 276' ' ' ARG . 4.8 mm-40 -35.64 -54.64 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.42 -51.72 67.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -46.48 -46.88 19.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.057 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.428 ' CG1' ' HD2' ' A' ' 284' ' ' LYS . 51.6 t -65.69 -54.47 27.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.084 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -50.13 -47.61 54.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.49 -31.37 68.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 67.6 ttp -66.82 -53.58 31.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.428 ' HD2' ' CG1' ' A' ' 280' ' ' VAL . 30.0 mtpt -65.92 -39.75 90.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -53.85 -53.83 47.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.466 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 35.2 mt -77.06 -35.49 56.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -41.15 95.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 114.83 32.53 1.87 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.524 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -113.66 160.35 18.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 0.0 110.863 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 294' ' ' SER . 95.8 t -123.23 103.59 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 293' ' ' GLY . 22.4 mt -95.64 150.85 19.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 41.92 24.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 77.32 38.17 29.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.472 ' N ' HG13 ' A' ' 290' ' ' VAL . 23.6 p -145.59 135.68 11.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 110.908 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 102.41 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.7 2.267 . . . . 0.0 112.328 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.3 pt -90.43 147.2 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.11 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -122.96 140.69 52.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.24 122.33 65.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 81.9 p -137.84 172.79 12.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.122 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 11.4 mt -90.22 110.02 21.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.418 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -71.43 153.42 42.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.105 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.35 142.45 24.57 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.578 0.704 . . . . 0.0 110.893 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 152.76 69.48 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.669 2.246 . . . . 0.0 112.373 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.42 135.68 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.092 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -104.16 126.07 50.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -156.15 120.42 4.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.2 84.44 7.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.862 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 19.4 t -78.49 161.99 26.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 15.8 t -69.55 155.13 40.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -40.6 160.81 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -17.47 37.44 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.671 2.247 . . . . 0.0 112.317 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 92.1 p -78.07 114.92 17.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.851 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 3.9 m -77.7 137.74 38.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.839 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.543 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 218' ' ' SER . 58.1 m -123.81 131.04 53.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.927 0.394 . . . . 0.0 110.854 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 217' ' ' SER . 1.8 t 37.85 42.08 0.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.876 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -84.02 -58.19 2.26 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 75.6 m -105.28 83.24 1.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.3 p -86.35 -35.0 20.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.852 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 175.86 -148.35 9.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.528 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -172.17 120.58 0.43 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.78 143.73 46.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -99.3 156.13 17.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 27.2 m -62.48 -52.81 62.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 81.8 mtp -63.48 -53.98 43.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.853 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 1.9 m -87.23 92.92 9.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.842 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 88.9 p -101.35 109.81 21.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.836 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.54 131.98 62.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.138 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.21 116.83 17.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 21.9 mt -147.94 140.77 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.567 HD13 ' CE1' ' A' ' 273' ' ' PHE . 39.5 mt -126.28 106.89 9.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.514 ' CE2' ' HG3' ' A' ' 236' ' ' ARG . 38.9 t80 -91.38 123.95 35.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.96 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 20.8 t -104.45 148.36 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.514 ' HG3' ' CE2' ' A' ' 234' ' ' TYR . 24.0 mtp180 -138.72 160.31 39.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.453 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 26.7 t-20 67.72 53.03 0.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 27.0 mt -109.46 120.63 43.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 8.4 mmt -54.97 133.64 48.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.849 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.489 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 54.4 mt -51.91 -25.01 7.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 61.5 m -70.79 -32.3 69.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 93.9 m -65.82 139.95 58.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.1 t -121.11 164.11 17.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.83 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -47.92 -22.04 0.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -65.69 -45.3 83.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 2.3 mmt -67.59 -44.53 77.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 79.2 mt -65.97 -37.65 80.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.442 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 13.9 tt0 -71.62 -57.75 4.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 5.8 ptmt -49.34 -45.98 46.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.473 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 23.6 mm-40 -61.99 -58.21 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.531 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 6.0 m-85 -54.57 -27.53 39.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 16.2 m120 -71.77 -44.57 63.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.955 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -38.78 -40.76 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 17.0 mm -56.47 -64.24 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -139.48 131.75 15.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.58 0.705 . . . . 0.0 110.908 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 136.67 33.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.617 2.211 . . . . 0.0 112.39 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 63.37 33.32 86.93 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.445 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -100.75 -51.04 3.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.353 . . . . 0.0 111.108 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 260' ' ' GLU . 69.5 t -60.73 135.9 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.123 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.401 ' N ' HG13 ' A' ' 259' ' ' VAL . 18.1 mt-10 -96.89 -64.33 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.885 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -146.06 142.41 28.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 263' ' ' LYS . 66.6 t -120.92 136.55 57.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.419 ' N ' HG12 ' A' ' 262' ' ' VAL . 68.2 tttt -129.66 110.13 11.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' A' ' 265' ' ' ILE . 23.4 tptp -79.49 144.63 33.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.547 HD11 ' CD2' ' A' ' 268' ' ' TYR . 6.5 mt -132.3 173.1 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.141 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.491 ' C ' ' O ' ' A' ' 265' ' ' ILE . 20.3 mmm180 -29.4 -68.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -132.42 15.08 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.2 OUTLIER -142.86 173.38 11.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.928 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -162.18 158.98 25.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.086 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 95.3 m-85 -118.62 148.86 42.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 21.3 t -134.81 124.43 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -100.68 146.82 26.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.567 ' CE1' HD13 ' A' ' 233' ' ' LEU . 22.7 m-85 -126.84 167.59 15.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.887 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 45.8 m -74.79 -39.17 61.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -142.87 153.34 43.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.443 ' O ' ' C ' ' A' ' 277' ' ' GLU . 10.0 ttt85 -54.4 -57.7 10.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 276' ' ' ARG . 4.6 mp0 -34.36 -50.25 0.41 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -63.67 -53.65 48.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -51.86 -53.31 41.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.405 HG13 ' NZ ' ' A' ' 284' ' ' LYS . 56.1 t -52.74 -44.8 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.173 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.62 -51.83 67.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.15 -14.57 63.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.107 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -76.6 -60.8 2.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.405 ' NZ ' HG13 ' A' ' 280' ' ' VAL . 19.0 mtmm -64.22 -37.48 87.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -51.46 -54.7 24.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.111 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.531 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 50.5 mt -76.08 -40.16 53.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 286' ' ' LEU . 2.0 t30 -36.29 97.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 109.51 33.91 2.58 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.522 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -114.86 164.2 14.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.769 0.318 . . . . 0.0 110.953 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 56.8 t -124.64 110.79 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.114 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 293' ' ' GLY . 26.9 mt -102.96 146.38 28.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 39.62 29.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.59 47.55 12.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.469 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.8 m -154.52 134.68 8.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.678 0.751 . . . . 0.0 110.852 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.453 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.4 Cg_endo -69.76 94.78 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 10.1 pt -83.61 148.31 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 298' ' ' VAL . 4.5 tp10 -122.79 148.41 45.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.423 ' N ' ' HG3' ' A' ' 297' ' ' GLU . 4.2 t -130.97 117.88 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.156 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 24.7 p -134.78 160.57 37.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.175 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 8.8 mt -83.88 100.61 11.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -66.73 124.52 23.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.069 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.12 143.44 77.23 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.583 0.706 . . . . 0.0 110.918 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 162.8 40.67 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.321 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.77 135.26 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -72.09 139.17 48.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -171.75 117.14 0.4 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.919 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -105.6 103.62 13.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.874 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 82.9 p -79.72 140.6 36.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 35.3 t -108.26 122.97 48.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -177.66 146.08 7.44 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -175.28 1.1 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.683 2.255 . . . . 0.0 112.345 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 79.2 p -114.52 93.65 4.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.871 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 2.7 m -129.83 156.76 43.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.481 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 38.1 m -115.03 116.6 28.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 0.0 110.849 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 4.0 t -84.41 -56.83 3.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 142.18 -157.24 26.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 24.6 p -64.63 153.47 39.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.886 0.374 . . . . 0.0 110.882 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.9 t -101.31 -34.9 9.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 86.49 107.92 0.8 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.502 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -141.78 144.0 33.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.765 0.317 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -50.22 135.28 21.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . 0.401 ' O ' ' CG ' ' A' ' 225' ' ' ASP . 15.1 p-10 -50.22 97.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.825 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 23.8 m -90.88 137.8 32.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.171 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 23.0 ttt -84.19 -46.6 11.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 32.4 t -76.8 109.54 10.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.838 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 92.5 p -64.13 103.7 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.831 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -106.83 131.02 57.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.131 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.64 116.42 18.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 80.9 mt -147.9 142.66 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.139 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.546 HD11 ' CE1' ' A' ' 273' ' ' PHE . 81.7 mt -128.94 106.0 8.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.575 ' CD1' ' CE1' ' A' ' 270' ' ' PHE . 32.6 t80 -91.31 128.52 37.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.9 t -109.56 150.64 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.149 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -138.81 157.98 45.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 71.8 54.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 23.6 mt -107.04 113.14 26.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.45 ' CG ' ' OD2' ' A' ' 292' ' ' ASP . 13.4 mmt -53.89 128.15 28.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.443 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 25.7 mt -49.09 -30.38 6.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.906 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 97.8 p -64.49 -33.36 75.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.445 ' O ' ' NZ ' ' A' ' 264' ' ' LYS . 7.8 m -58.96 150.05 25.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.146 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 3.4 m -118.02 159.79 22.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -54.19 -41.62 68.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -54.84 -32.34 60.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.6 mtt -70.74 -37.25 73.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 25.9 mt -74.72 -39.81 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.156 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -68.81 -45.97 69.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.476 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 0.0 OUTLIER -62.35 -48.38 80.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.907 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.476 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 52.8 mm-40 -56.35 -50.11 72.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.457 ' CD2' HG12 ' A' ' 271' ' ' VAL . 7.2 m-85 -65.74 -23.56 66.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -75.49 -41.38 55.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -37.37 -46.96 0.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 49.7 mm -49.59 -63.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -141.17 129.38 12.29 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.596 0.712 . . . . 0.0 110.934 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 114.96 3.88 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.672 2.248 . . . . 0.0 112.324 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 90.36 38.23 6.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -114.35 -43.62 3.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 111.084 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.61 118.4 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -80.25 -67.99 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -144.76 150.92 38.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 93.7 t -127.22 130.1 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.12 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -115.54 106.26 13.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.445 ' NZ ' ' O ' ' A' ' 242' ' ' THR . 15.6 tptm -80.09 140.94 36.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.571 HD13 ' CD2' ' A' ' 268' ' ' TYR . 5.1 mt -132.26 172.42 16.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.465 ' C ' ' O ' ' A' ' 265' ' ' ILE . 30.7 mmt180 -31.78 -72.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 7.7 p-10 -126.51 17.48 7.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.2 OUTLIER -146.25 178.01 8.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -169.22 165.78 10.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.104 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.575 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 96.3 m-85 -126.89 145.4 50.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.457 HG12 ' CD2' ' A' ' 251' ' ' PHE . 66.6 t -129.79 134.54 62.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.117 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -113.99 156.29 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.546 ' CE1' HD11 ' A' ' 233' ' ' LEU . 44.9 m-85 -134.37 179.95 5.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 62.5 p -83.26 -34.68 25.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -147.49 153.18 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.872 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 277' ' ' GLU . 8.5 ttt85 -53.79 -54.57 36.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 276' ' ' ARG . 44.7 mt-10 -34.48 -56.52 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.81 -50.78 72.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.05 -54.23 21.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.038 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 71.6 t -53.39 -47.89 57.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.088 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -56.0 -58.45 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.19 -30.87 51.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.091 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 63.6 ttp -68.07 -55.74 11.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -68.6 -14.94 63.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -79.29 -52.73 7.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.082 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 287' ' ' ASN . 59.5 mt -82.69 -35.16 27.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 286' ' ' LEU . 2.3 t-20 -38.28 99.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 107.68 34.37 2.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.504 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -113.59 159.66 19.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.824 0.345 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 86.7 t -121.32 93.6 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.173 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 293' ' ' GLY . 27.7 mt -92.08 153.86 19.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.45 ' OD2' ' CG ' ' A' ' 239' ' ' MET . 3.2 p-10 42.15 25.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.1 38.29 40.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.51 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 291' ' ' LEU . 68.1 p -147.05 134.9 10.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.637 0.732 . . . . 0.0 110.887 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 92.0 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.629 2.22 . . . . 0.0 112.323 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.5 pt -82.85 148.38 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -125.87 143.71 50.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.409 ' C ' HG21 ' A' ' 299' ' ' THR . 4.6 t -123.86 127.22 73.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' THR . . . . . 0.409 HG21 ' C ' ' A' ' 298' ' ' VAL . 25.7 p -137.43 171.76 13.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 5.4 mt -94.74 100.15 12.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -65.5 151.72 45.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 17.0 mmtm -107.24 142.79 25.84 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.596 0.713 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 145.38 56.98 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.704 2.27 . . . . 0.0 112.351 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 89.5 t -109.14 124.05 65.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.104 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -143.68 171.99 13.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -158.66 141.81 14.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -39.41 122.77 1.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 79.9 p -77.86 157.45 29.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 29.5 m -109.83 101.55 10.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -138.13 -157.44 7.46 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 160.08 51.01 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.687 2.258 . . . . 0.0 112.34 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 22.4 t 67.24 36.26 4.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 19.8 m -101.88 131.96 47.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.473 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 19.7 m -89.83 81.11 6.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.909 0.385 . . . . 0.0 110.877 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 77.4 p -59.11 153.62 17.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.83 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 141.82 -80.7 0.25 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.508 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 63.8 p -91.93 40.53 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.38 . . . . 0.0 110.809 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.4 t -62.79 -35.18 79.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.843 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 148.13 92.82 0.11 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.505 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.14 110.71 0.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.791 0.329 . . . . 0.0 110.857 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -46.71 -45.82 19.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -37.57 -56.62 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.813 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 37.5 m -119.85 127.07 52.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -84.73 -52.95 5.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 1.9 t -145.18 134.44 22.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.871 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 57.7 p -60.61 100.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.15 137.68 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.466 ' HE2' ' CA ' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -136.71 116.99 13.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.923 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.461 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 70.2 mt -147.95 137.05 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.174 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 10.7 mt -122.07 110.96 16.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.922 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 236' ' ' ARG . 22.5 t80 -91.43 132.92 35.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.441 HG13 ' CD1' ' A' ' 238' ' ' LEU . 16.5 t -120.08 133.08 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.089 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 234' ' ' TYR . 9.7 ptm180 -129.59 161.98 29.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.418 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 35.2 t-20 71.79 38.79 0.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.441 ' CD1' HG13 ' A' ' 235' ' ' VAL . 26.2 mt -96.71 126.95 42.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 14.6 mmt -59.0 131.92 52.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.477 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 53.5 mt -51.35 -38.16 51.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 29.8 t -59.03 -24.43 62.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.874 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 30.9 m -60.38 157.09 14.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.177 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 64.9 m -134.6 153.89 51.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.845 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -44.94 -50.62 10.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -43.91 -41.71 5.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 9.5 mtt -65.7 -38.14 88.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 72.0 mt -72.42 -34.08 47.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 24.5 tt0 -75.32 -48.5 22.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 14.3 ptmt -57.96 -48.07 81.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.97 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.459 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 26.1 mm-40 -62.34 -59.48 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -59.15 -23.83 62.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.448 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 6.8 m-20 -80.99 -37.63 28.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -45.12 -45.11 11.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 42.8 mm -50.72 -63.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -134.87 127.07 18.18 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.527 0.68 . . . . 0.0 110.943 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 125.35 12.07 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.672 2.248 . . . . 0.0 112.341 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 75.84 33.7 50.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.487 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -105.17 -45.33 4.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 51.5 t -69.24 118.65 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.75 -60.7 2.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -146.78 154.56 41.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 94.4 t -126.58 142.69 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -134.85 109.61 8.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -82.71 146.68 28.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.563 HD13 ' CD2' ' A' ' 268' ' ' TYR . 6.8 mt -135.44 172.19 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.092 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.477 ' O ' ' CD2' ' A' ' 240' ' ' LEU . 21.4 mmt85 -31.71 -72.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.82 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.73 15.41 7.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -142.27 176.72 8.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.13 166.91 16.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.113 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -130.6 144.26 51.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 18.3 t -129.85 117.26 40.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -93.4 154.75 17.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -130.86 179.7 5.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.418 ' O ' ' ND2' ' A' ' 275' ' ' ASN . 3.8 m -102.28 -23.09 14.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.845 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.466 ' CA ' ' HE2' ' A' ' 231' ' ' LYS . 1.7 m120 -142.33 133.35 25.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.41 ' N ' ' CE ' ' A' ' 231' ' ' LYS . 6.0 ttp-105 -49.87 -46.58 51.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -46.99 -48.84 21.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.89 -57.63 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -48.59 -49.47 36.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.077 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 64.6 t -55.74 -52.98 42.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.137 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -57.81 -47.84 81.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.91 -26.69 68.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 9.6 tmm? -72.14 -50.13 30.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -70.38 -35.25 73.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -57.2 -57.96 10.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.108 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 47.9 mt -74.24 -32.81 63.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -41.93 99.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 109.3 29.9 3.8 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -109.14 161.19 15.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 0.0 110.873 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 294' ' ' SER . 71.8 t -123.59 93.87 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.105 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 294' ' ' SER . 31.8 mt -87.11 153.43 21.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 291' ' ' LEU . 3.9 p30 35.43 34.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 68.12 46.39 65.69 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.479 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 291' ' ' LEU . 5.6 t -155.07 133.65 7.16 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.651 0.738 . . . . 0.0 110.852 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.418 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.9 Cg_endo -69.75 101.27 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.682 2.254 . . . . 0.0 112.363 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.5 pt -89.44 145.37 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -120.92 137.64 54.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.42 ' C ' HG21 ' A' ' 299' ' ' THR . 3.7 t -123.52 122.26 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.072 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' THR . . . . . 0.42 HG21 ' C ' ' A' ' 298' ' ' VAL . 69.5 p -140.46 163.35 33.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.4 mt -77.61 114.15 16.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.461 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -68.42 155.77 39.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.086 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -112.93 90.5 15.72 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.554 0.693 . . . . 0.0 110.919 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 133.11 24.85 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.696 2.264 . . . . 0.0 112.327 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.79 152.96 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.15 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -172.04 119.11 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.49 148.15 29.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -119.83 131.88 55.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.84 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 309' ' ' SER . 92.4 p -78.36 132.69 37.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 308' ' ' SER . 2.0 m -37.61 152.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 171.61 83.43 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.466 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 89.51 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.654 2.236 . . . . 0.0 112.312 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 38.4 t -101.78 142.89 32.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 94.4 p -98.18 149.1 22.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.454 -179.968 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 96.0 p -163.75 111.76 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 0.0 110.861 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 42.1 p -128.89 140.2 51.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.894 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 116.83 -149.79 18.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.533 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 67.9 m -118.72 145.54 45.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 0.0 110.81 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 69.1 p -84.9 -33.37 22.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.891 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 107.36 136.95 8.26 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.43 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.33 -58.82 1.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.779 0.323 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -46.78 121.67 3.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.923 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -57.65 89.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 4.1 p -124.68 110.14 14.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 2.8 ttt -82.34 -44.58 16.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 25.0 p -75.43 108.69 8.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.842 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 93.1 p -77.35 103.27 7.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.842 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.75 135.38 50.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.116 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.93 116.78 17.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.7 mt -147.96 138.2 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 34.6 mt -123.85 110.63 15.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -92.56 127.76 38.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 51.5 t -110.39 139.88 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.087 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -135.34 162.97 31.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.407 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 35.0 t-20 67.56 47.45 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 64.9 mt -104.45 137.42 42.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.1 mmt -69.51 129.9 40.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 27.5 mt -50.28 -35.63 28.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.0 t -63.39 -26.92 68.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 93.5 m -64.83 140.44 58.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.8 m -113.94 167.68 10.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.872 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 247' ' ' ILE . 5.4 mp0 -53.17 -50.08 65.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.857 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -41.27 -42.29 2.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 3.1 mmt -65.81 -34.62 78.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 244' ' ' GLU . 21.6 mt -75.58 -40.69 41.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -65.45 -45.21 84.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.496 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 2.3 ptmm? -64.93 -49.15 71.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.892 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.496 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 44.4 mm-40 -56.9 -35.09 68.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.456 ' CD2' HG12 ' A' ' 271' ' ' VAL . 5.4 m-85 -87.85 -21.5 24.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -88.83 -8.7 53.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -75.6 -18.22 59.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.28 -52.58 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -140.39 129.32 13.13 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.56 0.695 . . . . 0.0 110.877 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 123.27 9.93 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.695 2.263 . . . . 0.0 112.343 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 73.18 39.35 52.96 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -104.0 -43.44 5.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 111.112 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 24.2 t -72.5 121.9 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -82.84 -58.65 2.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -145.56 151.67 38.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 97.9 t -126.11 135.43 63.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -127.25 106.04 8.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -79.56 146.24 32.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.564 HD13 ' CD2' ' A' ' 268' ' ' TYR . 6.9 mt -137.28 172.46 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.48 ' C ' ' O ' ' A' ' 265' ' ' ILE . 30.5 mmt180 -30.77 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -127.0 20.2 6.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.564 ' CD2' HD13 ' A' ' 265' ' ' ILE . 0.3 OUTLIER -148.81 175.93 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.03 168.86 18.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -130.57 137.81 49.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' A' ' 251' ' ' PHE . 18.0 t -127.56 122.69 59.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.134 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -98.85 155.72 17.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -129.43 179.58 5.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.3 t -98.69 -19.05 17.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.809 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.449 ' OD1' ' CG ' ' A' ' 278' ' ' ASP . 47.2 p30 -154.25 142.1 20.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -51.0 -47.39 61.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -41.02 -65.31 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.449 ' CG ' ' OD1' ' A' ' 275' ' ' ASN . 72.1 m-20 -52.5 -50.2 63.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.23 -44.6 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.447 ' CG1' ' HE3' ' A' ' 284' ' ' LYS . 54.2 t -60.97 -47.82 91.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -59.82 -60.98 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -53.2 -28.08 24.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.111 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.486 ' O ' ' CB ' ' A' ' 287' ' ' ASN . 65.9 ttp -68.18 -54.39 18.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.447 ' HE3' ' CG1' ' A' ' 280' ' ' VAL . 6.4 mtmp? -78.86 -15.62 58.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -75.02 -29.95 60.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 46.6 mt -111.95 -28.6 7.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.915 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 283' ' ' MET . 9.2 t-20 -55.99 106.12 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 114.26 4.57 22.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.464 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 289' ' ' LYS . 12.7 mptt -98.35 153.76 18.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 110.89 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 59.0 t -107.09 96.97 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.467 ' CD1' ' HG3' ' A' ' 250' ' ' GLU . 22.1 mt -83.64 146.62 28.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 292' ' ' ASP . 26.3 t70 36.3 40.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.839 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 65.19 44.56 93.71 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 291' ' ' LEU . 8.4 t -154.32 132.01 6.36 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.624 0.726 . . . . 0.0 110.886 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.407 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.6 Cg_endo -69.79 105.79 1.55 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.637 2.225 . . . . 0.0 112.348 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 19.3 pt -95.76 140.64 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -117.15 134.44 54.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.28 112.79 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.138 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 58.6 p -128.28 165.34 20.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 16.7 mt -82.59 102.47 11.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -66.88 141.6 57.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -98.72 137.87 20.65 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.572 0.701 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 146.0 59.01 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.659 2.239 . . . . 0.0 112.332 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 9.5 p -87.04 155.5 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.134 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -41.68 111.87 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.882 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -147.89 111.5 5.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -125.24 116.29 21.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 24.7 p -72.68 162.01 30.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 2.1 t -90.54 56.87 3.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.842 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -115.43 83.47 0.34 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.537 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -36.63 10.42 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.678 2.252 . . . . 0.0 112.349 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 12.7 m -170.87 158.18 5.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 26.2 m -121.01 87.78 2.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.844 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.47 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 7.0 m -66.46 134.71 53.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 0.0 110.843 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 14.2 t -165.88 149.5 7.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.882 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -135.02 -132.12 3.13 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.472 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 19.1 t -152.22 139.71 19.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 110.867 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 6.7 t -78.03 -34.39 50.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.846 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 147.27 60.81 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.89 121.51 21.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.332 . . . . 0.0 110.837 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.73 114.1 27.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.47 157.76 26.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 50.7 p -77.01 129.63 36.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.189 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 19.7 ttp -65.35 -38.36 89.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 7.4 t -120.22 91.8 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.862 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.2 t -76.26 103.51 6.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.41 129.24 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.148 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.414 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -130.92 116.68 18.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 75.1 mt -147.91 132.89 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.107 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.452 HD12 ' CE1' ' A' ' 273' ' ' PHE . 10.8 mt -117.17 109.28 16.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -91.67 132.71 36.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.26 140.53 41.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.123 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -137.63 166.71 23.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.833 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 38.5 t30 69.15 44.62 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 26.2 mt -101.52 154.34 18.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 4.4 mtt -83.38 133.96 34.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 63.9 mt -56.53 -13.91 2.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.947 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 2.0 m -90.14 9.03 29.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.419 HG21 ' N ' ' A' ' 243' ' ' SER . 98.6 m -100.88 135.16 42.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.419 ' N ' HG21 ' A' ' 242' ' ' THR . 21.4 p -106.57 171.21 7.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -64.61 -18.67 65.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -69.52 -44.2 71.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.888 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 9.7 mtt -64.96 -39.05 92.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.872 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 35.8 mt -70.97 -40.04 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -68.0 -50.77 53.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 2.4 ptmm? -56.81 -47.35 80.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.499 ' O ' ' ND2' ' A' ' 253' ' ' ASN . 54.0 mm-40 -56.87 -65.55 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.541 ' CD1' HD13 ' A' ' 286' ' ' LEU . 8.0 m-85 -52.43 -22.48 4.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.886 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -79.84 -43.73 21.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 250' ' ' GLU . 0.7 OUTLIER -46.82 -28.91 1.71 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 14.8 mm -74.8 -51.04 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -139.16 112.16 7.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.557 0.694 . . . . 0.0 110.9 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 125.93 12.7 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.685 2.256 . . . . 0.0 112.335 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 74.96 28.86 61.75 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.492 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -106.97 -48.03 3.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 111.093 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.3 131.63 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.159 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -89.78 -62.64 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -147.76 158.46 44.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.1 t -137.93 142.83 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.2 116.01 19.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -81.53 139.52 35.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.569 HD12 ' CD2' ' A' ' 268' ' ' TYR . 5.2 mt -129.13 172.41 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.151 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.476 ' C ' ' O ' ' A' ' 265' ' ' ILE . 18.2 mmm180 -31.32 -75.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.63 19.45 8.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.577 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.2 OUTLIER -146.79 174.9 11.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.81 167.37 18.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.111 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -126.67 151.09 48.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.03 117.46 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.074 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -94.76 158.15 15.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.452 ' CE1' HD12 ' A' ' 233' ' ' LEU . 28.5 m-85 -133.45 178.69 6.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 85.7 p -95.45 -14.95 23.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.865 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -160.0 145.85 15.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 18.4 ttt-85 -55.22 -41.69 72.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -45.67 -58.39 3.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -60.95 -46.44 90.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.58 -51.21 50.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.101 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 66.2 t -58.53 -49.83 81.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.167 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -55.4 -57.3 12.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.66 -33.96 61.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.102 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 53.5 ttp -59.87 -68.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -61.29 -20.28 62.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -67.0 -56.97 7.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.541 HD13 ' CD1' ' A' ' 251' ' ' PHE . 26.4 mt -79.93 -30.37 39.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -40.55 112.3 0.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 95.4 32.3 7.07 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.471 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -109.74 158.94 17.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 83.1 t -118.79 96.26 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.12 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 294' ' ' SER . 38.0 mt -92.72 153.47 18.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 61.7 t0 40.96 28.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 72.97 41.46 48.48 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.446 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 291' ' ' LEU . 1.8 m -154.3 138.7 11.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.674 0.749 . . . . 0.0 110.908 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 105.99 1.58 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 0.0 112.381 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 9.8 pt -93.54 151.36 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -123.22 148.38 45.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 11.1 t -133.36 124.72 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.108 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 67.7 p -141.06 165.02 28.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 6.9 mt -81.48 106.63 13.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -71.24 139.81 50.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.106 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -75.68 137.54 70.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.577 0.704 . . . . 0.0 110.887 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 151.56 68.81 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.642 2.228 . . . . 0.0 112.323 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 9.0 p -85.93 124.29 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.114 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -58.92 128.6 38.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.865 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.8 154.05 47.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -53.85 118.47 4.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 31.0 m -88.37 131.22 34.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.6 t -131.59 107.2 8.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -159.03 70.55 0.24 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.511 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 148.63 65.74 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.657 2.238 . . . . 0.0 112.397 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 4.8 t -96.72 140.79 30.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 92.2 p -131.63 131.43 43.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 -179.968 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 25.7 m -90.24 155.54 18.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 0.0 110.912 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.4 t -72.03 130.36 40.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 42.62 -153.18 0.2 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.488 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 27.1 t -144.32 148.59 34.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.86 0.362 . . . . 0.0 110.862 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 86.5 p -103.41 -34.81 8.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -112.54 100.5 1.13 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.455 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -129.35 98.15 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.813 0.34 . . . . 0.0 110.875 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.93 175.29 14.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -100.65 95.46 6.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 84.9 m -89.37 106.19 18.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.169 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 12.1 ptp -85.99 -8.04 58.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 19.6 m -106.57 79.94 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 97.5 p -56.71 103.01 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.09 131.33 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.56 116.83 19.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.406 HG23 ' N ' ' A' ' 233' ' ' LEU . 66.3 mt -148.07 138.82 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.139 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.516 HD13 ' CE1' ' A' ' 273' ' ' PHE . 76.8 mt -126.9 111.09 13.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -93.34 128.46 39.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.969 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 16.8 t -112.02 129.06 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.112 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.473 ' HG3' ' N ' ' A' ' 237' ' ' ASN . 13.5 tpt180 -120.57 161.3 21.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.473 ' N ' ' HG3' ' A' ' 236' ' ' ARG . 9.0 t30 74.87 35.22 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 42.2 mt -85.24 124.82 32.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.858 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 3.6 mmt -62.82 133.6 54.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 58.2 mt -59.46 -12.74 6.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 20.7 m -98.2 15.56 24.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 38.8 m -102.62 129.88 49.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.133 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.0 m -97.16 145.86 25.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 247' ' ' ILE . 45.7 mt-10 -42.03 -48.29 4.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.886 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -42.14 -38.77 1.8 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 10.8 mtt -66.05 -39.56 90.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 244' ' ' GLU . 44.9 mt -72.64 -34.97 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.454 ' HG2' ' ND2' ' A' ' 252' ' ' ASN . 25.9 tt0 -73.75 -46.62 44.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.472 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 13.7 ptmt -60.54 -45.14 94.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.472 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 25.3 mm-40 -61.76 -58.26 8.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.546 ' CE1' HD13 ' A' ' 286' ' ' LEU . 7.6 m-85 -55.81 -46.42 78.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.454 ' ND2' ' HG2' ' A' ' 248' ' ' GLU . 79.6 m-20 -66.02 -23.42 66.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.845 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -51.98 -37.31 52.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 14.5 mm -65.71 -52.57 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -142.71 133.48 12.58 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.609 0.719 . . . . 0.0 110.885 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 137.78 36.21 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.257 . . . . 0.0 112.32 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.93 41.04 96.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.534 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -106.63 -45.62 4.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 111.11 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 76.5 t -68.26 126.24 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -83.3 -60.59 2.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -147.85 150.15 33.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.824 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 85.7 t -127.68 110.82 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.16 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -100.78 110.07 22.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 265' ' ' ILE . 15.9 tptp -79.49 147.86 32.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.531 HD11 ' CD2' ' A' ' 268' ' ' TYR . 6.0 mt -137.1 172.11 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.103 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.469 ' C ' ' O ' ' A' ' 265' ' ' ILE . 23.5 mmt180 -31.32 -71.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.45 ' OD1' ' C ' ' A' ' 266' ' ' ARG . 1.0 OUTLIER -127.86 16.52 6.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -143.59 176.32 9.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.42 158.33 13.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.061 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.446 ' CE2' HD12 ' A' ' 265' ' ' ILE . 98.3 m-85 -117.86 146.61 43.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.544 HG22 ' CE2' ' A' ' 251' ' ' PHE . 21.0 t -130.41 119.64 46.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -98.2 147.51 24.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.516 ' CE1' HD13 ' A' ' 233' ' ' LEU . 38.5 m-85 -126.15 171.74 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.4 ' C ' ' OD1' ' A' ' 275' ' ' ASN . 13.2 t -79.13 -41.58 28.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.403 ' O ' ' OD1' ' A' ' 278' ' ' ASP . 5.9 m-20 -135.48 170.25 16.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.902 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -74.36 -36.05 63.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 278' ' ' ASP . 12.1 pt-20 -53.04 -52.5 58.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 278' ' ' ASP . 7.4 p-10 -70.07 -47.32 62.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -51.14 -49.67 60.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.122 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.45 -52.93 45.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.093 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -47.19 -41.69 18.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.834 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.46 -40.05 77.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.0 ttp -50.37 -54.2 23.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -68.45 -42.1 79.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.883 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -51.18 -54.38 26.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.064 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.546 HD13 ' CE1' ' A' ' 251' ' ' PHE . 42.1 mt -78.4 -41.53 32.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 286' ' ' LEU . 9.5 t30 -35.99 109.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 98.15 34.26 5.44 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 38.3 mmtt -112.63 147.33 36.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 89.6 t -114.39 97.92 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 41.6 mt -96.06 153.72 17.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.2 t0 42.97 24.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 75.66 38.0 38.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 33.1 p -146.43 133.93 10.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.659 0.742 . . . . 0.0 110.877 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 92.78 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 6.9 pt -81.32 146.2 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.121 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -112.19 156.59 22.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 20.8 t -143.77 115.1 2.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.12 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 29.4 p -138.5 172.94 12.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 6.8 mt -88.88 100.34 13.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.61 137.68 50.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.109 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -95.0 139.24 22.02 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.584 0.707 . . . . 0.0 110.921 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 164.24 35.22 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.679 2.253 . . . . 0.0 112.388 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 305' ' ' ASP . 35.1 m -85.71 121.33 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.122 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 304' ' ' VAL . 27.0 m-20 -36.15 114.21 0.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.837 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -147.83 109.59 4.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -105.83 135.89 46.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 8.5 t -72.8 136.65 45.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 14.9 t -135.81 113.82 11.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 165.12 148.32 5.44 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.447 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 169.01 19.89 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.658 2.239 . . . . 0.0 112.385 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 3.6 m -91.79 157.89 16.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.864 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 58.2 m -102.95 170.42 7.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.504 179.965 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 89.6 p -140.83 171.7 13.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.0 110.865 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 80.6 p -165.64 163.83 19.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.837 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -72.77 -173.28 23.31 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.437 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 29.6 t -89.73 117.55 28.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 110.82 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 7.2 t -119.47 -33.71 4.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.26 85.94 0.26 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.513 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -66.34 140.84 58.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.76 0.314 . . . . 0.0 110.887 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -104.89 163.66 12.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -64.91 114.07 4.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 63.8 p -96.04 113.11 24.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -54.39 -45.32 72.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.6 m -95.03 124.53 39.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.869 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 42.0 p -87.66 98.38 11.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.22 129.62 62.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.156 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.452 ' HD3' ' N ' ' A' ' 276' ' ' ARG . 1.6 pttm -131.35 116.79 18.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 96.8 mt -147.92 142.32 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.149 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.559 HD12 ' CE1' ' A' ' 273' ' ' PHE . 92.3 mt -127.08 111.72 14.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -91.98 132.36 36.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.6 t -116.24 142.39 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.136 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -132.35 170.34 15.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 295' ' ' PRO . 28.1 t-20 62.31 49.21 4.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 39.4 mt -102.95 115.39 30.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.93 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 6.2 mtt -56.67 122.91 13.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.438 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 38.6 mt -45.16 -33.12 2.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.939 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 13.3 t -63.22 -39.27 94.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.842 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.415 ' O ' ' NZ ' ' A' ' 264' ' ' LYS . 52.1 m -58.46 142.47 48.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.166 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 49.8 m -111.71 168.0 9.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.852 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.453 ' OE1' ' N ' ' A' ' 244' ' ' GLU . 1.2 mp0 -56.25 -46.87 79.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.911 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -43.31 -37.09 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.5 mmt -70.37 -45.03 66.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.856 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 48.9 mt -65.02 -40.18 88.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -67.51 -60.91 2.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 8.1 ptpt -45.85 -46.23 15.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 23.0 mm-40 -59.38 -69.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.46 ' CD2' HG11 ' A' ' 271' ' ' VAL . 16.1 m-85 -49.34 -24.19 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 253' ' ' ASN . 3.6 m-20 -73.3 -44.82 58.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 249' ' ' LYS . 6.8 m120 -36.36 -49.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.913 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 45.2 mm -47.95 -62.43 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -139.51 135.02 16.63 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.539 0.685 . . . . 0.0 110.934 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 127.44 14.63 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.684 2.256 . . . . 0.0 112.386 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 67.23 38.89 92.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.52 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -104.04 -43.67 5.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 251' ' ' PHE . 21.7 t -72.62 112.57 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -70.55 -64.61 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 262' ' ' VAL . 0.5 OUTLIER -140.83 165.05 28.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.447 ' N ' ' HD2' ' A' ' 261' ' ' ARG . 40.3 t -140.2 113.98 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -101.53 107.4 18.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.415 ' NZ ' ' O ' ' A' ' 242' ' ' THR . 16.0 tptm -79.83 143.28 34.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.558 HD12 ' CD2' ' A' ' 268' ' ' TYR . 5.3 mt -133.97 172.41 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.476 ' C ' ' O ' ' A' ' 265' ' ' ILE . 12.7 mmm180 -31.34 -73.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -125.36 18.8 8.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.558 ' CD2' HD12 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -148.03 177.75 9.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.72 174.05 9.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.116 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -130.69 143.6 50.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.46 HG11 ' CD2' ' A' ' 251' ' ' PHE . 70.0 t -127.07 123.03 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -102.47 155.42 18.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.559 ' CE1' HD12 ' A' ' 233' ' ' LEU . 37.8 m-85 -132.65 177.67 7.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.408 ' C ' ' HE3' ' A' ' 231' ' ' LYS . 78.8 p -89.11 -14.14 36.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.822 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.418 ' N ' ' HD2' ' A' ' 231' ' ' LYS . 11.1 p30 -162.03 147.19 12.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.452 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 27.5 ttt180 -55.25 -45.83 76.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.889 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -40.82 -56.29 2.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -63.78 -48.32 77.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -48.25 -45.52 34.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.2 -59.1 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -46.74 -43.91 18.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.0 -34.56 73.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 59.4 ttp -53.33 -66.4 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -62.61 -37.76 87.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -46.47 -55.85 6.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.06 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 287' ' ' ASN . 46.7 mt -80.61 -36.61 32.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 286' ' ' LEU . 22.9 t-20 -36.88 103.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 104.91 31.33 4.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -111.79 156.65 21.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.836 0.35 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . 0.418 HG13 ' N ' ' A' ' 294' ' ' SER . 55.9 t -120.09 96.36 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.139 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 294' ' ' SER . 32.2 mt -90.33 153.96 20.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 291' ' ' LEU . 7.7 t70 37.48 39.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.868 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 61.98 43.97 98.45 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.493 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.418 ' N ' HG13 ' A' ' 290' ' ' VAL . 1.8 m -152.42 138.26 11.6 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.661 0.743 . . . . 0.0 110.841 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.401 ' O ' ' OD1' ' A' ' 237' ' ' ASN . 53.4 Cg_endo -69.8 100.78 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 8.3 pt -93.62 145.46 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -117.79 157.27 26.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 6.3 t -146.05 121.77 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 82.6 p -144.05 175.27 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 8.7 mt -87.11 102.6 14.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.954 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -66.27 138.61 57.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.072 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -96.04 117.41 66.32 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.613 0.72 . . . . 0.0 110.902 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 150.05 67.53 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.663 2.242 . . . . 0.0 112.39 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 90.1 t -109.09 125.92 66.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.08 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.86 163.71 29.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -94.94 120.09 34.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -87.75 130.6 34.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.84 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 72.9 m -89.24 111.6 22.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.852 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 17.1 m -70.92 121.4 18.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.873 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 122.61 -98.32 0.61 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.463 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 143.08 49.85 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.693 2.262 . . . . 0.0 112.365 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 18.4 m -114.86 -51.15 2.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 74.4 p -52.9 110.49 0.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.474 179.992 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.431 -0.268 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.4 t -168.02 134.12 1.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.389 . . . . 0.0 110.845 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 45.3 m -43.19 114.28 0.6 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.866 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -106.19 -93.0 2.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.494 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 77.7 p -136.96 120.15 16.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 110.9 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 57.8 m -88.07 -35.4 17.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.842 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 89.0 167.09 42.76 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.512 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.64 118.7 20.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.767 0.317 . . . . 0.0 110.877 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -173.87 154.89 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -125.75 79.38 1.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 88.6 m -134.72 125.72 27.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.187 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 17.7 tpp -65.34 -54.8 23.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 60.6 p -46.19 134.6 8.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 57.3 m -81.26 102.38 10.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.54 132.55 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.417 ' HD3' ' C ' ' A' ' 275' ' ' ASN . 0.1 OUTLIER -131.22 116.91 18.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 233' ' ' LEU . 55.0 mt -147.86 141.33 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.098 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.564 HD12 ' CE1' ' A' ' 273' ' ' PHE . 15.4 mt -124.25 105.09 9.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.472 ' HB2' ' CE2' ' A' ' 270' ' ' PHE . 6.5 t80 -91.21 125.12 35.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 23.4 t -106.35 135.75 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.091 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -128.66 170.88 12.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.543 ' ND2' ' HG ' ' A' ' 294' ' ' SER . 6.9 t30 62.84 43.46 7.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 15.3 mt -100.83 140.81 34.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.411 ' CE ' ' HB2' ' A' ' 294' ' ' SER . 20.3 mmt -80.14 141.07 36.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 37.1 mt -53.72 -28.54 34.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.4 m -66.88 -25.31 66.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.441 HG21 ' N ' ' A' ' 243' ' ' SER . 39.6 m -65.82 144.11 57.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.106 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.441 ' N ' HG21 ' A' ' 242' ' ' THR . 1.3 t -128.77 150.92 50.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -46.89 -20.82 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -66.7 -68.77 0.35 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.468 ' HA ' ' CD ' ' A' ' 249' ' ' LYS . 20.2 ptm -53.12 -37.08 61.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 77.8 mt -61.44 -50.87 78.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.112 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.464 ' HG2' ' ND2' ' A' ' 252' ' ' ASN . 3.4 tt0 -59.37 -64.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.473 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 13.9 pttt -39.47 -46.09 1.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.473 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 33.6 mm-40 -57.82 -51.81 68.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.862 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.684 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 4.8 m-85 -61.76 -56.12 22.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.464 ' ND2' ' HG2' ' A' ' 248' ' ' GLU . 5.7 m-80 -54.32 -40.07 67.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -48.04 -31.35 5.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 29.2 mm -68.76 -54.24 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.157 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -142.27 120.3 7.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.58 0.705 . . . . 0.0 110.894 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 121.91 8.61 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.367 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 84.25 37.82 10.68 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -118.13 -43.84 2.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.336 . . . . 0.0 111.05 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 41.5 t -74.73 136.65 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.153 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -100.08 -62.02 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . 0.461 ' CD ' ' HB2' ' A' ' 272' ' ' HIS . 0.1 OUTLIER -143.67 153.59 42.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 263' ' ' LYS . 89.9 t -122.65 147.35 26.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . 0.403 ' N ' HG12 ' A' ' 262' ' ' VAL . 18.4 tptm -136.18 110.74 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.919 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' A' ' 265' ' ' ILE . 11.0 tptm -87.58 144.8 26.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.574 HD12 ' CD2' ' A' ' 268' ' ' TYR . 6.7 mt -136.12 172.35 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.148 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.471 ' C ' ' O ' ' A' ' 265' ' ' ILE . 18.9 mmt180 -31.55 -72.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.08 14.13 7.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -140.82 176.88 8.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.14 179.1 7.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.11 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 234' ' ' TYR . 95.7 m-85 -144.29 148.94 35.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.558 HG22 ' CE2' ' A' ' 251' ' ' PHE . 3.1 t -135.54 123.12 36.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.141 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . 0.461 ' HB2' ' CD ' ' A' ' 261' ' ' ARG . 3.9 m-70 -97.8 150.74 20.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.564 ' CE1' HD12 ' A' ' 233' ' ' LEU . 19.3 m-85 -126.92 176.87 6.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.895 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.8 t -97.52 -25.93 14.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.417 ' C ' ' HD3' ' A' ' 231' ' ' LYS . 7.6 m-80 -144.83 135.19 24.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 277' ' ' GLU . 14.0 ttt180 -45.53 -54.33 7.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 276' ' ' ARG . 62.9 mm-40 -37.01 -56.03 0.9 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.51 -47.89 83.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.94 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -54.86 -40.59 69.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.58 -42.99 90.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -65.39 -51.52 59.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.84 -38.72 79.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.075 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 47.4 ttp -52.23 -66.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.412 ' HA ' ' CB ' ' A' ' 287' ' ' ASN . 40.1 mtmt -58.79 -48.75 80.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 284' ' ' LYS . . . -36.53 -52.65 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.684 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 73.4 mt -85.75 -29.24 24.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.412 ' CB ' ' HA ' ' A' ' 284' ' ' LYS . 19.1 t-20 -42.53 95.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 112.08 29.63 3.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.494 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -108.52 155.9 20.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.828 0.347 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 75.5 t -118.02 109.59 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 26.9 mt -106.54 153.24 22.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 42.53 29.16 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 71.99 42.55 51.75 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.506 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.543 ' HG ' ' ND2' ' A' ' 237' ' ' ASN . 10.9 t -153.78 140.03 12.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.626 0.727 . . . . 0.0 110.866 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.491 ' O ' ' ND2' ' A' ' 237' ' ' ASN . 53.6 Cg_endo -69.78 98.56 0.7 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.727 2.285 . . . . 0.0 112.306 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 8.1 pt -86.14 147.45 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.126 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -121.77 153.33 38.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 8.4 t -135.32 119.2 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.174 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 16.3 p -137.8 168.11 20.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 11.1 mt -83.87 100.1 10.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.408 ' CB ' ' HB2' ' A' ' 234' ' ' TYR . . . -71.11 138.45 49.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.079 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 15.5 pttm -81.47 143.2 51.08 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.596 0.712 . . . . 0.0 110.891 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 168.5 21.44 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.745 2.297 . . . . 0.0 112.324 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 305' ' ' ASP . 34.9 m -90.5 115.57 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.129 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 304' ' ' VAL . 2.7 t70 -34.42 141.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 307' ' ' ASP . 49.4 tttt -172.76 117.04 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 306' ' ' LYS . 10.2 t0 -35.09 137.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 12.7 m -108.2 112.74 25.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.847 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.1 m -94.4 124.94 38.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.813 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -171.57 92.83 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.496 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 176.36 6.86 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.63 2.22 . . . . 0.0 112.382 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 9.0 t -135.16 167.88 20.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 41.2 p 42.66 42.44 2.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.857 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.456 -179.973 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 4.7 t -97.97 91.45 5.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.372 . . . . 0.0 110.838 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 4.3 m -123.65 136.45 54.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.838 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -111.97 88.41 0.5 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.507 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 70.3 m -77.86 85.33 4.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.889 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 52.5 m -107.56 23.17 14.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.83 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -134.61 79.04 0.33 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.522 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.18 111.33 14.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.743 0.306 . . . . 0.0 110.861 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -50.43 119.8 4.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -84.11 81.63 8.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 45.7 p -121.74 130.71 53.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 3.3 mmt -67.51 -42.16 83.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 68.1 m -82.1 88.94 6.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 56.9 m -62.51 98.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.809 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.1 132.39 60.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.131 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.41 ' CD ' ' C ' ' A' ' 275' ' ' ASN . 4.3 pttm -131.49 117.02 18.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 92.2 mt -147.93 138.88 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.149 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 68.6 mt -122.8 108.93 13.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -92.37 124.22 36.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.98 143.29 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.123 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -134.6 165.62 24.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 72.16 39.97 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.7 mt -99.15 115.87 30.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.4 mtt -56.21 130.78 45.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 46.1 mt -44.68 -39.05 4.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 30.9 m -56.98 -36.77 70.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 24.6 m -60.86 137.4 58.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.177 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.7 m -113.9 170.39 8.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.834 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 247' ' ' ILE . 25.8 mt-10 -53.68 -52.59 59.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -40.03 -47.83 2.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.4 mtt -60.24 -37.94 81.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 244' ' ' GLU . 55.7 mt -73.75 -36.43 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.11 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.498 ' O ' ' ND2' ' A' ' 252' ' ' ASN . 16.8 tt0 -70.66 -46.77 62.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.477 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 4.6 ptmm? -62.91 -47.98 80.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.917 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.477 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 25.8 mm-40 -56.08 -54.8 40.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.546 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 10.2 m-85 -63.28 -47.47 82.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 248' ' ' GLU . 1.1 m-80 -54.73 -46.9 74.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -38.1 -48.35 1.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.861 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 48.2 mm -48.35 -57.95 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.121 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -141.06 128.19 11.87 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.564 0.697 . . . . 0.0 110.902 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 120.19 7.01 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.717 2.278 . . . . 0.0 112.311 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 76.39 34.54 45.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.515 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -104.32 -34.23 8.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 0.0 111.102 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.452 HG21 ' ND2' ' A' ' 252' ' ' ASN . 74.4 t -80.75 149.04 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -106.42 -59.21 1.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . 0.424 ' CZ ' ' HB3' ' A' ' 261' ' ' ARG . 4.8 ptp180 -151.73 155.62 38.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.879 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.21 152.28 37.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.106 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -140.78 109.79 6.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 11.4 tptp -79.68 141.76 36.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.571 HD11 ' CD2' ' A' ' 268' ' ' TYR . 6.5 mt -132.33 172.52 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.115 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' A' ' 265' ' ' ILE . 13.9 mmm180 -31.39 -72.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 0.5 OUTLIER -126.8 17.26 7.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.571 ' CD2' HD11 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -145.14 176.13 9.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -165.87 158.95 15.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.135 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -117.57 151.53 36.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 57.8 t -139.44 134.4 39.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.121 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -113.57 157.99 21.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.824 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -132.86 173.37 11.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.403 ' O ' ' ND2' ' A' ' 275' ' ' ASN . 43.4 t -81.49 -18.4 45.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.825 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.41 ' C ' ' CD ' ' A' ' 231' ' ' LYS . 4.8 m120 -157.12 159.4 37.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -61.73 -48.31 81.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -48.21 -44.25 32.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -65.28 -51.42 60.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -56.04 -39.02 71.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.087 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.443 ' CG1' ' HE3' ' A' ' 284' ' ' LYS . 77.8 t -67.87 -47.94 77.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -59.08 -48.12 82.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.0 -34.82 76.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.2 ttp -60.38 -58.92 6.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.443 ' HE3' ' CG1' ' A' ' 280' ' ' VAL . 84.4 mttt -63.62 -28.35 69.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.59 68.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.546 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 55.1 mt -85.21 -17.48 36.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.957 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -57.01 109.55 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 97.32 32.79 6.21 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.523 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -112.0 154.81 24.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.909 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 87.4 t -117.81 96.61 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 293' ' ' GLY . 25.3 mt -92.73 152.0 19.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 41.77 25.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.21 43.52 25.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.499 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.1 t -154.75 137.62 10.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.692 0.758 . . . . 0.0 110.852 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 97.45 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.699 2.266 . . . . 0.0 112.329 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.9 pt -85.96 144.07 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.152 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -115.59 141.95 47.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.1 t -128.92 111.3 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 63.8 p -132.92 178.97 6.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 10.2 mt -95.79 110.22 22.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -65.79 145.78 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.37 124.26 80.6 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.566 0.698 . . . . 0.0 110.916 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 144.79 54.77 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 0.0 112.329 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 8.2 p -84.11 131.36 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.142 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -117.01 160.46 20.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.812 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -147.68 150.7 34.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -38.06 99.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.904 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 83.6 p -84.32 126.22 32.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 61.5 p -58.59 -52.35 66.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.864 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 122.89 79.51 0.47 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.514 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -12.3 32.62 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.709 2.273 . . . . 0.0 112.315 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 90.1 p -40.79 161.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 29.5 m -41.4 136.25 1.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.506 179.987 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 10.6 t -155.25 107.35 2.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.852 0.358 . . . . 0.0 110.821 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 2.8 t -109.49 -59.28 1.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 116.95 -109.81 1.98 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.523 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 64.3 m -46.32 129.95 10.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.891 0.377 . . . . 0.0 110.868 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.2 t -95.66 -34.55 11.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -152.64 117.99 0.85 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.492 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -79.62 120.9 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.806 0.336 . . . . 0.0 110.837 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -62.57 139.58 58.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -119.8 104.31 10.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 31.0 p -90.51 171.9 9.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 45.2 mtt -64.13 -46.5 83.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 4.1 m -86.98 146.63 26.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 93.4 p -85.05 98.43 10.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.824 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.1 130.46 68.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.135 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.412 ' HD2' ' CA ' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -130.47 116.64 18.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.915 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 56.8 mt -147.9 125.19 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.177 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 16.1 mt -115.6 112.09 21.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.419 ' CE2' ' HB2' ' A' ' 236' ' ' ARG . 51.3 t80 -91.88 121.45 33.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.3 t -108.67 121.9 62.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.163 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.419 ' HB2' ' CE2' ' A' ' 234' ' ' TYR . 28.3 ttt180 -115.64 160.31 20.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.418 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 28.8 t-20 71.55 48.35 0.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 19.8 mt -102.08 124.32 47.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 8.0 mmt -60.17 141.5 55.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 26.3 mt -65.55 -24.09 67.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 34.2 m -82.99 16.0 2.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 23.0 m -102.83 141.36 35.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.124 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 67.7 m -111.11 147.68 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -43.52 -46.75 7.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -39.88 -46.24 1.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 12.1 mtt -62.6 -43.45 98.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 59.2 mt -64.52 -36.76 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.143 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -68.49 -57.29 6.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.911 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 18.6 pttt -52.33 -46.86 66.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.51 ' O ' ' ND2' ' A' ' 253' ' ' ASN . 19.3 mm-40 -55.99 -51.29 68.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.889 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.544 ' CE2' HG22 ' A' ' 271' ' ' VAL . 8.2 m-85 -72.7 -20.3 61.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -90.65 -11.03 41.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 250' ' ' GLU . 16.9 p30 -72.47 -17.92 61.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.434 ' N ' ' OD1' ' A' ' 253' ' ' ASN . 4.9 mp -79.47 -55.9 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.108 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -143.56 125.66 8.5 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.538 0.685 . . . . 0.0 110.903 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 120.23 7.05 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 87.09 33.41 12.11 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.423 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -108.74 -54.95 2.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 111.081 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.57 142.42 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -102.94 -61.79 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -144.92 152.99 41.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.68 127.85 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -119.08 104.7 10.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 265' ' ' ILE . 9.9 tptp -79.4 145.14 33.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.569 HD13 ' CD2' ' A' ' 268' ' ' TYR . 5.3 mt -135.86 172.43 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.158 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.471 ' C ' ' O ' ' A' ' 265' ' ' ILE . 39.9 mmm-85 -31.34 -74.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 8.4 p-10 -125.36 22.25 7.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.569 ' CD2' HD13 ' A' ' 265' ' ' ILE . 0.4 OUTLIER -151.52 177.01 10.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.9 171.37 14.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.093 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -135.58 134.51 39.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.891 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.544 HG22 ' CE2' ' A' ' 251' ' ' PHE . 39.4 t -120.16 129.82 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -104.85 155.34 19.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.4 ' C ' ' HG3' ' A' ' 231' ' ' LYS . 43.7 m-85 -136.41 -176.02 4.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.924 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 30.8 t -88.89 -31.86 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.412 ' CA ' ' HD2' ' A' ' 231' ' ' LYS . 2.7 m120 -152.17 144.65 24.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.501 ' O ' ' CG2' ' A' ' 280' ' ' VAL . 0.0 OUTLIER -50.07 -29.46 8.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -54.42 -62.7 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -59.77 -39.11 83.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -64.11 -35.89 82.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.102 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 276' ' ' ARG . 97.2 t -68.55 -39.59 80.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.194 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -68.46 -51.4 43.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.7 -40.48 72.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.09 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.1 ttp -60.8 -45.78 93.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -75.02 -19.26 60.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -78.39 -39.15 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 41.3 mt -95.82 -21.27 18.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -48.67 96.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 113.79 30.84 2.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.444 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -107.48 160.16 15.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.809 0.338 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 58.6 t -123.46 107.92 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.107 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 294' ' ' SER . 34.7 mt -102.86 153.25 20.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 41.83 26.62 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.76 38.52 49.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.476 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 291' ' ' LEU . 23.7 p -146.4 137.39 12.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.687 0.756 . . . . 0.0 110.833 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.418 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.5 Cg_endo -69.8 101.79 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.718 2.279 . . . . 0.0 112.323 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 12.0 pt -90.65 147.75 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.36 133.42 52.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 28.2 t -115.36 116.77 53.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.111 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 28.7 p -131.16 169.23 16.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 10.9 mt -88.71 99.98 12.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.98 137.49 53.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -88.63 143.57 32.18 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.546 0.688 . . . . 0.0 110.913 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 141.78 46.29 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.679 2.252 . . . . 0.0 112.338 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 34.9 m -93.02 127.21 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.101 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -88.04 96.14 10.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -145.91 120.58 9.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.8 t70 57.65 41.69 25.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 15.0 t -61.56 108.23 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 37.9 t 38.2 42.37 0.49 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -70.42 -67.05 2.01 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.525 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 120.63 7.39 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.718 2.279 . . . . 0.0 112.353 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 18.0 t -53.0 130.38 33.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.882 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 1.3 t -135.21 128.08 31.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.836 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.488 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 61.6 p -139.76 111.3 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 51.6 p -65.02 163.86 13.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.887 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -95.15 124.23 7.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.493 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 4.6 m -109.77 119.05 38.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.372 . . . . 0.0 110.864 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -76.4 -35.02 58.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.881 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 132.93 96.39 0.61 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.477 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -74.86 -64.44 1.04 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 110.866 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 46.37 41.07 8.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.907 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -111.83 81.84 1.52 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 43.0 p -121.62 116.48 24.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -49.12 -47.15 45.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 83.6 p -109.33 119.19 38.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 79.3 p -59.73 104.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.852 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.5 p -110.8 137.91 41.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.164 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.449 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -135.14 116.88 15.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 36.0 mt -147.98 136.55 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.121 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 11.5 mt -120.64 108.11 13.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -91.18 129.04 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.2 135.76 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.128 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -129.26 163.04 26.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.834 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 7.9 t30 70.91 48.07 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.427 ' CD1' ' HB3' ' A' ' 269' ' ' ALA . 21.2 mt -103.28 123.09 46.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.1 mmt -60.88 123.33 17.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.45 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 38.1 mt -45.73 -29.03 1.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 9.9 t -65.21 -37.6 87.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 35.1 m -58.82 156.35 11.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.127 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 58.3 m -128.8 167.9 16.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 247' ' ' ILE . 7.5 mp0 -54.42 -54.26 43.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 244' ' ' GLU . 41.6 tp10 -37.95 -39.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 5.8 mtt -71.18 -40.39 71.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 244' ' ' GLU . 44.3 mt -68.05 -40.46 83.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.122 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 18.8 tt0 -70.27 -56.23 7.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.471 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 0.0 OUTLIER -49.21 -46.55 45.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.904 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 39.2 mm-40 -60.74 -51.35 69.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 5.3 m-85 -65.86 -25.46 67.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 22.6 m120 -70.06 -46.47 64.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.868 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 252' ' ' ASN . 74.8 m-20 -36.2 -41.87 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.436 HD12 ' CB ' ' A' ' 285' ' ' ALA . 26.0 mm -56.44 -63.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.474 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 4.2 tppt? -141.89 136.42 15.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.6 0.714 . . . . 0.0 110.898 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.474 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 53.6 Cg_endo -69.78 132.56 23.55 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.715 2.277 . . . . 0.0 112.326 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 61.83 37.02 93.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.52 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -99.16 -43.72 6.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.838 0.351 . . . . 0.0 111.162 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.6 t -70.14 118.33 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.108 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -78.53 -57.58 3.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -144.14 149.45 36.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 69.0 t -133.13 111.57 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.125 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -107.32 117.63 34.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -86.53 142.19 28.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.569 HD12 ' CD2' ' A' ' 268' ' ' TYR . 6.5 mt -131.12 172.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.492 ' C ' ' O ' ' A' ' 265' ' ' ILE . 70.9 mtm-85 -30.1 -73.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.82 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.48 0.15 8.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -124.25 176.47 6.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.427 ' HB3' ' CD1' ' A' ' 238' ' ' LEU . . . -160.52 172.99 16.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.18 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.568 ' CE2' HD13 ' A' ' 265' ' ' ILE . 68.1 m-85 -136.37 135.4 38.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 8.1 t -130.16 126.08 61.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -103.36 159.3 15.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -133.53 168.18 19.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.826 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.1 t -75.72 -39.2 57.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.467 ' N ' ' OD1' ' A' ' 275' ' ' ASN . 4.6 p-10 -139.58 149.07 43.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.938 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' A' ' 277' ' ' GLU . 15.2 ttt180 -51.35 -55.14 20.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.848 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 276' ' ' ARG . 5.8 mp0 -35.12 -60.28 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -55.75 -52.53 63.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -48.28 -45.62 34.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.094 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.21 -51.83 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.25 -54.1 41.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.89 -30.86 68.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' MET . . . . . 0.445 ' O ' ' CB ' ' A' ' 287' ' ' ASN . 66.0 ttp -65.78 -57.33 8.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -68.78 -32.68 72.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.436 ' CB ' HD12 ' A' ' 254' ' ' ILE . . . -62.08 -56.51 18.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.084 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.633 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 35.0 mt -76.17 -35.83 58.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 283' ' ' MET . 6.1 t-20 -41.81 106.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 100.59 37.5 3.72 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.473 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -114.17 153.19 30.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.856 0.36 . . . . 0.0 110.893 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 81.9 t -117.93 94.51 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.144 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 294' ' ' SER . 37.9 mt -94.46 153.59 17.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 41.88 25.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.84 38.51 36.16 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.542 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 291' ' ' LEU . 31.8 p -146.34 133.12 9.89 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.661 0.744 . . . . 0.0 110.821 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 86.19 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.687 2.258 . . . . 0.0 112.333 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 6.9 pt -72.95 149.63 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.141 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -118.82 156.43 29.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 20.2 t -143.6 118.51 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 60.6 p -143.55 162.79 34.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.187 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 9.3 mt -77.39 100.05 5.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -67.66 112.86 5.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.077 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -80.5 137.83 51.6 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.621 0.724 . . . . 0.0 110.923 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 143.1 49.89 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.729 2.286 . . . . 0.0 112.366 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 92.1 t -104.61 108.41 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.145 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -163.62 151.64 13.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -95.28 166.43 11.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -114.93 130.41 56.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.862 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.3 t -88.79 137.45 32.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.837 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 5.7 t -92.36 135.3 34.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.849 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 135.26 92.28 0.39 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.488 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -9.09 25.25 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.635 2.223 . . . . 0.0 112.334 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 2.4 m -134.02 161.06 35.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 15.2 m -39.15 159.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.81 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 179.967 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 23.0 m -152.01 130.44 12.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.844 0.354 . . . . 0.0 110.834 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 41.2 t -127.24 155.21 43.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -132.14 -117.06 1.82 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 76.0 p -72.33 166.97 21.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.89 0.376 . . . . 0.0 110.857 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 55.4 m -110.49 -35.01 6.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.845 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -128.97 122.2 3.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.529 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -143.44 157.54 44.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 110.854 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -64.12 138.67 58.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.86 109.17 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 25.4 p -58.94 163.32 3.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 7.5 mtt -97.19 -53.94 3.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 56.7 m -40.93 125.12 2.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 96.0 p -74.12 100.84 3.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.473 ' O ' ' CD ' ' A' ' 276' ' ' ARG . 0.9 OUTLIER -119.68 139.8 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.123 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.449 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -133.56 116.73 16.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.4 mt -147.94 132.35 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.106 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 12.2 mt -115.48 109.13 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.888 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.525 ' CE2' ' HB3' ' A' ' 236' ' ' ARG . 12.9 t80 -91.49 134.12 34.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 22.7 t -120.91 131.07 73.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.18 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.525 ' HB3' ' CE2' ' A' ' 234' ' ' TYR . 14.6 ptt180 -123.47 163.39 20.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 69.84 50.79 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 11.8 mt -108.52 121.54 45.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.944 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 24.2 mtt -60.2 134.86 57.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 19.5 mt -53.94 -26.84 27.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 64.0 p -65.03 -40.31 94.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.441 ' O ' ' NZ ' ' A' ' 264' ' ' LYS . 52.1 m -59.46 147.9 34.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 59.5 m -121.17 164.19 17.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 247' ' ' ILE . 35.2 mt-10 -52.95 -54.38 35.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 244' ' ' GLU . 27.3 tt0 -36.81 -43.42 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.418 ' HA ' ' NZ ' ' A' ' 249' ' ' LYS . 9.5 mtp -63.63 -45.93 88.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 244' ' ' GLU . 28.4 mt -64.07 -29.39 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.149 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -71.27 -54.4 11.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 4.4 ptpp? -58.29 -41.82 85.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.474 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 17.4 mm-40 -61.94 -54.0 47.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -68.21 -28.27 67.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . 0.42 ' OD1' ' CG2' ' A' ' 259' ' ' VAL . 4.6 m-20 -81.76 -23.9 36.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -59.97 -31.44 69.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.463 HD13 ' CB ' ' A' ' 285' ' ' ALA . 13.2 mm -66.44 -56.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.146 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -142.84 131.88 11.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.549 0.69 . . . . 0.0 110.934 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 133.65 26.07 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.717 2.278 . . . . 0.0 112.306 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 65.61 39.83 95.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.475 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -110.72 -27.04 9.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.756 0.312 . . . . 0.0 111.048 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.42 ' CG2' ' OD1' ' A' ' 252' ' ' ASN . 75.8 t -91.77 128.75 43.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.134 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -89.23 -54.66 4.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 30.5 ptt85 -151.11 150.74 31.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.87 138.44 54.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 33.4 tttp -132.95 115.96 15.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . 0.441 ' NZ ' ' O ' ' A' ' 242' ' ' THR . 17.0 tptm -86.48 146.73 26.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.563 HD13 ' CD2' ' A' ' 268' ' ' TYR . 5.7 mt -134.28 172.08 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.142 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.464 ' C ' ' O ' ' A' ' 265' ' ' ILE . 21.7 mmm180 -31.96 -72.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -125.82 15.71 8.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.606 ' CD1' ' N ' ' A' ' 268' ' ' TYR . 0.1 OUTLIER -143.33 177.75 8.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.95 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -165.14 167.05 18.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.062 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.466 ' CD2' HD11 ' A' ' 265' ' ' ILE . 89.9 m-85 -130.6 143.68 50.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 40.5 t -135.11 126.61 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -102.24 153.89 19.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -125.83 -177.66 4.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.0 t -91.89 -31.62 15.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.869 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -144.51 156.51 44.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.473 ' CD ' ' O ' ' A' ' 230' ' ' VAL . 1.5 tpp85 -52.62 -67.06 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 276' ' ' ARG . 67.7 mm-40 -35.6 -57.84 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -47.93 -52.23 20.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -58.98 -46.67 87.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.99 -48.49 84.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.113 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.44 -53.51 57.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.63 -31.97 71.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 58.2 ttp -59.59 -53.96 51.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 285' ' ' ALA . 85.5 mttt -68.68 -53.23 23.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.463 ' CB ' HD13 ' A' ' 254' ' ' ILE . . . -36.55 -43.53 0.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.106 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.428 ' O ' ' C ' ' A' ' 287' ' ' ASN . 49.0 mt -90.56 -39.95 12.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.859 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 286' ' ' LEU . 20.7 t-20 -36.3 113.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 93.28 33.62 7.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.476 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -109.95 160.79 16.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 25.3 t -122.42 101.73 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.074 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.456 HD11 ' CD1' ' A' ' 296' ' ' ILE . 29.8 mt -99.1 154.2 18.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.8 p30 39.59 28.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 71.98 40.85 56.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.486 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 291' ' ' LEU . 1.9 m -149.23 137.5 11.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.681 0.753 . . . . 0.0 110.877 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 99.19 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.456 ' CD1' HD11 ' A' ' 291' ' ' LEU . 7.2 pt -90.69 147.85 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -118.62 155.89 30.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.1 119.54 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.169 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 80.4 p -139.85 174.63 10.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.83 118.28 26.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.46 151.69 39.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -105.23 121.55 45.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.586 0.708 . . . . 0.0 110.86 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 142.08 46.83 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.715 2.277 . . . . 0.0 112.325 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 8.9 p -87.68 127.46 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.127 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -142.03 123.48 14.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -76.9 167.69 21.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.938 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 27.6 t70 44.63 39.09 3.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 3.6 m -79.29 145.54 33.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 33.2 t -120.17 138.24 53.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.817 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -119.48 67.6 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.507 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 158.26 57.7 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.69 2.26 . . . . 0.0 112.37 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 2.3 t -123.64 113.47 18.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 34.3 t -90.53 142.59 27.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.863 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.522 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 218' ' ' SER . 67.4 m -118.8 -178.99 3.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 110.829 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 217' ' ' SER . 55.5 p 34.73 43.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 106.23 -173.74 19.95 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.481 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 5.4 m -88.79 149.38 23.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 110.889 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.7 t -103.59 -35.13 8.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.855 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -116.68 172.64 14.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.497 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -111.07 84.77 1.99 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.761 0.315 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -129.8 93.84 3.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -82.4 106.79 14.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 22.0 m -81.61 116.02 21.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 13.4 ttm -61.25 -47.67 84.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.887 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 1.2 t -75.53 129.16 36.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.8 m -71.4 98.41 1.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.893 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.457 ' O ' ' CD ' ' A' ' 276' ' ' ARG . 1.1 p -121.72 132.72 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.147 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 116.9 18.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 69.9 mt -147.92 151.23 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.166 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.563 HD11 ' CE1' ' A' ' 273' ' ' PHE . 85.9 mt -136.8 110.12 7.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.523 ' CE2' ' HB3' ' A' ' 236' ' ' ARG . 23.9 t80 -91.18 129.42 37.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.1 126.96 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.11 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.523 ' HB3' ' CE2' ' A' ' 234' ' ' TYR . 23.6 ptt85 -120.17 169.72 9.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 63.94 47.77 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 64.3 mt -104.43 131.93 51.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.494 ' CB ' ' OD2' ' A' ' 292' ' ' ASP . 8.7 mmt -71.25 132.09 44.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.443 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 62.8 mt -50.27 -29.11 8.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.951 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 72.7 m -63.71 -33.26 75.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.86 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' THR . . . . . 0.438 HG21 ' N ' ' A' ' 243' ' ' SER . 87.4 m -66.5 138.04 57.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.103 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.438 ' N ' HG21 ' A' ' 242' ' ' THR . 6.2 m -117.77 164.77 14.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.825 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 245' ' ' GLU . 17.4 mt-10 -44.49 -60.47 1.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 244' ' ' GLU . 30.7 tt0 -34.86 -62.23 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 25.9 mmm -40.33 -56.96 1.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 250' ' ' GLU . 36.8 mt -62.94 -65.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -39.55 -34.4 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.835 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -77.99 -38.94 43.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 247' ' ' ILE . 21.4 mm-40 -66.08 -48.5 70.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.465 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 15.1 m-85 -67.24 -42.13 84.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -61.88 -40.67 96.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -42.74 -42.17 3.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 31.9 mm -55.64 -58.7 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.416 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 10.6 tppt? -142.82 135.03 13.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.585 0.707 . . . . 0.0 110.889 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.416 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 54.3 Cg_endo -69.73 133.64 26.1 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.673 2.249 . . . . 0.0 112.354 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 65.9 39.02 94.8 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.507 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -103.33 -55.23 2.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.855 0.36 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 251' ' ' PHE . 58.0 t -69.6 114.98 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.085 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -74.2 -55.97 5.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -150.61 144.22 25.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.2 t -121.84 119.41 58.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -105.77 108.87 20.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -79.42 143.44 35.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.566 HD13 ' CD2' ' A' ' 268' ' ' TYR . 5.7 mt -135.66 172.8 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.117 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.49 ' C ' ' O ' ' A' ' 265' ' ' ILE . 21.1 mmt180 -30.17 -72.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 4.4 p-10 -128.29 20.35 6.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' TYR . . . . . 0.566 ' CD2' HD13 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -148.37 173.08 13.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -160.92 163.09 32.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -122.81 136.42 54.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.868 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 42.3 t -123.13 129.04 75.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.098 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -102.43 159.21 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.563 ' CE1' HD11 ' A' ' 233' ' ' LEU . 29.7 m-85 -137.19 -178.62 5.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.7 m -98.65 -28.28 13.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.841 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -145.95 147.68 31.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.891 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.457 ' CD ' ' O ' ' A' ' 230' ' ' VAL . 1.3 tpt180 -50.52 -61.72 2.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 276' ' ' ARG . 27.8 mt-10 -36.62 -50.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.83 -57.83 10.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -54.83 -37.6 66.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.43 ' CG1' ' HE2' ' A' ' 284' ' ' LYS . 76.7 t -65.77 -47.26 86.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.171 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.21 -50.4 73.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.26 -26.2 68.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.081 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.0 ttp -64.01 -67.64 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.43 ' HE2' ' CG1' ' A' ' 280' ' ' VAL . 26.7 mtmt -59.79 -29.29 68.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -56.31 -55.67 30.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.085 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.465 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 60.7 mt -81.54 -30.64 33.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -40.31 104.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 105.52 20.54 9.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -97.48 154.9 17.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.339 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 98.3 t -122.09 98.17 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.104 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 294' ' ' SER . 32.1 mt -94.57 153.69 17.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.494 ' OD2' ' CB ' ' A' ' 239' ' ' MET . 25.0 t0 42.33 26.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.33 38.21 53.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.484 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 291' ' ' LEU . 22.4 p -146.34 134.04 10.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.63 0.729 . . . . 0.0 110.856 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 102.35 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 2.237 . . . . 0.0 112.38 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 11.4 pt -89.49 148.22 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -121.87 136.1 54.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.4 t -119.09 121.92 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.124 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 68.4 p -139.73 168.34 20.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.112 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.92 101.89 13.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -64.25 161.63 16.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.061 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' LYS . . . . . 0.407 ' HD2' ' C ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -99.52 142.21 24.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.569 0.699 . . . . 0.0 110.889 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 141.65 46.01 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.647 2.231 . . . . 0.0 112.38 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 13.2 p -79.99 140.79 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.163 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -119.82 174.12 6.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.875 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -168.62 124.05 0.94 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -66.22 80.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 4.7 t -97.0 142.6 28.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 14.1 m -113.12 117.24 31.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -129.14 147.05 17.56 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.519 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 112.75 3.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.635 2.223 . . . . 0.0 112.355 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 62.2 m -114.51 103.71 11.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 79.8 p -75.7 150.0 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.812 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.486 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.7 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.898 0.38 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.7 p -122.48 132.99 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.51 116.85 18.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.503 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 63.2 mt -147.9 145.32 18.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.766 HD12 ' HE1' ' A' ' 273' ' ' PHE . 88.4 mt -133.26 109.21 9.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -91.71 133.28 35.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 23.1 t -114.58 137.44 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.106 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.0 ttp85 -129.78 156.13 44.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 73.83 44.28 0.28 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 25.0 mt -93.69 131.61 38.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 10.6 mmt -67.16 123.3 19.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 266' ' ' ARG . 26.0 mt -48.27 -32.01 6.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 9.5 t -66.72 -35.75 80.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 39.2 m -59.62 141.72 54.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.135 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.3 m -110.61 166.15 11.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 247' ' ' ILE . 29.7 mt-10 -52.27 -52.03 55.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -41.49 -43.52 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 21.2 mmm -63.99 -36.25 83.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 244' ' ' GLU . 43.0 mt -74.8 -38.31 44.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.123 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -71.13 -43.97 66.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 16.4 ptmt -63.89 -47.88 78.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.489 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 31.7 mm-40 -58.29 -46.95 85.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -72.57 -34.05 67.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.926 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -69.03 -32.22 71.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -47.02 -29.98 2.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 25.0 mm -68.2 -53.28 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -143.78 137.31 14.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.554 0.692 . . . . 0.0 110.936 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 126.24 13.11 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.682 2.255 . . . . 0.0 112.388 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 60.9 39.5 97.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.512 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -101.08 -45.13 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.24 109.93 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.14 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -61.37 -57.68 11.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' ARG . . . . . 0.4 ' HB3' ' NH1' ' A' ' 261' ' ' ARG . 1.1 ptp180 -153.34 158.05 40.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 91.1 t -132.41 115.89 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -110.31 106.95 16.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' LYS . . . . . 0.424 ' HD3' ' CD1' ' A' ' 247' ' ' ILE . 14.7 tptm -79.51 148.56 31.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.787 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.1 mt -137.36 172.19 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.161 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.661 ' H ' HG22 ' A' ' 265' ' ' ILE . 20.1 mmt180 -31.86 -70.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.29 17.76 6.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.787 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -146.08 177.93 8.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -170.14 165.02 9.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.109 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -127.59 142.18 51.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.38 123.44 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.143 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -99.96 157.59 16.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.766 ' HE1' HD12 ' A' ' 233' ' ' LEU . 41.3 m-85 -135.0 170.83 15.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.4 t -84.3 -34.24 23.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -138.67 144.66 39.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.662 ' O ' HG23 ' A' ' 280' ' ' VAL . 26.4 ttt180 -55.07 -42.51 72.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -46.49 -55.26 7.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -60.32 -51.31 70.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -51.17 -42.48 60.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 276' ' ' ARG . 91.8 t -61.54 -48.57 88.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.13 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -58.33 -55.58 33.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.69 -26.72 64.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.078 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 51.2 ttp -65.5 -60.24 3.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 285' ' ' ALA . 6.1 mtmp? -65.26 -55.21 19.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.907 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 284' ' ' LYS . . . -36.4 -47.85 0.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.091 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 287' ' ' ASN . 34.3 mt -84.46 -39.71 18.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.9 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 286' ' ' LEU . 31.9 t30 -37.1 104.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 98.97 38.24 3.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.478 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -114.35 159.17 20.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.786 0.327 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 98.8 t -121.51 97.4 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.127 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.86 HD12 HD13 ' A' ' 296' ' ' ILE . 60.4 mt -92.99 153.15 18.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 291' ' ' LEU . 23.7 m-20 37.73 28.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.828 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 74.0 44.61 29.54 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.493 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 291' ' ' LEU . 8.2 t -155.02 134.7 7.96 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.669 0.747 . . . . 0.0 110.81 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 102.08 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.367 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.86 HD13 HD12 ' A' ' 291' ' ' LEU . 7.8 pt -93.89 144.37 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -116.66 154.71 30.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.8 t -141.26 119.4 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.162 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 76.9 p -137.88 169.44 17.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.151 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 232' ' ' ILE . 8.0 mt -83.78 108.49 16.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.503 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -66.1 140.75 58.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.625 0.726 . . . . 0.0 110.882 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.914 0.387 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.93 134.85 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.2 116.58 17.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.54 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 37.6 mt -147.89 131.98 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 232' ' ' ILE . 15.7 mt -117.46 111.16 18.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.538 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 21.6 t80 -91.31 122.53 34.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.968 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.537 HG11 HD21 ' A' ' 238' ' ' LEU . 21.9 t -102.23 128.87 54.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.116 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 15.9 ttp85 -122.4 160.5 25.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.463 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 32.8 t-20 65.8 53.32 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.537 HD21 HG11 ' A' ' 235' ' ' VAL . 89.6 mt -106.16 131.31 53.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.9 mmt -66.33 136.99 56.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 266' ' ' ARG . 72.3 mt -56.4 -24.2 43.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 11.4 t -75.1 -26.4 59.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.429 ' HB ' ' NZ ' ' A' ' 264' ' ' LYS . 49.3 m -68.15 139.48 56.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.1 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.0 m -115.36 170.46 8.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.857 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 247' ' ' ILE . 48.8 mt-10 -50.95 -54.22 26.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -40.85 -48.06 3.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 2.9 mmt -55.98 -36.13 67.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 244' ' ' GLU . 40.6 mt -78.55 -46.72 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.115 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -60.22 -37.5 80.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 5.8 ptmt -73.47 -47.2 43.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.481 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 49.6 mm-40 -65.19 -22.78 66.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.613 ' CE1' HD13 ' A' ' 286' ' ' LEU . 7.3 m-85 -94.51 -26.32 16.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.44 ' OD1' ' CG2' ' A' ' 259' ' ' VAL . 78.6 m-20 -84.66 -18.99 33.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -59.6 -23.3 62.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 13.7 mm -75.7 -56.03 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -139.52 134.61 16.41 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.524 0.678 . . . . 0.0 110.923 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 138.09 37.09 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.679 2.253 . . . . 0.0 112.359 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 56.08 41.09 84.82 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -105.07 -53.06 2.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 111.073 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.44 ' CG2' ' OD1' ' A' ' 252' ' ' ASN . 96.9 t -61.15 114.61 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.154 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -72.02 -62.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.926 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -149.07 151.45 34.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.498 HG22 HG13 ' A' ' 271' ' ' VAL . 58.0 t -128.86 151.71 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -141.47 116.2 9.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' LYS . . . . . 0.429 ' NZ ' ' HB ' ' A' ' 242' ' ' THR . 30.1 tptt -84.88 145.94 27.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.773 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.3 mt -133.88 172.18 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.655 ' H ' HG22 ' A' ' 265' ' ' ILE . 14.4 mmm180 -31.51 -72.04 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -126.88 19.13 7.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.773 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -148.4 177.85 9.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -163.98 170.55 16.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -133.35 146.24 51.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.498 HG13 HG22 ' A' ' 262' ' ' VAL . 16.6 t -133.55 134.2 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.136 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -112.41 152.34 28.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -129.2 -177.82 4.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 41.8 t -95.45 -22.01 17.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.45 151.4 31.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.575 ' O ' HG23 ' A' ' 280' ' ' VAL . 16.2 ttt180 -62.44 -37.39 85.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -48.24 -63.49 1.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.92 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -44.88 94.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.847 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.98 -47.15 61.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 276' ' ' ARG . 85.9 t -63.87 -42.67 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -60.87 -49.26 78.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.829 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.0 -29.93 71.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.125 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 53.6 ttp -70.42 -50.37 39.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -69.97 -30.09 67.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.59 -45.1 84.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.613 HD13 ' CE1' ' A' ' 251' ' ' PHE . 41.5 mt -87.28 -27.6 22.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ASN . . . . . 0.436 ' C ' ' OD1' ' A' ' 287' ' ' ASN . 23.4 t-20 -48.8 108.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 97.62 33.74 5.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.505 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -113.95 151.13 32.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.932 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 86.3 t -110.05 103.47 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.162 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 1.018 HD12 HD13 ' A' ' 296' ' ' ILE . 25.1 mt -102.4 147.11 27.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 44.97 24.96 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.847 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 77.97 41.31 18.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.49 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 3.0 t -153.81 135.16 8.71 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.681 0.753 . . . . 0.0 110.836 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.463 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 54.3 Cg_endo -69.72 93.94 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 1.018 HD13 HD12 ' A' ' 291' ' ' LEU . 11.4 pt -76.64 146.51 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.629 ' OE1' HG23 ' A' ' 299' ' ' THR . 0.2 OUTLIER -122.12 135.11 54.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.908 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.79 118.21 54.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' THR . . . . . 0.629 HG23 ' OE1' ' A' ' 297' ' ' GLU . 18.9 p -132.45 166.29 22.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.153 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.2 mt -83.77 102.87 12.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.54 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -71.16 157.33 38.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.115 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 121.586 0.708 . . . . 0.0 110.908 179.957 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.935 0.397 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.2 p -113.68 132.03 63.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -133.95 117.03 16.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.627 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 98.6 mt -147.73 139.14 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 232' ' ' ILE . 12.1 mt -121.09 107.63 12.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.751 ' CD1' ' CE1' ' A' ' 270' ' ' PHE . 33.3 t80 -91.46 121.32 33.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.19 132.23 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -119.69 155.78 31.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.409 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 38.6 t-20 70.68 52.62 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.23 126.62 52.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 22.8 mtt -71.49 139.98 49.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.622 HD23 ' O ' ' A' ' 266' ' ' ARG . 39.9 mt -55.96 -18.74 9.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.3 t -75.89 -28.59 58.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.833 HG23 ' SD ' ' A' ' 246' ' ' MET . 42.8 m -64.5 146.66 54.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 44.1 m -120.63 165.71 14.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.805 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 264' ' ' LYS . 49.0 mt-10 -64.5 -16.37 62.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -69.59 -64.02 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.833 ' SD ' HG23 ' A' ' 242' ' ' THR . 13.0 ptp -54.7 -30.87 56.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.854 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 73.1 mt -69.81 -45.13 78.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -65.53 -53.56 40.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.484 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 0.7 OUTLIER -53.32 -49.48 66.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.484 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 61.4 mm-40 -52.92 -53.46 49.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.615 ' CE2' HG21 ' A' ' 271' ' ' VAL . 5.8 m-85 -61.83 -58.49 7.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 253' ' ' ASN . 2.3 m120 -47.12 -49.1 22.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.952 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 252' ' ' ASN . 29.8 m-20 -36.65 -46.77 0.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.905 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.61 HD12 ' HB1' ' A' ' 285' ' ' ALA . 43.1 mm -51.64 -56.79 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.124 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.475 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 0.1 OUTLIER -143.95 137.06 13.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.548 0.689 . . . . 0.0 110.932 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.475 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 53.0 Cg_endo -69.82 136.75 33.64 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.63 2.22 . . . . 0.0 112.309 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 60.12 36.42 90.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -99.43 -39.15 8.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 111.13 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.5 t -90.99 132.99 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.171 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.424 ' OE1' ' N ' ' A' ' 260' ' ' GLU . 0.7 OUTLIER -94.37 -52.17 4.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 261' ' ' ARG . . . . . 0.481 ' HD3' ' N ' ' A' ' 262' ' ' VAL . 0.1 OUTLIER -151.23 161.75 42.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.481 ' N ' ' HD3' ' A' ' 261' ' ' ARG . 32.5 t -131.63 138.89 51.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.154 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 6.6 tppt? -123.99 113.6 18.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' LYS . . . . . 0.409 ' HB2' ' CG ' ' A' ' 244' ' ' GLU . 13.9 tptp -87.66 143.31 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.754 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.7 mt -133.61 172.93 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.13 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.683 ' H ' HG22 ' A' ' 265' ' ' ILE . 20.4 mmt180 -30.66 -73.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.99 15.92 7.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.754 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -142.49 172.39 12.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.943 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -159.28 165.54 33.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.08 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.751 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 86.8 m-85 -128.35 149.6 50.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.615 HG21 ' CE2' ' A' ' 251' ' ' PHE . 19.8 t -132.56 123.78 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.115 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -97.15 144.24 27.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.835 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -120.4 177.52 5.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 33.4 t -90.86 -33.4 15.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.84 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -143.15 161.38 38.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 277' ' ' GLU . 11.1 ttp180 -64.49 -61.77 2.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 276' ' ' ARG . 16.1 mt-10 -35.99 -49.11 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -64.19 -50.73 66.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -53.4 -47.3 69.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.646 HG12 ' HD2' ' A' ' 284' ' ' LYS . 83.5 t -59.69 -43.12 90.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.84 -56.39 17.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.09 -38.24 67.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.124 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 65.0 ttp -60.32 -47.71 84.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.872 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.646 ' HD2' HG12 ' A' ' 280' ' ' VAL . 2.9 mtpm? -70.08 -37.6 75.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.61 ' HB1' HD12 ' A' ' 254' ' ' ILE . . . -55.19 -47.96 74.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.091 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.503 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 64.8 mt -84.6 -36.65 21.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 286' ' ' LEU . 11.3 t30 -36.74 93.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 113.03 33.82 1.93 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.475 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -110.79 157.88 19.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 91.3 t -119.8 96.13 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.837 HD12 HD13 ' A' ' 296' ' ' ILE . 31.3 mt -92.9 147.29 22.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.4 ' OD1' ' SD ' ' A' ' 246' ' ' MET . 3.2 m-20 46.64 30.47 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 69.91 43.05 67.4 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.459 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.9 m -155.05 137.35 9.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.693 0.759 . . . . 0.0 110.856 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.409 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.3 Cg_endo -69.79 108.74 2.15 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.627 2.218 . . . . 0.0 112.365 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.837 HD13 HD12 ' A' ' 291' ' ' LEU . 10.1 pt -97.54 141.72 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -112.34 143.9 42.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.847 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.07 117.84 51.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 10.5 p -132.84 167.57 19.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.209 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 9.3 mt -85.91 113.18 21.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.627 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -66.23 139.01 58.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.125 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.586 0.708 . . . . 0.0 110.872 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.91 0.386 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -116.25 132.69 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.112 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.405 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -130.72 116.9 18.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 68.5 mt -147.91 136.42 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.129 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 23.4 mt -118.57 110.16 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.595 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 28.2 t80 -93.47 125.74 38.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.472 HG11 HD21 ' A' ' 238' ' ' LEU . 21.3 t -108.83 142.52 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.089 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 7.3 ttt-85 -134.87 157.23 47.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 295' ' ' PRO . 12.2 t30 71.92 47.95 0.3 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.472 HD21 HG11 ' A' ' 235' ' ' VAL . 31.0 mt -100.99 125.34 47.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 14.3 mtt -63.75 125.73 25.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.836 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 266' ' ' ARG . 20.3 mt -50.93 -23.95 3.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.934 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 7.2 m -68.87 -33.32 73.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.529 HG23 ' SD ' ' A' ' 246' ' ' MET . 24.9 m -63.56 144.9 56.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.196 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.6 m -112.17 165.81 11.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.855 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.57 -46.69 80.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -45.17 -36.65 3.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.529 ' SD ' HG23 ' A' ' 242' ' ' THR . 27.5 mtt -69.53 -42.02 75.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.879 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 46.0 mt -68.89 -39.92 80.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.452 ' OE1' ' CG2' ' A' ' 262' ' ' VAL . 4.3 tp10 -64.69 -43.79 92.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.864 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 1.7 ptmm? -72.54 -46.27 55.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.528 ' CD ' HD21 ' A' ' 291' ' ' LEU . 62.3 mm-40 -56.82 -33.51 66.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.915 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.639 ' CE2' HG21 ' A' ' 271' ' ' VAL . 8.0 m-85 -87.93 -30.61 19.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -76.42 -26.91 55.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -52.72 -23.84 7.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 16.0 mm -78.19 -52.82 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -144.14 134.0 11.76 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.587 0.708 . . . . 0.0 110.924 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 142.53 48.28 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 0.0 112.348 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 55.13 26.23 41.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.519 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -90.52 -53.72 4.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.333 . . . . 0.0 111.08 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.5 t -62.25 114.42 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -73.98 -60.02 2.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -150.2 146.2 26.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.87 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.452 ' CG2' ' OE1' ' A' ' 248' ' ' GLU . 61.3 t -116.92 128.84 74.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.13 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -115.63 108.41 16.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -85.22 142.17 29.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.771 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.7 mt -133.86 172.41 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.66 ' H ' HG22 ' A' ' 265' ' ' ILE . 15.6 mmt180 -31.11 -72.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.82 15.84 8.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.85 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.771 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -143.37 175.27 10.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -163.79 160.32 22.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.052 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.441 ' CD2' HD11 ' A' ' 265' ' ' ILE . 86.4 m-85 -124.56 138.15 54.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.639 HG21 ' CE2' ' A' ' 251' ' ' PHE . 3.1 t -123.12 129.58 74.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.11 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -106.69 151.74 24.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.865 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -129.73 174.62 9.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 25.4 t -80.96 -38.41 27.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.878 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -144.28 153.31 41.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 277' ' ' GLU . 21.5 ttt180 -50.87 -56.17 13.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.876 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 276' ' ' ARG . 4.9 mm-40 -35.76 -54.76 0.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -59.63 -49.93 75.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.813 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -53.05 -50.18 64.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 48.9 t -53.75 -48.9 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -59.01 -59.93 4.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.844 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.28 -18.64 6.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 56.9 ttp -78.01 -57.67 3.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -66.89 -29.56 69.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -62.42 -56.99 12.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.095 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.631 ' CD1' ' CD1' ' A' ' 251' ' ' PHE . 55.2 mt -76.71 -40.19 49.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.945 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -39.87 121.14 1.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 90.63 27.33 20.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.525 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -110.37 161.78 15.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.406 HG13 ' C ' ' A' ' 294' ' ' SER . 72.9 t -123.85 95.11 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.078 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.758 HD12 HD13 ' A' ' 296' ' ' ILE . 33.1 mt -87.07 148.01 25.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 40.6 t0 41.47 41.54 1.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.902 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 59.58 45.85 94.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.406 ' C ' HG13 ' A' ' 290' ' ' VAL . 2.0 t -154.62 136.59 9.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.683 0.754 . . . . 0.0 110.883 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.425 ' O ' ' ND2' ' A' ' 237' ' ' ASN . 53.6 Cg_endo -69.76 110.9 2.67 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.712 2.275 . . . . 0.0 112.306 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.758 HD13 HD12 ' A' ' 291' ' ' LEU . 10.8 pt -101.33 144.38 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.176 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -115.45 151.79 34.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 8.8 t -140.43 113.52 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 51.2 p -134.35 167.65 20.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.163 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 10.9 mt -81.54 108.87 15.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.595 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -68.92 137.41 53.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 94.6 p . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.928 0.394 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.19 136.5 51.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.112 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -137.61 116.88 12.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.682 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 77.0 mt -147.91 140.29 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.055 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 11.4 mt -120.83 111.87 18.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.921 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.517 ' CE2' ' HB2' ' A' ' 236' ' ' ARG . 16.2 t80 -92.08 129.72 37.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.843 HG11 HD21 ' A' ' 238' ' ' LEU . 17.4 t -115.18 133.82 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.517 ' HB2' ' CE2' ' A' ' 234' ' ' TYR . 30.3 ttp85 -129.31 161.17 30.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 71.26 35.84 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.843 HD21 HG11 ' A' ' 235' ' ' VAL . 11.5 mt -91.76 122.6 34.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' MET . . . . . 0.496 ' CB ' ' OD2' ' A' ' 292' ' ' ASP . 4.7 mmt -57.43 139.66 52.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.495 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 40.4 mt -63.34 -7.66 6.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.885 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 37.6 m -97.44 16.64 19.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.615 HG23 ' SD ' ' A' ' 246' ' ' MET . 49.2 m -99.02 145.33 27.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 2.3 m -119.05 155.07 32.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -56.1 -15.04 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.835 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -72.58 -66.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.615 ' SD ' HG23 ' A' ' 242' ' ' THR . 13.2 ptp -55.64 -29.08 58.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 63.4 mt -75.77 -45.84 37.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.134 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.434 ' HG2' ' ND2' ' A' ' 252' ' ' ASN . 17.9 tt0 -63.1 -44.28 96.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 16.2 ptmt -64.61 -47.58 78.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.595 ' HG3' HD21 ' A' ' 291' ' ' LEU . 21.6 mm-40 -57.25 -34.72 68.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -81.89 -32.16 31.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.434 ' ND2' ' HG2' ' A' ' 248' ' ' GLU . 59.2 m-20 -79.86 -14.6 58.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.431 ' OD1' HD13 ' A' ' 254' ' ' ILE . 34.7 p-10 -60.17 -18.48 48.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.431 HD13 ' OD1' ' A' ' 253' ' ' ASN . 10.0 mm -79.86 -60.21 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -136.67 135.32 20.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.556 0.693 . . . . 0.0 110.959 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 137.45 35.56 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.727 2.285 . . . . 0.0 112.317 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.57 40.43 94.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.511 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -102.56 -56.41 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 111.112 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.2 t -59.76 136.13 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -93.91 -55.77 3.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -152.74 149.32 28.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 19.2 t -122.41 137.85 54.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -128.31 109.1 11.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -80.35 140.62 36.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.954 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.704 HG22 ' H ' ' A' ' 266' ' ' ARG . 6.2 mt -130.82 173.33 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.083 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.704 ' H ' HG22 ' A' ' 265' ' ' ILE . 22.0 mmt180 -28.66 -75.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.879 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -125.0 14.26 8.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.746 ' HA ' HD12 ' A' ' 238' ' ' LEU . 0.1 OUTLIER -140.58 171.67 13.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.944 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -157.87 154.88 28.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -116.07 146.06 42.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.892 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 18.1 t -134.49 125.35 46.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.145 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -98.9 154.68 17.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.889 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -131.85 167.88 18.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.6 t -77.18 -33.78 56.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -146.63 153.13 39.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 277' ' ' GLU . 5.8 ttt-85 -54.04 -55.95 22.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 276' ' ' ARG . 77.8 mt-10 -34.91 -59.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.885 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -56.84 -49.11 76.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.83 -53.33 33.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.66 -37.0 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.159 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -65.41 -49.4 69.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.97 -21.17 65.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 51.2 ttp -71.3 -58.45 3.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -66.16 -30.02 70.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -60.66 -55.67 30.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 42.8 mt -79.49 -31.29 42.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -40.65 115.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 93.08 32.92 7.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -109.83 157.46 19.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.802 0.334 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 76.5 t -118.79 96.19 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.152 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.936 HD12 HD13 ' A' ' 296' ' ' ILE . 30.6 mt -95.0 152.81 18.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.496 ' OD2' ' CB ' ' A' ' 239' ' ' MET . 34.2 t70 41.86 26.51 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.83 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.7 43.84 34.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.516 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 2.0 m -154.39 137.88 10.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.62 0.724 . . . . 0.0 110.897 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 91.93 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.685 2.257 . . . . 0.0 112.352 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.936 HD13 HD12 ' A' ' 291' ' ' LEU . 17.2 pt -78.35 144.97 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -120.44 140.06 51.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.91 134.61 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 41.0 p -147.32 176.43 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 232' ' ' ILE . 15.5 mt -95.64 105.78 17.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.682 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -71.78 145.01 48.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 19.7 pttm . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.582 0.706 . . . . 0.0 110.886 179.973 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.906 0.384 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.42 130.5 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.116 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.32 116.85 18.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.518 ' O ' HD23 ' A' ' 300' ' ' LEU . 40.6 mt -148.05 136.5 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.114 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.612 HD12 ' HE1' ' A' ' 273' ' ' PHE . 36.0 mt -124.04 108.57 12.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.891 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 22.8 t80 -92.02 126.27 37.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.873 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 24.3 t -108.0 144.49 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.134 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -136.98 157.81 45.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 72.9 53.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 14.8 mt -111.14 134.46 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 3.8 mtt -70.51 137.47 50.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 266' ' ' ARG . 70.3 mt -53.95 -18.65 3.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 36.7 m -75.09 -31.36 61.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.554 HG23 ' HB2' ' A' ' 246' ' ' MET . 50.6 m -67.5 127.27 32.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.151 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.1 t -107.08 157.4 17.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -43.34 -28.04 0.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -60.55 -42.55 96.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.554 ' HB2' HG23 ' A' ' 242' ' ' THR . 7.3 mmt -63.82 -42.47 97.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.478 ' HB ' HG11 ' A' ' 262' ' ' VAL . 69.1 mt -67.12 -36.9 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.439 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 19.3 tt0 -70.34 -49.12 52.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 4.8 ptmt -63.23 -46.77 85.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.584 ' HG3' HD21 ' A' ' 291' ' ' LEU . 27.7 mm-40 -59.79 -56.29 23.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.865 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.592 ' CE2' HG21 ' A' ' 271' ' ' VAL . 7.4 m-85 -62.33 -41.77 98.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.439 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 5.8 m-20 -62.03 -42.35 99.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -38.49 -42.62 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 44.2 mm -53.99 -58.95 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.445 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 26.6 tptt -141.05 136.81 16.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.538 0.685 . . . . 0.0 110.909 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.445 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 53.4 Cg_endo -69.77 131.28 20.89 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.677 2.251 . . . . 0.0 112.325 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 62.82 39.52 98.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.509 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -103.94 -45.11 4.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 0.0 111.069 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.409 ' CG2' ' OD1' ' A' ' 252' ' ' ASN . 93.8 t -71.62 117.89 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.64 -60.32 2.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -145.52 152.96 40.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.478 HG11 ' HB ' ' A' ' 247' ' ' ILE . 92.2 t -127.8 130.74 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -118.94 109.65 16.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -86.66 143.61 27.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.902 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.689 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.5 mt -133.95 172.65 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.687 ' H ' HG22 ' A' ' 265' ' ' ILE . 22.7 mmt180 -30.89 -70.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -125.62 -1.11 7.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.689 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -124.45 177.54 5.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.96 164.94 16.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.101 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 265' ' ' ILE . 97.8 m-85 -127.21 142.81 51.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.592 HG21 ' CE2' ' A' ' 251' ' ' PHE . 5.2 t -129.99 122.65 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -105.74 133.38 50.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.817 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.612 ' HE1' HD12 ' A' ' 233' ' ' LEU . 30.9 m-85 -108.02 175.71 5.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 17.3 t -86.5 -28.46 23.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -146.92 149.52 33.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -52.48 -49.19 65.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 278' ' ' ASP . 13.8 pt-20 -44.35 -51.85 8.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.425 ' N ' ' HG3' ' A' ' 277' ' ' GLU . 2.5 m-20 -60.62 -50.53 73.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.844 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.463 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -52.44 -49.79 63.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.06 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 77.9 t -53.77 -54.97 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -53.56 -59.83 4.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.431 ' CB ' ' CZ ' ' A' ' 273' ' ' PHE . . . -54.33 -29.36 47.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 62.2 ttp -68.84 -57.14 5.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -63.67 -51.62 64.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -45.12 -51.97 9.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.074 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.532 HD13 ' CE1' ' A' ' 251' ' ' PHE . 81.4 mt -79.13 -29.15 42.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.914 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ASN . . . . . 0.402 ' O ' ' ND2' ' A' ' 287' ' ' ASN . 2.7 t30 -49.52 91.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 115.88 31.49 1.91 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.458 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.411 ' HB2' HD11 ' A' ' 296' ' ' ILE . 3.7 mmpt? -106.5 163.2 13.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 110.931 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 51.9 t -125.53 96.59 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.106 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.584 HD21 ' HG3' ' A' ' 250' ' ' GLU . 72.0 mt -89.92 152.67 21.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.899 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 291' ' ' LEU . 1.6 m-20 34.94 36.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 66.62 46.99 71.51 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.477 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 291' ' ' LEU . 5.2 t -154.77 136.25 9.22 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.667 0.746 . . . . 0.0 110.86 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 106.05 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.719 2.279 . . . . 0.0 112.367 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.475 HD13 HD12 ' A' ' 291' ' ' LEU . 7.9 pt -94.09 145.28 8.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.16 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -118.6 146.83 44.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.0 117.81 39.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 33.9 p -135.67 170.31 16.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.518 HD23 ' O ' ' A' ' 232' ' ' ILE . 22.3 mt -86.89 102.2 14.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.934 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -72.41 114.16 10.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 121.537 0.684 . . . . 0.0 110.894 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.877 0.37 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.88 133.11 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.139 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.34 116.84 19.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.44 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 20.0 mt -147.95 130.93 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.09 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 279' ' ' ALA . 15.2 mt -117.49 112.49 20.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.914 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -91.85 128.99 37.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.09 128.74 73.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.127 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -125.23 159.55 31.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 71.88 51.23 0.23 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 41.5 mt -107.83 119.09 38.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 7.0 mmt -54.3 125.39 19.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.705 HD23 ' O ' ' A' ' 266' ' ' ARG . 65.1 mt -44.44 -30.17 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 36.0 t -59.92 -40.53 89.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.449 ' HA ' ' CE ' ' A' ' 246' ' ' MET . 30.9 m -60.56 155.16 19.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.153 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.42 ' N ' HG22 ' A' ' 242' ' ' THR . 43.2 m -134.64 168.28 19.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.838 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 245' ' ' GLU . 54.3 mt-10 -47.43 -57.74 4.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 244' ' ' GLU . 38.0 tt0 -35.68 -59.73 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.449 ' CE ' ' HA ' ' A' ' 242' ' ' THR . 6.9 mtt -47.52 -51.66 19.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.0 -34.02 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.118 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -64.66 -51.38 62.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 1.6 ptpp? -65.81 -44.34 85.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.888 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.554 ' HG3' HD21 ' A' ' 291' ' ' LEU . 52.0 mm-40 -61.0 -28.8 69.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 271' ' ' VAL . 7.2 m-85 -95.24 -23.19 17.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.77 -35.7 32.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 250' ' ' GLU . 0.6 OUTLIER -42.56 -29.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 15.5 mm -68.76 -66.79 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -131.35 131.96 23.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.519 0.676 . . . . 0.0 110.887 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 121.83 8.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 72.9 33.25 60.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.522 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -101.34 -39.71 7.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 78.8 t -73.16 113.75 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.061 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -66.84 -65.0 0.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.907 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' ARG . . . . . 0.476 ' CD ' ' HB2' ' A' ' 272' ' ' HIS . 0.0 OUTLIER -146.86 162.62 38.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.877 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 48.1 t -133.53 137.57 52.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' LYS . . . . . 0.423 ' C ' ' HD3' ' A' ' 263' ' ' LYS . 9.4 tmtm? -127.06 105.2 8.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' LYS . . . . . 0.429 ' CB ' ' HG3' ' A' ' 244' ' ' GLU . 11.4 tptp -79.67 145.17 33.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.836 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.8 mt -133.6 172.05 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.148 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.705 ' O ' HD23 ' A' ' 240' ' ' LEU . 51.9 mtt85 -32.01 -71.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.64 15.57 7.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.836 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -142.56 177.37 8.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -167.6 164.74 14.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.075 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.442 ' CD2' HD11 ' A' ' 265' ' ' ILE . 98.3 m-85 -130.94 142.9 50.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 251' ' ' PHE . 21.4 t -124.47 125.51 70.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.107 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' HIS . . . . . 0.476 ' HB2' ' CD ' ' A' ' 261' ' ' ARG . 3.5 m-70 -105.3 137.55 42.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -117.03 -177.51 3.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.83 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.3 t -99.45 -24.99 14.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -144.78 144.17 31.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.865 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 277' ' ' GLU . 9.6 ttp180 -54.4 -54.17 44.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 276' ' ' ARG . 4.8 mm-40 -35.64 -54.64 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.42 -51.72 67.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.417 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -46.48 -46.88 19.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.057 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.453 ' CG1' ' HD2' ' A' ' 284' ' ' LYS . 51.6 t -65.69 -54.47 27.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.084 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -50.13 -47.61 54.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.49 -31.37 68.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 67.6 ttp -66.82 -53.58 31.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.453 ' HD2' ' CG1' ' A' ' 280' ' ' VAL . 30.0 mtpt -65.92 -39.75 90.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -53.85 -53.83 47.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.475 HD13 ' CE1' ' A' ' 251' ' ' PHE . 35.2 mt -77.06 -35.49 56.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -41.15 95.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 114.83 32.53 1.87 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.524 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -113.66 160.35 18.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 0.0 110.863 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 95.8 t -123.23 103.59 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.612 HD12 HD13 ' A' ' 296' ' ' ILE . 22.4 mt -95.64 150.85 19.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 41.92 24.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 77.32 38.17 29.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 291' ' ' LEU . 23.6 p -145.59 135.68 11.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 110.908 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 102.41 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.7 2.267 . . . . 0.0 112.328 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.612 HD13 HD12 ' A' ' 291' ' ' LEU . 7.3 pt -90.43 147.2 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.11 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -122.96 140.69 52.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.24 122.33 65.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 81.9 p -137.84 172.79 12.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.122 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 11.4 mt -90.22 110.02 21.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.44 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -71.43 153.42 42.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.105 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.578 0.704 . . . . 0.0 110.893 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.943 0.402 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.54 131.98 62.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.138 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.21 116.83 17.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.525 ' O ' HD23 ' A' ' 233' ' ' LEU . 21.9 mt -147.94 140.77 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.592 HD12 ' CE1' ' A' ' 273' ' ' PHE . 39.5 mt -126.28 106.89 9.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.731 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 38.9 t80 -91.38 123.95 35.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.96 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.482 HG11 HD21 ' A' ' 238' ' ' LEU . 20.8 t -104.45 148.36 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.527 ' HG3' ' CE2' ' A' ' 234' ' ' TYR . 24.0 mtp180 -138.72 160.31 39.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.46 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 26.7 t-20 67.72 53.03 0.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.672 HD13 HD11 ' A' ' 247' ' ' ILE . 27.0 mt -109.46 120.63 43.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 8.4 mmt -54.97 133.64 48.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.849 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.507 HD23 ' O ' ' A' ' 266' ' ' ARG . 54.4 mt -51.91 -25.01 7.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 61.5 m -70.79 -32.3 69.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.52 HG23 ' HB2' ' A' ' 246' ' ' MET . 93.9 m -65.82 139.95 58.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.1 t -121.11 164.11 17.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.83 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -47.92 -22.04 0.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -65.69 -45.3 83.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.52 ' HB2' HG23 ' A' ' 242' ' ' THR . 2.3 mmt -67.59 -44.53 77.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.672 HD11 HD13 ' A' ' 238' ' ' LEU . 79.2 mt -65.97 -37.65 80.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.442 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 13.9 tt0 -71.62 -57.75 4.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 5.8 ptmt -49.34 -45.98 46.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.488 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 23.6 mm-40 -61.99 -58.21 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.531 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 6.0 m-85 -54.57 -27.53 39.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 16.2 m120 -71.77 -44.57 63.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.955 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -38.78 -40.76 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 17.0 mm -56.47 -64.24 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -139.48 131.75 15.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.58 0.705 . . . . 0.0 110.908 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 136.67 33.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.617 2.211 . . . . 0.0 112.39 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 63.37 33.32 86.93 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.445 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -100.75 -51.04 3.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.353 . . . . 0.0 111.108 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.73 135.9 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.123 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -96.89 -64.33 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -146.06 142.41 28.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 66.6 t -120.92 136.55 57.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -129.66 110.13 11.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 265' ' ' ILE . 23.4 tptp -79.49 144.63 33.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.693 HG22 ' H ' ' A' ' 266' ' ' ARG . 6.5 mt -132.3 173.1 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.141 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.693 ' H ' HG22 ' A' ' 265' ' ' ILE . 20.3 mmm180 -29.4 -68.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -132.42 15.08 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.649 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -142.86 173.38 11.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.928 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -162.18 158.98 25.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.086 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 95.3 m-85 -118.62 148.86 42.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.427 HG11 ' CD2' ' A' ' 251' ' ' PHE . 21.3 t -134.81 124.43 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -100.68 146.82 26.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.592 ' CE1' HD12 ' A' ' 233' ' ' LEU . 22.7 m-85 -126.84 167.59 15.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.887 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 45.8 m -74.79 -39.17 61.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -142.87 153.34 43.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.443 ' O ' ' C ' ' A' ' 277' ' ' GLU . 10.0 ttt85 -54.4 -57.7 10.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 276' ' ' ARG . 4.6 mp0 -34.36 -50.25 0.41 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -63.67 -53.65 48.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.57 ' HB1' HD21 ' A' ' 233' ' ' LEU . . . -51.86 -53.31 41.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.429 HG12 ' NZ ' ' A' ' 284' ' ' LYS . 56.1 t -52.74 -44.8 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.173 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.62 -51.83 67.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.15 -14.57 63.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.107 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -76.6 -60.8 2.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.429 ' NZ ' HG12 ' A' ' 280' ' ' VAL . 19.0 mtmm -64.22 -37.48 87.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -51.46 -54.7 24.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.111 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.531 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 50.5 mt -76.08 -40.16 53.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 286' ' ' LEU . 2.0 t30 -36.29 97.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 109.51 33.91 2.58 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.522 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -114.86 164.2 14.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.769 0.318 . . . . 0.0 110.953 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.413 HG13 ' N ' ' A' ' 294' ' ' SER . 56.8 t -124.64 110.79 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.114 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 293' ' ' GLY . 26.9 mt -102.96 146.38 28.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 39.62 29.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.59 47.55 12.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.469 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.413 ' N ' HG13 ' A' ' 290' ' ' VAL . 1.8 m -154.52 134.68 8.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.678 0.751 . . . . 0.0 110.852 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.46 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.4 Cg_endo -69.76 94.78 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 10.1 pt -83.61 148.31 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 298' ' ' VAL . 4.5 tp10 -122.79 148.41 45.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 286' ' ' LEU . 4.2 t -130.97 117.88 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.156 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 24.7 p -134.78 160.57 37.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.175 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 232' ' ' ILE . 8.8 mt -83.88 100.61 11.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.731 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -66.73 124.52 23.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.069 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.469 ' CD ' ' H ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.583 0.706 . . . . 0.0 110.918 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.932 0.396 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -106.83 131.02 57.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.131 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.64 116.42 18.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.49 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 80.9 mt -147.9 142.66 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.139 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.796 HD12 ' HE1' ' A' ' 273' ' ' PHE . 81.7 mt -128.94 106.0 8.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.638 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 32.6 t80 -91.31 128.52 37.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.9 t -109.56 150.64 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.149 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -138.81 157.98 45.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 71.8 54.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 23.6 mt -107.04 113.14 26.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' MET . . . . . 0.45 ' CG ' ' OD2' ' A' ' 292' ' ' ASP . 13.4 mmt -53.89 128.15 28.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.443 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 25.7 mt -49.09 -30.38 6.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.906 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 97.8 p -64.49 -33.36 75.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.444 ' O ' ' NZ ' ' A' ' 264' ' ' LYS . 7.8 m -58.96 150.05 25.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.146 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 3.4 m -118.02 159.79 22.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -54.19 -41.62 68.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -54.84 -32.34 60.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.6 mtt -70.74 -37.25 73.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 25.9 mt -74.72 -39.81 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.156 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -68.81 -45.97 69.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.476 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 0.0 OUTLIER -62.35 -48.38 80.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.907 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.52 ' HA ' ' ND2' ' A' ' 253' ' ' ASN . 52.8 mm-40 -56.35 -50.11 72.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.467 ' CD2' HG11 ' A' ' 271' ' ' VAL . 7.2 m-85 -65.74 -23.56 66.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -75.49 -41.38 55.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.52 ' ND2' ' HA ' ' A' ' 250' ' ' GLU . 25.0 m-20 -37.37 -46.96 0.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 49.7 mm -49.59 -63.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -141.17 129.38 12.29 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.596 0.712 . . . . 0.0 110.934 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 114.96 3.88 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.672 2.248 . . . . 0.0 112.324 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 90.36 38.23 6.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -114.35 -43.62 3.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 111.084 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.61 118.4 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -80.25 -67.99 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -144.76 150.92 38.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 93.7 t -127.22 130.1 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.12 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -115.54 106.26 13.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 242' ' ' THR . 15.6 tptm -80.09 140.94 36.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.768 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.1 mt -132.26 172.42 16.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.668 ' H ' HG22 ' A' ' 265' ' ' ILE . 30.7 mmt180 -31.78 -72.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 7.7 p-10 -126.51 17.48 7.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.768 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -146.25 178.01 8.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -169.22 165.78 10.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.104 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.575 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 96.3 m-85 -126.89 145.4 50.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 251' ' ' PHE . 66.6 t -129.79 134.54 62.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.117 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -113.99 156.29 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.796 ' HE1' HD12 ' A' ' 233' ' ' LEU . 44.9 m-85 -134.37 179.95 5.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 62.5 p -83.26 -34.68 25.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -147.49 153.18 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.872 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 277' ' ' GLU . 8.5 ttt85 -53.79 -54.57 36.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 276' ' ' ARG . 44.7 mt-10 -34.48 -56.52 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.81 -50.78 72.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.05 -54.23 21.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.038 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 71.6 t -53.39 -47.89 57.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.088 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -56.0 -58.45 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.19 -30.87 51.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.091 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 63.6 ttp -68.07 -55.74 11.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -68.6 -14.94 63.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -79.29 -52.73 7.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.082 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 287' ' ' ASN . 59.5 mt -82.69 -35.16 27.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 286' ' ' LEU . 2.3 t-20 -38.28 99.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 107.68 34.37 2.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.504 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -113.59 159.66 19.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.824 0.345 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 86.7 t -121.32 93.6 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.173 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.475 HD12 HD13 ' A' ' 296' ' ' ILE . 27.7 mt -92.08 153.86 19.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.45 ' OD2' ' CG ' ' A' ' 239' ' ' MET . 3.2 p-10 42.15 25.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.1 38.29 40.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.51 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 291' ' ' LEU . 68.1 p -147.05 134.9 10.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.637 0.732 . . . . 0.0 110.887 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 92.0 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.629 2.22 . . . . 0.0 112.323 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.475 HD13 HD12 ' A' ' 291' ' ' LEU . 7.5 pt -82.85 148.38 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -125.87 143.71 50.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.6 t -123.86 127.22 73.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 25.7 p -137.43 171.76 13.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 232' ' ' ILE . 5.4 mt -94.74 100.15 12.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.638 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -65.5 151.72 45.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 17.0 mmtm . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 121.596 0.713 . . . . 0.0 110.897 179.949 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.91 0.386 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.15 137.68 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.476 ' HE2' ' CA ' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -136.71 116.99 13.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.923 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.618 ' O ' HD23 ' A' ' 233' ' ' LEU . 70.2 mt -147.95 137.05 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.174 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 232' ' ' ILE . 10.7 mt -122.07 110.96 16.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.922 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 236' ' ' ARG . 22.5 t80 -91.43 132.92 35.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.42 ' CG1' HD11 ' A' ' 238' ' ' LEU . 16.5 t -120.08 133.08 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.089 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 234' ' ' TYR . 9.7 ptm180 -129.59 161.98 29.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.419 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 35.2 t-20 71.79 38.79 0.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.42 HD11 ' CG1' ' A' ' 235' ' ' VAL . 26.2 mt -96.71 126.95 42.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 14.6 mmt -59.0 131.92 52.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.477 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 53.5 mt -51.35 -38.16 51.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 29.8 t -59.03 -24.43 62.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.874 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.463 HG22 ' N ' ' A' ' 243' ' ' SER . 30.9 m -60.38 157.09 14.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.177 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.463 ' N ' HG22 ' A' ' 242' ' ' THR . 64.9 m -134.6 153.89 51.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.845 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -44.94 -50.62 10.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -43.91 -41.71 5.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 9.5 mtt -65.7 -38.14 88.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 72.0 mt -72.42 -34.08 47.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 24.5 tt0 -75.32 -48.5 22.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 14.3 ptmt -57.96 -48.07 81.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.97 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.474 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 26.1 mm-40 -62.34 -59.48 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -59.15 -23.83 62.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.448 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 6.8 m-20 -80.99 -37.63 28.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -45.12 -45.11 11.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 42.8 mm -50.72 -63.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -134.87 127.07 18.18 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.527 0.68 . . . . 0.0 110.943 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 125.35 12.07 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.672 2.248 . . . . 0.0 112.341 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 75.84 33.7 50.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.487 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -105.17 -45.33 4.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 51.5 t -69.24 118.65 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.75 -60.7 2.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -146.78 154.56 41.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 94.4 t -126.58 142.69 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -134.85 109.61 8.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -82.71 146.68 28.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.814 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.8 mt -135.44 172.19 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.092 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.652 ' H ' HG22 ' A' ' 265' ' ' ILE . 21.4 mmt85 -31.71 -72.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.82 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.73 15.41 7.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.814 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -142.27 176.72 8.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.13 166.91 16.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.113 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -130.6 144.26 51.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 18.3 t -129.85 117.26 40.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -93.4 154.75 17.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.475 ' HE1' HD12 ' A' ' 233' ' ' LEU . 45.6 m-85 -130.86 179.7 5.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.8 m -102.28 -23.09 14.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.845 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.476 ' CA ' ' HE2' ' A' ' 231' ' ' LYS . 3.5 m-20 -142.33 133.35 25.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.41 ' N ' ' CE ' ' A' ' 231' ' ' LYS . 6.0 ttp-105 -49.87 -46.58 51.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -46.99 -48.84 21.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.89 -57.63 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.426 ' HB1' HD21 ' A' ' 233' ' ' LEU . . . -48.59 -49.47 36.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.077 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 64.6 t -55.74 -52.98 42.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.137 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -57.81 -47.84 81.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.91 -26.69 68.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 9.6 tmm? -72.14 -50.13 30.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -70.38 -35.25 73.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -57.2 -57.96 10.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.108 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 47.9 mt -74.24 -32.81 63.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -41.93 99.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 109.3 29.9 3.8 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -109.14 161.19 15.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 0.0 110.873 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 71.8 t -123.59 93.87 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.105 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.606 HD12 HD13 ' A' ' 296' ' ' ILE . 31.8 mt -87.11 153.43 21.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 291' ' ' LEU . 3.9 p30 35.43 34.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 68.12 46.39 65.69 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.479 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 291' ' ' LEU . 5.6 t -155.07 133.65 7.16 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.651 0.738 . . . . 0.0 110.852 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.419 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.9 Cg_endo -69.75 101.27 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.682 2.254 . . . . 0.0 112.363 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.606 HD13 HD12 ' A' ' 291' ' ' LEU . 7.5 pt -89.44 145.37 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -120.92 137.64 54.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.52 122.26 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.072 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 69.5 p -140.46 163.35 33.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.4 mt -77.61 114.15 16.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.543 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -68.42 155.77 39.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.086 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.554 0.693 . . . . 0.0 110.919 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 93.1 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.927 0.394 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.75 135.38 50.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.116 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.93 116.78 17.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.553 ' O ' HD23 ' A' ' 300' ' ' LEU . 19.7 mt -147.96 138.2 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.524 HD12 ' CE1' ' A' ' 273' ' ' PHE . 34.6 mt -123.85 110.63 15.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.62 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 52.9 t80 -92.56 127.76 38.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.577 HG11 HD21 ' A' ' 238' ' ' LEU . 51.5 t -110.39 139.88 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.087 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -135.34 162.97 31.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.412 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 35.0 t-20 67.56 47.45 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.577 HD21 HG11 ' A' ' 235' ' ' VAL . 64.9 mt -104.45 137.42 42.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.1 mmt -69.51 129.9 40.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 266' ' ' ARG . 27.5 mt -50.28 -35.63 28.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.0 t -63.39 -26.92 68.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 93.5 m -64.83 140.44 58.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.8 m -113.94 167.68 10.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.872 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 247' ' ' ILE . 5.4 mp0 -53.17 -50.08 65.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.857 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -41.27 -42.29 2.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 3.1 mmt -65.81 -34.62 78.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 244' ' ' GLU . 21.6 mt -75.58 -40.69 41.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -65.45 -45.21 84.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.496 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 2.3 ptmm? -64.93 -49.15 71.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.892 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.528 ' HG3' HD11 ' A' ' 291' ' ' LEU . 44.4 mm-40 -56.9 -35.09 68.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.463 ' CD2' HG11 ' A' ' 271' ' ' VAL . 5.4 m-85 -87.85 -21.5 24.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -88.83 -8.7 53.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -75.6 -18.22 59.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.642 ' H ' HD12 ' A' ' 254' ' ' ILE . 3.7 mp -85.28 -52.58 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -140.39 129.32 13.13 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.56 0.695 . . . . 0.0 110.877 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 123.27 9.93 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.695 2.263 . . . . 0.0 112.343 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 73.18 39.35 52.96 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -104.0 -43.44 5.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 111.112 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 251' ' ' PHE . 24.2 t -72.5 121.9 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -82.84 -58.65 2.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -145.56 151.67 38.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 97.9 t -126.11 135.43 63.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -127.25 106.04 8.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -79.56 146.24 32.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.752 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.9 mt -137.28 172.46 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.668 ' H ' HG22 ' A' ' 265' ' ' ILE . 30.5 mmt180 -30.77 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -127.0 20.2 6.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.752 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.3 OUTLIER -148.81 175.93 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.03 168.86 18.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.427 ' CD2' HD11 ' A' ' 265' ' ' ILE . 92.7 m-85 -130.57 137.81 49.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.463 HG11 ' CD2' ' A' ' 251' ' ' PHE . 18.0 t -127.56 122.69 59.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.134 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -98.85 155.72 17.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.524 ' CE1' HD12 ' A' ' 233' ' ' LEU . 16.2 m-85 -129.43 179.58 5.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.3 t -98.69 -19.05 17.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.809 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.449 ' OD1' ' CG ' ' A' ' 278' ' ' ASP . 47.2 p30 -154.25 142.1 20.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -51.0 -47.39 61.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -41.02 -65.31 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.449 ' CG ' ' OD1' ' A' ' 275' ' ' ASN . 72.1 m-20 -52.5 -50.2 63.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.23 -44.6 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.609 HG12 ' HE3' ' A' ' 284' ' ' LYS . 54.2 t -60.97 -47.82 91.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -59.82 -60.98 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -53.2 -28.08 24.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.111 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.486 ' O ' ' CB ' ' A' ' 287' ' ' ASN . 65.9 ttp -68.18 -54.39 18.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.609 ' HE3' HG12 ' A' ' 280' ' ' VAL . 6.4 mtmp? -78.86 -15.62 58.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.402 ' HB3' HG12 ' A' ' 254' ' ' ILE . . . -75.02 -29.95 60.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.527 HD11 ' O ' ' A' ' 250' ' ' GLU . 46.6 mt -111.95 -28.6 7.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.915 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 283' ' ' MET . 9.2 t-20 -55.99 106.12 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 114.26 4.57 22.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.464 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 289' ' ' LYS . 12.7 mptt -98.35 153.76 18.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 110.89 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 294' ' ' SER . 59.0 t -107.09 96.97 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.692 HD12 HD13 ' A' ' 296' ' ' ILE . 22.1 mt -83.64 146.62 28.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 292' ' ' ASP . 26.3 t70 36.3 40.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.839 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 65.19 44.56 93.71 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.477 ' N ' HG13 ' A' ' 290' ' ' VAL . 8.4 t -154.32 132.01 6.36 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.624 0.726 . . . . 0.0 110.886 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.412 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.6 Cg_endo -69.79 105.79 1.55 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.637 2.225 . . . . 0.0 112.348 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.692 HD13 HD12 ' A' ' 291' ' ' LEU . 19.3 pt -95.76 140.64 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -117.15 134.44 54.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.28 112.79 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.138 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 58.6 p -128.28 165.34 20.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 232' ' ' ILE . 16.7 mt -82.59 102.47 11.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -66.88 141.6 57.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.572 0.701 . . . . 0.0 110.873 -179.996 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.931 0.396 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.41 129.24 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.148 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -130.92 116.68 18.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.474 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 75.1 mt -147.91 132.89 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.107 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 232' ' ' ILE . 10.8 mt -117.17 109.28 16.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.535 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 24.3 t80 -91.67 132.71 36.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.26 140.53 41.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.123 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -137.63 166.71 23.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.833 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 38.5 t30 69.15 44.62 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 26.2 mt -101.52 154.34 18.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 4.4 mtt -83.38 133.96 34.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 266' ' ' ARG . 63.9 mt -56.53 -13.91 2.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.947 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 2.0 m -90.14 9.03 29.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 98.6 m -100.88 135.16 42.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 21.4 p -106.57 171.21 7.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -64.61 -18.67 65.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -69.52 -44.2 71.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.888 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 9.7 mtt -64.96 -39.05 92.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.872 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 35.8 mt -70.97 -40.04 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -68.0 -50.77 53.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 2.4 ptmm? -56.81 -47.35 80.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.499 ' O ' ' ND2' ' A' ' 253' ' ' ASN . 54.0 mm-40 -56.87 -65.55 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.623 ' CE1' HD13 ' A' ' 286' ' ' LEU . 8.0 m-85 -52.43 -22.48 4.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.886 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -79.84 -43.73 21.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.63 ' OD1' HD13 ' A' ' 254' ' ' ILE . 0.7 OUTLIER -46.82 -28.91 1.71 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.63 HD13 ' OD1' ' A' ' 253' ' ' ASN . 14.8 mm -74.8 -51.04 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.536 ' HG2' ' HB2' ' A' ' 258' ' ' ALA . 34.8 tptt -139.16 112.16 7.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.557 0.694 . . . . 0.0 110.9 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 125.93 12.7 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.685 2.256 . . . . 0.0 112.335 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 74.96 28.86 61.75 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.492 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.536 ' HB2' ' HG2' ' A' ' 255' ' ' LYS . . . -106.97 -48.03 3.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 111.093 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.3 131.63 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.159 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -89.78 -62.64 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -147.76 158.46 44.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.505 HG22 HG13 ' A' ' 271' ' ' VAL . 90.1 t -137.93 142.83 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.2 116.01 19.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -81.53 139.52 35.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.825 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.2 mt -129.13 172.41 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.151 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.669 ' H ' HG22 ' A' ' 265' ' ' ILE . 18.2 mmm180 -31.32 -75.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.63 19.45 8.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.825 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -146.79 174.9 11.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.81 167.37 18.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.111 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -126.67 151.09 48.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.53 HG11 ' CD2' ' A' ' 251' ' ' PHE . 15.1 t -138.03 117.46 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.074 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -94.76 158.15 15.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -133.45 178.69 6.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 85.7 p -95.45 -14.95 23.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.865 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -160.0 145.85 15.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 280' ' ' VAL . 18.4 ttt-85 -55.22 -41.69 72.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -45.67 -58.39 3.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -60.95 -46.44 90.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.58 -51.21 50.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.101 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 276' ' ' ARG . 66.2 t -58.53 -49.83 81.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.167 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -55.4 -57.3 12.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.66 -33.96 61.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.102 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 53.5 ttp -59.87 -68.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -61.29 -20.28 62.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -67.0 -56.97 7.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.623 HD13 ' CE1' ' A' ' 251' ' ' PHE . 26.4 mt -79.93 -30.37 39.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -40.55 112.3 0.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 95.4 32.3 7.07 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.471 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -109.74 158.94 17.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 83.1 t -118.79 96.26 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.12 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.728 HD12 HD13 ' A' ' 296' ' ' ILE . 38.0 mt -92.72 153.47 18.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 61.7 t0 40.96 28.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 72.97 41.46 48.48 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.446 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 291' ' ' LEU . 1.8 m -154.3 138.7 11.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.674 0.749 . . . . 0.0 110.908 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 105.99 1.58 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 0.0 112.381 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.728 HD13 HD12 ' A' ' 291' ' ' LEU . 9.8 pt -93.54 151.36 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -123.22 148.38 45.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 11.1 t -133.36 124.72 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.108 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 67.7 p -141.06 165.02 28.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 6.9 mt -81.48 106.63 13.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -71.24 139.81 50.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.106 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.577 0.704 . . . . 0.0 110.887 -179.999 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 97.5 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.938 0.399 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.09 131.33 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 279' ' ' ALA . 0.0 OUTLIER -129.56 116.83 19.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.485 ' O ' HD23 ' A' ' 300' ' ' LEU . 66.3 mt -148.07 138.82 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.139 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.734 HD12 ' CE1' ' A' ' 273' ' ' PHE . 76.8 mt -126.9 111.09 13.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.837 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 72.6 t80 -93.34 128.46 39.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.969 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 297' ' ' GLU . 16.8 t -112.02 129.06 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.112 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.461 ' HG3' ' N ' ' A' ' 237' ' ' ASN . 13.5 tpt180 -120.57 161.3 21.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.461 ' N ' ' HG3' ' A' ' 236' ' ' ARG . 7.0 t-20 74.87 35.22 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 42.2 mt -85.24 124.82 32.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.858 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 3.6 mmt -62.82 133.6 54.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 266' ' ' ARG . 58.2 mt -59.46 -12.74 6.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 20.7 m -98.2 15.56 24.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 38.8 m -102.62 129.88 49.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.133 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.0 m -97.16 145.86 25.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 247' ' ' ILE . 45.7 mt-10 -42.03 -48.29 4.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.886 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -42.14 -38.77 1.8 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 10.8 mtt -66.05 -39.56 90.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 244' ' ' GLU . 44.9 mt -72.64 -34.97 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.468 ' HG2' ' ND2' ' A' ' 252' ' ' ASN . 25.9 tt0 -73.75 -46.62 44.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 13.7 ptmt -60.54 -45.14 94.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.576 ' HG3' HD11 ' A' ' 291' ' ' LEU . 25.3 mm-40 -61.76 -58.26 8.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.789 ' CD2' HG11 ' A' ' 271' ' ' VAL . 7.6 m-85 -55.81 -46.42 78.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.468 ' ND2' ' HG2' ' A' ' 248' ' ' GLU . 79.6 m-20 -66.02 -23.42 66.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.845 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -51.98 -37.31 52.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 14.5 mm -65.71 -52.57 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -142.71 133.48 12.58 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.609 0.719 . . . . 0.0 110.885 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 137.78 36.21 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.257 . . . . 0.0 112.32 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.93 41.04 96.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.534 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -106.63 -45.62 4.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 111.11 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 76.5 t -68.26 126.24 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -83.3 -60.59 2.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -147.85 150.15 33.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.824 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 85.7 t -127.68 110.82 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.16 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -100.78 110.07 22.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -79.49 147.86 32.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.804 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.0 mt -137.1 172.11 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.103 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.66 ' H ' HG22 ' A' ' 265' ' ' ILE . 23.5 mmt180 -31.32 -71.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.45 ' OD1' ' C ' ' A' ' 266' ' ' ARG . 1.0 OUTLIER -127.86 16.52 6.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.804 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -143.59 176.32 9.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.42 158.33 13.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.061 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.485 ' CD2' HD11 ' A' ' 265' ' ' ILE . 98.3 m-85 -117.86 146.61 43.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.789 HG11 ' CD2' ' A' ' 251' ' ' PHE . 21.0 t -130.41 119.64 46.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -98.2 147.51 24.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.734 ' CE1' HD12 ' A' ' 233' ' ' LEU . 38.5 m-85 -126.15 171.74 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.4 ' C ' ' OD1' ' A' ' 275' ' ' ASN . 13.2 t -79.13 -41.58 28.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.403 ' O ' ' OD1' ' A' ' 278' ' ' ASP . 5.9 m-20 -135.48 170.25 16.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.902 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 280' ' ' VAL . 3.8 ttp85 -74.36 -36.05 63.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 278' ' ' ASP . 12.1 pt-20 -53.04 -52.5 58.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.433 ' N ' ' HG3' ' A' ' 277' ' ' GLU . 7.4 p-10 -70.07 -47.32 62.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.585 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -51.14 -49.67 60.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.122 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 276' ' ' ARG . 84.4 t -65.45 -52.93 45.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.093 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -47.19 -41.69 18.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.834 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.46 -40.05 77.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.0 ttp -50.37 -54.2 23.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -68.45 -42.1 79.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.883 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -51.18 -54.38 26.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.064 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.569 HD13 ' CE1' ' A' ' 251' ' ' PHE . 42.1 mt -78.4 -41.53 32.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 286' ' ' LEU . 9.5 t30 -35.99 109.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 98.15 34.26 5.44 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 38.3 mmtt -112.63 147.33 36.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 89.6 t -114.39 97.92 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.576 HD11 ' HG3' ' A' ' 250' ' ' GLU . 41.6 mt -96.06 153.72 17.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.2 t0 42.97 24.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 75.66 38.0 38.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 33.1 p -146.43 133.93 10.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.659 0.742 . . . . 0.0 110.877 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 92.78 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.476 HD13 HD12 ' A' ' 291' ' ' LEU . 6.9 pt -81.32 146.2 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.121 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.403 ' O ' HG13 ' A' ' 235' ' ' VAL . 27.3 tt0 -112.19 156.59 22.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 20.8 t -143.77 115.1 2.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.12 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 29.4 p -138.5 172.94 12.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 232' ' ' ILE . 6.8 mt -88.88 100.34 13.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.837 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -70.61 137.68 50.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.109 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.584 0.707 . . . . 0.0 110.921 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 42.0 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.917 0.389 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.22 129.62 62.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.156 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' A' ' 276' ' ' ARG . 1.6 pttm -131.35 116.79 18.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 96.8 mt -147.92 142.32 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.149 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.766 HD12 ' CE1' ' A' ' 273' ' ' PHE . 92.3 mt -127.08 111.72 14.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.721 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 35.1 t80 -91.98 132.36 36.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.619 HG11 HD21 ' A' ' 238' ' ' LEU . 55.6 t -116.24 142.39 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.136 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -132.35 170.34 15.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 295' ' ' PRO . 28.1 t-20 62.31 49.21 4.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.619 HD21 HG11 ' A' ' 235' ' ' VAL . 39.4 mt -102.95 115.39 30.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.93 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 6.2 mtt -56.67 122.91 13.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 266' ' ' ARG . 38.6 mt -45.16 -33.12 2.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.939 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 13.3 t -63.22 -39.27 94.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.842 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 52.1 m -58.46 142.47 48.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.166 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 49.8 m -111.71 168.0 9.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.852 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.449 ' N ' ' OE1' ' A' ' 244' ' ' GLU . 1.2 mp0 -56.25 -46.87 79.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.911 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -43.31 -37.09 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.5 mmt -70.37 -45.03 66.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.856 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 48.9 mt -65.02 -40.18 88.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -67.51 -60.91 2.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 8.1 ptpt -45.85 -46.23 15.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.519 ' HA ' ' ND2' ' A' ' 253' ' ' ASN . 23.0 mm-40 -59.38 -69.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.486 ' CE1' HD13 ' A' ' 286' ' ' LEU . 16.1 m-85 -49.34 -24.19 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 253' ' ' ASN . 3.6 m-20 -73.3 -44.82 58.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 250' ' ' GLU . 29.2 m-20 -36.36 -49.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.913 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 45.2 mm -47.95 -62.43 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -139.51 135.02 16.63 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.539 0.685 . . . . 0.0 110.934 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 127.44 14.63 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.684 2.256 . . . . 0.0 112.386 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 67.23 38.89 92.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.52 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -104.04 -43.67 5.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 251' ' ' PHE . 21.7 t -72.62 112.57 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -70.55 -64.61 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 262' ' ' VAL . 0.5 OUTLIER -140.83 165.05 28.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' A' ' 261' ' ' ARG . 40.3 t -140.2 113.98 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -101.53 107.4 18.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -79.83 143.28 34.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.758 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.3 mt -133.97 172.41 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.663 ' H ' HG22 ' A' ' 265' ' ' ILE . 12.7 mmm180 -31.34 -73.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -125.36 18.8 8.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.758 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -148.03 177.75 9.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.72 174.05 9.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.116 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -130.69 143.6 50.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.483 HG11 ' CD2' ' A' ' 251' ' ' PHE . 70.0 t -127.07 123.03 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -102.47 155.42 18.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.766 ' CE1' HD12 ' A' ' 233' ' ' LEU . 37.8 m-85 -132.65 177.67 7.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.418 ' C ' ' HE3' ' A' ' 231' ' ' LYS . 78.8 p -89.11 -14.14 36.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.822 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.427 ' N ' ' HD2' ' A' ' 231' ' ' LYS . 11.1 p30 -162.03 147.19 12.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.473 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 27.5 ttt180 -55.25 -45.83 76.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.889 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -40.82 -56.29 2.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -63.78 -48.32 77.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.435 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -48.25 -45.52 34.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.2 -59.1 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -46.74 -43.91 18.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.0 -34.56 73.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 59.4 ttp -53.33 -66.4 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -62.61 -37.76 87.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -46.47 -55.85 6.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.06 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.486 HD13 ' CE1' ' A' ' 251' ' ' PHE . 46.7 mt -80.61 -36.61 32.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 286' ' ' LEU . 22.9 t-20 -36.88 103.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 104.91 31.33 4.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -111.79 156.65 21.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.836 0.35 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.09 96.36 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.139 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 1.047 HD12 HD13 ' A' ' 296' ' ' ILE . 32.2 mt -90.33 153.96 20.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 291' ' ' LEU . 7.7 t70 37.48 39.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.868 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 61.98 43.97 98.45 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.493 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 291' ' ' LEU . 1.8 m -152.42 138.26 11.6 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.661 0.743 . . . . 0.0 110.841 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.401 ' O ' ' OD1' ' A' ' 237' ' ' ASN . 53.4 Cg_endo -69.8 100.78 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 1.047 HD13 HD12 ' A' ' 291' ' ' LEU . 8.3 pt -93.62 145.46 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -117.79 157.27 26.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 6.3 t -146.05 121.77 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 82.6 p -144.05 175.27 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 232' ' ' ILE . 8.7 mt -87.11 102.6 14.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.954 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.721 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -66.27 138.61 57.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.072 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 24.1 tttm . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.613 0.72 . . . . 0.0 110.902 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 57.3 m . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.939 0.399 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.54 132.55 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.428 ' HD3' ' C ' ' A' ' 275' ' ' ASN . 0.1 OUTLIER -131.22 116.91 18.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.613 ' O ' HD23 ' A' ' 233' ' ' LEU . 55.0 mt -147.86 141.33 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.098 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 232' ' ' ILE . 15.4 mt -124.25 105.09 9.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.831 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 6.5 t80 -91.21 125.12 35.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.402 ' CG1' HD11 ' A' ' 238' ' ' LEU . 23.4 t -106.35 135.75 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 234' ' ' TYR . 21.8 ptt180 -128.66 170.88 12.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 62.84 43.46 7.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.402 HD11 ' CG1' ' A' ' 235' ' ' VAL . 15.3 mt -100.83 140.81 34.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' MET . . . . . 0.408 ' CE ' ' HB2' ' A' ' 294' ' ' SER . 20.3 mmt -80.14 141.07 36.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 266' ' ' ARG . 37.1 mt -53.72 -28.54 34.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.929 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.4 m -66.88 -25.31 66.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.923 HG23 ' SD ' ' A' ' 246' ' ' MET . 39.6 m -65.82 144.11 57.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.106 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.3 t -128.77 150.92 50.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.42 ' CG ' ' HB2' ' A' ' 264' ' ' LYS . 79.2 mt-10 -46.89 -20.82 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.861 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -66.7 -68.77 0.35 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.923 ' SD ' HG23 ' A' ' 242' ' ' THR . 20.2 ptm -53.12 -37.08 61.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 77.8 mt -61.44 -50.87 78.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.112 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -59.37 -64.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.486 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 13.9 pttt -39.47 -46.09 1.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.486 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 33.6 mm-40 -57.82 -51.81 68.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.862 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.866 ' CE2' HG21 ' A' ' 271' ' ' VAL . 4.8 m-85 -61.76 -56.12 22.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -54.32 -40.07 67.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -48.04 -31.35 5.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.548 HD12 ' HB1' ' A' ' 285' ' ' ALA . 29.2 mm -68.76 -54.24 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.157 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -142.27 120.3 7.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.58 0.705 . . . . 0.0 110.894 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 121.91 8.61 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.367 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 84.25 37.82 10.68 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -118.13 -43.84 2.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.336 . . . . 0.0 111.05 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 41.5 t -74.73 136.65 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.153 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' GLU . . . . . 0.408 ' HB3' ' NH1' ' A' ' 261' ' ' ARG . 65.1 mm-40 -100.08 -62.02 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' ARG . . . . . 0.475 ' CD ' ' HB2' ' A' ' 272' ' ' HIS . 0.1 OUTLIER -143.67 153.59 42.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.9 t -122.65 147.35 26.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -136.18 110.74 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.919 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' LYS . . . . . 0.42 ' HB2' ' CG ' ' A' ' 244' ' ' GLU . 11.0 tptm -87.58 144.8 26.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.815 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.7 mt -136.12 172.35 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.148 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.663 ' H ' HG22 ' A' ' 265' ' ' ILE . 18.9 mmt180 -31.55 -72.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.08 14.13 7.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.815 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -140.82 176.88 8.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.14 179.1 7.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.11 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.466 ' CE2' ' HB2' ' A' ' 234' ' ' TYR . 95.7 m-85 -144.29 148.94 35.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.866 HG21 ' CE2' ' A' ' 251' ' ' PHE . 3.1 t -135.54 123.12 36.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.141 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' HIS . . . . . 0.475 ' HB2' ' CD ' ' A' ' 261' ' ' ARG . 3.9 m-70 -97.8 150.74 20.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -126.92 176.87 6.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.895 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.8 t -97.52 -25.93 14.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.428 ' C ' ' HD3' ' A' ' 231' ' ' LYS . 7.6 m-80 -144.83 135.19 24.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 277' ' ' GLU . 14.0 ttt180 -45.53 -54.33 7.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 276' ' ' ARG . 62.9 mm-40 -37.01 -56.03 0.9 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.51 -47.89 83.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.94 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -54.86 -40.59 69.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.58 -42.99 90.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -65.39 -51.52 59.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.84 -38.72 79.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.075 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 47.4 ttp -52.23 -66.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.424 ' HA ' ' CB ' ' A' ' 287' ' ' ASN . 40.1 mtmt -58.79 -48.75 80.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.548 ' HB1' HD12 ' A' ' 254' ' ' ILE . . . -36.53 -52.65 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.684 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 73.4 mt -85.75 -29.24 24.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' ASN . . . . . 0.424 ' CB ' ' HA ' ' A' ' 284' ' ' LYS . 19.1 t-20 -42.53 95.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 112.08 29.63 3.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.494 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -108.52 155.9 20.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.828 0.347 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 75.5 t -118.02 109.59 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.548 ' HB3' ' HE1' ' A' ' 246' ' ' MET . 26.9 mt -106.54 153.24 22.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 42.53 29.16 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 71.99 42.55 51.75 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.506 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.408 ' HB2' ' CE ' ' A' ' 239' ' ' MET . 10.9 t -153.78 140.03 12.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.626 0.727 . . . . 0.0 110.866 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 98.56 0.7 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.727 2.285 . . . . 0.0 112.306 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.488 HD13 HD12 ' A' ' 291' ' ' LEU . 8.1 pt -86.14 147.45 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.126 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -121.77 153.33 38.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.423 HG21 ' HB2' ' A' ' 286' ' ' LEU . 8.4 t -135.32 119.2 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.174 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 16.3 p -137.8 168.11 20.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 232' ' ' ILE . 11.1 mt -83.87 100.1 10.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.831 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -71.11 138.45 49.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.079 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 15.5 pttm . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.596 0.712 . . . . 0.0 110.891 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.949 0.404 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.1 132.39 60.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.131 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.42 ' HD2' ' N ' ' A' ' 275' ' ' ASN . 4.3 pttm -131.49 117.02 18.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.638 ' O ' HD23 ' A' ' 300' ' ' LEU . 92.2 mt -147.93 138.88 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.149 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.665 HD12 ' CE1' ' A' ' 273' ' ' PHE . 68.6 mt -122.8 108.93 13.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.686 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 14.3 t80 -92.37 124.22 36.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.98 143.29 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.123 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -134.6 165.62 24.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 72.16 39.97 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.7 mt -99.15 115.87 30.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.4 mtt -56.21 130.78 45.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.662 HD23 ' O ' ' A' ' 266' ' ' ARG . 46.1 mt -44.68 -39.05 4.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 30.9 m -56.98 -36.77 70.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 24.6 m -60.86 137.4 58.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.177 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.7 m -113.9 170.39 8.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.834 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 247' ' ' ILE . 25.8 mt-10 -53.68 -52.59 59.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -40.03 -47.83 2.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.4 mtt -60.24 -37.94 81.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 244' ' ' GLU . 55.7 mt -73.75 -36.43 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.11 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -70.66 -46.77 62.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.477 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 4.6 ptmm? -62.91 -47.98 80.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.917 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.484 ' OE1' HD21 ' A' ' 291' ' ' LEU . 25.8 mm-40 -56.08 -54.8 40.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.546 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 10.2 m-85 -63.28 -47.47 82.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -54.73 -46.9 74.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -38.1 -48.35 1.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.861 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.436 HD12 ' HB1' ' A' ' 285' ' ' ALA . 48.2 mm -48.35 -57.95 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.121 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -141.06 128.19 11.87 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.564 0.697 . . . . 0.0 110.902 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 120.19 7.01 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.717 2.278 . . . . 0.0 112.311 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 76.39 34.54 45.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.515 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -104.32 -34.23 8.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 0.0 111.102 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 74.4 t -80.75 149.04 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -106.42 -59.21 1.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' ARG . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 261' ' ' ARG . 4.8 ptp180 -151.73 155.62 38.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.879 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.21 152.28 37.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.106 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -140.78 109.79 6.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 11.4 tptp -79.68 141.76 36.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.764 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.5 mt -132.33 172.52 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.115 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.673 ' H ' HG22 ' A' ' 265' ' ' ILE . 13.9 mmm180 -31.39 -72.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 0.5 OUTLIER -126.8 17.26 7.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.764 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -145.14 176.13 9.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -165.87 158.95 15.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.135 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.449 ' CD2' HD11 ' A' ' 265' ' ' ILE . 96.8 m-85 -117.57 151.53 36.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 57.8 t -139.44 134.4 39.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.121 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -113.57 157.99 21.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.824 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.665 ' CE1' HD12 ' A' ' 233' ' ' LEU . 30.4 m-85 -132.86 173.37 11.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 43.4 t -81.49 -18.4 45.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.825 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.42 ' N ' ' HD2' ' A' ' 231' ' ' LYS . 5.2 m-80 -157.12 159.4 37.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -61.73 -48.31 81.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -48.21 -44.25 32.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -65.28 -51.42 60.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' ALA . . . . . 0.547 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -56.04 -39.02 71.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.087 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.446 ' CG1' ' HE3' ' A' ' 284' ' ' LYS . 77.8 t -67.87 -47.94 77.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -59.08 -48.12 82.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.0 -34.82 76.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.2 ttp -60.38 -58.92 6.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.446 ' HE3' ' CG1' ' A' ' 280' ' ' VAL . 84.4 mttt -63.62 -28.35 69.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.436 ' HB1' HD12 ' A' ' 254' ' ' ILE . . . -65.42 -49.59 68.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.546 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 55.1 mt -85.21 -17.48 36.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.957 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -57.01 109.55 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 97.32 32.79 6.21 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.523 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -112.0 154.81 24.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.909 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 87.4 t -117.81 96.61 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.586 HD12 HD13 ' A' ' 296' ' ' ILE . 25.3 mt -92.73 152.0 19.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 41.77 25.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.21 43.52 25.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.499 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.1 t -154.75 137.62 10.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.692 0.758 . . . . 0.0 110.852 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 97.45 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.699 2.266 . . . . 0.0 112.329 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.586 HD13 HD12 ' A' ' 291' ' ' LEU . 7.9 pt -85.96 144.07 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.152 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -115.59 141.95 47.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' A' ' 286' ' ' LEU . 3.1 t -128.92 111.3 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 63.8 p -132.92 178.97 6.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 232' ' ' ILE . 10.2 mt -95.79 110.22 22.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.686 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -65.79 145.78 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 121.566 0.698 . . . . 0.0 110.916 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 93.4 p . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.899 0.381 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.1 130.46 68.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.135 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.428 ' HD2' ' CA ' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -130.47 116.64 18.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.915 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.419 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 56.8 mt -147.9 125.19 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.177 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 16.1 mt -115.6 112.09 21.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.638 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 51.3 t80 -91.88 121.45 33.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.585 HG11 HD21 ' A' ' 238' ' ' LEU . 34.3 t -108.67 121.9 62.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.163 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.424 ' HB2' ' CE2' ' A' ' 234' ' ' TYR . 28.3 ttt180 -115.64 160.31 20.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.42 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 28.8 t-20 71.55 48.35 0.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.585 HD21 HG11 ' A' ' 235' ' ' VAL . 19.8 mt -102.08 124.32 47.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 8.0 mmt -60.17 141.5 55.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 266' ' ' ARG . 26.3 mt -65.55 -24.09 67.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 34.2 m -82.99 16.0 2.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 23.0 m -102.83 141.36 35.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.124 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 67.7 m -111.11 147.68 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -43.52 -46.75 7.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -39.88 -46.24 1.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 12.1 mtt -62.6 -43.45 98.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 59.2 mt -64.52 -36.76 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.143 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -68.49 -57.29 6.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.911 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 18.6 pttt -52.33 -46.86 66.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.51 ' O ' ' ND2' ' A' ' 253' ' ' ASN . 19.3 mm-40 -55.99 -51.29 68.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.889 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.489 ' CE2' HG21 ' A' ' 271' ' ' VAL . 8.2 m-85 -72.7 -20.3 61.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -90.65 -11.03 41.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 250' ' ' GLU . 16.9 p30 -72.47 -17.92 61.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.547 ' H ' HD12 ' A' ' 254' ' ' ILE . 4.9 mp -79.47 -55.9 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.108 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -143.56 125.66 8.5 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.538 0.685 . . . . 0.0 110.903 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 120.23 7.05 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 87.09 33.41 12.11 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.423 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -108.74 -54.95 2.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 111.081 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.57 142.42 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -102.94 -61.79 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -144.92 152.99 41.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.68 127.85 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -119.08 104.7 10.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' LYS . . . . . 0.417 ' HZ3' HD13 ' A' ' 238' ' ' LEU . 9.9 tptp -79.4 145.14 33.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.759 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.3 mt -135.86 172.43 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.158 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.668 ' H ' HG22 ' A' ' 265' ' ' ILE . 39.9 mmm-85 -31.34 -74.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 8.4 p-10 -125.36 22.25 7.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.759 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.4 OUTLIER -151.52 177.01 10.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.9 171.37 14.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.093 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -135.58 134.51 39.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.891 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.489 HG21 ' CE2' ' A' ' 251' ' ' PHE . 39.4 t -120.16 129.82 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -104.85 155.34 19.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.412 ' C ' ' HG3' ' A' ' 231' ' ' LYS . 43.7 m-85 -136.41 -176.02 4.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.924 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 30.8 t -88.89 -31.86 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.428 ' CA ' ' HD2' ' A' ' 231' ' ' LYS . 2.7 m120 -152.17 144.65 24.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.988 ' O ' HG23 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -50.07 -29.46 8.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -54.42 -62.7 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -59.77 -39.11 83.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -64.11 -35.89 82.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.102 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.988 HG23 ' O ' ' A' ' 276' ' ' ARG . 97.2 t -68.55 -39.59 80.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.194 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -68.46 -51.4 43.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.7 -40.48 72.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.09 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.1 ttp -60.8 -45.78 93.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -75.02 -19.26 60.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -78.39 -39.15 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 41.3 mt -95.82 -21.27 18.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -48.67 96.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 113.79 30.84 2.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.444 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -107.48 160.16 15.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.809 0.338 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 58.6 t -123.46 107.92 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.107 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.428 HD11 ' HG3' ' A' ' 250' ' ' GLU . 34.7 mt -102.86 153.25 20.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 41.83 26.62 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.76 38.52 49.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.476 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 291' ' ' LEU . 23.7 p -146.4 137.39 12.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.687 0.756 . . . . 0.0 110.833 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.42 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.5 Cg_endo -69.8 101.79 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.718 2.279 . . . . 0.0 112.323 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 12.0 pt -90.65 147.75 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.36 133.42 52.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 28.2 t -115.36 116.77 53.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.111 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 28.7 p -131.16 169.23 16.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 10.9 mt -88.71 99.98 12.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.638 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -68.98 137.49 53.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 23.9 pttt . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 121.546 0.688 . . . . 0.0 110.913 179.974 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 79.3 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.945 0.402 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.5 p -110.8 137.91 41.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.164 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -135.14 116.88 15.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.488 ' O ' HD23 ' A' ' 233' ' ' LEU . 36.0 mt -147.98 136.55 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.121 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 232' ' ' ILE . 11.5 mt -120.64 108.11 13.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.786 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 17.9 t80 -91.18 129.04 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.2 135.76 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.128 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -129.26 163.04 26.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.834 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 70.91 48.07 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 21.2 mt -103.28 123.09 46.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.1 mmt -60.88 123.33 17.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 266' ' ' ARG . 38.1 mt -45.73 -29.03 1.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 9.9 t -65.21 -37.6 87.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.449 HG22 ' N ' ' A' ' 243' ' ' SER . 35.1 m -58.82 156.35 11.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.127 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.449 ' N ' HG22 ' A' ' 242' ' ' THR . 58.3 m -128.8 167.9 16.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 247' ' ' ILE . 7.5 mp0 -54.42 -54.26 43.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 244' ' ' GLU . 41.6 tp10 -37.95 -39.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 5.8 mtt -71.18 -40.39 71.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 244' ' ' GLU . 44.3 mt -68.05 -40.46 83.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.122 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 18.8 tt0 -70.27 -56.23 7.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 0.0 OUTLIER -49.21 -46.55 45.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.904 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.485 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 39.2 mm-40 -60.74 -51.35 69.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 5.3 m-85 -65.86 -25.46 67.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 22.6 m120 -70.06 -46.47 64.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.868 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 252' ' ' ASN . 74.8 m-20 -36.2 -41.87 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 26.0 mm -56.44 -63.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.489 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 4.2 tppt? -141.89 136.42 15.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.6 0.714 . . . . 0.0 110.898 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.489 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 53.6 Cg_endo -69.78 132.56 23.55 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.715 2.277 . . . . 0.0 112.326 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 61.83 37.02 93.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.52 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 255' ' ' LYS . . . -99.16 -43.72 6.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.838 0.351 . . . . 0.0 111.162 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.416 HG11 ' CG2' ' A' ' 262' ' ' VAL . 96.6 t -70.14 118.33 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.108 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -78.53 -57.58 3.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -144.14 149.45 36.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.425 HG22 HG13 ' A' ' 271' ' ' VAL . 69.0 t -133.13 111.57 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.125 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -107.32 117.63 34.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -86.53 142.19 28.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.8 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.5 mt -131.12 172.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.685 ' H ' HG22 ' A' ' 265' ' ' ILE . 70.9 mtm-85 -30.1 -73.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.82 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.48 0.15 8.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.8 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -124.25 176.47 6.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -160.52 172.99 16.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.18 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.558 ' CE2' HD11 ' A' ' 265' ' ' ILE . 68.1 m-85 -136.37 135.4 38.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.544 HG11 ' CD2' ' A' ' 251' ' ' PHE . 8.1 t -130.16 126.08 61.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -103.36 159.3 15.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.415 ' HE1' HD12 ' A' ' 233' ' ' LEU . 34.9 m-85 -133.53 168.18 19.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.826 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.1 t -75.72 -39.2 57.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 275' ' ' ASN . 4.6 p-10 -139.58 149.07 43.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.938 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' A' ' 277' ' ' GLU . 15.2 ttt180 -51.35 -55.14 20.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.848 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 276' ' ' ARG . 5.8 mp0 -35.12 -60.28 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -55.75 -52.53 63.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -48.28 -45.62 34.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.094 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.613 HG12 ' HE2' ' A' ' 284' ' ' LYS . 86.6 t -59.21 -51.83 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.25 -54.1 41.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.89 -30.86 68.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' MET . . . . . 0.445 ' O ' ' CB ' ' A' ' 287' ' ' ASN . 66.0 ttp -65.78 -57.33 8.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.613 ' HE2' HG12 ' A' ' 280' ' ' VAL . 42.8 mtmt -68.78 -32.68 72.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -62.08 -56.51 18.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.084 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.633 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 35.0 mt -76.17 -35.83 58.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 283' ' ' MET . 6.1 t-20 -41.81 106.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 100.59 37.5 3.72 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.473 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -114.17 153.19 30.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.856 0.36 . . . . 0.0 110.893 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 81.9 t -117.93 94.51 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.144 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.455 HD12 HD13 ' A' ' 296' ' ' ILE . 37.9 mt -94.46 153.59 17.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 41.88 25.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.84 38.51 36.16 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.542 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 291' ' ' LEU . 31.8 p -146.34 133.12 9.89 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.661 0.744 . . . . 0.0 110.821 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 86.19 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.687 2.258 . . . . 0.0 112.333 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.455 HD13 HD12 ' A' ' 291' ' ' LEU . 6.9 pt -72.95 149.63 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.141 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -118.82 156.43 29.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 20.2 t -143.6 118.51 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 60.6 p -143.55 162.79 34.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.187 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 9.3 mt -77.39 100.05 5.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.786 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -67.66 112.86 5.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.077 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 27.1 mttp . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 121.621 0.724 . . . . 0.0 110.923 179.963 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 96.0 p . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.931 0.396 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.473 ' O ' ' CD ' ' A' ' 276' ' ' ARG . 0.9 OUTLIER -119.68 139.8 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.123 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.452 ' HD3' ' N ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -133.56 116.73 16.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.4 mt -147.94 132.35 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.106 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 12.2 mt -115.48 109.13 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.888 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.538 ' CE2' ' HB3' ' A' ' 236' ' ' ARG . 12.9 t80 -91.49 134.12 34.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.42 HG11 HD21 ' A' ' 238' ' ' LEU . 22.7 t -120.91 131.07 73.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.18 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.538 ' HB3' ' CE2' ' A' ' 234' ' ' TYR . 14.6 ptt180 -123.47 163.39 20.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.4 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 38.6 t-20 69.84 50.79 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.439 HD12 ' CA ' ' A' ' 268' ' ' TYR . 11.8 mt -108.52 121.54 45.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.944 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 24.2 mtt -60.2 134.86 57.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 266' ' ' ARG . 19.5 mt -53.94 -26.84 27.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 64.0 p -65.03 -40.31 94.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' THR . . . . . 0.441 ' O ' ' NZ ' ' A' ' 264' ' ' LYS . 52.1 m -59.46 147.9 34.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 59.5 m -121.17 164.19 17.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 247' ' ' ILE . 35.2 mt-10 -52.95 -54.38 35.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 244' ' ' GLU . 27.3 tt0 -36.81 -43.42 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.427 ' HA ' ' NZ ' ' A' ' 249' ' ' LYS . 9.5 mtp -63.63 -45.93 88.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 244' ' ' GLU . 28.4 mt -64.07 -29.39 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.149 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -71.27 -54.4 11.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 4.4 ptpp? -58.29 -41.82 85.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 17.4 mm-40 -61.94 -54.0 47.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.516 ' CE1' HD13 ' A' ' 286' ' ' LEU . 6.8 m-85 -68.21 -28.27 67.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.879 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ASN . . . . . 0.445 ' OD1' HG21 ' A' ' 259' ' ' VAL . 4.6 m-20 -81.76 -23.9 36.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -59.97 -31.44 69.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.628 HD12 ' HB1' ' A' ' 285' ' ' ALA . 13.2 mm -66.44 -56.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.146 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -142.84 131.88 11.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.549 0.69 . . . . 0.0 110.934 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 133.65 26.07 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.717 2.278 . . . . 0.0 112.306 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 65.61 39.83 95.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.475 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -110.72 -27.04 9.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.756 0.312 . . . . 0.0 111.048 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.445 HG21 ' OD1' ' A' ' 252' ' ' ASN . 75.8 t -91.77 128.75 43.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.134 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -89.23 -54.66 4.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 30.5 ptt85 -151.11 150.74 31.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.87 138.44 54.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 33.4 tttp -132.95 115.96 15.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' LYS . . . . . 0.441 ' NZ ' ' O ' ' A' ' 242' ' ' THR . 17.0 tptm -86.48 146.73 26.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.82 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.7 mt -134.28 172.08 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.142 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.66 ' H ' HG22 ' A' ' 265' ' ' ILE . 21.7 mmm180 -31.96 -72.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -125.82 15.71 8.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.82 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -143.33 177.75 8.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.95 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -165.14 167.05 18.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.062 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.514 ' CD2' HD11 ' A' ' 265' ' ' ILE . 89.9 m-85 -130.6 143.68 50.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 40.5 t -135.11 126.61 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -102.24 153.89 19.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -125.83 -177.66 4.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.0 t -91.89 -31.62 15.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.869 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -144.51 156.51 44.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.473 ' CD ' ' O ' ' A' ' 230' ' ' VAL . 1.5 tpp85 -52.62 -67.06 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 276' ' ' ARG . 67.7 mm-40 -35.6 -57.84 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -47.93 -52.23 20.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -58.98 -46.67 87.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.99 -48.49 84.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.113 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.44 -53.51 57.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.63 -31.97 71.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 58.2 ttp -59.59 -53.96 51.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 285' ' ' ALA . 85.5 mttt -68.68 -53.23 23.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.628 ' HB1' HD12 ' A' ' 254' ' ' ILE . . . -36.55 -43.53 0.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.106 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.516 HD13 ' CE1' ' A' ' 251' ' ' PHE . 49.0 mt -90.56 -39.95 12.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.859 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 286' ' ' LEU . 20.7 t-20 -36.3 113.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 93.28 33.62 7.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.476 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -109.95 160.79 16.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 25.3 t -122.42 101.73 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.074 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.82 HD12 HD13 ' A' ' 296' ' ' ILE . 29.8 mt -99.1 154.2 18.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.8 p30 39.59 28.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 71.98 40.85 56.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.486 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 291' ' ' LEU . 1.9 m -149.23 137.5 11.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.681 0.753 . . . . 0.0 110.877 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' PRO . . . . . 0.4 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.8 Cg_endo -69.81 99.19 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.82 HD13 HD12 ' A' ' 291' ' ' LEU . 7.2 pt -90.69 147.85 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -118.62 155.89 30.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.1 119.54 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.169 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 80.4 p -139.85 174.63 10.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.83 118.28 26.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.46 151.69 39.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 16.0 pttp . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.586 0.708 . . . . 0.0 110.86 -179.973 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.86 0.362 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.457 ' O ' ' CD ' ' A' ' 276' ' ' ARG . 1.1 p -121.72 132.72 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.147 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 116.9 18.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.626 ' O ' HD23 ' A' ' 300' ' ' LEU . 69.9 mt -147.92 151.23 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.166 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.799 HD12 ' CE1' ' A' ' 273' ' ' PHE . 85.9 mt -136.8 110.12 7.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.558 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 23.9 t80 -91.18 129.42 37.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.1 126.96 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.11 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.538 ' HB3' ' CE2' ' A' ' 234' ' ' TYR . 23.6 ptt85 -120.17 169.72 9.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 63.94 47.77 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 64.3 mt -104.43 131.93 51.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' MET . . . . . 0.494 ' CB ' ' OD2' ' A' ' 292' ' ' ASP . 8.7 mmt -71.25 132.09 44.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 266' ' ' ARG . 62.8 mt -50.27 -29.11 8.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.951 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 72.7 m -63.71 -33.26 75.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.86 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 87.4 m -66.5 138.04 57.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.103 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.2 m -117.77 164.77 14.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.825 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 245' ' ' GLU . 17.4 mt-10 -44.49 -60.47 1.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 244' ' ' GLU . 30.7 tt0 -34.86 -62.23 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 25.9 mmm -40.33 -56.96 1.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 250' ' ' GLU . 36.8 mt -62.94 -65.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -39.55 -34.4 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.835 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -77.99 -38.94 43.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 247' ' ' ILE . 21.4 mm-40 -66.08 -48.5 70.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.465 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 15.1 m-85 -67.24 -42.13 84.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -61.88 -40.67 96.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -42.74 -42.17 3.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 31.9 mm -55.64 -58.7 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.427 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 10.6 tppt? -142.82 135.03 13.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.585 0.707 . . . . 0.0 110.889 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.427 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 54.3 Cg_endo -69.73 133.64 26.1 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.673 2.249 . . . . 0.0 112.354 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 65.9 39.02 94.8 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.507 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -103.33 -55.23 2.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.855 0.36 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 251' ' ' PHE . 58.0 t -69.6 114.98 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.085 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -74.2 -55.97 5.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -150.61 144.22 25.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.2 t -121.84 119.41 58.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -105.77 108.87 20.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -79.42 143.44 35.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.737 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.7 mt -135.66 172.8 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.117 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.676 ' H ' HG22 ' A' ' 265' ' ' ILE . 21.1 mmt180 -30.17 -72.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 4.4 p-10 -128.29 20.35 6.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' TYR . . . . . 0.737 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -148.37 173.08 13.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -160.92 163.09 32.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' PHE . . . . . 0.471 ' CD2' HD11 ' A' ' 265' ' ' ILE . 92.6 m-85 -122.81 136.42 54.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.868 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.456 HG13 HG13 ' A' ' 259' ' ' VAL . 42.3 t -123.13 129.04 75.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.098 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -102.43 159.21 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.799 ' CE1' HD12 ' A' ' 233' ' ' LEU . 29.7 m-85 -137.19 -178.62 5.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.7 m -98.65 -28.28 13.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.841 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -145.95 147.68 31.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.891 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.579 HH21 HD22 ' A' ' 300' ' ' LEU . 1.3 tpt180 -50.52 -61.72 2.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 276' ' ' ARG . 27.8 mt-10 -36.62 -50.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.83 -57.83 10.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -54.83 -37.6 66.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.701 HG12 ' HE2' ' A' ' 284' ' ' LYS . 76.7 t -65.77 -47.26 86.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.171 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.21 -50.4 73.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.26 -26.2 68.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.081 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.0 ttp -64.01 -67.64 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.701 ' HE2' HG12 ' A' ' 280' ' ' VAL . 26.7 mtmt -59.79 -29.29 68.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -56.31 -55.67 30.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.085 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.465 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 60.7 mt -81.54 -30.64 33.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -40.31 104.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 105.52 20.54 9.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -97.48 154.9 17.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.339 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 98.3 t -122.09 98.17 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.104 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.402 HD12 HD13 ' A' ' 296' ' ' ILE . 32.1 mt -94.57 153.69 17.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.494 ' OD2' ' CB ' ' A' ' 239' ' ' MET . 25.0 t0 42.33 26.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.33 38.21 53.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.484 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 291' ' ' LEU . 22.4 p -146.34 134.04 10.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.63 0.729 . . . . 0.0 110.856 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 102.35 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 2.237 . . . . 0.0 112.38 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.402 HD13 HD12 ' A' ' 291' ' ' LEU . 11.4 pt -89.49 148.22 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -121.87 136.1 54.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.4 t -119.09 121.92 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.124 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 68.4 p -139.73 168.34 20.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.112 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 232' ' ' ILE . 11.7 mt -86.92 101.89 13.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -64.25 161.63 16.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.061 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 302' ' ' LYS . . . . . 0.409 ' C ' ' HD2' ' A' ' 302' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 121.569 0.699 . . . . 0.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 20.0 m -76.08 156.86 33.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.4 m -43.46 -50.34 7.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 108.68 -77.73 0.23 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.45 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 1.2 t -123.02 134.01 54.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 110.852 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 27.4 t -87.69 -34.5 18.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 89.46 87.69 1.27 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.491 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -174.97 173.78 2.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.717 0.294 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -130.06 108.07 9.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -76.14 -50.29 15.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 5.6 m -124.09 104.23 8.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.147 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 12.3 ptp -65.73 -34.01 77.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 2.8 m -108.82 85.34 2.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.7 p -93.59 110.27 21.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.866 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.7 p -122.48 132.99 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.51 116.85 18.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.503 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 63.2 mt -147.9 145.32 18.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.766 HD12 ' HE1' ' A' ' 273' ' ' PHE . 88.4 mt -133.26 109.21 9.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -91.71 133.28 35.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 23.1 t -114.58 137.44 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.106 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.0 ttp85 -129.78 156.13 44.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 73.83 44.28 0.28 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 25.0 mt -93.69 131.61 38.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 10.6 mmt -67.16 123.3 19.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 266' ' ' ARG . 26.0 mt -48.27 -32.01 6.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 9.5 t -66.72 -35.75 80.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 39.2 m -59.62 141.72 54.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.135 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.3 m -110.61 166.15 11.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 247' ' ' ILE . 29.7 mt-10 -52.27 -52.03 55.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -41.49 -43.52 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 21.2 mmm -63.99 -36.25 83.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 244' ' ' GLU . 43.0 mt -74.8 -38.31 44.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.123 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -71.13 -43.97 66.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 16.4 ptmt -63.89 -47.88 78.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.489 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 31.7 mm-40 -58.29 -46.95 85.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -72.57 -34.05 67.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.926 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -69.03 -32.22 71.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -47.02 -29.98 2.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 25.0 mm -68.2 -53.28 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -143.78 137.31 14.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.554 0.692 . . . . 0.0 110.936 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 126.24 13.11 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.682 2.255 . . . . 0.0 112.388 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 60.9 39.5 97.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.512 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -101.08 -45.13 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.24 109.93 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.14 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -61.37 -57.68 11.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' ARG . . . . . 0.4 ' HB3' ' NH1' ' A' ' 261' ' ' ARG . 1.1 ptp180 -153.34 158.05 40.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 91.1 t -132.41 115.89 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -110.31 106.95 16.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.424 ' HD3' ' CD1' ' A' ' 247' ' ' ILE . 14.7 tptm -79.51 148.56 31.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.787 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.1 mt -137.36 172.19 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.161 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.661 ' H ' HG22 ' A' ' 265' ' ' ILE . 20.1 mmt180 -31.86 -70.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.29 17.76 6.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.787 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -146.08 177.93 8.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -170.14 165.02 9.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.109 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -127.59 142.18 51.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.38 123.44 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.143 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -99.96 157.59 16.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.766 ' HE1' HD12 ' A' ' 233' ' ' LEU . 41.3 m-85 -135.0 170.83 15.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.4 t -84.3 -34.24 23.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -138.67 144.66 39.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.662 ' O ' HG23 ' A' ' 280' ' ' VAL . 26.4 ttt180 -55.07 -42.51 72.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -46.49 -55.26 7.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -60.32 -51.31 70.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -51.17 -42.48 60.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 276' ' ' ARG . 91.8 t -61.54 -48.57 88.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.13 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -58.33 -55.58 33.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.69 -26.72 64.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.078 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 51.2 ttp -65.5 -60.24 3.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 285' ' ' ALA . 6.1 mtmp? -65.26 -55.21 19.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.907 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 284' ' ' LYS . . . -36.4 -47.85 0.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.091 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 287' ' ' ASN . 34.3 mt -84.46 -39.71 18.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.9 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 286' ' ' LEU . 31.9 t30 -37.1 104.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 98.97 38.24 3.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.478 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -114.35 159.17 20.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.786 0.327 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 98.8 t -121.51 97.4 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.127 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.86 HD12 HD13 ' A' ' 296' ' ' ILE . 60.4 mt -92.99 153.15 18.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 291' ' ' LEU . 23.7 m-20 37.73 28.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.828 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 74.0 44.61 29.54 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.493 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 291' ' ' LEU . 8.2 t -155.02 134.7 7.96 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.669 0.747 . . . . 0.0 110.81 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 102.08 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.367 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.86 HD13 HD12 ' A' ' 291' ' ' LEU . 7.8 pt -93.89 144.37 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -116.66 154.71 30.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.8 t -141.26 119.4 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.162 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 76.9 p -137.88 169.44 17.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.151 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 232' ' ' ILE . 8.0 mt -83.78 108.49 16.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.503 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -66.1 140.75 58.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.35 90.55 7.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.625 0.726 . . . . 0.0 110.882 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 140.67 43.04 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.34 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.14 138.3 21.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.14 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -163.66 162.33 24.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.912 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -135.29 131.83 37.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -40.92 115.54 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 39.7 p -60.81 141.17 57.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 28.4 p -96.2 129.04 43.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -153.09 -172.56 21.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.483 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 114.72 3.8 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.717 2.278 . . . . 0.0 112.348 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 3.3 t -56.83 -50.3 72.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.852 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 66.1 m -96.03 88.24 4.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.886 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.458 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 68.5 m -90.29 169.65 10.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.909 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 25.2 t -91.82 -56.6 3.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.874 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 142.74 60.96 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.465 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 67.9 m -142.88 114.3 7.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 110.875 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 74.2 m -66.53 -34.77 78.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 66.89 150.59 0.15 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.498 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 43.56 41.93 3.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.317 . . . . 0.0 110.846 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -58.16 102.94 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -148.69 161.4 41.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 32.9 p -123.04 43.72 2.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.146 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 42.1 ttp -80.71 -50.35 10.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 3.2 m -164.76 148.14 8.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.876 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 50.9 m -71.55 98.57 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.851 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.93 134.85 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.2 116.58 17.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.54 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 37.6 mt -147.89 131.98 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 232' ' ' ILE . 15.7 mt -117.46 111.16 18.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.538 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 21.6 t80 -91.31 122.53 34.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.968 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.537 HG11 HD21 ' A' ' 238' ' ' LEU . 21.9 t -102.23 128.87 54.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.116 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 15.9 ttp85 -122.4 160.5 25.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.463 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 32.8 t-20 65.8 53.32 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.537 HD21 HG11 ' A' ' 235' ' ' VAL . 89.6 mt -106.16 131.31 53.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.9 mmt -66.33 136.99 56.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 266' ' ' ARG . 72.3 mt -56.4 -24.2 43.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 11.4 t -75.1 -26.4 59.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.429 ' HB ' ' NZ ' ' A' ' 264' ' ' LYS . 49.3 m -68.15 139.48 56.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.1 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.0 m -115.36 170.46 8.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.857 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 247' ' ' ILE . 48.8 mt-10 -50.95 -54.22 26.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -40.85 -48.06 3.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 2.9 mmt -55.98 -36.13 67.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 244' ' ' GLU . 40.6 mt -78.55 -46.72 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.115 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -60.22 -37.5 80.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 5.8 ptmt -73.47 -47.2 43.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.481 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 49.6 mm-40 -65.19 -22.78 66.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.613 ' CE1' HD13 ' A' ' 286' ' ' LEU . 7.3 m-85 -94.51 -26.32 16.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.44 ' OD1' ' CG2' ' A' ' 259' ' ' VAL . 78.6 m-20 -84.66 -18.99 33.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -59.6 -23.3 62.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 13.7 mm -75.7 -56.03 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -139.52 134.61 16.41 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.524 0.678 . . . . 0.0 110.923 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 138.09 37.09 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.679 2.253 . . . . 0.0 112.359 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 56.08 41.09 84.82 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -105.07 -53.06 2.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 111.073 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.44 ' CG2' ' OD1' ' A' ' 252' ' ' ASN . 96.9 t -61.15 114.61 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.154 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -72.02 -62.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.926 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -149.07 151.45 34.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.498 HG22 HG13 ' A' ' 271' ' ' VAL . 58.0 t -128.86 151.71 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -141.47 116.2 9.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.429 ' NZ ' ' HB ' ' A' ' 242' ' ' THR . 30.1 tptt -84.88 145.94 27.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.773 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.3 mt -133.88 172.18 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.655 ' H ' HG22 ' A' ' 265' ' ' ILE . 14.4 mmm180 -31.51 -72.04 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -126.88 19.13 7.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.773 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -148.4 177.85 9.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -163.98 170.55 16.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -133.35 146.24 51.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.498 HG13 HG22 ' A' ' 262' ' ' VAL . 16.6 t -133.55 134.2 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.136 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -112.41 152.34 28.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -129.2 -177.82 4.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 41.8 t -95.45 -22.01 17.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.45 151.4 31.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.575 ' O ' HG23 ' A' ' 280' ' ' VAL . 16.2 ttt180 -62.44 -37.39 85.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -48.24 -63.49 1.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.92 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -44.88 94.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.847 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.98 -47.15 61.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 276' ' ' ARG . 85.9 t -63.87 -42.67 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -60.87 -49.26 78.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.829 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.0 -29.93 71.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.125 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 53.6 ttp -70.42 -50.37 39.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -69.97 -30.09 67.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.59 -45.1 84.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.613 HD13 ' CE1' ' A' ' 251' ' ' PHE . 41.5 mt -87.28 -27.6 22.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.436 ' C ' ' OD1' ' A' ' 287' ' ' ASN . 23.4 t-20 -48.8 108.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 97.62 33.74 5.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.505 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -113.95 151.13 32.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.932 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 86.3 t -110.05 103.47 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.162 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 1.018 HD12 HD13 ' A' ' 296' ' ' ILE . 25.1 mt -102.4 147.11 27.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 44.97 24.96 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.847 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 77.97 41.31 18.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.49 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 3.0 t -153.81 135.16 8.71 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.681 0.753 . . . . 0.0 110.836 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.463 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 54.3 Cg_endo -69.72 93.94 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 1.018 HD13 HD12 ' A' ' 291' ' ' LEU . 11.4 pt -76.64 146.51 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.629 ' OE1' HG23 ' A' ' 299' ' ' THR . 0.2 OUTLIER -122.12 135.11 54.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.908 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.79 118.21 54.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' THR . . . . . 0.629 HG23 ' OE1' ' A' ' 297' ' ' GLU . 18.9 p -132.45 166.29 22.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.153 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.2 mt -83.77 102.87 12.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.54 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -71.16 157.33 38.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.115 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -106.71 140.93 21.83 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.586 0.708 . . . . 0.0 110.908 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 143.55 51.27 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.678 2.252 . . . . 0.0 112.34 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 90.8 t -108.85 110.42 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -156.54 134.58 11.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.76 135.22 33.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.911 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -59.2 105.22 0.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 4.6 m -73.97 154.94 39.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 59.0 p -95.45 -44.77 7.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 125.24 146.75 6.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 136.14 32.1 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.661 2.241 . . . . 0.0 112.345 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 34.0 p -71.78 -58.65 3.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 1.8 t 66.84 42.22 2.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 37.3 p -83.48 101.04 11.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.861 0.362 . . . . 0.0 110.851 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 45.6 m -88.69 -45.69 9.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 121.87 142.08 6.23 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 51.9 p -88.9 138.29 31.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 16.9 m -80.56 -29.34 37.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 101.8 -94.28 1.2 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -115.22 130.7 56.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.787 0.327 . . . . 0.0 110.896 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.44 ' N ' ' CD ' ' A' ' 224' ' ' GLU . 1.4 pm0 -142.53 174.17 10.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -128.27 102.27 6.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 82.6 p -83.34 45.3 1.02 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.76 -48.24 5.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 96.6 p -148.8 126.99 12.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.855 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 43.7 m -86.91 102.56 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.843 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.2 p -113.68 132.03 63.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -133.95 117.03 16.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.627 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 98.6 mt -147.73 139.14 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 232' ' ' ILE . 12.1 mt -121.09 107.63 12.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.751 ' CD1' ' CE1' ' A' ' 270' ' ' PHE . 33.3 t80 -91.46 121.32 33.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.19 132.23 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -119.69 155.78 31.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.409 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 38.6 t-20 70.68 52.62 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.23 126.62 52.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 22.8 mtt -71.49 139.98 49.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.622 HD23 ' O ' ' A' ' 266' ' ' ARG . 39.9 mt -55.96 -18.74 9.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.3 t -75.89 -28.59 58.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.833 HG23 ' SD ' ' A' ' 246' ' ' MET . 42.8 m -64.5 146.66 54.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 44.1 m -120.63 165.71 14.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.805 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 264' ' ' LYS . 49.0 mt-10 -64.5 -16.37 62.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -69.59 -64.02 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.833 ' SD ' HG23 ' A' ' 242' ' ' THR . 13.0 ptp -54.7 -30.87 56.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.854 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 73.1 mt -69.81 -45.13 78.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -65.53 -53.56 40.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.484 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 0.7 OUTLIER -53.32 -49.48 66.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.484 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 61.4 mm-40 -52.92 -53.46 49.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.615 ' CE2' HG21 ' A' ' 271' ' ' VAL . 5.8 m-85 -61.83 -58.49 7.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 253' ' ' ASN . 2.3 m120 -47.12 -49.1 22.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.952 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 252' ' ' ASN . 29.8 m-20 -36.65 -46.77 0.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.905 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.61 HD12 ' HB1' ' A' ' 285' ' ' ALA . 43.1 mm -51.64 -56.79 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.124 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.475 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 0.1 OUTLIER -143.95 137.06 13.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.548 0.689 . . . . 0.0 110.932 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.475 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 53.0 Cg_endo -69.82 136.75 33.64 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.63 2.22 . . . . 0.0 112.309 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 60.12 36.42 90.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -99.43 -39.15 8.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 111.13 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.5 t -90.99 132.99 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.171 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.424 ' OE1' ' N ' ' A' ' 260' ' ' GLU . 0.7 OUTLIER -94.37 -52.17 4.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 261' ' ' ARG . . . . . 0.481 ' HD3' ' N ' ' A' ' 262' ' ' VAL . 0.1 OUTLIER -151.23 161.75 42.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.481 ' N ' ' HD3' ' A' ' 261' ' ' ARG . 32.5 t -131.63 138.89 51.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.154 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 6.6 tppt? -123.99 113.6 18.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.409 ' HB2' ' CG ' ' A' ' 244' ' ' GLU . 13.9 tptp -87.66 143.31 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.754 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.7 mt -133.61 172.93 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.13 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.683 ' H ' HG22 ' A' ' 265' ' ' ILE . 20.4 mmt180 -30.66 -73.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.99 15.92 7.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.754 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -142.49 172.39 12.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.943 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -159.28 165.54 33.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.08 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.751 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 86.8 m-85 -128.35 149.6 50.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.615 HG21 ' CE2' ' A' ' 251' ' ' PHE . 19.8 t -132.56 123.78 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.115 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -97.15 144.24 27.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.835 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -120.4 177.52 5.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 33.4 t -90.86 -33.4 15.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.84 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -143.15 161.38 38.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 277' ' ' GLU . 11.1 ttp180 -64.49 -61.77 2.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 276' ' ' ARG . 16.1 mt-10 -35.99 -49.11 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -64.19 -50.73 66.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -53.4 -47.3 69.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.646 HG12 ' HD2' ' A' ' 284' ' ' LYS . 83.5 t -59.69 -43.12 90.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.84 -56.39 17.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.09 -38.24 67.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.124 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 65.0 ttp -60.32 -47.71 84.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.872 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.646 ' HD2' HG12 ' A' ' 280' ' ' VAL . 2.9 mtpm? -70.08 -37.6 75.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.61 ' HB1' HD12 ' A' ' 254' ' ' ILE . . . -55.19 -47.96 74.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.091 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.503 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 64.8 mt -84.6 -36.65 21.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 286' ' ' LEU . 11.3 t30 -36.74 93.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 113.03 33.82 1.93 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.475 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -110.79 157.88 19.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 91.3 t -119.8 96.13 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.837 HD12 HD13 ' A' ' 296' ' ' ILE . 31.3 mt -92.9 147.29 22.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.4 ' OD1' ' SD ' ' A' ' 246' ' ' MET . 3.2 m-20 46.64 30.47 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 69.91 43.05 67.4 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.459 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.9 m -155.05 137.35 9.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.693 0.759 . . . . 0.0 110.856 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.409 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.3 Cg_endo -69.79 108.74 2.15 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.627 2.218 . . . . 0.0 112.365 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.837 HD13 HD12 ' A' ' 291' ' ' LEU . 10.1 pt -97.54 141.72 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -112.34 143.9 42.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.847 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.07 117.84 51.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 10.5 p -132.84 167.57 19.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.209 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 9.3 mt -85.91 113.18 21.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.627 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -66.23 139.01 58.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.125 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.0 141.77 59.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.586 0.708 . . . . 0.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 141.7 45.69 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.701 2.267 . . . . 0.0 112.297 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 91.4 t -104.32 99.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -82.3 51.24 1.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.83 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -44.17 117.42 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.92 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -62.81 134.59 56.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 60.2 p -107.92 132.63 53.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.874 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 2.7 m -115.55 136.52 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 114.79 148.21 9.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.487 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 91.61 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.656 2.237 . . . . 0.0 112.352 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 7.4 t -156.93 125.2 5.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.862 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 3.5 m -58.08 176.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.907 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.526 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.3 m -101.05 97.73 8.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.844 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 18.2 p -126.28 161.07 28.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.847 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 104.87 40.78 2.08 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.509 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 96.6 p -116.33 149.83 38.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.881 0.372 . . . . 0.0 110.87 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 43.9 m -101.0 -35.15 9.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 156.39 -156.1 26.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.509 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.38 118.96 33.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.748 0.309 . . . . 0.0 110.902 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -78.81 85.25 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.92 167.01 8.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 9.4 t -164.08 158.93 19.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.117 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 11.0 mmt -75.37 -51.77 12.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.936 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 24.4 m -83.17 93.18 7.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 80.1 p -109.62 107.75 17.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -116.25 132.69 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.112 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.405 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -130.72 116.9 18.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 68.5 mt -147.91 136.42 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.129 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 23.4 mt -118.57 110.16 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.595 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 28.2 t80 -93.47 125.74 38.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.472 HG11 HD21 ' A' ' 238' ' ' LEU . 21.3 t -108.83 142.52 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.089 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 7.3 ttt-85 -134.87 157.23 47.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 295' ' ' PRO . 12.2 t30 71.92 47.95 0.3 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.472 HD21 HG11 ' A' ' 235' ' ' VAL . 31.0 mt -100.99 125.34 47.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 14.3 mtt -63.75 125.73 25.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.836 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 266' ' ' ARG . 20.3 mt -50.93 -23.95 3.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.934 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 7.2 m -68.87 -33.32 73.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.529 HG23 ' SD ' ' A' ' 246' ' ' MET . 24.9 m -63.56 144.9 56.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.196 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.6 m -112.17 165.81 11.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.855 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.57 -46.69 80.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -45.17 -36.65 3.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.529 ' SD ' HG23 ' A' ' 242' ' ' THR . 27.5 mtt -69.53 -42.02 75.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.879 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 46.0 mt -68.89 -39.92 80.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.452 ' OE1' ' CG2' ' A' ' 262' ' ' VAL . 4.3 tp10 -64.69 -43.79 92.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.864 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 1.7 ptmm? -72.54 -46.27 55.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.528 ' CD ' HD21 ' A' ' 291' ' ' LEU . 62.3 mm-40 -56.82 -33.51 66.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.915 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.639 ' CE2' HG21 ' A' ' 271' ' ' VAL . 8.0 m-85 -87.93 -30.61 19.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -76.42 -26.91 55.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -52.72 -23.84 7.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 16.0 mm -78.19 -52.82 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -144.14 134.0 11.76 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.587 0.708 . . . . 0.0 110.924 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 142.53 48.28 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 0.0 112.348 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 55.13 26.23 41.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.519 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -90.52 -53.72 4.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.333 . . . . 0.0 111.08 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.5 t -62.25 114.42 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -73.98 -60.02 2.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -150.2 146.2 26.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.87 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.452 ' CG2' ' OE1' ' A' ' 248' ' ' GLU . 61.3 t -116.92 128.84 74.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.13 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -115.63 108.41 16.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -85.22 142.17 29.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.771 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.7 mt -133.86 172.41 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.66 ' H ' HG22 ' A' ' 265' ' ' ILE . 15.6 mmt180 -31.11 -72.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.82 15.84 8.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.85 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.771 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -143.37 175.27 10.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -163.79 160.32 22.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.052 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.441 ' CD2' HD11 ' A' ' 265' ' ' ILE . 86.4 m-85 -124.56 138.15 54.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.639 HG21 ' CE2' ' A' ' 251' ' ' PHE . 3.1 t -123.12 129.58 74.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.11 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -106.69 151.74 24.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.865 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -129.73 174.62 9.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 25.4 t -80.96 -38.41 27.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.878 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -144.28 153.31 41.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 277' ' ' GLU . 21.5 ttt180 -50.87 -56.17 13.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.876 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 276' ' ' ARG . 4.9 mm-40 -35.76 -54.76 0.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -59.63 -49.93 75.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.813 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -53.05 -50.18 64.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 48.9 t -53.75 -48.9 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -59.01 -59.93 4.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.844 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.28 -18.64 6.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 56.9 ttp -78.01 -57.67 3.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -66.89 -29.56 69.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -62.42 -56.99 12.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.095 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.631 ' CD1' ' CD1' ' A' ' 251' ' ' PHE . 55.2 mt -76.71 -40.19 49.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.945 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -39.87 121.14 1.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 90.63 27.33 20.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.525 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -110.37 161.78 15.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.406 HG13 ' C ' ' A' ' 294' ' ' SER . 72.9 t -123.85 95.11 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.078 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.758 HD12 HD13 ' A' ' 296' ' ' ILE . 33.1 mt -87.07 148.01 25.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 40.6 t0 41.47 41.54 1.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.902 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 59.58 45.85 94.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.406 ' C ' HG13 ' A' ' 290' ' ' VAL . 2.0 t -154.62 136.59 9.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.683 0.754 . . . . 0.0 110.883 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.425 ' O ' ' ND2' ' A' ' 237' ' ' ASN . 53.6 Cg_endo -69.76 110.9 2.67 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.712 2.275 . . . . 0.0 112.306 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.758 HD13 HD12 ' A' ' 291' ' ' LEU . 10.8 pt -101.33 144.38 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.176 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -115.45 151.79 34.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 8.8 t -140.43 113.52 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 51.2 p -134.35 167.65 20.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.163 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 10.9 mt -81.54 108.87 15.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.595 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -68.92 137.41 53.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.42 90.49 5.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 0.0 110.942 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 133.41 25.54 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.661 2.241 . . . . 0.0 112.384 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 29.1 m -82.96 143.2 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.141 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -158.81 111.46 2.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.28 -44.06 53.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -50.54 110.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 309' ' ' SER . 11.2 t -72.19 120.94 18.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 308' ' ' SER . 47.3 p -37.32 108.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.836 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -174.18 83.85 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.514 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 163.88 36.59 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.656 2.237 . . . . 0.0 112.352 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 68.9 m -70.0 167.25 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 51.2 m -58.86 168.92 1.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.886 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.508 -179.926 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 39.7 t -68.24 -54.49 17.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.378 . . . . 0.0 110.877 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 2.7 t -46.74 153.14 0.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -168.87 -66.6 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 43.1 m -82.95 145.69 29.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 110.863 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 t -62.7 -14.79 48.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.832 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 122.55 -101.81 0.75 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.509 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -135.69 124.88 24.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 110.828 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -119.4 -45.82 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 6.5 t70 57.34 30.84 19.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 9.9 t -68.61 137.94 54.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.094 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 3.9 ttp -72.87 -30.26 63.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 30.2 t -81.79 110.13 16.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 94.6 p -70.29 105.77 3.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.19 136.5 51.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.112 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -137.61 116.88 12.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.682 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 77.0 mt -147.91 140.29 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.055 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 11.4 mt -120.83 111.87 18.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.921 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.517 ' CE2' ' HB2' ' A' ' 236' ' ' ARG . 16.2 t80 -92.08 129.72 37.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.843 HG11 HD21 ' A' ' 238' ' ' LEU . 17.4 t -115.18 133.82 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.517 ' HB2' ' CE2' ' A' ' 234' ' ' TYR . 30.3 ttp85 -129.31 161.17 30.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 71.26 35.84 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.843 HD21 HG11 ' A' ' 235' ' ' VAL . 11.5 mt -91.76 122.6 34.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.496 ' CB ' ' OD2' ' A' ' 292' ' ' ASP . 4.7 mmt -57.43 139.66 52.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.495 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 40.4 mt -63.34 -7.66 6.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.885 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 37.6 m -97.44 16.64 19.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.615 HG23 ' SD ' ' A' ' 246' ' ' MET . 49.2 m -99.02 145.33 27.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 2.3 m -119.05 155.07 32.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -56.1 -15.04 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.835 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -72.58 -66.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.615 ' SD ' HG23 ' A' ' 242' ' ' THR . 13.2 ptp -55.64 -29.08 58.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 63.4 mt -75.77 -45.84 37.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.134 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.434 ' HG2' ' ND2' ' A' ' 252' ' ' ASN . 17.9 tt0 -63.1 -44.28 96.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 16.2 ptmt -64.61 -47.58 78.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.595 ' HG3' HD21 ' A' ' 291' ' ' LEU . 21.6 mm-40 -57.25 -34.72 68.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -81.89 -32.16 31.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.434 ' ND2' ' HG2' ' A' ' 248' ' ' GLU . 59.2 m-20 -79.86 -14.6 58.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.431 ' OD1' HD13 ' A' ' 254' ' ' ILE . 34.7 p-10 -60.17 -18.48 48.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.431 HD13 ' OD1' ' A' ' 253' ' ' ASN . 10.0 mm -79.86 -60.21 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -136.67 135.32 20.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.556 0.693 . . . . 0.0 110.959 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 137.45 35.56 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.727 2.285 . . . . 0.0 112.317 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.57 40.43 94.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.511 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -102.56 -56.41 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 111.112 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.2 t -59.76 136.13 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -93.91 -55.77 3.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -152.74 149.32 28.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 19.2 t -122.41 137.85 54.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -128.31 109.1 11.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -80.35 140.62 36.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.954 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.704 HG22 ' H ' ' A' ' 266' ' ' ARG . 6.2 mt -130.82 173.33 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.083 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.704 ' H ' HG22 ' A' ' 265' ' ' ILE . 22.0 mmt180 -28.66 -75.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.879 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -125.0 14.26 8.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.746 ' HA ' HD12 ' A' ' 238' ' ' LEU . 0.1 OUTLIER -140.58 171.67 13.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.944 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -157.87 154.88 28.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -116.07 146.06 42.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.892 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 18.1 t -134.49 125.35 46.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.145 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -98.9 154.68 17.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.889 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -131.85 167.88 18.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.6 t -77.18 -33.78 56.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -146.63 153.13 39.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 277' ' ' GLU . 5.8 ttt-85 -54.04 -55.95 22.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 276' ' ' ARG . 77.8 mt-10 -34.91 -59.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.885 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -56.84 -49.11 76.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.83 -53.33 33.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.66 -37.0 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.159 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -65.41 -49.4 69.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.97 -21.17 65.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 51.2 ttp -71.3 -58.45 3.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -66.16 -30.02 70.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -60.66 -55.67 30.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 42.8 mt -79.49 -31.29 42.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -40.65 115.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 93.08 32.92 7.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -109.83 157.46 19.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.802 0.334 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 76.5 t -118.79 96.19 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.152 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.936 HD12 HD13 ' A' ' 296' ' ' ILE . 30.6 mt -95.0 152.81 18.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.496 ' OD2' ' CB ' ' A' ' 239' ' ' MET . 34.2 t70 41.86 26.51 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.83 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.7 43.84 34.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.516 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 2.0 m -154.39 137.88 10.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.62 0.724 . . . . 0.0 110.897 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 91.93 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.685 2.257 . . . . 0.0 112.352 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.936 HD13 HD12 ' A' ' 291' ' ' LEU . 17.2 pt -78.35 144.97 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -120.44 140.06 51.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.91 134.61 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 41.0 p -147.32 176.43 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 232' ' ' ILE . 15.5 mt -95.64 105.78 17.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.682 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -71.78 145.01 48.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -94.65 143.97 27.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.582 0.706 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 150.78 68.59 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.717 2.278 . . . . 0.0 112.32 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 304' ' ' VAL . 9.3 p -90.29 121.24 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.13 147.31 35.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.822 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -133.51 136.27 44.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -72.65 84.98 1.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 8.5 t -59.09 127.28 31.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.839 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 18.2 m -123.3 164.82 18.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.884 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 105.31 83.03 1.63 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.429 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 159.13 54.54 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.665 2.244 . . . . 0.0 112.375 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 22.1 p -139.58 138.68 36.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 40.0 t -55.75 124.66 18.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.7 t -131.91 167.57 19.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.87 0.367 . . . . 0.0 110.876 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 31.3 t -85.6 136.1 33.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 86.12 51.64 3.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.491 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 88.1 p -138.84 121.73 16.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.382 . . . . 0.0 110.86 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.4 t -116.94 -34.69 4.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.895 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -166.63 84.71 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.401 ' HB2' HG22 ' A' ' 226' ' ' THR . 2.6 p30 -92.31 140.5 29.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.745 0.307 . . . . 0.0 110.851 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -119.64 86.45 2.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.891 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 46.86 39.81 8.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 226' ' ' THR . 10.1 t -104.46 116.14 31.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.134 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 17.4 ptm -96.41 -45.37 6.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 87.8 p -79.36 129.93 34.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 69.0 m -61.75 103.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.859 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.42 130.5 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.116 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.32 116.85 18.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.518 ' O ' HD23 ' A' ' 300' ' ' LEU . 40.6 mt -148.05 136.5 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.114 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.612 HD12 ' HE1' ' A' ' 273' ' ' PHE . 36.0 mt -124.04 108.57 12.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.891 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 22.8 t80 -92.02 126.27 37.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.873 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 24.3 t -108.0 144.49 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.134 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -136.98 157.81 45.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 72.9 53.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 14.8 mt -111.14 134.46 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 3.8 mtt -70.51 137.47 50.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 266' ' ' ARG . 70.3 mt -53.95 -18.65 3.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 36.7 m -75.09 -31.36 61.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.554 HG23 ' HB2' ' A' ' 246' ' ' MET . 50.6 m -67.5 127.27 32.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.151 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.1 t -107.08 157.4 17.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -43.34 -28.04 0.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -60.55 -42.55 96.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.554 ' HB2' HG23 ' A' ' 242' ' ' THR . 7.3 mmt -63.82 -42.47 97.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.478 ' HB ' HG11 ' A' ' 262' ' ' VAL . 69.1 mt -67.12 -36.9 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.439 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 19.3 tt0 -70.34 -49.12 52.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 4.8 ptmt -63.23 -46.77 85.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.584 ' HG3' HD21 ' A' ' 291' ' ' LEU . 27.7 mm-40 -59.79 -56.29 23.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.865 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.592 ' CE2' HG21 ' A' ' 271' ' ' VAL . 7.4 m-85 -62.33 -41.77 98.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.439 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 5.8 m-20 -62.03 -42.35 99.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -38.49 -42.62 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 44.2 mm -53.99 -58.95 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.445 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 26.6 tptt -141.05 136.81 16.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.538 0.685 . . . . 0.0 110.909 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.445 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 53.4 Cg_endo -69.77 131.28 20.89 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.677 2.251 . . . . 0.0 112.325 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 62.82 39.52 98.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.509 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -103.94 -45.11 4.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 0.0 111.069 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.409 ' CG2' ' OD1' ' A' ' 252' ' ' ASN . 93.8 t -71.62 117.89 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.64 -60.32 2.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -145.52 152.96 40.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.478 HG11 ' HB ' ' A' ' 247' ' ' ILE . 92.2 t -127.8 130.74 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -118.94 109.65 16.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -86.66 143.61 27.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.902 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.689 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.5 mt -133.95 172.65 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.687 ' H ' HG22 ' A' ' 265' ' ' ILE . 22.7 mmt180 -30.89 -70.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -125.62 -1.11 7.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.689 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -124.45 177.54 5.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.96 164.94 16.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.101 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 265' ' ' ILE . 97.8 m-85 -127.21 142.81 51.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.592 HG21 ' CE2' ' A' ' 251' ' ' PHE . 5.2 t -129.99 122.65 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -105.74 133.38 50.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.817 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.612 ' HE1' HD12 ' A' ' 233' ' ' LEU . 30.9 m-85 -108.02 175.71 5.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 17.3 t -86.5 -28.46 23.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -146.92 149.52 33.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -52.48 -49.19 65.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 278' ' ' ASP . 13.8 pt-20 -44.35 -51.85 8.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.425 ' N ' ' HG3' ' A' ' 277' ' ' GLU . 2.5 m-20 -60.62 -50.53 73.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.844 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.463 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -52.44 -49.79 63.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.06 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 77.9 t -53.77 -54.97 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -53.56 -59.83 4.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.431 ' CB ' ' CZ ' ' A' ' 273' ' ' PHE . . . -54.33 -29.36 47.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 62.2 ttp -68.84 -57.14 5.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -63.67 -51.62 64.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -45.12 -51.97 9.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.074 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.532 HD13 ' CE1' ' A' ' 251' ' ' PHE . 81.4 mt -79.13 -29.15 42.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.914 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.402 ' O ' ' ND2' ' A' ' 287' ' ' ASN . 2.7 t30 -49.52 91.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 115.88 31.49 1.91 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.458 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.411 ' HB2' HD11 ' A' ' 296' ' ' ILE . 3.7 mmpt? -106.5 163.2 13.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 110.931 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 51.9 t -125.53 96.59 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.106 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.584 HD21 ' HG3' ' A' ' 250' ' ' GLU . 72.0 mt -89.92 152.67 21.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.899 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 291' ' ' LEU . 1.6 m-20 34.94 36.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 66.62 46.99 71.51 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.477 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 291' ' ' LEU . 5.2 t -154.77 136.25 9.22 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.667 0.746 . . . . 0.0 110.86 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 106.05 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.719 2.279 . . . . 0.0 112.367 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.475 HD13 HD12 ' A' ' 291' ' ' LEU . 7.9 pt -94.09 145.28 8.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.16 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -118.6 146.83 44.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.0 117.81 39.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 33.9 p -135.67 170.31 16.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.518 HD23 ' O ' ' A' ' 232' ' ' ILE . 22.3 mt -86.89 102.2 14.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.934 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -72.41 114.16 10.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -79.31 143.99 61.35 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.537 0.684 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 141.48 45.41 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.67 2.247 . . . . 0.0 112.334 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 91.6 t -103.22 97.28 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.129 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -139.5 135.67 33.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -63.64 153.58 35.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.35 123.92 23.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 21.9 p -82.31 155.31 24.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 60.3 p -100.06 151.92 20.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.866 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 178.72 -178.15 48.64 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.493 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 135.69 31.25 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.707 2.272 . . . . 0.0 112.321 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 70.6 m -96.28 -55.71 2.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.86 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 1.9 t -112.39 107.38 16.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.836 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.479 -179.982 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 7.3 t 52.25 41.53 30.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 110.831 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 31.5 t -109.76 103.24 12.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 109.97 57.21 0.52 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.473 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 93.4 p -114.5 42.26 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.875 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.3 t -112.25 -34.5 5.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 80.68 -100.96 1.99 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.458 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -50.01 104.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.766 0.317 . . . . 0.0 110.838 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.21 94.47 2.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -55.97 -47.11 78.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 42.1 p 40.1 41.1 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 33.8 mtt -95.4 -46.06 6.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 42.9 m -159.41 148.73 18.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.9 m -65.66 99.35 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.884 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.88 133.11 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.139 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.34 116.84 19.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.44 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 20.0 mt -147.95 130.93 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.09 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 279' ' ' ALA . 15.2 mt -117.49 112.49 20.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.914 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -91.85 128.99 37.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.09 128.74 73.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.127 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -125.23 159.55 31.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 71.88 51.23 0.23 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 41.5 mt -107.83 119.09 38.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 7.0 mmt -54.3 125.39 19.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.705 HD23 ' O ' ' A' ' 266' ' ' ARG . 65.1 mt -44.44 -30.17 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 36.0 t -59.92 -40.53 89.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.449 ' HA ' ' CE ' ' A' ' 246' ' ' MET . 30.9 m -60.56 155.16 19.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.153 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.42 ' N ' HG22 ' A' ' 242' ' ' THR . 43.2 m -134.64 168.28 19.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.838 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 245' ' ' GLU . 54.3 mt-10 -47.43 -57.74 4.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 244' ' ' GLU . 38.0 tt0 -35.68 -59.73 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.449 ' CE ' ' HA ' ' A' ' 242' ' ' THR . 6.9 mtt -47.52 -51.66 19.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.0 -34.02 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.118 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -64.66 -51.38 62.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 1.6 ptpp? -65.81 -44.34 85.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.888 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.554 ' HG3' HD21 ' A' ' 291' ' ' LEU . 52.0 mm-40 -61.0 -28.8 69.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 271' ' ' VAL . 7.2 m-85 -95.24 -23.19 17.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.77 -35.7 32.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 250' ' ' GLU . 0.6 OUTLIER -42.56 -29.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 15.5 mm -68.76 -66.79 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -131.35 131.96 23.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.519 0.676 . . . . 0.0 110.887 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 121.83 8.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 72.9 33.25 60.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.522 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -101.34 -39.71 7.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 78.8 t -73.16 113.75 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.061 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -66.84 -65.0 0.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.907 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' ARG . . . . . 0.476 ' CD ' ' HB2' ' A' ' 272' ' ' HIS . 0.0 OUTLIER -146.86 162.62 38.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.877 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 48.1 t -133.53 137.57 52.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' LYS . . . . . 0.423 ' C ' ' HD3' ' A' ' 263' ' ' LYS . 9.4 tmtm? -127.06 105.2 8.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.429 ' CB ' ' HG3' ' A' ' 244' ' ' GLU . 11.4 tptp -79.67 145.17 33.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.836 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.8 mt -133.6 172.05 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.148 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.705 ' O ' HD23 ' A' ' 240' ' ' LEU . 51.9 mtt85 -32.01 -71.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.64 15.57 7.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.836 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -142.56 177.37 8.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -167.6 164.74 14.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.075 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.442 ' CD2' HD11 ' A' ' 265' ' ' ILE . 98.3 m-85 -130.94 142.9 50.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 251' ' ' PHE . 21.4 t -124.47 125.51 70.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.107 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' HIS . . . . . 0.476 ' HB2' ' CD ' ' A' ' 261' ' ' ARG . 3.5 m-70 -105.3 137.55 42.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -117.03 -177.51 3.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.83 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.3 t -99.45 -24.99 14.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -144.78 144.17 31.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.865 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 277' ' ' GLU . 9.6 ttp180 -54.4 -54.17 44.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 276' ' ' ARG . 4.8 mm-40 -35.64 -54.64 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.42 -51.72 67.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.417 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -46.48 -46.88 19.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.057 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.453 ' CG1' ' HD2' ' A' ' 284' ' ' LYS . 51.6 t -65.69 -54.47 27.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.084 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -50.13 -47.61 54.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.49 -31.37 68.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 67.6 ttp -66.82 -53.58 31.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.453 ' HD2' ' CG1' ' A' ' 280' ' ' VAL . 30.0 mtpt -65.92 -39.75 90.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -53.85 -53.83 47.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.475 HD13 ' CE1' ' A' ' 251' ' ' PHE . 35.2 mt -77.06 -35.49 56.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -41.15 95.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 114.83 32.53 1.87 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.524 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -113.66 160.35 18.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 0.0 110.863 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 95.8 t -123.23 103.59 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.612 HD12 HD13 ' A' ' 296' ' ' ILE . 22.4 mt -95.64 150.85 19.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 41.92 24.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 77.32 38.17 29.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 291' ' ' LEU . 23.6 p -145.59 135.68 11.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 110.908 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 102.41 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.7 2.267 . . . . 0.0 112.328 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.612 HD13 HD12 ' A' ' 291' ' ' LEU . 7.3 pt -90.43 147.2 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.11 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -122.96 140.69 52.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.24 122.33 65.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 81.9 p -137.84 172.79 12.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.122 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 11.4 mt -90.22 110.02 21.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.44 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -71.43 153.42 42.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.105 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.35 142.45 24.57 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.578 0.704 . . . . 0.0 110.893 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 152.76 69.48 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.669 2.246 . . . . 0.0 112.373 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.42 135.68 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.092 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -104.16 126.07 50.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -156.15 120.42 4.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.2 84.44 7.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.862 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 19.4 t -78.49 161.99 26.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 15.8 t -69.55 155.13 40.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -40.6 160.81 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -17.47 37.44 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.671 2.247 . . . . 0.0 112.317 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 92.1 p -78.07 114.92 17.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.851 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 3.9 m -77.7 137.74 38.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.839 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.543 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 218' ' ' SER . 58.1 m -123.81 131.04 53.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.927 0.394 . . . . 0.0 110.854 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 217' ' ' SER . 1.8 t 37.85 42.08 0.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.876 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -84.02 -58.19 2.26 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 75.6 m -105.28 83.24 1.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.3 p -86.35 -35.0 20.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.852 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 175.86 -148.35 9.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.528 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -172.17 120.58 0.43 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.78 143.73 46.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -99.3 156.13 17.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 27.2 m -62.48 -52.81 62.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 81.8 mtp -63.48 -53.98 43.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.853 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 1.9 m -87.23 92.92 9.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.842 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 88.9 p -101.35 109.81 21.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.836 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.54 131.98 62.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.138 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.21 116.83 17.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.525 ' O ' HD23 ' A' ' 233' ' ' LEU . 21.9 mt -147.94 140.77 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.592 HD12 ' CE1' ' A' ' 273' ' ' PHE . 39.5 mt -126.28 106.89 9.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.731 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 38.9 t80 -91.38 123.95 35.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.96 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.482 HG11 HD21 ' A' ' 238' ' ' LEU . 20.8 t -104.45 148.36 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.527 ' HG3' ' CE2' ' A' ' 234' ' ' TYR . 24.0 mtp180 -138.72 160.31 39.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.46 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 26.7 t-20 67.72 53.03 0.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.672 HD13 HD11 ' A' ' 247' ' ' ILE . 27.0 mt -109.46 120.63 43.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 8.4 mmt -54.97 133.64 48.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.849 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.507 HD23 ' O ' ' A' ' 266' ' ' ARG . 54.4 mt -51.91 -25.01 7.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 61.5 m -70.79 -32.3 69.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.52 HG23 ' HB2' ' A' ' 246' ' ' MET . 93.9 m -65.82 139.95 58.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.1 t -121.11 164.11 17.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.83 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -47.92 -22.04 0.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -65.69 -45.3 83.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.52 ' HB2' HG23 ' A' ' 242' ' ' THR . 2.3 mmt -67.59 -44.53 77.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.672 HD11 HD13 ' A' ' 238' ' ' LEU . 79.2 mt -65.97 -37.65 80.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.442 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 13.9 tt0 -71.62 -57.75 4.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 5.8 ptmt -49.34 -45.98 46.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.488 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 23.6 mm-40 -61.99 -58.21 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.531 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 6.0 m-85 -54.57 -27.53 39.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 16.2 m120 -71.77 -44.57 63.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.955 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -38.78 -40.76 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 17.0 mm -56.47 -64.24 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -139.48 131.75 15.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.58 0.705 . . . . 0.0 110.908 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 136.67 33.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.617 2.211 . . . . 0.0 112.39 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 63.37 33.32 86.93 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.445 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -100.75 -51.04 3.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.353 . . . . 0.0 111.108 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.73 135.9 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.123 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -96.89 -64.33 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -146.06 142.41 28.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 66.6 t -120.92 136.55 57.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -129.66 110.13 11.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 265' ' ' ILE . 23.4 tptp -79.49 144.63 33.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.693 HG22 ' H ' ' A' ' 266' ' ' ARG . 6.5 mt -132.3 173.1 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.141 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.693 ' H ' HG22 ' A' ' 265' ' ' ILE . 20.3 mmm180 -29.4 -68.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -132.42 15.08 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.649 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -142.86 173.38 11.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.928 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -162.18 158.98 25.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.086 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 95.3 m-85 -118.62 148.86 42.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.427 HG11 ' CD2' ' A' ' 251' ' ' PHE . 21.3 t -134.81 124.43 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -100.68 146.82 26.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.592 ' CE1' HD12 ' A' ' 233' ' ' LEU . 22.7 m-85 -126.84 167.59 15.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.887 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 45.8 m -74.79 -39.17 61.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -142.87 153.34 43.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.443 ' O ' ' C ' ' A' ' 277' ' ' GLU . 10.0 ttt85 -54.4 -57.7 10.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 276' ' ' ARG . 4.6 mp0 -34.36 -50.25 0.41 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -63.67 -53.65 48.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.57 ' HB1' HD21 ' A' ' 233' ' ' LEU . . . -51.86 -53.31 41.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.429 HG12 ' NZ ' ' A' ' 284' ' ' LYS . 56.1 t -52.74 -44.8 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.173 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.62 -51.83 67.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.15 -14.57 63.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.107 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -76.6 -60.8 2.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.429 ' NZ ' HG12 ' A' ' 280' ' ' VAL . 19.0 mtmm -64.22 -37.48 87.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -51.46 -54.7 24.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.111 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.531 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 50.5 mt -76.08 -40.16 53.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 286' ' ' LEU . 2.0 t30 -36.29 97.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 109.51 33.91 2.58 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.522 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -114.86 164.2 14.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.769 0.318 . . . . 0.0 110.953 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.413 HG13 ' N ' ' A' ' 294' ' ' SER . 56.8 t -124.64 110.79 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.114 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 293' ' ' GLY . 26.9 mt -102.96 146.38 28.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 39.62 29.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.59 47.55 12.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.469 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.413 ' N ' HG13 ' A' ' 290' ' ' VAL . 1.8 m -154.52 134.68 8.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.678 0.751 . . . . 0.0 110.852 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.46 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.4 Cg_endo -69.76 94.78 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 10.1 pt -83.61 148.31 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 298' ' ' VAL . 4.5 tp10 -122.79 148.41 45.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 286' ' ' LEU . 4.2 t -130.97 117.88 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.156 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 24.7 p -134.78 160.57 37.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.175 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 232' ' ' ILE . 8.8 mt -83.88 100.61 11.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.731 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -66.73 124.52 23.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.069 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.469 ' CD ' ' H ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -75.12 143.44 77.23 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.583 0.706 . . . . 0.0 110.918 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 162.8 40.67 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.321 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.77 135.26 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -72.09 139.17 48.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -171.75 117.14 0.4 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.919 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -105.6 103.62 13.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.874 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 82.9 p -79.72 140.6 36.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 35.3 t -108.26 122.97 48.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -177.66 146.08 7.44 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -175.28 1.1 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.683 2.255 . . . . 0.0 112.345 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 79.2 p -114.52 93.65 4.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.871 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 2.7 m -129.83 156.76 43.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.481 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 38.1 m -115.03 116.6 28.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 0.0 110.849 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 4.0 t -84.41 -56.83 3.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 142.18 -157.24 26.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 24.6 p -64.63 153.47 39.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.886 0.374 . . . . 0.0 110.882 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.9 t -101.31 -34.9 9.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 86.49 107.92 0.8 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.502 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -141.78 144.0 33.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.765 0.317 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -50.22 135.28 21.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASP . . . . . 0.401 ' O ' ' CG ' ' A' ' 225' ' ' ASP . 15.1 p-10 -50.22 97.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.825 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 23.8 m -90.88 137.8 32.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.171 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 23.0 ttt -84.19 -46.6 11.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 32.4 t -76.8 109.54 10.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.838 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 92.5 p -64.13 103.7 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.831 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -106.83 131.02 57.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.131 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.64 116.42 18.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.49 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 80.9 mt -147.9 142.66 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.139 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.796 HD12 ' HE1' ' A' ' 273' ' ' PHE . 81.7 mt -128.94 106.0 8.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.638 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 32.6 t80 -91.31 128.52 37.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.9 t -109.56 150.64 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.149 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -138.81 157.98 45.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 71.8 54.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 23.6 mt -107.04 113.14 26.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.45 ' CG ' ' OD2' ' A' ' 292' ' ' ASP . 13.4 mmt -53.89 128.15 28.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.443 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 25.7 mt -49.09 -30.38 6.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.906 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 97.8 p -64.49 -33.36 75.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.444 ' O ' ' NZ ' ' A' ' 264' ' ' LYS . 7.8 m -58.96 150.05 25.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.146 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 3.4 m -118.02 159.79 22.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -54.19 -41.62 68.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -54.84 -32.34 60.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.6 mtt -70.74 -37.25 73.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 25.9 mt -74.72 -39.81 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.156 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -68.81 -45.97 69.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.476 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 0.0 OUTLIER -62.35 -48.38 80.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.907 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.52 ' HA ' ' ND2' ' A' ' 253' ' ' ASN . 52.8 mm-40 -56.35 -50.11 72.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.467 ' CD2' HG11 ' A' ' 271' ' ' VAL . 7.2 m-85 -65.74 -23.56 66.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -75.49 -41.38 55.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.52 ' ND2' ' HA ' ' A' ' 250' ' ' GLU . 25.0 m-20 -37.37 -46.96 0.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 49.7 mm -49.59 -63.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -141.17 129.38 12.29 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.596 0.712 . . . . 0.0 110.934 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 114.96 3.88 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.672 2.248 . . . . 0.0 112.324 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 90.36 38.23 6.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -114.35 -43.62 3.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 111.084 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.61 118.4 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -80.25 -67.99 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -144.76 150.92 38.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 93.7 t -127.22 130.1 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.12 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -115.54 106.26 13.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 242' ' ' THR . 15.6 tptm -80.09 140.94 36.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.768 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.1 mt -132.26 172.42 16.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.668 ' H ' HG22 ' A' ' 265' ' ' ILE . 30.7 mmt180 -31.78 -72.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 7.7 p-10 -126.51 17.48 7.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.768 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -146.25 178.01 8.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -169.22 165.78 10.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.104 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.575 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 96.3 m-85 -126.89 145.4 50.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 251' ' ' PHE . 66.6 t -129.79 134.54 62.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.117 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -113.99 156.29 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.796 ' HE1' HD12 ' A' ' 233' ' ' LEU . 44.9 m-85 -134.37 179.95 5.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 62.5 p -83.26 -34.68 25.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -147.49 153.18 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.872 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 277' ' ' GLU . 8.5 ttt85 -53.79 -54.57 36.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 276' ' ' ARG . 44.7 mt-10 -34.48 -56.52 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.81 -50.78 72.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.05 -54.23 21.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.038 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 71.6 t -53.39 -47.89 57.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.088 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -56.0 -58.45 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.19 -30.87 51.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.091 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 63.6 ttp -68.07 -55.74 11.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -68.6 -14.94 63.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -79.29 -52.73 7.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.082 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 287' ' ' ASN . 59.5 mt -82.69 -35.16 27.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 286' ' ' LEU . 2.3 t-20 -38.28 99.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 107.68 34.37 2.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.504 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -113.59 159.66 19.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.824 0.345 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 86.7 t -121.32 93.6 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.173 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.475 HD12 HD13 ' A' ' 296' ' ' ILE . 27.7 mt -92.08 153.86 19.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.45 ' OD2' ' CG ' ' A' ' 239' ' ' MET . 3.2 p-10 42.15 25.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.1 38.29 40.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.51 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 291' ' ' LEU . 68.1 p -147.05 134.9 10.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.637 0.732 . . . . 0.0 110.887 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 92.0 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.629 2.22 . . . . 0.0 112.323 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.475 HD13 HD12 ' A' ' 291' ' ' LEU . 7.5 pt -82.85 148.38 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -125.87 143.71 50.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.6 t -123.86 127.22 73.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 25.7 p -137.43 171.76 13.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 232' ' ' ILE . 5.4 mt -94.74 100.15 12.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.638 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -65.5 151.72 45.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 17.0 mmtm -107.24 142.79 25.84 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.596 0.713 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 145.38 56.98 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.704 2.27 . . . . 0.0 112.351 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 89.5 t -109.14 124.05 65.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.104 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -143.68 171.99 13.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -158.66 141.81 14.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -39.41 122.77 1.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 79.9 p -77.86 157.45 29.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 29.5 m -109.83 101.55 10.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -138.13 -157.44 7.46 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 160.08 51.01 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.687 2.258 . . . . 0.0 112.34 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 22.4 t 67.24 36.26 4.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 19.8 m -101.88 131.96 47.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.473 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 19.7 m -89.83 81.11 6.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.909 0.385 . . . . 0.0 110.877 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 77.4 p -59.11 153.62 17.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.83 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 141.82 -80.7 0.25 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.508 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 63.8 p -91.93 40.53 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.38 . . . . 0.0 110.809 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.4 t -62.79 -35.18 79.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.843 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 148.13 92.82 0.11 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.505 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.14 110.71 0.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.791 0.329 . . . . 0.0 110.857 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -46.71 -45.82 19.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -37.57 -56.62 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.813 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 37.5 m -119.85 127.07 52.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -84.73 -52.95 5.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 1.9 t -145.18 134.44 22.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.871 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 57.7 p -60.61 100.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.15 137.68 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.476 ' HE2' ' CA ' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -136.71 116.99 13.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.923 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.618 ' O ' HD23 ' A' ' 233' ' ' LEU . 70.2 mt -147.95 137.05 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.174 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 232' ' ' ILE . 10.7 mt -122.07 110.96 16.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.922 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 236' ' ' ARG . 22.5 t80 -91.43 132.92 35.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.42 ' CG1' HD11 ' A' ' 238' ' ' LEU . 16.5 t -120.08 133.08 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.089 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 234' ' ' TYR . 9.7 ptm180 -129.59 161.98 29.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.419 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 35.2 t-20 71.79 38.79 0.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.42 HD11 ' CG1' ' A' ' 235' ' ' VAL . 26.2 mt -96.71 126.95 42.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 14.6 mmt -59.0 131.92 52.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.477 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 53.5 mt -51.35 -38.16 51.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 29.8 t -59.03 -24.43 62.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.874 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.463 HG22 ' N ' ' A' ' 243' ' ' SER . 30.9 m -60.38 157.09 14.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.177 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.463 ' N ' HG22 ' A' ' 242' ' ' THR . 64.9 m -134.6 153.89 51.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.845 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -44.94 -50.62 10.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -43.91 -41.71 5.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 9.5 mtt -65.7 -38.14 88.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 72.0 mt -72.42 -34.08 47.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 24.5 tt0 -75.32 -48.5 22.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 14.3 ptmt -57.96 -48.07 81.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.97 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.474 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 26.1 mm-40 -62.34 -59.48 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -59.15 -23.83 62.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.448 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 6.8 m-20 -80.99 -37.63 28.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -45.12 -45.11 11.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 42.8 mm -50.72 -63.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -134.87 127.07 18.18 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.527 0.68 . . . . 0.0 110.943 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 125.35 12.07 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.672 2.248 . . . . 0.0 112.341 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 75.84 33.7 50.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.487 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -105.17 -45.33 4.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 51.5 t -69.24 118.65 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.75 -60.7 2.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -146.78 154.56 41.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 94.4 t -126.58 142.69 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -134.85 109.61 8.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -82.71 146.68 28.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.814 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.8 mt -135.44 172.19 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.092 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.652 ' H ' HG22 ' A' ' 265' ' ' ILE . 21.4 mmt85 -31.71 -72.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.82 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.73 15.41 7.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.814 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -142.27 176.72 8.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.13 166.91 16.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.113 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -130.6 144.26 51.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 18.3 t -129.85 117.26 40.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -93.4 154.75 17.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.475 ' HE1' HD12 ' A' ' 233' ' ' LEU . 45.6 m-85 -130.86 179.7 5.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 3.8 m -102.28 -23.09 14.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.845 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.476 ' CA ' ' HE2' ' A' ' 231' ' ' LYS . 3.5 m-20 -142.33 133.35 25.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.41 ' N ' ' CE ' ' A' ' 231' ' ' LYS . 6.0 ttp-105 -49.87 -46.58 51.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -46.99 -48.84 21.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.89 -57.63 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.426 ' HB1' HD21 ' A' ' 233' ' ' LEU . . . -48.59 -49.47 36.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.077 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 64.6 t -55.74 -52.98 42.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.137 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -57.81 -47.84 81.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.91 -26.69 68.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 9.6 tmm? -72.14 -50.13 30.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -70.38 -35.25 73.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -57.2 -57.96 10.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.108 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 47.9 mt -74.24 -32.81 63.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -41.93 99.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 109.3 29.9 3.8 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -109.14 161.19 15.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 0.0 110.873 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 71.8 t -123.59 93.87 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.105 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.606 HD12 HD13 ' A' ' 296' ' ' ILE . 31.8 mt -87.11 153.43 21.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 291' ' ' LEU . 3.9 p30 35.43 34.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 68.12 46.39 65.69 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.479 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 291' ' ' LEU . 5.6 t -155.07 133.65 7.16 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.651 0.738 . . . . 0.0 110.852 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.419 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.9 Cg_endo -69.75 101.27 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.682 2.254 . . . . 0.0 112.363 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.606 HD13 HD12 ' A' ' 291' ' ' LEU . 7.5 pt -89.44 145.37 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -120.92 137.64 54.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.52 122.26 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.072 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 69.5 p -140.46 163.35 33.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.4 mt -77.61 114.15 16.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.543 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -68.42 155.77 39.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.086 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 303' ' ' PRO . 0.6 OUTLIER -112.93 90.5 15.72 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.554 0.693 . . . . 0.0 110.919 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 302' ' ' LYS . 54.0 Cg_endo -69.72 133.11 24.85 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.696 2.264 . . . . 0.0 112.327 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.79 152.96 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.15 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -172.04 119.11 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.49 148.15 29.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -119.83 131.88 55.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.84 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 309' ' ' SER . 92.4 p -78.36 132.69 37.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 308' ' ' SER . 2.0 m -37.61 152.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 171.61 83.43 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.466 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 89.51 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.654 2.236 . . . . 0.0 112.312 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 38.4 t -101.78 142.89 32.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 94.4 p -98.18 149.1 22.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.454 -179.968 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 96.0 p -163.75 111.76 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 0.0 110.861 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 42.1 p -128.89 140.2 51.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.894 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 116.83 -149.79 18.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.533 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 67.9 m -118.72 145.54 45.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 0.0 110.81 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 69.1 p -84.9 -33.37 22.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.891 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 107.36 136.95 8.26 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.43 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.33 -58.82 1.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.779 0.323 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -46.78 121.67 3.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.923 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -57.65 89.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 4.1 p -124.68 110.14 14.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 2.8 ttt -82.34 -44.58 16.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 25.0 p -75.43 108.69 8.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.842 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 93.1 p -77.35 103.27 7.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.842 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.75 135.38 50.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.116 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.93 116.78 17.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.553 ' O ' HD23 ' A' ' 300' ' ' LEU . 19.7 mt -147.96 138.2 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.524 HD12 ' CE1' ' A' ' 273' ' ' PHE . 34.6 mt -123.85 110.63 15.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.62 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 52.9 t80 -92.56 127.76 38.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.577 HG11 HD21 ' A' ' 238' ' ' LEU . 51.5 t -110.39 139.88 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.087 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -135.34 162.97 31.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.412 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 35.0 t-20 67.56 47.45 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.577 HD21 HG11 ' A' ' 235' ' ' VAL . 64.9 mt -104.45 137.42 42.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.1 mmt -69.51 129.9 40.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 266' ' ' ARG . 27.5 mt -50.28 -35.63 28.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.0 t -63.39 -26.92 68.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 93.5 m -64.83 140.44 58.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.8 m -113.94 167.68 10.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.872 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 247' ' ' ILE . 5.4 mp0 -53.17 -50.08 65.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.857 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -41.27 -42.29 2.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 3.1 mmt -65.81 -34.62 78.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 244' ' ' GLU . 21.6 mt -75.58 -40.69 41.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -65.45 -45.21 84.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.496 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 2.3 ptmm? -64.93 -49.15 71.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.892 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.528 ' HG3' HD11 ' A' ' 291' ' ' LEU . 44.4 mm-40 -56.9 -35.09 68.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.463 ' CD2' HG11 ' A' ' 271' ' ' VAL . 5.4 m-85 -87.85 -21.5 24.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -88.83 -8.7 53.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -75.6 -18.22 59.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.642 ' H ' HD12 ' A' ' 254' ' ' ILE . 3.7 mp -85.28 -52.58 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -140.39 129.32 13.13 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.56 0.695 . . . . 0.0 110.877 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 123.27 9.93 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.695 2.263 . . . . 0.0 112.343 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 73.18 39.35 52.96 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -104.0 -43.44 5.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 111.112 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 251' ' ' PHE . 24.2 t -72.5 121.9 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -82.84 -58.65 2.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -145.56 151.67 38.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 97.9 t -126.11 135.43 63.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -127.25 106.04 8.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -79.56 146.24 32.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.752 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.9 mt -137.28 172.46 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.668 ' H ' HG22 ' A' ' 265' ' ' ILE . 30.5 mmt180 -30.77 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -127.0 20.2 6.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.752 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.3 OUTLIER -148.81 175.93 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.03 168.86 18.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.427 ' CD2' HD11 ' A' ' 265' ' ' ILE . 92.7 m-85 -130.57 137.81 49.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.463 HG11 ' CD2' ' A' ' 251' ' ' PHE . 18.0 t -127.56 122.69 59.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.134 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -98.85 155.72 17.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.524 ' CE1' HD12 ' A' ' 233' ' ' LEU . 16.2 m-85 -129.43 179.58 5.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.3 t -98.69 -19.05 17.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.809 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.449 ' OD1' ' CG ' ' A' ' 278' ' ' ASP . 47.2 p30 -154.25 142.1 20.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -51.0 -47.39 61.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -41.02 -65.31 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.449 ' CG ' ' OD1' ' A' ' 275' ' ' ASN . 72.1 m-20 -52.5 -50.2 63.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.23 -44.6 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.609 HG12 ' HE3' ' A' ' 284' ' ' LYS . 54.2 t -60.97 -47.82 91.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -59.82 -60.98 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -53.2 -28.08 24.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.111 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.486 ' O ' ' CB ' ' A' ' 287' ' ' ASN . 65.9 ttp -68.18 -54.39 18.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.609 ' HE3' HG12 ' A' ' 280' ' ' VAL . 6.4 mtmp? -78.86 -15.62 58.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.402 ' HB3' HG12 ' A' ' 254' ' ' ILE . . . -75.02 -29.95 60.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.527 HD11 ' O ' ' A' ' 250' ' ' GLU . 46.6 mt -111.95 -28.6 7.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.915 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 283' ' ' MET . 9.2 t-20 -55.99 106.12 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 114.26 4.57 22.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.464 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 289' ' ' LYS . 12.7 mptt -98.35 153.76 18.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 110.89 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 294' ' ' SER . 59.0 t -107.09 96.97 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.692 HD12 HD13 ' A' ' 296' ' ' ILE . 22.1 mt -83.64 146.62 28.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 292' ' ' ASP . 26.3 t70 36.3 40.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.839 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 65.19 44.56 93.71 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.477 ' N ' HG13 ' A' ' 290' ' ' VAL . 8.4 t -154.32 132.01 6.36 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.624 0.726 . . . . 0.0 110.886 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.412 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.6 Cg_endo -69.79 105.79 1.55 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.637 2.225 . . . . 0.0 112.348 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.692 HD13 HD12 ' A' ' 291' ' ' LEU . 19.3 pt -95.76 140.64 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -117.15 134.44 54.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.28 112.79 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.138 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 58.6 p -128.28 165.34 20.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 232' ' ' ILE . 16.7 mt -82.59 102.47 11.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -66.88 141.6 57.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -98.72 137.87 20.65 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.572 0.701 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 146.0 59.01 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.659 2.239 . . . . 0.0 112.332 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 305' ' ' ASP . 9.5 p -87.04 155.5 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.134 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.403 ' N ' HG22 ' A' ' 304' ' ' VAL . 25.4 t0 -41.68 111.87 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.882 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -147.89 111.5 5.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -125.24 116.29 21.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 24.7 p -72.68 162.01 30.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 2.1 t -90.54 56.87 3.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.842 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -115.43 83.47 0.34 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.537 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -36.63 10.42 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.678 2.252 . . . . 0.0 112.349 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 12.7 m -170.87 158.18 5.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 26.2 m -121.01 87.78 2.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.844 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.47 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 7.0 m -66.46 134.71 53.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 0.0 110.843 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 14.2 t -165.88 149.5 7.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.882 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -135.02 -132.12 3.13 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.472 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 19.1 t -152.22 139.71 19.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 110.867 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 6.7 t -78.03 -34.39 50.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.846 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 147.27 60.81 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.89 121.51 21.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.332 . . . . 0.0 110.837 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.73 114.1 27.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.47 157.76 26.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 50.7 p -77.01 129.63 36.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.189 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 19.7 ttp -65.35 -38.36 89.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 7.4 t -120.22 91.8 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.862 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.2 t -76.26 103.51 6.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.41 129.24 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.148 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -130.92 116.68 18.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.474 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 75.1 mt -147.91 132.89 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.107 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 232' ' ' ILE . 10.8 mt -117.17 109.28 16.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.535 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 24.3 t80 -91.67 132.71 36.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.26 140.53 41.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.123 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -137.63 166.71 23.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.833 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 38.5 t30 69.15 44.62 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 26.2 mt -101.52 154.34 18.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 4.4 mtt -83.38 133.96 34.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 266' ' ' ARG . 63.9 mt -56.53 -13.91 2.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.947 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 2.0 m -90.14 9.03 29.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 98.6 m -100.88 135.16 42.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 21.4 p -106.57 171.21 7.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -64.61 -18.67 65.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -69.52 -44.2 71.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.888 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 9.7 mtt -64.96 -39.05 92.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.872 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 35.8 mt -70.97 -40.04 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -68.0 -50.77 53.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 2.4 ptmm? -56.81 -47.35 80.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.499 ' O ' ' ND2' ' A' ' 253' ' ' ASN . 54.0 mm-40 -56.87 -65.55 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.623 ' CE1' HD13 ' A' ' 286' ' ' LEU . 8.0 m-85 -52.43 -22.48 4.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.886 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -79.84 -43.73 21.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.63 ' OD1' HD13 ' A' ' 254' ' ' ILE . 0.7 OUTLIER -46.82 -28.91 1.71 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.63 HD13 ' OD1' ' A' ' 253' ' ' ASN . 14.8 mm -74.8 -51.04 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.536 ' HG2' ' HB2' ' A' ' 258' ' ' ALA . 34.8 tptt -139.16 112.16 7.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.557 0.694 . . . . 0.0 110.9 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 125.93 12.7 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.685 2.256 . . . . 0.0 112.335 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 74.96 28.86 61.75 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.492 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.536 ' HB2' ' HG2' ' A' ' 255' ' ' LYS . . . -106.97 -48.03 3.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 111.093 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.3 131.63 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.159 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -89.78 -62.64 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -147.76 158.46 44.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.505 HG22 HG13 ' A' ' 271' ' ' VAL . 90.1 t -137.93 142.83 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.2 116.01 19.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -81.53 139.52 35.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.825 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.2 mt -129.13 172.41 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.151 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.669 ' H ' HG22 ' A' ' 265' ' ' ILE . 18.2 mmm180 -31.32 -75.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.63 19.45 8.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.825 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -146.79 174.9 11.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.81 167.37 18.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.111 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -126.67 151.09 48.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.53 HG11 ' CD2' ' A' ' 251' ' ' PHE . 15.1 t -138.03 117.46 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.074 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -94.76 158.15 15.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -133.45 178.69 6.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 85.7 p -95.45 -14.95 23.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.865 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -160.0 145.85 15.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 280' ' ' VAL . 18.4 ttt-85 -55.22 -41.69 72.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -45.67 -58.39 3.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -60.95 -46.44 90.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.58 -51.21 50.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.101 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 276' ' ' ARG . 66.2 t -58.53 -49.83 81.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.167 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -55.4 -57.3 12.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.66 -33.96 61.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.102 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 53.5 ttp -59.87 -68.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -61.29 -20.28 62.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -67.0 -56.97 7.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.623 HD13 ' CE1' ' A' ' 251' ' ' PHE . 26.4 mt -79.93 -30.37 39.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -40.55 112.3 0.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 95.4 32.3 7.07 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.471 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -109.74 158.94 17.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 83.1 t -118.79 96.26 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.12 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.728 HD12 HD13 ' A' ' 296' ' ' ILE . 38.0 mt -92.72 153.47 18.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 61.7 t0 40.96 28.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 72.97 41.46 48.48 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.446 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 291' ' ' LEU . 1.8 m -154.3 138.7 11.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.674 0.749 . . . . 0.0 110.908 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 105.99 1.58 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 0.0 112.381 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.728 HD13 HD12 ' A' ' 291' ' ' LEU . 9.8 pt -93.54 151.36 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -123.22 148.38 45.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 11.1 t -133.36 124.72 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.108 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 67.7 p -141.06 165.02 28.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 6.9 mt -81.48 106.63 13.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -71.24 139.81 50.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.106 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -75.68 137.54 70.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.577 0.704 . . . . 0.0 110.887 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 151.56 68.81 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.642 2.228 . . . . 0.0 112.323 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 304' ' ' VAL . 9.0 p -85.93 124.29 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.114 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -58.92 128.6 38.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.865 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.8 154.05 47.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -53.85 118.47 4.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 31.0 m -88.37 131.22 34.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.6 t -131.59 107.2 8.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -159.03 70.55 0.24 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.511 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 148.63 65.74 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.657 2.238 . . . . 0.0 112.397 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 4.8 t -96.72 140.79 30.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 92.2 p -131.63 131.43 43.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 -179.968 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 25.7 m -90.24 155.54 18.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 0.0 110.912 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.4 t -72.03 130.36 40.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 42.62 -153.18 0.2 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.488 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 27.1 t -144.32 148.59 34.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.86 0.362 . . . . 0.0 110.862 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 86.5 p -103.41 -34.81 8.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -112.54 100.5 1.13 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.455 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -129.35 98.15 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.813 0.34 . . . . 0.0 110.875 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.93 175.29 14.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -100.65 95.46 6.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 84.9 m -89.37 106.19 18.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.169 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 12.1 ptp -85.99 -8.04 58.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 19.6 m -106.57 79.94 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 97.5 p -56.71 103.01 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.09 131.33 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 279' ' ' ALA . 0.0 OUTLIER -129.56 116.83 19.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.485 ' O ' HD23 ' A' ' 300' ' ' LEU . 66.3 mt -148.07 138.82 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.139 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.734 HD12 ' CE1' ' A' ' 273' ' ' PHE . 76.8 mt -126.9 111.09 13.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.837 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 72.6 t80 -93.34 128.46 39.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.969 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 297' ' ' GLU . 16.8 t -112.02 129.06 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.112 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.461 ' HG3' ' N ' ' A' ' 237' ' ' ASN . 13.5 tpt180 -120.57 161.3 21.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.461 ' N ' ' HG3' ' A' ' 236' ' ' ARG . 7.0 t-20 74.87 35.22 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 42.2 mt -85.24 124.82 32.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.858 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 3.6 mmt -62.82 133.6 54.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 266' ' ' ARG . 58.2 mt -59.46 -12.74 6.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 20.7 m -98.2 15.56 24.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 38.8 m -102.62 129.88 49.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.133 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.0 m -97.16 145.86 25.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 247' ' ' ILE . 45.7 mt-10 -42.03 -48.29 4.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.886 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -42.14 -38.77 1.8 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 10.8 mtt -66.05 -39.56 90.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 244' ' ' GLU . 44.9 mt -72.64 -34.97 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.468 ' HG2' ' ND2' ' A' ' 252' ' ' ASN . 25.9 tt0 -73.75 -46.62 44.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 13.7 ptmt -60.54 -45.14 94.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.576 ' HG3' HD11 ' A' ' 291' ' ' LEU . 25.3 mm-40 -61.76 -58.26 8.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.789 ' CD2' HG11 ' A' ' 271' ' ' VAL . 7.6 m-85 -55.81 -46.42 78.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.468 ' ND2' ' HG2' ' A' ' 248' ' ' GLU . 79.6 m-20 -66.02 -23.42 66.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.845 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -51.98 -37.31 52.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 14.5 mm -65.71 -52.57 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -142.71 133.48 12.58 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.609 0.719 . . . . 0.0 110.885 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 137.78 36.21 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.257 . . . . 0.0 112.32 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.93 41.04 96.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.534 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -106.63 -45.62 4.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 111.11 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 76.5 t -68.26 126.24 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -83.3 -60.59 2.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -147.85 150.15 33.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.824 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 85.7 t -127.68 110.82 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.16 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -100.78 110.07 22.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -79.49 147.86 32.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.804 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.0 mt -137.1 172.11 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.103 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.66 ' H ' HG22 ' A' ' 265' ' ' ILE . 23.5 mmt180 -31.32 -71.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.45 ' OD1' ' C ' ' A' ' 266' ' ' ARG . 1.0 OUTLIER -127.86 16.52 6.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.804 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -143.59 176.32 9.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.42 158.33 13.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.061 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.485 ' CD2' HD11 ' A' ' 265' ' ' ILE . 98.3 m-85 -117.86 146.61 43.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.789 HG11 ' CD2' ' A' ' 251' ' ' PHE . 21.0 t -130.41 119.64 46.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -98.2 147.51 24.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.734 ' CE1' HD12 ' A' ' 233' ' ' LEU . 38.5 m-85 -126.15 171.74 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.4 ' C ' ' OD1' ' A' ' 275' ' ' ASN . 13.2 t -79.13 -41.58 28.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.403 ' O ' ' OD1' ' A' ' 278' ' ' ASP . 5.9 m-20 -135.48 170.25 16.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.902 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 280' ' ' VAL . 3.8 ttp85 -74.36 -36.05 63.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 278' ' ' ASP . 12.1 pt-20 -53.04 -52.5 58.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.433 ' N ' ' HG3' ' A' ' 277' ' ' GLU . 7.4 p-10 -70.07 -47.32 62.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.585 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -51.14 -49.67 60.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.122 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 276' ' ' ARG . 84.4 t -65.45 -52.93 45.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.093 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -47.19 -41.69 18.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.834 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.46 -40.05 77.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.0 ttp -50.37 -54.2 23.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -68.45 -42.1 79.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.883 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -51.18 -54.38 26.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.064 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.569 HD13 ' CE1' ' A' ' 251' ' ' PHE . 42.1 mt -78.4 -41.53 32.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 286' ' ' LEU . 9.5 t30 -35.99 109.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 98.15 34.26 5.44 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 38.3 mmtt -112.63 147.33 36.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 89.6 t -114.39 97.92 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.576 HD11 ' HG3' ' A' ' 250' ' ' GLU . 41.6 mt -96.06 153.72 17.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.2 t0 42.97 24.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 75.66 38.0 38.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 33.1 p -146.43 133.93 10.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.659 0.742 . . . . 0.0 110.877 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 92.78 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.476 HD13 HD12 ' A' ' 291' ' ' LEU . 6.9 pt -81.32 146.2 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.121 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.403 ' O ' HG13 ' A' ' 235' ' ' VAL . 27.3 tt0 -112.19 156.59 22.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 20.8 t -143.77 115.1 2.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.12 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 29.4 p -138.5 172.94 12.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 232' ' ' ILE . 6.8 mt -88.88 100.34 13.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.837 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -70.61 137.68 50.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.109 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -95.0 139.24 22.02 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.584 0.707 . . . . 0.0 110.921 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 164.24 35.22 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.679 2.253 . . . . 0.0 112.388 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 304' ' ' VAL . 35.1 m -85.71 121.33 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.122 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 304' ' ' VAL . 27.0 m-20 -36.15 114.21 0.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.837 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -147.83 109.59 4.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -105.83 135.89 46.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 8.5 t -72.8 136.65 45.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 14.9 t -135.81 113.82 11.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 165.12 148.32 5.44 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.447 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 169.01 19.89 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.658 2.239 . . . . 0.0 112.385 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 3.6 m -91.79 157.89 16.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.864 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 58.2 m -102.95 170.42 7.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.504 179.965 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 89.6 p -140.83 171.7 13.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.0 110.865 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 80.6 p -165.64 163.83 19.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.837 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -72.77 -173.28 23.31 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.437 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 29.6 t -89.73 117.55 28.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 110.82 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 7.2 t -119.47 -33.71 4.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.26 85.94 0.26 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.513 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -66.34 140.84 58.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.76 0.314 . . . . 0.0 110.887 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -104.89 163.66 12.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -64.91 114.07 4.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 63.8 p -96.04 113.11 24.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -54.39 -45.32 72.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.6 m -95.03 124.53 39.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.869 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 42.0 p -87.66 98.38 11.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.22 129.62 62.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.156 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' A' ' 276' ' ' ARG . 1.6 pttm -131.35 116.79 18.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 96.8 mt -147.92 142.32 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.149 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.766 HD12 ' CE1' ' A' ' 273' ' ' PHE . 92.3 mt -127.08 111.72 14.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.721 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 35.1 t80 -91.98 132.36 36.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.619 HG11 HD21 ' A' ' 238' ' ' LEU . 55.6 t -116.24 142.39 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.136 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -132.35 170.34 15.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 295' ' ' PRO . 28.1 t-20 62.31 49.21 4.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.619 HD21 HG11 ' A' ' 235' ' ' VAL . 39.4 mt -102.95 115.39 30.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.93 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 6.2 mtt -56.67 122.91 13.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 266' ' ' ARG . 38.6 mt -45.16 -33.12 2.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.939 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 13.3 t -63.22 -39.27 94.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.842 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 52.1 m -58.46 142.47 48.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.166 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 49.8 m -111.71 168.0 9.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.852 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.449 ' N ' ' OE1' ' A' ' 244' ' ' GLU . 1.2 mp0 -56.25 -46.87 79.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.911 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -43.31 -37.09 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.5 mmt -70.37 -45.03 66.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.856 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 48.9 mt -65.02 -40.18 88.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -67.51 -60.91 2.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 8.1 ptpt -45.85 -46.23 15.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.519 ' HA ' ' ND2' ' A' ' 253' ' ' ASN . 23.0 mm-40 -59.38 -69.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.486 ' CE1' HD13 ' A' ' 286' ' ' LEU . 16.1 m-85 -49.34 -24.19 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 253' ' ' ASN . 3.6 m-20 -73.3 -44.82 58.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 250' ' ' GLU . 29.2 m-20 -36.36 -49.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.913 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 45.2 mm -47.95 -62.43 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -139.51 135.02 16.63 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.539 0.685 . . . . 0.0 110.934 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 127.44 14.63 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.684 2.256 . . . . 0.0 112.386 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 67.23 38.89 92.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.52 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -104.04 -43.67 5.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 251' ' ' PHE . 21.7 t -72.62 112.57 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -70.55 -64.61 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 262' ' ' VAL . 0.5 OUTLIER -140.83 165.05 28.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' A' ' 261' ' ' ARG . 40.3 t -140.2 113.98 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -101.53 107.4 18.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -79.83 143.28 34.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.758 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.3 mt -133.97 172.41 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.663 ' H ' HG22 ' A' ' 265' ' ' ILE . 12.7 mmm180 -31.34 -73.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -125.36 18.8 8.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.758 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -148.03 177.75 9.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.72 174.05 9.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.116 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -130.69 143.6 50.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.483 HG11 ' CD2' ' A' ' 251' ' ' PHE . 70.0 t -127.07 123.03 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -102.47 155.42 18.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.766 ' CE1' HD12 ' A' ' 233' ' ' LEU . 37.8 m-85 -132.65 177.67 7.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.418 ' C ' ' HE3' ' A' ' 231' ' ' LYS . 78.8 p -89.11 -14.14 36.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.822 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.427 ' N ' ' HD2' ' A' ' 231' ' ' LYS . 11.1 p30 -162.03 147.19 12.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.473 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 27.5 ttt180 -55.25 -45.83 76.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.889 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -40.82 -56.29 2.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -63.78 -48.32 77.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.435 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -48.25 -45.52 34.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.2 -59.1 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -46.74 -43.91 18.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.0 -34.56 73.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 59.4 ttp -53.33 -66.4 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -62.61 -37.76 87.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -46.47 -55.85 6.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.06 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.486 HD13 ' CE1' ' A' ' 251' ' ' PHE . 46.7 mt -80.61 -36.61 32.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 286' ' ' LEU . 22.9 t-20 -36.88 103.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 104.91 31.33 4.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -111.79 156.65 21.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.836 0.35 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.09 96.36 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.139 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 1.047 HD12 HD13 ' A' ' 296' ' ' ILE . 32.2 mt -90.33 153.96 20.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 291' ' ' LEU . 7.7 t70 37.48 39.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.868 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 61.98 43.97 98.45 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.493 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 291' ' ' LEU . 1.8 m -152.42 138.26 11.6 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.661 0.743 . . . . 0.0 110.841 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.401 ' O ' ' OD1' ' A' ' 237' ' ' ASN . 53.4 Cg_endo -69.8 100.78 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 1.047 HD13 HD12 ' A' ' 291' ' ' LEU . 8.3 pt -93.62 145.46 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -117.79 157.27 26.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 6.3 t -146.05 121.77 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 82.6 p -144.05 175.27 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 232' ' ' ILE . 8.7 mt -87.11 102.6 14.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.954 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.721 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -66.27 138.61 57.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.072 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -96.04 117.41 66.32 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.613 0.72 . . . . 0.0 110.902 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 150.05 67.53 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.663 2.242 . . . . 0.0 112.39 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 90.1 t -109.09 125.92 66.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.08 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.86 163.71 29.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -94.94 120.09 34.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -87.75 130.6 34.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.84 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 72.9 m -89.24 111.6 22.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.852 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 17.1 m -70.92 121.4 18.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.873 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 122.61 -98.32 0.61 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.463 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 143.08 49.85 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.693 2.262 . . . . 0.0 112.365 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 18.4 m -114.86 -51.15 2.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 74.4 p -52.9 110.49 0.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.474 179.992 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.431 -0.268 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.4 t -168.02 134.12 1.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.389 . . . . 0.0 110.845 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 45.3 m -43.19 114.28 0.6 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.866 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -106.19 -93.0 2.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.494 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 77.7 p -136.96 120.15 16.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 110.9 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 57.8 m -88.07 -35.4 17.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.842 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 89.0 167.09 42.76 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.512 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.64 118.7 20.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.767 0.317 . . . . 0.0 110.877 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -173.87 154.89 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -125.75 79.38 1.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 88.6 m -134.72 125.72 27.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.187 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 17.7 tpp -65.34 -54.8 23.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 60.6 p -46.19 134.6 8.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 57.3 m -81.26 102.38 10.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.54 132.55 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.428 ' HD3' ' C ' ' A' ' 275' ' ' ASN . 0.1 OUTLIER -131.22 116.91 18.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.613 ' O ' HD23 ' A' ' 233' ' ' LEU . 55.0 mt -147.86 141.33 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.098 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 232' ' ' ILE . 15.4 mt -124.25 105.09 9.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.831 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 6.5 t80 -91.21 125.12 35.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.402 ' CG1' HD11 ' A' ' 238' ' ' LEU . 23.4 t -106.35 135.75 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 234' ' ' TYR . 21.8 ptt180 -128.66 170.88 12.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 62.84 43.46 7.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.402 HD11 ' CG1' ' A' ' 235' ' ' VAL . 15.3 mt -100.83 140.81 34.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.408 ' CE ' ' HB2' ' A' ' 294' ' ' SER . 20.3 mmt -80.14 141.07 36.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 266' ' ' ARG . 37.1 mt -53.72 -28.54 34.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.929 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.4 m -66.88 -25.31 66.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.923 HG23 ' SD ' ' A' ' 246' ' ' MET . 39.6 m -65.82 144.11 57.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.106 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.3 t -128.77 150.92 50.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.42 ' CG ' ' HB2' ' A' ' 264' ' ' LYS . 79.2 mt-10 -46.89 -20.82 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.861 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -66.7 -68.77 0.35 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.923 ' SD ' HG23 ' A' ' 242' ' ' THR . 20.2 ptm -53.12 -37.08 61.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 77.8 mt -61.44 -50.87 78.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.112 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -59.37 -64.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.486 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 13.9 pttt -39.47 -46.09 1.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.486 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 33.6 mm-40 -57.82 -51.81 68.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.862 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.866 ' CE2' HG21 ' A' ' 271' ' ' VAL . 4.8 m-85 -61.76 -56.12 22.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -54.32 -40.07 67.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -48.04 -31.35 5.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.548 HD12 ' HB1' ' A' ' 285' ' ' ALA . 29.2 mm -68.76 -54.24 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.157 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -142.27 120.3 7.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.58 0.705 . . . . 0.0 110.894 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 121.91 8.61 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.367 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 84.25 37.82 10.68 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -118.13 -43.84 2.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.336 . . . . 0.0 111.05 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 41.5 t -74.73 136.65 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.153 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.408 ' HB3' ' NH1' ' A' ' 261' ' ' ARG . 65.1 mm-40 -100.08 -62.02 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' ARG . . . . . 0.475 ' CD ' ' HB2' ' A' ' 272' ' ' HIS . 0.1 OUTLIER -143.67 153.59 42.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.9 t -122.65 147.35 26.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -136.18 110.74 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.919 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.42 ' HB2' ' CG ' ' A' ' 244' ' ' GLU . 11.0 tptm -87.58 144.8 26.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.815 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.7 mt -136.12 172.35 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.148 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.663 ' H ' HG22 ' A' ' 265' ' ' ILE . 18.9 mmt180 -31.55 -72.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.08 14.13 7.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.815 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -140.82 176.88 8.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.14 179.1 7.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.11 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.466 ' CE2' ' HB2' ' A' ' 234' ' ' TYR . 95.7 m-85 -144.29 148.94 35.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.866 HG21 ' CE2' ' A' ' 251' ' ' PHE . 3.1 t -135.54 123.12 36.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.141 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' HIS . . . . . 0.475 ' HB2' ' CD ' ' A' ' 261' ' ' ARG . 3.9 m-70 -97.8 150.74 20.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -126.92 176.87 6.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.895 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.8 t -97.52 -25.93 14.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.428 ' C ' ' HD3' ' A' ' 231' ' ' LYS . 7.6 m-80 -144.83 135.19 24.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 277' ' ' GLU . 14.0 ttt180 -45.53 -54.33 7.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 276' ' ' ARG . 62.9 mm-40 -37.01 -56.03 0.9 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.51 -47.89 83.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.94 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -54.86 -40.59 69.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.58 -42.99 90.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -65.39 -51.52 59.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.84 -38.72 79.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.075 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 47.4 ttp -52.23 -66.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.424 ' HA ' ' CB ' ' A' ' 287' ' ' ASN . 40.1 mtmt -58.79 -48.75 80.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.548 ' HB1' HD12 ' A' ' 254' ' ' ILE . . . -36.53 -52.65 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.684 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 73.4 mt -85.75 -29.24 24.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.424 ' CB ' ' HA ' ' A' ' 284' ' ' LYS . 19.1 t-20 -42.53 95.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 112.08 29.63 3.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.494 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -108.52 155.9 20.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.828 0.347 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 75.5 t -118.02 109.59 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.548 ' HB3' ' HE1' ' A' ' 246' ' ' MET . 26.9 mt -106.54 153.24 22.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 42.53 29.16 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 71.99 42.55 51.75 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.506 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.408 ' HB2' ' CE ' ' A' ' 239' ' ' MET . 10.9 t -153.78 140.03 12.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.626 0.727 . . . . 0.0 110.866 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 98.56 0.7 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.727 2.285 . . . . 0.0 112.306 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.488 HD13 HD12 ' A' ' 291' ' ' LEU . 8.1 pt -86.14 147.45 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.126 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -121.77 153.33 38.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.423 HG21 ' HB2' ' A' ' 286' ' ' LEU . 8.4 t -135.32 119.2 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.174 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 16.3 p -137.8 168.11 20.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 232' ' ' ILE . 11.1 mt -83.87 100.1 10.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.831 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -71.11 138.45 49.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.079 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 15.5 pttm -81.47 143.2 51.08 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.596 0.712 . . . . 0.0 110.891 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 168.5 21.44 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.745 2.297 . . . . 0.0 112.324 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.56 ' O ' HG23 ' A' ' 304' ' ' VAL . 34.9 m -90.5 115.57 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.129 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 304' ' ' VAL . 2.7 t70 -34.42 141.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 307' ' ' ASP . 49.4 tttt -172.76 117.04 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 306' ' ' LYS . 10.2 t0 -35.09 137.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 12.7 m -108.2 112.74 25.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.847 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.1 m -94.4 124.94 38.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.813 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -171.57 92.83 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.496 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 176.36 6.86 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.63 2.22 . . . . 0.0 112.382 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 9.0 t -135.16 167.88 20.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 41.2 p 42.66 42.44 2.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.857 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.456 -179.973 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 4.7 t -97.97 91.45 5.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.372 . . . . 0.0 110.838 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 4.3 m -123.65 136.45 54.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.838 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -111.97 88.41 0.5 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.507 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 70.3 m -77.86 85.33 4.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.889 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 52.5 m -107.56 23.17 14.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.83 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -134.61 79.04 0.33 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.522 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.18 111.33 14.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.743 0.306 . . . . 0.0 110.861 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -50.43 119.8 4.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -84.11 81.63 8.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 45.7 p -121.74 130.71 53.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 3.3 mmt -67.51 -42.16 83.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 68.1 m -82.1 88.94 6.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 56.9 m -62.51 98.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.809 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.1 132.39 60.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.131 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.42 ' HD2' ' N ' ' A' ' 275' ' ' ASN . 4.3 pttm -131.49 117.02 18.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.638 ' O ' HD23 ' A' ' 300' ' ' LEU . 92.2 mt -147.93 138.88 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.149 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.665 HD12 ' CE1' ' A' ' 273' ' ' PHE . 68.6 mt -122.8 108.93 13.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.686 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 14.3 t80 -92.37 124.22 36.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.98 143.29 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.123 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -134.6 165.62 24.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 72.16 39.97 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.7 mt -99.15 115.87 30.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.4 mtt -56.21 130.78 45.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.662 HD23 ' O ' ' A' ' 266' ' ' ARG . 46.1 mt -44.68 -39.05 4.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 30.9 m -56.98 -36.77 70.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 24.6 m -60.86 137.4 58.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.177 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.7 m -113.9 170.39 8.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.834 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 247' ' ' ILE . 25.8 mt-10 -53.68 -52.59 59.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -40.03 -47.83 2.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.4 mtt -60.24 -37.94 81.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 244' ' ' GLU . 55.7 mt -73.75 -36.43 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.11 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -70.66 -46.77 62.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.477 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 4.6 ptmm? -62.91 -47.98 80.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.917 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.484 ' OE1' HD21 ' A' ' 291' ' ' LEU . 25.8 mm-40 -56.08 -54.8 40.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.546 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 10.2 m-85 -63.28 -47.47 82.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -54.73 -46.9 74.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -38.1 -48.35 1.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.861 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.436 HD12 ' HB1' ' A' ' 285' ' ' ALA . 48.2 mm -48.35 -57.95 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.121 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -141.06 128.19 11.87 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.564 0.697 . . . . 0.0 110.902 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 120.19 7.01 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.717 2.278 . . . . 0.0 112.311 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 76.39 34.54 45.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.515 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -104.32 -34.23 8.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 0.0 111.102 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 74.4 t -80.75 149.04 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -106.42 -59.21 1.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' ARG . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 261' ' ' ARG . 4.8 ptp180 -151.73 155.62 38.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.879 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.21 152.28 37.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.106 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -140.78 109.79 6.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 11.4 tptp -79.68 141.76 36.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.764 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.5 mt -132.33 172.52 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.115 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.673 ' H ' HG22 ' A' ' 265' ' ' ILE . 13.9 mmm180 -31.39 -72.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 0.5 OUTLIER -126.8 17.26 7.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.764 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -145.14 176.13 9.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -165.87 158.95 15.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.135 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.449 ' CD2' HD11 ' A' ' 265' ' ' ILE . 96.8 m-85 -117.57 151.53 36.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 57.8 t -139.44 134.4 39.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.121 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -113.57 157.99 21.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.824 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.665 ' CE1' HD12 ' A' ' 233' ' ' LEU . 30.4 m-85 -132.86 173.37 11.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 43.4 t -81.49 -18.4 45.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.825 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.42 ' N ' ' HD2' ' A' ' 231' ' ' LYS . 5.2 m-80 -157.12 159.4 37.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -61.73 -48.31 81.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -48.21 -44.25 32.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -65.28 -51.42 60.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ALA . . . . . 0.547 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -56.04 -39.02 71.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.087 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.446 ' CG1' ' HE3' ' A' ' 284' ' ' LYS . 77.8 t -67.87 -47.94 77.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -59.08 -48.12 82.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.0 -34.82 76.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.2 ttp -60.38 -58.92 6.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.446 ' HE3' ' CG1' ' A' ' 280' ' ' VAL . 84.4 mttt -63.62 -28.35 69.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.436 ' HB1' HD12 ' A' ' 254' ' ' ILE . . . -65.42 -49.59 68.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.546 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 55.1 mt -85.21 -17.48 36.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.957 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -57.01 109.55 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 97.32 32.79 6.21 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.523 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -112.0 154.81 24.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.909 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 87.4 t -117.81 96.61 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.586 HD12 HD13 ' A' ' 296' ' ' ILE . 25.3 mt -92.73 152.0 19.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 41.77 25.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.21 43.52 25.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.499 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.1 t -154.75 137.62 10.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.692 0.758 . . . . 0.0 110.852 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 97.45 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.699 2.266 . . . . 0.0 112.329 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.586 HD13 HD12 ' A' ' 291' ' ' LEU . 7.9 pt -85.96 144.07 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.152 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -115.59 141.95 47.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' A' ' 286' ' ' LEU . 3.1 t -128.92 111.3 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 63.8 p -132.92 178.97 6.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 232' ' ' ILE . 10.2 mt -95.79 110.22 22.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.686 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -65.79 145.78 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.37 124.26 80.6 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.566 0.698 . . . . 0.0 110.916 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 144.79 54.77 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 0.0 112.329 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 8.2 p -84.11 131.36 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.142 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -117.01 160.46 20.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.812 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -147.68 150.7 34.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -38.06 99.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.904 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 83.6 p -84.32 126.22 32.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 61.5 p -58.59 -52.35 66.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.864 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 122.89 79.51 0.47 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.514 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -12.3 32.62 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.709 2.273 . . . . 0.0 112.315 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 90.1 p -40.79 161.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 29.5 m -41.4 136.25 1.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.506 179.987 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 10.6 t -155.25 107.35 2.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.852 0.358 . . . . 0.0 110.821 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 2.8 t -109.49 -59.28 1.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 116.95 -109.81 1.98 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.523 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 64.3 m -46.32 129.95 10.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.891 0.377 . . . . 0.0 110.868 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.2 t -95.66 -34.55 11.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -152.64 117.99 0.85 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.492 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -79.62 120.9 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.806 0.336 . . . . 0.0 110.837 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -62.57 139.58 58.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -119.8 104.31 10.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 31.0 p -90.51 171.9 9.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 45.2 mtt -64.13 -46.5 83.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 4.1 m -86.98 146.63 26.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 93.4 p -85.05 98.43 10.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.824 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.1 130.46 68.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.135 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.428 ' HD2' ' CA ' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -130.47 116.64 18.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.915 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.419 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 56.8 mt -147.9 125.19 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.177 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 16.1 mt -115.6 112.09 21.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.638 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 51.3 t80 -91.88 121.45 33.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.585 HG11 HD21 ' A' ' 238' ' ' LEU . 34.3 t -108.67 121.9 62.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.163 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.424 ' HB2' ' CE2' ' A' ' 234' ' ' TYR . 28.3 ttt180 -115.64 160.31 20.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.42 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 28.8 t-20 71.55 48.35 0.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.585 HD21 HG11 ' A' ' 235' ' ' VAL . 19.8 mt -102.08 124.32 47.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 8.0 mmt -60.17 141.5 55.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 266' ' ' ARG . 26.3 mt -65.55 -24.09 67.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 34.2 m -82.99 16.0 2.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 23.0 m -102.83 141.36 35.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.124 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 67.7 m -111.11 147.68 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -43.52 -46.75 7.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -39.88 -46.24 1.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 12.1 mtt -62.6 -43.45 98.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 59.2 mt -64.52 -36.76 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.143 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -68.49 -57.29 6.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.911 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 18.6 pttt -52.33 -46.86 66.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.51 ' O ' ' ND2' ' A' ' 253' ' ' ASN . 19.3 mm-40 -55.99 -51.29 68.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.889 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.489 ' CE2' HG21 ' A' ' 271' ' ' VAL . 8.2 m-85 -72.7 -20.3 61.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -90.65 -11.03 41.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 250' ' ' GLU . 16.9 p30 -72.47 -17.92 61.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.547 ' H ' HD12 ' A' ' 254' ' ' ILE . 4.9 mp -79.47 -55.9 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.108 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -143.56 125.66 8.5 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.538 0.685 . . . . 0.0 110.903 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 120.23 7.05 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 87.09 33.41 12.11 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.423 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -108.74 -54.95 2.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 111.081 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.57 142.42 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -102.94 -61.79 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -144.92 152.99 41.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.68 127.85 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -119.08 104.7 10.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.417 ' HZ3' HD13 ' A' ' 238' ' ' LEU . 9.9 tptp -79.4 145.14 33.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.759 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.3 mt -135.86 172.43 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.158 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.668 ' H ' HG22 ' A' ' 265' ' ' ILE . 39.9 mmm-85 -31.34 -74.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 8.4 p-10 -125.36 22.25 7.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.759 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.4 OUTLIER -151.52 177.01 10.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.9 171.37 14.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.093 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -135.58 134.51 39.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.891 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.489 HG21 ' CE2' ' A' ' 251' ' ' PHE . 39.4 t -120.16 129.82 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -104.85 155.34 19.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.412 ' C ' ' HG3' ' A' ' 231' ' ' LYS . 43.7 m-85 -136.41 -176.02 4.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.924 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 30.8 t -88.89 -31.86 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.428 ' CA ' ' HD2' ' A' ' 231' ' ' LYS . 2.7 m120 -152.17 144.65 24.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.988 ' O ' HG23 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -50.07 -29.46 8.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -54.42 -62.7 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -59.77 -39.11 83.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -64.11 -35.89 82.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.102 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.988 HG23 ' O ' ' A' ' 276' ' ' ARG . 97.2 t -68.55 -39.59 80.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.194 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -68.46 -51.4 43.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.7 -40.48 72.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.09 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.1 ttp -60.8 -45.78 93.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -75.02 -19.26 60.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -78.39 -39.15 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 41.3 mt -95.82 -21.27 18.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -48.67 96.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 113.79 30.84 2.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.444 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -107.48 160.16 15.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.809 0.338 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 58.6 t -123.46 107.92 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.107 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.428 HD11 ' HG3' ' A' ' 250' ' ' GLU . 34.7 mt -102.86 153.25 20.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 41.83 26.62 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.76 38.52 49.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.476 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 291' ' ' LEU . 23.7 p -146.4 137.39 12.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.687 0.756 . . . . 0.0 110.833 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.42 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.5 Cg_endo -69.8 101.79 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.718 2.279 . . . . 0.0 112.323 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 12.0 pt -90.65 147.75 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.36 133.42 52.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 28.2 t -115.36 116.77 53.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.111 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 28.7 p -131.16 169.23 16.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 10.9 mt -88.71 99.98 12.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.638 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -68.98 137.49 53.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -88.63 143.57 32.18 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.546 0.688 . . . . 0.0 110.913 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 141.78 46.29 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.679 2.252 . . . . 0.0 112.338 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 304' ' ' VAL . 34.9 m -93.02 127.21 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.101 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -88.04 96.14 10.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -145.91 120.58 9.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.8 t70 57.65 41.69 25.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 15.0 t -61.56 108.23 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 37.9 t 38.2 42.37 0.49 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -70.42 -67.05 2.01 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.525 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 120.63 7.39 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.718 2.279 . . . . 0.0 112.353 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 18.0 t -53.0 130.38 33.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.882 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 1.3 t -135.21 128.08 31.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.836 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.488 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 61.6 p -139.76 111.3 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 51.6 p -65.02 163.86 13.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.887 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -95.15 124.23 7.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.493 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 4.6 m -109.77 119.05 38.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.372 . . . . 0.0 110.864 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -76.4 -35.02 58.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.881 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 132.93 96.39 0.61 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.477 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -74.86 -64.44 1.04 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 110.866 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 46.37 41.07 8.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.907 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -111.83 81.84 1.52 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 43.0 p -121.62 116.48 24.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -49.12 -47.15 45.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 83.6 p -109.33 119.19 38.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 79.3 p -59.73 104.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.852 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.5 p -110.8 137.91 41.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.164 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -135.14 116.88 15.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.488 ' O ' HD23 ' A' ' 233' ' ' LEU . 36.0 mt -147.98 136.55 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.121 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 232' ' ' ILE . 11.5 mt -120.64 108.11 13.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.786 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 17.9 t80 -91.18 129.04 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.2 135.76 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.128 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -129.26 163.04 26.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.834 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 70.91 48.07 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 21.2 mt -103.28 123.09 46.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.1 mmt -60.88 123.33 17.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 266' ' ' ARG . 38.1 mt -45.73 -29.03 1.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 9.9 t -65.21 -37.6 87.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.449 HG22 ' N ' ' A' ' 243' ' ' SER . 35.1 m -58.82 156.35 11.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.127 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.449 ' N ' HG22 ' A' ' 242' ' ' THR . 58.3 m -128.8 167.9 16.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 247' ' ' ILE . 7.5 mp0 -54.42 -54.26 43.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 244' ' ' GLU . 41.6 tp10 -37.95 -39.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 5.8 mtt -71.18 -40.39 71.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 244' ' ' GLU . 44.3 mt -68.05 -40.46 83.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.122 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 18.8 tt0 -70.27 -56.23 7.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 0.0 OUTLIER -49.21 -46.55 45.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.904 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.485 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 39.2 mm-40 -60.74 -51.35 69.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 5.3 m-85 -65.86 -25.46 67.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 22.6 m120 -70.06 -46.47 64.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.868 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 252' ' ' ASN . 74.8 m-20 -36.2 -41.87 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 26.0 mm -56.44 -63.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.489 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 4.2 tppt? -141.89 136.42 15.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.6 0.714 . . . . 0.0 110.898 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.489 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 53.6 Cg_endo -69.78 132.56 23.55 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.715 2.277 . . . . 0.0 112.326 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 61.83 37.02 93.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.52 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 255' ' ' LYS . . . -99.16 -43.72 6.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.838 0.351 . . . . 0.0 111.162 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.416 HG11 ' CG2' ' A' ' 262' ' ' VAL . 96.6 t -70.14 118.33 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.108 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -78.53 -57.58 3.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -144.14 149.45 36.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.425 HG22 HG13 ' A' ' 271' ' ' VAL . 69.0 t -133.13 111.57 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.125 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -107.32 117.63 34.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -86.53 142.19 28.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.8 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.5 mt -131.12 172.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.685 ' H ' HG22 ' A' ' 265' ' ' ILE . 70.9 mtm-85 -30.1 -73.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.82 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.48 0.15 8.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.8 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -124.25 176.47 6.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -160.52 172.99 16.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.18 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.558 ' CE2' HD11 ' A' ' 265' ' ' ILE . 68.1 m-85 -136.37 135.4 38.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.544 HG11 ' CD2' ' A' ' 251' ' ' PHE . 8.1 t -130.16 126.08 61.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -103.36 159.3 15.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.415 ' HE1' HD12 ' A' ' 233' ' ' LEU . 34.9 m-85 -133.53 168.18 19.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.826 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.1 t -75.72 -39.2 57.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 275' ' ' ASN . 4.6 p-10 -139.58 149.07 43.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.938 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' A' ' 277' ' ' GLU . 15.2 ttt180 -51.35 -55.14 20.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.848 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 276' ' ' ARG . 5.8 mp0 -35.12 -60.28 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -55.75 -52.53 63.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -48.28 -45.62 34.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.094 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.613 HG12 ' HE2' ' A' ' 284' ' ' LYS . 86.6 t -59.21 -51.83 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.25 -54.1 41.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.89 -30.86 68.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' MET . . . . . 0.445 ' O ' ' CB ' ' A' ' 287' ' ' ASN . 66.0 ttp -65.78 -57.33 8.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.613 ' HE2' HG12 ' A' ' 280' ' ' VAL . 42.8 mtmt -68.78 -32.68 72.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -62.08 -56.51 18.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.084 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.633 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 35.0 mt -76.17 -35.83 58.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 283' ' ' MET . 6.1 t-20 -41.81 106.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 100.59 37.5 3.72 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.473 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -114.17 153.19 30.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.856 0.36 . . . . 0.0 110.893 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 81.9 t -117.93 94.51 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.144 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.455 HD12 HD13 ' A' ' 296' ' ' ILE . 37.9 mt -94.46 153.59 17.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 41.88 25.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.84 38.51 36.16 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.542 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 291' ' ' LEU . 31.8 p -146.34 133.12 9.89 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.661 0.744 . . . . 0.0 110.821 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 86.19 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.687 2.258 . . . . 0.0 112.333 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.455 HD13 HD12 ' A' ' 291' ' ' LEU . 6.9 pt -72.95 149.63 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.141 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -118.82 156.43 29.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 20.2 t -143.6 118.51 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 60.6 p -143.55 162.79 34.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.187 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 9.3 mt -77.39 100.05 5.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.786 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -67.66 112.86 5.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.077 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -80.5 137.83 51.6 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.621 0.724 . . . . 0.0 110.923 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 143.1 49.89 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.729 2.286 . . . . 0.0 112.366 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 92.1 t -104.61 108.41 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.145 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -163.62 151.64 13.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -95.28 166.43 11.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -114.93 130.41 56.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.862 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.3 t -88.79 137.45 32.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.837 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 5.7 t -92.36 135.3 34.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.849 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 135.26 92.28 0.39 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.488 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -9.09 25.25 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.635 2.223 . . . . 0.0 112.334 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 2.4 m -134.02 161.06 35.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 15.2 m -39.15 159.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.81 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 179.967 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 23.0 m -152.01 130.44 12.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.844 0.354 . . . . 0.0 110.834 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 41.2 t -127.24 155.21 43.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -132.14 -117.06 1.82 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 76.0 p -72.33 166.97 21.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.89 0.376 . . . . 0.0 110.857 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 55.4 m -110.49 -35.01 6.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.845 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -128.97 122.2 3.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.529 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -143.44 157.54 44.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 110.854 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -64.12 138.67 58.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.86 109.17 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 25.4 p -58.94 163.32 3.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 7.5 mtt -97.19 -53.94 3.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 56.7 m -40.93 125.12 2.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 96.0 p -74.12 100.84 3.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.473 ' O ' ' CD ' ' A' ' 276' ' ' ARG . 0.9 OUTLIER -119.68 139.8 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.123 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.452 ' HD3' ' N ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -133.56 116.73 16.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.4 mt -147.94 132.35 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.106 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 12.2 mt -115.48 109.13 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.888 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.538 ' CE2' ' HB3' ' A' ' 236' ' ' ARG . 12.9 t80 -91.49 134.12 34.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.42 HG11 HD21 ' A' ' 238' ' ' LEU . 22.7 t -120.91 131.07 73.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.18 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.538 ' HB3' ' CE2' ' A' ' 234' ' ' TYR . 14.6 ptt180 -123.47 163.39 20.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.4 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 38.6 t-20 69.84 50.79 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.439 HD12 ' CA ' ' A' ' 268' ' ' TYR . 11.8 mt -108.52 121.54 45.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.944 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 24.2 mtt -60.2 134.86 57.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 266' ' ' ARG . 19.5 mt -53.94 -26.84 27.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 64.0 p -65.03 -40.31 94.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' THR . . . . . 0.441 ' O ' ' NZ ' ' A' ' 264' ' ' LYS . 52.1 m -59.46 147.9 34.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 59.5 m -121.17 164.19 17.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 247' ' ' ILE . 35.2 mt-10 -52.95 -54.38 35.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 244' ' ' GLU . 27.3 tt0 -36.81 -43.42 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.427 ' HA ' ' NZ ' ' A' ' 249' ' ' LYS . 9.5 mtp -63.63 -45.93 88.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 244' ' ' GLU . 28.4 mt -64.07 -29.39 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.149 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -71.27 -54.4 11.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 4.4 ptpp? -58.29 -41.82 85.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 17.4 mm-40 -61.94 -54.0 47.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.516 ' CE1' HD13 ' A' ' 286' ' ' LEU . 6.8 m-85 -68.21 -28.27 67.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.879 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ASN . . . . . 0.445 ' OD1' HG21 ' A' ' 259' ' ' VAL . 4.6 m-20 -81.76 -23.9 36.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -59.97 -31.44 69.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.628 HD12 ' HB1' ' A' ' 285' ' ' ALA . 13.2 mm -66.44 -56.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.146 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -142.84 131.88 11.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.549 0.69 . . . . 0.0 110.934 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 133.65 26.07 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.717 2.278 . . . . 0.0 112.306 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 65.61 39.83 95.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.475 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -110.72 -27.04 9.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.756 0.312 . . . . 0.0 111.048 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.445 HG21 ' OD1' ' A' ' 252' ' ' ASN . 75.8 t -91.77 128.75 43.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.134 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -89.23 -54.66 4.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 30.5 ptt85 -151.11 150.74 31.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.87 138.44 54.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 33.4 tttp -132.95 115.96 15.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' LYS . . . . . 0.441 ' NZ ' ' O ' ' A' ' 242' ' ' THR . 17.0 tptm -86.48 146.73 26.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.82 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.7 mt -134.28 172.08 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.142 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.66 ' H ' HG22 ' A' ' 265' ' ' ILE . 21.7 mmm180 -31.96 -72.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -125.82 15.71 8.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.82 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -143.33 177.75 8.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.95 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -165.14 167.05 18.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.062 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.514 ' CD2' HD11 ' A' ' 265' ' ' ILE . 89.9 m-85 -130.6 143.68 50.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 40.5 t -135.11 126.61 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -102.24 153.89 19.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -125.83 -177.66 4.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.0 t -91.89 -31.62 15.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.869 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -144.51 156.51 44.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.473 ' CD ' ' O ' ' A' ' 230' ' ' VAL . 1.5 tpp85 -52.62 -67.06 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 276' ' ' ARG . 67.7 mm-40 -35.6 -57.84 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -47.93 -52.23 20.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -58.98 -46.67 87.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.99 -48.49 84.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.113 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.44 -53.51 57.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.63 -31.97 71.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 58.2 ttp -59.59 -53.96 51.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 285' ' ' ALA . 85.5 mttt -68.68 -53.23 23.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.628 ' HB1' HD12 ' A' ' 254' ' ' ILE . . . -36.55 -43.53 0.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.106 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.516 HD13 ' CE1' ' A' ' 251' ' ' PHE . 49.0 mt -90.56 -39.95 12.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.859 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 286' ' ' LEU . 20.7 t-20 -36.3 113.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 93.28 33.62 7.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.476 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -109.95 160.79 16.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 25.3 t -122.42 101.73 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.074 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.82 HD12 HD13 ' A' ' 296' ' ' ILE . 29.8 mt -99.1 154.2 18.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.8 p30 39.59 28.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 71.98 40.85 56.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.486 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 291' ' ' LEU . 1.9 m -149.23 137.5 11.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.681 0.753 . . . . 0.0 110.877 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.4 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.8 Cg_endo -69.81 99.19 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.82 HD13 HD12 ' A' ' 291' ' ' LEU . 7.2 pt -90.69 147.85 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -118.62 155.89 30.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.1 119.54 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.169 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 80.4 p -139.85 174.63 10.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.83 118.28 26.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.46 151.69 39.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -105.23 121.55 45.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.586 0.708 . . . . 0.0 110.86 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 142.08 46.83 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.715 2.277 . . . . 0.0 112.325 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 304' ' ' VAL . 8.9 p -87.68 127.46 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.127 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -142.03 123.48 14.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -76.9 167.69 21.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.938 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 27.6 t70 44.63 39.09 3.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 3.6 m -79.29 145.54 33.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 33.2 t -120.17 138.24 53.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.817 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -119.48 67.6 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.507 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 158.26 57.7 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.69 2.26 . . . . 0.0 112.37 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 2.3 t -123.64 113.47 18.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 34.3 t -90.53 142.59 27.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.863 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.522 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 218' ' ' SER . 67.4 m -118.8 -178.99 3.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 110.829 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 217' ' ' SER . 55.5 p 34.73 43.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 106.23 -173.74 19.95 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.481 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 5.4 m -88.79 149.38 23.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 110.889 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.7 t -103.59 -35.13 8.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.855 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -116.68 172.64 14.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.497 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -111.07 84.77 1.99 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.761 0.315 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -129.8 93.84 3.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -82.4 106.79 14.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 22.0 m -81.61 116.02 21.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 13.4 ttm -61.25 -47.67 84.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.887 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 1.2 t -75.53 129.16 36.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.8 m -71.4 98.41 1.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.893 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.457 ' O ' ' CD ' ' A' ' 276' ' ' ARG . 1.1 p -121.72 132.72 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.147 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 116.9 18.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.626 ' O ' HD23 ' A' ' 300' ' ' LEU . 69.9 mt -147.92 151.23 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.166 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.799 HD12 ' CE1' ' A' ' 273' ' ' PHE . 85.9 mt -136.8 110.12 7.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.558 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 23.9 t80 -91.18 129.42 37.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.1 126.96 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.11 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.538 ' HB3' ' CE2' ' A' ' 234' ' ' TYR . 23.6 ptt85 -120.17 169.72 9.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 63.94 47.77 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 64.3 mt -104.43 131.93 51.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.494 ' CB ' ' OD2' ' A' ' 292' ' ' ASP . 8.7 mmt -71.25 132.09 44.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 266' ' ' ARG . 62.8 mt -50.27 -29.11 8.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.951 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 72.7 m -63.71 -33.26 75.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.86 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 87.4 m -66.5 138.04 57.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.103 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.2 m -117.77 164.77 14.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.825 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 245' ' ' GLU . 17.4 mt-10 -44.49 -60.47 1.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 244' ' ' GLU . 30.7 tt0 -34.86 -62.23 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 25.9 mmm -40.33 -56.96 1.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 250' ' ' GLU . 36.8 mt -62.94 -65.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -39.55 -34.4 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.835 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -77.99 -38.94 43.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 247' ' ' ILE . 21.4 mm-40 -66.08 -48.5 70.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.465 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 15.1 m-85 -67.24 -42.13 84.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -61.88 -40.67 96.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -42.74 -42.17 3.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 31.9 mm -55.64 -58.7 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.427 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 10.6 tppt? -142.82 135.03 13.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.585 0.707 . . . . 0.0 110.889 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.427 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 54.3 Cg_endo -69.73 133.64 26.1 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.673 2.249 . . . . 0.0 112.354 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 65.9 39.02 94.8 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.507 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -103.33 -55.23 2.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.855 0.36 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 251' ' ' PHE . 58.0 t -69.6 114.98 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.085 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -74.2 -55.97 5.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -150.61 144.22 25.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.2 t -121.84 119.41 58.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -105.77 108.87 20.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -79.42 143.44 35.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.737 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.7 mt -135.66 172.8 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.117 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.676 ' H ' HG22 ' A' ' 265' ' ' ILE . 21.1 mmt180 -30.17 -72.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 4.4 p-10 -128.29 20.35 6.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' TYR . . . . . 0.737 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -148.37 173.08 13.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -160.92 163.09 32.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.471 ' CD2' HD11 ' A' ' 265' ' ' ILE . 92.6 m-85 -122.81 136.42 54.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.868 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.456 HG13 HG13 ' A' ' 259' ' ' VAL . 42.3 t -123.13 129.04 75.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.098 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -102.43 159.21 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.799 ' CE1' HD12 ' A' ' 233' ' ' LEU . 29.7 m-85 -137.19 -178.62 5.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.7 m -98.65 -28.28 13.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.841 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -145.95 147.68 31.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.891 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.579 HH21 HD22 ' A' ' 300' ' ' LEU . 1.3 tpt180 -50.52 -61.72 2.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 276' ' ' ARG . 27.8 mt-10 -36.62 -50.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.83 -57.83 10.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -54.83 -37.6 66.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.701 HG12 ' HE2' ' A' ' 284' ' ' LYS . 76.7 t -65.77 -47.26 86.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.171 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.21 -50.4 73.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.26 -26.2 68.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.081 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.0 ttp -64.01 -67.64 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.701 ' HE2' HG12 ' A' ' 280' ' ' VAL . 26.7 mtmt -59.79 -29.29 68.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -56.31 -55.67 30.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.085 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.465 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 60.7 mt -81.54 -30.64 33.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -40.31 104.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 105.52 20.54 9.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -97.48 154.9 17.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.339 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 98.3 t -122.09 98.17 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.104 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.402 HD12 HD13 ' A' ' 296' ' ' ILE . 32.1 mt -94.57 153.69 17.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.494 ' OD2' ' CB ' ' A' ' 239' ' ' MET . 25.0 t0 42.33 26.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.33 38.21 53.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.484 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 291' ' ' LEU . 22.4 p -146.34 134.04 10.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.63 0.729 . . . . 0.0 110.856 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 102.35 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 2.237 . . . . 0.0 112.38 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.402 HD13 HD12 ' A' ' 291' ' ' LEU . 11.4 pt -89.49 148.22 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -121.87 136.1 54.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.4 t -119.09 121.92 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.124 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 68.4 p -139.73 168.34 20.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.112 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 232' ' ' ILE . 11.7 mt -86.92 101.89 13.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -64.25 161.63 16.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.061 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' LYS . . . . . 0.409 ' C ' ' HD2' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -99.52 142.21 24.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.569 0.699 . . . . 0.0 110.889 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 141.65 46.01 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.647 2.231 . . . . 0.0 112.38 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 13.2 p -79.99 140.79 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.163 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -119.82 174.12 6.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.875 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -168.62 124.05 0.94 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -66.22 80.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 4.7 t -97.0 142.6 28.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 14.1 m -113.12 117.24 31.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -129.14 147.05 17.56 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.519 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 112.75 3.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.635 2.223 . . . . 0.0 112.355 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 62.2 m -114.51 103.71 11.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 79.8 p -75.7 150.0 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.812 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.486 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.7 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.898 0.38 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.7 p -122.48 132.99 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.51 116.85 18.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.503 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 63.2 mt -147.9 145.32 18.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.766 HD12 ' HE1' ' A' ' 273' ' ' PHE . 88.4 mt -133.26 109.21 9.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -91.71 133.28 35.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 23.1 t -114.58 137.44 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.106 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.0 ttp85 -129.78 156.13 44.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 73.83 44.28 0.28 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 25.0 mt -93.69 131.61 38.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 10.6 mmt -67.16 123.3 19.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 266' ' ' ARG . 26.0 mt -48.27 -32.01 6.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 9.5 t -66.72 -35.75 80.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 39.2 m -59.62 141.72 54.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.135 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.3 m -110.61 166.15 11.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 247' ' ' ILE . 29.7 mt-10 -52.27 -52.03 55.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -41.49 -43.52 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 21.2 mmm -63.99 -36.25 83.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 244' ' ' GLU . 43.0 mt -74.8 -38.31 44.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.123 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -71.13 -43.97 66.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 16.4 ptmt -63.89 -47.88 78.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.489 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 31.7 mm-40 -58.29 -46.95 85.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -72.57 -34.05 67.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.926 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -69.03 -32.22 71.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -47.02 -29.98 2.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 25.0 mm -68.2 -53.28 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -143.78 137.31 14.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.554 0.692 . . . . 0.0 110.936 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 126.24 13.11 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.682 2.255 . . . . 0.0 112.388 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 60.9 39.5 97.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.512 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -101.08 -45.13 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.24 109.93 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.14 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -61.37 -57.68 11.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . 0.4 ' HB3' ' NH1' ' A' ' 261' ' ' ARG . 1.1 ptp180 -153.34 158.05 40.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 91.1 t -132.41 115.89 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -110.31 106.95 16.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . 0.424 ' HD3' ' CD1' ' A' ' 247' ' ' ILE . 14.7 tptm -79.51 148.56 31.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.787 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.1 mt -137.36 172.19 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.161 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.661 ' H ' HG22 ' A' ' 265' ' ' ILE . 20.1 mmt180 -31.86 -70.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.29 17.76 6.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.787 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -146.08 177.93 8.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -170.14 165.02 9.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.109 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -127.59 142.18 51.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.38 123.44 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.143 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -99.96 157.59 16.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.766 ' HE1' HD12 ' A' ' 233' ' ' LEU . 41.3 m-85 -135.0 170.83 15.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.4 t -84.3 -34.24 23.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -138.67 144.66 39.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.662 ' O ' HG23 ' A' ' 280' ' ' VAL . 26.4 ttt180 -55.07 -42.51 72.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -46.49 -55.26 7.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -60.32 -51.31 70.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -51.17 -42.48 60.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 276' ' ' ARG . 91.8 t -61.54 -48.57 88.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.13 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -58.33 -55.58 33.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.69 -26.72 64.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.078 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 51.2 ttp -65.5 -60.24 3.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 285' ' ' ALA . 6.1 mtmp? -65.26 -55.21 19.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.907 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 284' ' ' LYS . . . -36.4 -47.85 0.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.091 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 287' ' ' ASN . 34.3 mt -84.46 -39.71 18.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.9 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 286' ' ' LEU . 31.9 t30 -37.1 104.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 98.97 38.24 3.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.478 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -114.35 159.17 20.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.786 0.327 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 98.8 t -121.51 97.4 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.127 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.86 HD12 HD13 ' A' ' 296' ' ' ILE . 60.4 mt -92.99 153.15 18.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 291' ' ' LEU . 23.7 m-20 37.73 28.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.828 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 74.0 44.61 29.54 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.493 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 291' ' ' LEU . 8.2 t -155.02 134.7 7.96 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.669 0.747 . . . . 0.0 110.81 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 102.08 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.367 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.86 HD13 HD12 ' A' ' 291' ' ' LEU . 7.8 pt -93.89 144.37 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -116.66 154.71 30.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.8 t -141.26 119.4 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.162 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 76.9 p -137.88 169.44 17.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.151 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 232' ' ' ILE . 8.0 mt -83.78 108.49 16.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.503 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -66.1 140.75 58.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.625 0.726 . . . . 0.0 110.882 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.914 0.387 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.93 134.85 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.2 116.58 17.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.54 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 37.6 mt -147.89 131.98 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 232' ' ' ILE . 15.7 mt -117.46 111.16 18.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.538 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 21.6 t80 -91.31 122.53 34.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.968 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.537 HG11 HD21 ' A' ' 238' ' ' LEU . 21.9 t -102.23 128.87 54.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.116 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 15.9 ttp85 -122.4 160.5 25.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.463 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 32.8 t-20 65.8 53.32 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.537 HD21 HG11 ' A' ' 235' ' ' VAL . 89.6 mt -106.16 131.31 53.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.9 mmt -66.33 136.99 56.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 266' ' ' ARG . 72.3 mt -56.4 -24.2 43.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 11.4 t -75.1 -26.4 59.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.429 ' HB ' ' NZ ' ' A' ' 264' ' ' LYS . 49.3 m -68.15 139.48 56.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.1 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.0 m -115.36 170.46 8.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.857 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 247' ' ' ILE . 48.8 mt-10 -50.95 -54.22 26.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -40.85 -48.06 3.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 2.9 mmt -55.98 -36.13 67.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 244' ' ' GLU . 40.6 mt -78.55 -46.72 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.115 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -60.22 -37.5 80.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 5.8 ptmt -73.47 -47.2 43.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.481 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 49.6 mm-40 -65.19 -22.78 66.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.613 ' CE1' HD13 ' A' ' 286' ' ' LEU . 7.3 m-85 -94.51 -26.32 16.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.44 ' OD1' ' CG2' ' A' ' 259' ' ' VAL . 78.6 m-20 -84.66 -18.99 33.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -59.6 -23.3 62.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 13.7 mm -75.7 -56.03 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -139.52 134.61 16.41 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.524 0.678 . . . . 0.0 110.923 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 138.09 37.09 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.679 2.253 . . . . 0.0 112.359 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 56.08 41.09 84.82 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -105.07 -53.06 2.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 111.073 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.44 ' CG2' ' OD1' ' A' ' 252' ' ' ASN . 96.9 t -61.15 114.61 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.154 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -72.02 -62.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.926 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -149.07 151.45 34.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.498 HG22 HG13 ' A' ' 271' ' ' VAL . 58.0 t -128.86 151.71 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -141.47 116.2 9.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . 0.429 ' NZ ' ' HB ' ' A' ' 242' ' ' THR . 30.1 tptt -84.88 145.94 27.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.773 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.3 mt -133.88 172.18 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.655 ' H ' HG22 ' A' ' 265' ' ' ILE . 14.4 mmm180 -31.51 -72.04 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -126.88 19.13 7.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.773 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -148.4 177.85 9.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -163.98 170.55 16.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -133.35 146.24 51.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.498 HG13 HG22 ' A' ' 262' ' ' VAL . 16.6 t -133.55 134.2 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.136 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -112.41 152.34 28.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -129.2 -177.82 4.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 41.8 t -95.45 -22.01 17.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.45 151.4 31.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.575 ' O ' HG23 ' A' ' 280' ' ' VAL . 16.2 ttt180 -62.44 -37.39 85.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -48.24 -63.49 1.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.92 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -44.88 94.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.847 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.98 -47.15 61.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 276' ' ' ARG . 85.9 t -63.87 -42.67 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -60.87 -49.26 78.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.829 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.0 -29.93 71.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.125 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 53.6 ttp -70.42 -50.37 39.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -69.97 -30.09 67.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.59 -45.1 84.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.613 HD13 ' CE1' ' A' ' 251' ' ' PHE . 41.5 mt -87.28 -27.6 22.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . 0.436 ' OD1' ' C ' ' A' ' 287' ' ' ASN . 23.4 t-20 -48.8 108.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 97.62 33.74 5.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.505 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -113.95 151.13 32.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.932 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 86.3 t -110.05 103.47 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.162 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 1.018 HD12 HD13 ' A' ' 296' ' ' ILE . 25.1 mt -102.4 147.11 27.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 44.97 24.96 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.847 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 77.97 41.31 18.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.49 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 3.0 t -153.81 135.16 8.71 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.681 0.753 . . . . 0.0 110.836 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.463 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 54.3 Cg_endo -69.72 93.94 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 1.018 HD13 HD12 ' A' ' 291' ' ' LEU . 11.4 pt -76.64 146.51 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.629 ' OE1' HG23 ' A' ' 299' ' ' THR . 0.2 OUTLIER -122.12 135.11 54.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.908 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.79 118.21 54.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . 0.629 HG23 ' OE1' ' A' ' 297' ' ' GLU . 18.9 p -132.45 166.29 22.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.153 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.2 mt -83.77 102.87 12.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.54 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -71.16 157.33 38.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.115 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 121.586 0.708 . . . . 0.0 110.908 179.957 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.935 0.397 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.2 p -113.68 132.03 63.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.449 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -133.95 117.03 16.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.627 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 98.6 mt -147.73 139.14 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 232' ' ' ILE . 12.1 mt -121.09 107.63 12.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.751 ' CD1' ' CE1' ' A' ' 270' ' ' PHE . 33.3 t80 -91.46 121.32 33.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.19 132.23 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -119.69 155.78 31.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.409 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 38.6 t-20 70.68 52.62 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.23 126.62 52.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 22.8 mtt -71.49 139.98 49.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.622 HD23 ' O ' ' A' ' 266' ' ' ARG . 39.9 mt -55.96 -18.74 9.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.3 t -75.89 -28.59 58.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.833 HG23 ' SD ' ' A' ' 246' ' ' MET . 42.8 m -64.5 146.66 54.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 44.1 m -120.63 165.71 14.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.805 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 264' ' ' LYS . 49.0 mt-10 -64.5 -16.37 62.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -69.59 -64.02 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.833 ' SD ' HG23 ' A' ' 242' ' ' THR . 13.0 ptp -54.7 -30.87 56.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.854 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 73.1 mt -69.81 -45.13 78.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -65.53 -53.56 40.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.484 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 0.7 OUTLIER -53.32 -49.48 66.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.484 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 61.4 mm-40 -52.92 -53.46 49.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.615 ' CE2' HG21 ' A' ' 271' ' ' VAL . 5.8 m-85 -61.83 -58.49 7.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 253' ' ' ASN . 2.3 m120 -47.12 -49.1 22.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.952 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 252' ' ' ASN . 29.8 m-20 -36.65 -46.77 0.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.905 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.61 HD12 ' HB1' ' A' ' 285' ' ' ALA . 43.1 mm -51.64 -56.79 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.124 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.475 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 0.1 OUTLIER -143.95 137.06 13.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.548 0.689 . . . . 0.0 110.932 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.475 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 53.0 Cg_endo -69.82 136.75 33.64 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.63 2.22 . . . . 0.0 112.309 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 60.12 36.42 90.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -99.43 -39.15 8.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 111.13 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.5 t -90.99 132.99 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.171 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.424 ' OE1' ' N ' ' A' ' 260' ' ' GLU . 0.7 OUTLIER -94.37 -52.17 4.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . 0.481 ' HD3' ' N ' ' A' ' 262' ' ' VAL . 0.1 OUTLIER -151.23 161.75 42.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.481 ' N ' ' HD3' ' A' ' 261' ' ' ARG . 32.5 t -131.63 138.89 51.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.154 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 6.6 tppt? -123.99 113.6 18.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . 0.409 ' HB2' ' CG ' ' A' ' 244' ' ' GLU . 13.9 tptp -87.66 143.31 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.754 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.7 mt -133.61 172.93 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.13 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.683 ' H ' HG22 ' A' ' 265' ' ' ILE . 20.4 mmt180 -30.66 -73.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.99 15.92 7.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.754 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -142.49 172.39 12.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.943 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -159.28 165.54 33.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.08 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.751 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 86.8 m-85 -128.35 149.6 50.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.615 HG21 ' CE2' ' A' ' 251' ' ' PHE . 19.8 t -132.56 123.78 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.115 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -97.15 144.24 27.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.835 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -120.4 177.52 5.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 33.4 t -90.86 -33.4 15.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.84 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -143.15 161.38 38.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 277' ' ' GLU . 11.1 ttp180 -64.49 -61.77 2.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 276' ' ' ARG . 16.1 mt-10 -35.99 -49.11 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -64.19 -50.73 66.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -53.4 -47.3 69.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.646 HG12 ' HD2' ' A' ' 284' ' ' LYS . 83.5 t -59.69 -43.12 90.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.84 -56.39 17.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.09 -38.24 67.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.124 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 65.0 ttp -60.32 -47.71 84.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.872 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.646 ' HD2' HG12 ' A' ' 280' ' ' VAL . 2.9 mtpm? -70.08 -37.6 75.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.61 ' HB1' HD12 ' A' ' 254' ' ' ILE . . . -55.19 -47.96 74.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.091 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.503 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 64.8 mt -84.6 -36.65 21.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 286' ' ' LEU . 11.3 t30 -36.74 93.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 113.03 33.82 1.93 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.475 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -110.79 157.88 19.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 91.3 t -119.8 96.13 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.837 HD12 HD13 ' A' ' 296' ' ' ILE . 31.3 mt -92.9 147.29 22.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.4 ' OD1' ' SD ' ' A' ' 246' ' ' MET . 3.2 m-20 46.64 30.47 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 69.91 43.05 67.4 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.459 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.9 m -155.05 137.35 9.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.693 0.759 . . . . 0.0 110.856 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.409 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.3 Cg_endo -69.79 108.74 2.15 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.627 2.218 . . . . 0.0 112.365 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.837 HD13 HD12 ' A' ' 291' ' ' LEU . 10.1 pt -97.54 141.72 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -112.34 143.9 42.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.847 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.07 117.84 51.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 10.5 p -132.84 167.57 19.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.209 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 9.3 mt -85.91 113.18 21.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.627 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -66.23 139.01 58.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.125 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.586 0.708 . . . . 0.0 110.872 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.91 0.386 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -116.25 132.69 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.112 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.405 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -130.72 116.9 18.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 68.5 mt -147.91 136.42 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.129 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 23.4 mt -118.57 110.16 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.595 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 28.2 t80 -93.47 125.74 38.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.472 HG11 HD21 ' A' ' 238' ' ' LEU . 21.3 t -108.83 142.52 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.089 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 7.3 ttt-85 -134.87 157.23 47.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 295' ' ' PRO . 12.2 t30 71.92 47.95 0.3 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.472 HD21 HG11 ' A' ' 235' ' ' VAL . 31.0 mt -100.99 125.34 47.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 14.3 mtt -63.75 125.73 25.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.836 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 266' ' ' ARG . 20.3 mt -50.93 -23.95 3.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.934 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 7.2 m -68.87 -33.32 73.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.529 HG23 ' SD ' ' A' ' 246' ' ' MET . 24.9 m -63.56 144.9 56.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.196 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.6 m -112.17 165.81 11.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.855 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.57 -46.69 80.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -45.17 -36.65 3.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.529 ' SD ' HG23 ' A' ' 242' ' ' THR . 27.5 mtt -69.53 -42.02 75.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.879 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 46.0 mt -68.89 -39.92 80.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.452 ' OE1' ' CG2' ' A' ' 262' ' ' VAL . 4.3 tp10 -64.69 -43.79 92.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.864 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 1.7 ptmm? -72.54 -46.27 55.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.528 ' CD ' HD21 ' A' ' 291' ' ' LEU . 62.3 mm-40 -56.82 -33.51 66.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.915 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.639 ' CE2' HG21 ' A' ' 271' ' ' VAL . 8.0 m-85 -87.93 -30.61 19.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -76.42 -26.91 55.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -52.72 -23.84 7.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 16.0 mm -78.19 -52.82 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -144.14 134.0 11.76 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.587 0.708 . . . . 0.0 110.924 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 142.53 48.28 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 0.0 112.348 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 55.13 26.23 41.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.519 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -90.52 -53.72 4.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.333 . . . . 0.0 111.08 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.5 t -62.25 114.42 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -73.98 -60.02 2.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -150.2 146.2 26.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.87 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.452 ' CG2' ' OE1' ' A' ' 248' ' ' GLU . 61.3 t -116.92 128.84 74.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.13 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -115.63 108.41 16.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -85.22 142.17 29.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.771 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.7 mt -133.86 172.41 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.66 ' H ' HG22 ' A' ' 265' ' ' ILE . 15.6 mmt180 -31.11 -72.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.82 15.84 8.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.85 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.771 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -143.37 175.27 10.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -163.79 160.32 22.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.052 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.441 ' CD2' HD11 ' A' ' 265' ' ' ILE . 86.4 m-85 -124.56 138.15 54.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.639 HG21 ' CE2' ' A' ' 251' ' ' PHE . 3.1 t -123.12 129.58 74.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.11 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -106.69 151.74 24.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.865 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -129.73 174.62 9.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 25.4 t -80.96 -38.41 27.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.878 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -144.28 153.31 41.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 277' ' ' GLU . 21.5 ttt180 -50.87 -56.17 13.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.876 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 276' ' ' ARG . 4.9 mm-40 -35.76 -54.76 0.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -59.63 -49.93 75.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.813 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -53.05 -50.18 64.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 48.9 t -53.75 -48.9 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -59.01 -59.93 4.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.844 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.28 -18.64 6.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 56.9 ttp -78.01 -57.67 3.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -66.89 -29.56 69.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -62.42 -56.99 12.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.095 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.631 ' CD1' ' CD1' ' A' ' 251' ' ' PHE . 55.2 mt -76.71 -40.19 49.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.945 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -39.87 121.14 1.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 90.63 27.33 20.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.525 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -110.37 161.78 15.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.406 HG13 ' C ' ' A' ' 294' ' ' SER . 72.9 t -123.85 95.11 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.078 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.758 HD12 HD13 ' A' ' 296' ' ' ILE . 33.1 mt -87.07 148.01 25.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 40.6 t0 41.47 41.54 1.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.902 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 59.58 45.85 94.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.406 ' C ' HG13 ' A' ' 290' ' ' VAL . 2.0 t -154.62 136.59 9.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.683 0.754 . . . . 0.0 110.883 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.425 ' O ' ' ND2' ' A' ' 237' ' ' ASN . 53.6 Cg_endo -69.76 110.9 2.67 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.712 2.275 . . . . 0.0 112.306 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.758 HD13 HD12 ' A' ' 291' ' ' LEU . 10.8 pt -101.33 144.38 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.176 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -115.45 151.79 34.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 8.8 t -140.43 113.52 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 51.2 p -134.35 167.65 20.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.163 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 10.9 mt -81.54 108.87 15.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.595 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -68.92 137.41 53.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 94.6 p . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.928 0.394 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.19 136.5 51.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.112 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.451 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -137.61 116.88 12.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.682 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 77.0 mt -147.91 140.29 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.055 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 11.4 mt -120.83 111.87 18.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.921 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.517 ' CE2' ' HB2' ' A' ' 236' ' ' ARG . 16.2 t80 -92.08 129.72 37.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.843 HG11 HD21 ' A' ' 238' ' ' LEU . 17.4 t -115.18 133.82 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.517 ' HB2' ' CE2' ' A' ' 234' ' ' TYR . 30.3 ttp85 -129.31 161.17 30.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 71.26 35.84 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.843 HD21 HG11 ' A' ' 235' ' ' VAL . 11.5 mt -91.76 122.6 34.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . 0.496 ' CB ' ' OD2' ' A' ' 292' ' ' ASP . 4.7 mmt -57.43 139.66 52.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.495 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 40.4 mt -63.34 -7.66 6.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.885 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 37.6 m -97.44 16.64 19.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.615 HG23 ' SD ' ' A' ' 246' ' ' MET . 49.2 m -99.02 145.33 27.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 2.3 m -119.05 155.07 32.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -56.1 -15.04 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.835 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -72.58 -66.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.615 ' SD ' HG23 ' A' ' 242' ' ' THR . 13.2 ptp -55.64 -29.08 58.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 63.4 mt -75.77 -45.84 37.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.134 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.434 ' HG2' ' ND2' ' A' ' 252' ' ' ASN . 17.9 tt0 -63.1 -44.28 96.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 16.2 ptmt -64.61 -47.58 78.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.595 ' HG3' HD21 ' A' ' 291' ' ' LEU . 21.6 mm-40 -57.25 -34.72 68.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -81.89 -32.16 31.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.434 ' ND2' ' HG2' ' A' ' 248' ' ' GLU . 59.2 m-20 -79.86 -14.6 58.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.431 ' OD1' HD13 ' A' ' 254' ' ' ILE . 34.7 p-10 -60.17 -18.48 48.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.431 HD13 ' OD1' ' A' ' 253' ' ' ASN . 10.0 mm -79.86 -60.21 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -136.67 135.32 20.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.556 0.693 . . . . 0.0 110.959 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 137.45 35.56 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.727 2.285 . . . . 0.0 112.317 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.57 40.43 94.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.511 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -102.56 -56.41 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 111.112 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.2 t -59.76 136.13 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -93.91 -55.77 3.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -152.74 149.32 28.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 19.2 t -122.41 137.85 54.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -128.31 109.1 11.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -80.35 140.62 36.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.954 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.704 HG22 ' H ' ' A' ' 266' ' ' ARG . 6.2 mt -130.82 173.33 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.083 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.704 ' H ' HG22 ' A' ' 265' ' ' ILE . 22.0 mmt180 -28.66 -75.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.879 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -125.0 14.26 8.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.746 ' HA ' HD12 ' A' ' 238' ' ' LEU . 0.1 OUTLIER -140.58 171.67 13.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.944 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -157.87 154.88 28.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -116.07 146.06 42.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.892 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 18.1 t -134.49 125.35 46.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.145 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -98.9 154.68 17.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.889 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -131.85 167.88 18.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.6 t -77.18 -33.78 56.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -146.63 153.13 39.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 277' ' ' GLU . 5.8 ttt-85 -54.04 -55.95 22.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 276' ' ' ARG . 77.8 mt-10 -34.91 -59.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.885 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -56.84 -49.11 76.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.83 -53.33 33.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.66 -37.0 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.159 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -65.41 -49.4 69.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.97 -21.17 65.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 51.2 ttp -71.3 -58.45 3.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -66.16 -30.02 70.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -60.66 -55.67 30.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 42.8 mt -79.49 -31.29 42.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -40.65 115.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 93.08 32.92 7.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -109.83 157.46 19.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.802 0.334 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 76.5 t -118.79 96.19 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.152 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.936 HD12 HD13 ' A' ' 296' ' ' ILE . 30.6 mt -95.0 152.81 18.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.496 ' OD2' ' CB ' ' A' ' 239' ' ' MET . 34.2 t70 41.86 26.51 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.83 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.7 43.84 34.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.516 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 2.0 m -154.39 137.88 10.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.62 0.724 . . . . 0.0 110.897 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 91.93 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.685 2.257 . . . . 0.0 112.352 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.936 HD13 HD12 ' A' ' 291' ' ' LEU . 17.2 pt -78.35 144.97 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -120.44 140.06 51.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.91 134.61 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 41.0 p -147.32 176.43 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 232' ' ' ILE . 15.5 mt -95.64 105.78 17.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.682 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -71.78 145.01 48.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 19.7 pttm . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.582 0.706 . . . . 0.0 110.886 179.973 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.906 0.384 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.42 130.5 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.116 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.32 116.85 18.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.518 ' O ' HD23 ' A' ' 300' ' ' LEU . 40.6 mt -148.05 136.5 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.114 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.612 HD12 ' HE1' ' A' ' 273' ' ' PHE . 36.0 mt -124.04 108.57 12.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.891 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 22.8 t80 -92.02 126.27 37.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.873 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 24.3 t -108.0 144.49 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.134 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -136.98 157.81 45.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 295' ' ' PRO . 15.1 t30 72.9 53.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 14.8 mt -111.14 134.46 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 3.8 mtt -70.51 137.47 50.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 266' ' ' ARG . 70.3 mt -53.95 -18.65 3.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 36.7 m -75.09 -31.36 61.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.554 HG23 ' HB2' ' A' ' 246' ' ' MET . 50.6 m -67.5 127.27 32.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.151 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.1 t -107.08 157.4 17.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -43.34 -28.04 0.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -60.55 -42.55 96.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.554 ' HB2' HG23 ' A' ' 242' ' ' THR . 7.3 mmt -63.82 -42.47 97.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.478 ' HB ' HG11 ' A' ' 262' ' ' VAL . 69.1 mt -67.12 -36.9 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.439 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 19.3 tt0 -70.34 -49.12 52.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 4.8 ptmt -63.23 -46.77 85.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.584 ' HG3' HD21 ' A' ' 291' ' ' LEU . 27.7 mm-40 -59.79 -56.29 23.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.865 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.592 ' CE2' HG21 ' A' ' 271' ' ' VAL . 7.4 m-85 -62.33 -41.77 98.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.439 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 5.8 m-20 -62.03 -42.35 99.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -38.49 -42.62 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 44.2 mm -53.99 -58.95 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.445 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 26.6 tptt -141.05 136.81 16.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.538 0.685 . . . . 0.0 110.909 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.445 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 53.4 Cg_endo -69.77 131.28 20.89 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.677 2.251 . . . . 0.0 112.325 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 62.82 39.52 98.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.509 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -103.94 -45.11 4.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 0.0 111.069 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.409 ' CG2' ' OD1' ' A' ' 252' ' ' ASN . 93.8 t -71.62 117.89 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.64 -60.32 2.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -145.52 152.96 40.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.478 HG11 ' HB ' ' A' ' 247' ' ' ILE . 92.2 t -127.8 130.74 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -118.94 109.65 16.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -86.66 143.61 27.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.902 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.689 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.5 mt -133.95 172.65 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.687 ' H ' HG22 ' A' ' 265' ' ' ILE . 22.7 mmt180 -30.89 -70.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -125.62 -1.11 7.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.689 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -124.45 177.54 5.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.96 164.94 16.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.101 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 265' ' ' ILE . 97.8 m-85 -127.21 142.81 51.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.592 HG21 ' CE2' ' A' ' 251' ' ' PHE . 5.2 t -129.99 122.65 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -105.74 133.38 50.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.817 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.612 ' HE1' HD12 ' A' ' 233' ' ' LEU . 30.9 m-85 -108.02 175.71 5.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.449 ' O ' ' ND2' ' A' ' 275' ' ' ASN . 17.3 t -86.5 -28.46 23.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 274' ' ' SER . 5.3 m120 -146.92 149.52 33.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -52.48 -49.19 65.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 278' ' ' ASP . 13.8 pt-20 -44.35 -51.85 8.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.425 ' N ' ' HG3' ' A' ' 277' ' ' GLU . 2.5 m-20 -60.62 -50.53 73.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.844 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.463 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -52.44 -49.79 63.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.06 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 77.9 t -53.77 -54.97 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -53.56 -59.83 4.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.431 ' CB ' ' CZ ' ' A' ' 273' ' ' PHE . . . -54.33 -29.36 47.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 62.2 ttp -68.84 -57.14 5.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -63.67 -51.62 64.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -45.12 -51.97 9.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.074 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.532 HD13 ' CE1' ' A' ' 251' ' ' PHE . 81.4 mt -79.13 -29.15 42.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.914 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . 0.402 ' O ' ' ND2' ' A' ' 287' ' ' ASN . 2.7 t30 -49.52 91.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 115.88 31.49 1.91 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.458 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.411 ' HB2' HD11 ' A' ' 296' ' ' ILE . 3.7 mmpt? -106.5 163.2 13.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 110.931 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 51.9 t -125.53 96.59 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.106 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.584 HD21 ' HG3' ' A' ' 250' ' ' GLU . 72.0 mt -89.92 152.67 21.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.899 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 291' ' ' LEU . 1.6 m-20 34.94 36.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 66.62 46.99 71.51 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.477 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 291' ' ' LEU . 5.2 t -154.77 136.25 9.22 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.667 0.746 . . . . 0.0 110.86 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.448 ' O ' ' ND2' ' A' ' 237' ' ' ASN . 54.1 Cg_endo -69.68 106.05 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.719 2.279 . . . . 0.0 112.367 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.475 HD13 HD12 ' A' ' 291' ' ' LEU . 7.9 pt -94.09 145.28 8.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.16 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -118.6 146.83 44.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.0 117.81 39.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 33.9 p -135.67 170.31 16.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.518 HD23 ' O ' ' A' ' 232' ' ' ILE . 22.3 mt -86.89 102.2 14.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.934 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -72.41 114.16 10.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 121.537 0.684 . . . . 0.0 110.894 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.877 0.37 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.88 133.11 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.139 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.34 116.84 19.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.44 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 20.0 mt -147.95 130.93 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.09 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 279' ' ' ALA . 15.2 mt -117.49 112.49 20.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.914 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -91.85 128.99 37.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.09 128.74 73.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.127 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -125.23 159.55 31.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 7.0 t30 71.88 51.23 0.23 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 41.5 mt -107.83 119.09 38.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 7.0 mmt -54.3 125.39 19.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.705 HD23 ' O ' ' A' ' 266' ' ' ARG . 65.1 mt -44.44 -30.17 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 36.0 t -59.92 -40.53 89.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.449 ' HA ' ' CE ' ' A' ' 246' ' ' MET . 30.9 m -60.56 155.16 19.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.153 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.42 ' N ' HG22 ' A' ' 242' ' ' THR . 43.2 m -134.64 168.28 19.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.838 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 245' ' ' GLU . 54.3 mt-10 -47.43 -57.74 4.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 244' ' ' GLU . 38.0 tt0 -35.68 -59.73 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.449 ' CE ' ' HA ' ' A' ' 242' ' ' THR . 6.9 mtt -47.52 -51.66 19.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.0 -34.02 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.118 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -64.66 -51.38 62.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 1.6 ptpp? -65.81 -44.34 85.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.888 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.554 ' HG3' HD21 ' A' ' 291' ' ' LEU . 52.0 mm-40 -61.0 -28.8 69.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 271' ' ' VAL . 7.2 m-85 -95.24 -23.19 17.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.77 -35.7 32.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 250' ' ' GLU . 0.6 OUTLIER -42.56 -29.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 15.5 mm -68.76 -66.79 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -131.35 131.96 23.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.519 0.676 . . . . 0.0 110.887 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 121.83 8.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 72.9 33.25 60.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.522 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -101.34 -39.71 7.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 78.8 t -73.16 113.75 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.061 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -66.84 -65.0 0.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.907 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . 0.476 ' CD ' ' HB2' ' A' ' 272' ' ' HIS . 0.0 OUTLIER -146.86 162.62 38.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.877 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 48.1 t -133.53 137.57 52.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . 0.423 ' C ' ' HD3' ' A' ' 263' ' ' LYS . 9.4 tmtm? -127.06 105.2 8.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . 0.429 ' CB ' ' HG3' ' A' ' 244' ' ' GLU . 11.4 tptp -79.67 145.17 33.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.836 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.8 mt -133.6 172.05 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.148 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.705 ' O ' HD23 ' A' ' 240' ' ' LEU . 51.9 mtt85 -32.01 -71.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.64 15.57 7.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.836 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -142.56 177.37 8.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -167.6 164.74 14.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.075 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.442 ' CD2' HD11 ' A' ' 265' ' ' ILE . 98.3 m-85 -130.94 142.9 50.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 251' ' ' PHE . 21.4 t -124.47 125.51 70.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.107 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . 0.476 ' HB2' ' CD ' ' A' ' 261' ' ' ARG . 3.5 m-70 -105.3 137.55 42.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -117.03 -177.51 3.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.83 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.3 t -99.45 -24.99 14.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -144.78 144.17 31.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.865 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 277' ' ' GLU . 9.6 ttp180 -54.4 -54.17 44.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 276' ' ' ARG . 4.8 mm-40 -35.64 -54.64 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.42 -51.72 67.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.417 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -46.48 -46.88 19.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.057 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.453 ' CG1' ' HD2' ' A' ' 284' ' ' LYS . 51.6 t -65.69 -54.47 27.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.084 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -50.13 -47.61 54.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.49 -31.37 68.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 67.6 ttp -66.82 -53.58 31.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.453 ' HD2' ' CG1' ' A' ' 280' ' ' VAL . 30.0 mtpt -65.92 -39.75 90.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -53.85 -53.83 47.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.475 HD13 ' CE1' ' A' ' 251' ' ' PHE . 35.2 mt -77.06 -35.49 56.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -41.15 95.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 114.83 32.53 1.87 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.524 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -113.66 160.35 18.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 0.0 110.863 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 95.8 t -123.23 103.59 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.612 HD12 HD13 ' A' ' 296' ' ' ILE . 22.4 mt -95.64 150.85 19.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 41.92 24.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 77.32 38.17 29.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 291' ' ' LEU . 23.6 p -145.59 135.68 11.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 110.908 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 102.41 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.7 2.267 . . . . 0.0 112.328 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.612 HD13 HD12 ' A' ' 291' ' ' LEU . 7.3 pt -90.43 147.2 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.11 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -122.96 140.69 52.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.24 122.33 65.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 81.9 p -137.84 172.79 12.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.122 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 11.4 mt -90.22 110.02 21.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.44 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -71.43 153.42 42.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.105 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.578 0.704 . . . . 0.0 110.893 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.943 0.402 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.54 131.98 62.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.138 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.21 116.83 17.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.525 ' O ' HD23 ' A' ' 233' ' ' LEU . 21.9 mt -147.94 140.77 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.592 HD12 ' CE1' ' A' ' 273' ' ' PHE . 39.5 mt -126.28 106.89 9.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.731 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 38.9 t80 -91.38 123.95 35.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.96 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.482 HG11 HD21 ' A' ' 238' ' ' LEU . 20.8 t -104.45 148.36 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.527 ' HG3' ' CE2' ' A' ' 234' ' ' TYR . 24.0 mtp180 -138.72 160.31 39.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.46 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 26.7 t-20 67.72 53.03 0.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.672 HD13 HD11 ' A' ' 247' ' ' ILE . 27.0 mt -109.46 120.63 43.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 8.4 mmt -54.97 133.64 48.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.849 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.507 HD23 ' O ' ' A' ' 266' ' ' ARG . 54.4 mt -51.91 -25.01 7.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 61.5 m -70.79 -32.3 69.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.52 HG23 ' HB2' ' A' ' 246' ' ' MET . 93.9 m -65.82 139.95 58.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.1 t -121.11 164.11 17.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.83 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -47.92 -22.04 0.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -65.69 -45.3 83.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.52 ' HB2' HG23 ' A' ' 242' ' ' THR . 2.3 mmt -67.59 -44.53 77.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.672 HD11 HD13 ' A' ' 238' ' ' LEU . 79.2 mt -65.97 -37.65 80.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.442 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 13.9 tt0 -71.62 -57.75 4.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 5.8 ptmt -49.34 -45.98 46.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.488 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 23.6 mm-40 -61.99 -58.21 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.531 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 6.0 m-85 -54.57 -27.53 39.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 16.2 m120 -71.77 -44.57 63.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.955 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -38.78 -40.76 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 17.0 mm -56.47 -64.24 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -139.48 131.75 15.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.58 0.705 . . . . 0.0 110.908 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 136.67 33.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.617 2.211 . . . . 0.0 112.39 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 63.37 33.32 86.93 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.445 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -100.75 -51.04 3.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.353 . . . . 0.0 111.108 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.73 135.9 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.123 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -96.89 -64.33 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -146.06 142.41 28.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 66.6 t -120.92 136.55 57.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -129.66 110.13 11.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 265' ' ' ILE . 23.4 tptp -79.49 144.63 33.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.693 HG22 ' H ' ' A' ' 266' ' ' ARG . 6.5 mt -132.3 173.1 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.141 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.693 ' H ' HG22 ' A' ' 265' ' ' ILE . 20.3 mmm180 -29.4 -68.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -132.42 15.08 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.649 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -142.86 173.38 11.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.928 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -162.18 158.98 25.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.086 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 95.3 m-85 -118.62 148.86 42.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.427 HG11 ' CD2' ' A' ' 251' ' ' PHE . 21.3 t -134.81 124.43 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -100.68 146.82 26.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.592 ' CE1' HD12 ' A' ' 233' ' ' LEU . 22.7 m-85 -126.84 167.59 15.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.887 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 45.8 m -74.79 -39.17 61.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -142.87 153.34 43.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.443 ' O ' ' C ' ' A' ' 277' ' ' GLU . 10.0 ttt85 -54.4 -57.7 10.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 276' ' ' ARG . 4.6 mp0 -34.36 -50.25 0.41 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -63.67 -53.65 48.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.57 ' HB1' HD21 ' A' ' 233' ' ' LEU . . . -51.86 -53.31 41.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.429 HG12 ' NZ ' ' A' ' 284' ' ' LYS . 56.1 t -52.74 -44.8 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.173 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.62 -51.83 67.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.15 -14.57 63.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.107 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -76.6 -60.8 2.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.429 ' NZ ' HG12 ' A' ' 280' ' ' VAL . 19.0 mtmm -64.22 -37.48 87.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -51.46 -54.7 24.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.111 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.531 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 50.5 mt -76.08 -40.16 53.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 286' ' ' LEU . 2.0 t30 -36.29 97.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 109.51 33.91 2.58 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.522 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -114.86 164.2 14.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.769 0.318 . . . . 0.0 110.953 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.413 HG13 ' N ' ' A' ' 294' ' ' SER . 56.8 t -124.64 110.79 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.114 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 293' ' ' GLY . 26.9 mt -102.96 146.38 28.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 39.62 29.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.59 47.55 12.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.469 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.413 ' N ' HG13 ' A' ' 290' ' ' VAL . 1.8 m -154.52 134.68 8.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.678 0.751 . . . . 0.0 110.852 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.46 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.4 Cg_endo -69.76 94.78 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 10.1 pt -83.61 148.31 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 298' ' ' VAL . 4.5 tp10 -122.79 148.41 45.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 286' ' ' LEU . 4.2 t -130.97 117.88 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.156 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 24.7 p -134.78 160.57 37.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.175 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 232' ' ' ILE . 8.8 mt -83.88 100.61 11.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.731 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -66.73 124.52 23.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.069 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.469 ' CD ' ' H ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 121.583 0.706 . . . . 0.0 110.918 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.932 0.396 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -106.83 131.02 57.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.131 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.64 116.42 18.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.49 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 80.9 mt -147.9 142.66 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.139 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.796 HD12 ' HE1' ' A' ' 273' ' ' PHE . 81.7 mt -128.94 106.0 8.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.638 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 32.6 t80 -91.31 128.52 37.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.9 t -109.56 150.64 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.149 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -138.81 157.98 45.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 71.8 54.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 23.6 mt -107.04 113.14 26.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . 0.45 ' CG ' ' OD2' ' A' ' 292' ' ' ASP . 13.4 mmt -53.89 128.15 28.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.443 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 25.7 mt -49.09 -30.38 6.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.906 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 97.8 p -64.49 -33.36 75.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.444 ' O ' ' NZ ' ' A' ' 264' ' ' LYS . 7.8 m -58.96 150.05 25.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.146 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 3.4 m -118.02 159.79 22.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -54.19 -41.62 68.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -54.84 -32.34 60.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.6 mtt -70.74 -37.25 73.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 25.9 mt -74.72 -39.81 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.156 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -68.81 -45.97 69.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.476 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 0.0 OUTLIER -62.35 -48.38 80.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.907 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.476 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 52.8 mm-40 -56.35 -50.11 72.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.467 ' CD2' HG11 ' A' ' 271' ' ' VAL . 7.2 m-85 -65.74 -23.56 66.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -75.49 -41.38 55.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -37.37 -46.96 0.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 49.7 mm -49.59 -63.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -141.17 129.38 12.29 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.596 0.712 . . . . 0.0 110.934 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 114.96 3.88 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.672 2.248 . . . . 0.0 112.324 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 90.36 38.23 6.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -114.35 -43.62 3.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 111.084 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.61 118.4 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -80.25 -67.99 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -144.76 150.92 38.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 93.7 t -127.22 130.1 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.12 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -115.54 106.26 13.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 242' ' ' THR . 15.6 tptm -80.09 140.94 36.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.768 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.1 mt -132.26 172.42 16.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.668 ' H ' HG22 ' A' ' 265' ' ' ILE . 30.7 mmt180 -31.78 -72.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 7.7 p-10 -126.51 17.48 7.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.768 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -146.25 178.01 8.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -169.22 165.78 10.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.104 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.575 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 96.3 m-85 -126.89 145.4 50.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 251' ' ' PHE . 66.6 t -129.79 134.54 62.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.117 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -113.99 156.29 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.796 ' HE1' HD12 ' A' ' 233' ' ' LEU . 44.9 m-85 -134.37 179.95 5.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 62.5 p -83.26 -34.68 25.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -147.49 153.18 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.872 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 277' ' ' GLU . 8.5 ttt85 -53.79 -54.57 36.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 276' ' ' ARG . 44.7 mt-10 -34.48 -56.52 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.81 -50.78 72.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.05 -54.23 21.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.038 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 71.6 t -53.39 -47.89 57.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.088 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -56.0 -58.45 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.19 -30.87 51.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.091 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 63.6 ttp -68.07 -55.74 11.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -68.6 -14.94 63.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -79.29 -52.73 7.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.082 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 287' ' ' ASN . 59.5 mt -82.69 -35.16 27.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 286' ' ' LEU . 2.3 t-20 -38.28 99.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 107.68 34.37 2.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.504 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -113.59 159.66 19.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.824 0.345 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 86.7 t -121.32 93.6 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.173 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.475 HD12 HD13 ' A' ' 296' ' ' ILE . 27.7 mt -92.08 153.86 19.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.45 ' OD2' ' CG ' ' A' ' 239' ' ' MET . 3.2 p-10 42.15 25.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.1 38.29 40.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.51 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 291' ' ' LEU . 68.1 p -147.05 134.9 10.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.637 0.732 . . . . 0.0 110.887 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 92.0 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.629 2.22 . . . . 0.0 112.323 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.475 HD13 HD12 ' A' ' 291' ' ' LEU . 7.5 pt -82.85 148.38 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -125.87 143.71 50.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.6 t -123.86 127.22 73.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 25.7 p -137.43 171.76 13.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 232' ' ' ILE . 5.4 mt -94.74 100.15 12.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.638 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -65.5 151.72 45.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 17.0 mmtm . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 121.596 0.713 . . . . 0.0 110.897 179.949 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.91 0.386 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.15 137.68 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.476 ' HE2' ' CA ' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -136.71 116.99 13.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.923 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.618 ' O ' HD23 ' A' ' 233' ' ' LEU . 70.2 mt -147.95 137.05 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.174 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 232' ' ' ILE . 10.7 mt -122.07 110.96 16.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.922 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 236' ' ' ARG . 22.5 t80 -91.43 132.92 35.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.42 ' CG1' HD11 ' A' ' 238' ' ' LEU . 16.5 t -120.08 133.08 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.089 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 234' ' ' TYR . 9.7 ptm180 -129.59 161.98 29.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.419 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 35.2 t-20 71.79 38.79 0.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.42 HD11 ' CG1' ' A' ' 235' ' ' VAL . 26.2 mt -96.71 126.95 42.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 14.6 mmt -59.0 131.92 52.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.477 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 53.5 mt -51.35 -38.16 51.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 29.8 t -59.03 -24.43 62.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.874 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.463 HG22 ' N ' ' A' ' 243' ' ' SER . 30.9 m -60.38 157.09 14.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.177 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.463 ' N ' HG22 ' A' ' 242' ' ' THR . 64.9 m -134.6 153.89 51.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.845 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -44.94 -50.62 10.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -43.91 -41.71 5.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 9.5 mtt -65.7 -38.14 88.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 72.0 mt -72.42 -34.08 47.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 24.5 tt0 -75.32 -48.5 22.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 14.3 ptmt -57.96 -48.07 81.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.97 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.474 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 26.1 mm-40 -62.34 -59.48 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -59.15 -23.83 62.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.448 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 6.8 m-20 -80.99 -37.63 28.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -45.12 -45.11 11.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 42.8 mm -50.72 -63.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -134.87 127.07 18.18 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.527 0.68 . . . . 0.0 110.943 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 125.35 12.07 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.672 2.248 . . . . 0.0 112.341 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 75.84 33.7 50.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.487 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -105.17 -45.33 4.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 51.5 t -69.24 118.65 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.75 -60.7 2.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -146.78 154.56 41.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 94.4 t -126.58 142.69 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -134.85 109.61 8.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -82.71 146.68 28.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.814 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.8 mt -135.44 172.19 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.092 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.652 ' H ' HG22 ' A' ' 265' ' ' ILE . 21.4 mmt85 -31.71 -72.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.82 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.73 15.41 7.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.814 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -142.27 176.72 8.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.13 166.91 16.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.113 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -130.6 144.26 51.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 18.3 t -129.85 117.26 40.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -93.4 154.75 17.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.475 ' HE1' HD12 ' A' ' 233' ' ' LEU . 45.6 m-85 -130.86 179.7 5.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.418 ' O ' ' ND2' ' A' ' 275' ' ' ASN . 3.8 m -102.28 -23.09 14.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.845 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.476 ' CA ' ' HE2' ' A' ' 231' ' ' LYS . 1.7 m120 -142.33 133.35 25.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.41 ' N ' ' CE ' ' A' ' 231' ' ' LYS . 6.0 ttp-105 -49.87 -46.58 51.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -46.99 -48.84 21.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.89 -57.63 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.426 ' HB1' HD21 ' A' ' 233' ' ' LEU . . . -48.59 -49.47 36.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.077 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 64.6 t -55.74 -52.98 42.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.137 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -57.81 -47.84 81.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.91 -26.69 68.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 9.6 tmm? -72.14 -50.13 30.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -70.38 -35.25 73.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -57.2 -57.96 10.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.108 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 47.9 mt -74.24 -32.81 63.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -41.93 99.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 109.3 29.9 3.8 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -109.14 161.19 15.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 0.0 110.873 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 71.8 t -123.59 93.87 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.105 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.606 HD12 HD13 ' A' ' 296' ' ' ILE . 31.8 mt -87.11 153.43 21.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 291' ' ' LEU . 3.9 p30 35.43 34.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 68.12 46.39 65.69 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.479 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 291' ' ' LEU . 5.6 t -155.07 133.65 7.16 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.651 0.738 . . . . 0.0 110.852 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.419 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.9 Cg_endo -69.75 101.27 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.682 2.254 . . . . 0.0 112.363 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.606 HD13 HD12 ' A' ' 291' ' ' LEU . 7.5 pt -89.44 145.37 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -120.92 137.64 54.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.52 122.26 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.072 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 69.5 p -140.46 163.35 33.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.4 mt -77.61 114.15 16.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.543 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -68.42 155.77 39.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.086 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.554 0.693 . . . . 0.0 110.919 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 93.1 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.927 0.394 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.75 135.38 50.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.116 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.93 116.78 17.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.553 ' O ' HD23 ' A' ' 300' ' ' LEU . 19.7 mt -147.96 138.2 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.524 HD12 ' CE1' ' A' ' 273' ' ' PHE . 34.6 mt -123.85 110.63 15.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.62 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 52.9 t80 -92.56 127.76 38.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.577 HG11 HD21 ' A' ' 238' ' ' LEU . 51.5 t -110.39 139.88 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.087 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -135.34 162.97 31.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.412 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 35.0 t-20 67.56 47.45 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.577 HD21 HG11 ' A' ' 235' ' ' VAL . 64.9 mt -104.45 137.42 42.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.1 mmt -69.51 129.9 40.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 266' ' ' ARG . 27.5 mt -50.28 -35.63 28.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.0 t -63.39 -26.92 68.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 93.5 m -64.83 140.44 58.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.8 m -113.94 167.68 10.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.872 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 247' ' ' ILE . 5.4 mp0 -53.17 -50.08 65.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.857 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -41.27 -42.29 2.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 3.1 mmt -65.81 -34.62 78.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 244' ' ' GLU . 21.6 mt -75.58 -40.69 41.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -65.45 -45.21 84.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.496 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 2.3 ptmm? -64.93 -49.15 71.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.892 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.528 ' HG3' HD11 ' A' ' 291' ' ' LEU . 44.4 mm-40 -56.9 -35.09 68.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.463 ' CD2' HG11 ' A' ' 271' ' ' VAL . 5.4 m-85 -87.85 -21.5 24.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -88.83 -8.7 53.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -75.6 -18.22 59.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.642 ' H ' HD12 ' A' ' 254' ' ' ILE . 3.7 mp -85.28 -52.58 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -140.39 129.32 13.13 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.56 0.695 . . . . 0.0 110.877 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 123.27 9.93 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.695 2.263 . . . . 0.0 112.343 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 73.18 39.35 52.96 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -104.0 -43.44 5.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 111.112 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 251' ' ' PHE . 24.2 t -72.5 121.9 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -82.84 -58.65 2.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -145.56 151.67 38.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 97.9 t -126.11 135.43 63.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -127.25 106.04 8.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -79.56 146.24 32.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.752 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.9 mt -137.28 172.46 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.668 ' H ' HG22 ' A' ' 265' ' ' ILE . 30.5 mmt180 -30.77 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -127.0 20.2 6.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.752 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.3 OUTLIER -148.81 175.93 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.03 168.86 18.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.427 ' CD2' HD11 ' A' ' 265' ' ' ILE . 92.7 m-85 -130.57 137.81 49.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.463 HG11 ' CD2' ' A' ' 251' ' ' PHE . 18.0 t -127.56 122.69 59.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.134 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -98.85 155.72 17.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.524 ' CE1' HD12 ' A' ' 233' ' ' LEU . 16.2 m-85 -129.43 179.58 5.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.3 t -98.69 -19.05 17.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.809 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.449 ' OD1' ' CG ' ' A' ' 278' ' ' ASP . 47.2 p30 -154.25 142.1 20.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -51.0 -47.39 61.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -41.02 -65.31 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.449 ' CG ' ' OD1' ' A' ' 275' ' ' ASN . 72.1 m-20 -52.5 -50.2 63.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.23 -44.6 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.609 HG12 ' HE3' ' A' ' 284' ' ' LYS . 54.2 t -60.97 -47.82 91.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -59.82 -60.98 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -53.2 -28.08 24.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.111 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.486 ' O ' ' CB ' ' A' ' 287' ' ' ASN . 65.9 ttp -68.18 -54.39 18.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.609 ' HE3' HG12 ' A' ' 280' ' ' VAL . 6.4 mtmp? -78.86 -15.62 58.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.402 ' HB3' HG12 ' A' ' 254' ' ' ILE . . . -75.02 -29.95 60.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.527 HD11 ' O ' ' A' ' 250' ' ' GLU . 46.6 mt -111.95 -28.6 7.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.915 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 283' ' ' MET . 9.2 t-20 -55.99 106.12 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 114.26 4.57 22.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.464 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 289' ' ' LYS . 12.7 mptt -98.35 153.76 18.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 110.89 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 294' ' ' SER . 59.0 t -107.09 96.97 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.692 HD12 HD13 ' A' ' 296' ' ' ILE . 22.1 mt -83.64 146.62 28.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 292' ' ' ASP . 26.3 t70 36.3 40.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.839 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 65.19 44.56 93.71 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.477 ' N ' HG13 ' A' ' 290' ' ' VAL . 8.4 t -154.32 132.01 6.36 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.624 0.726 . . . . 0.0 110.886 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.412 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.6 Cg_endo -69.79 105.79 1.55 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.637 2.225 . . . . 0.0 112.348 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.692 HD13 HD12 ' A' ' 291' ' ' LEU . 19.3 pt -95.76 140.64 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -117.15 134.44 54.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.28 112.79 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.138 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 58.6 p -128.28 165.34 20.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 232' ' ' ILE . 16.7 mt -82.59 102.47 11.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -66.88 141.6 57.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.572 0.701 . . . . 0.0 110.873 -179.996 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.931 0.396 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.41 129.24 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.148 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -130.92 116.68 18.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.474 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 75.1 mt -147.91 132.89 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.107 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 232' ' ' ILE . 10.8 mt -117.17 109.28 16.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.535 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 24.3 t80 -91.67 132.71 36.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.26 140.53 41.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.123 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -137.63 166.71 23.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.833 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 38.5 t30 69.15 44.62 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 26.2 mt -101.52 154.34 18.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 4.4 mtt -83.38 133.96 34.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 266' ' ' ARG . 63.9 mt -56.53 -13.91 2.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.947 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 2.0 m -90.14 9.03 29.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 98.6 m -100.88 135.16 42.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 21.4 p -106.57 171.21 7.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -64.61 -18.67 65.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -69.52 -44.2 71.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.888 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 9.7 mtt -64.96 -39.05 92.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.872 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 35.8 mt -70.97 -40.04 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -68.0 -50.77 53.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 2.4 ptmm? -56.81 -47.35 80.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.499 ' O ' ' ND2' ' A' ' 253' ' ' ASN . 54.0 mm-40 -56.87 -65.55 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.623 ' CE1' HD13 ' A' ' 286' ' ' LEU . 8.0 m-85 -52.43 -22.48 4.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.886 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -79.84 -43.73 21.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.63 ' OD1' HD13 ' A' ' 254' ' ' ILE . 0.7 OUTLIER -46.82 -28.91 1.71 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.63 HD13 ' OD1' ' A' ' 253' ' ' ASN . 14.8 mm -74.8 -51.04 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.536 ' HG2' ' HB2' ' A' ' 258' ' ' ALA . 34.8 tptt -139.16 112.16 7.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.557 0.694 . . . . 0.0 110.9 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 125.93 12.7 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.685 2.256 . . . . 0.0 112.335 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 74.96 28.86 61.75 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.492 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.536 ' HB2' ' HG2' ' A' ' 255' ' ' LYS . . . -106.97 -48.03 3.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 111.093 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.3 131.63 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.159 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -89.78 -62.64 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -147.76 158.46 44.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.505 HG22 HG13 ' A' ' 271' ' ' VAL . 90.1 t -137.93 142.83 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.2 116.01 19.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -81.53 139.52 35.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.825 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.2 mt -129.13 172.41 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.151 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.669 ' H ' HG22 ' A' ' 265' ' ' ILE . 18.2 mmm180 -31.32 -75.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.63 19.45 8.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.825 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -146.79 174.9 11.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.81 167.37 18.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.111 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -126.67 151.09 48.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.53 HG11 ' CD2' ' A' ' 251' ' ' PHE . 15.1 t -138.03 117.46 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.074 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -94.76 158.15 15.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -133.45 178.69 6.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 85.7 p -95.45 -14.95 23.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.865 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -160.0 145.85 15.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 280' ' ' VAL . 18.4 ttt-85 -55.22 -41.69 72.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -45.67 -58.39 3.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -60.95 -46.44 90.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.58 -51.21 50.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.101 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 276' ' ' ARG . 66.2 t -58.53 -49.83 81.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.167 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -55.4 -57.3 12.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.66 -33.96 61.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.102 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 53.5 ttp -59.87 -68.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -61.29 -20.28 62.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -67.0 -56.97 7.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.623 HD13 ' CE1' ' A' ' 251' ' ' PHE . 26.4 mt -79.93 -30.37 39.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -40.55 112.3 0.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 95.4 32.3 7.07 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.471 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -109.74 158.94 17.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 83.1 t -118.79 96.26 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.12 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.728 HD12 HD13 ' A' ' 296' ' ' ILE . 38.0 mt -92.72 153.47 18.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 61.7 t0 40.96 28.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 72.97 41.46 48.48 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.446 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 291' ' ' LEU . 1.8 m -154.3 138.7 11.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.674 0.749 . . . . 0.0 110.908 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 105.99 1.58 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 0.0 112.381 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.728 HD13 HD12 ' A' ' 291' ' ' LEU . 9.8 pt -93.54 151.36 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -123.22 148.38 45.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 11.1 t -133.36 124.72 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.108 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 67.7 p -141.06 165.02 28.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 6.9 mt -81.48 106.63 13.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -71.24 139.81 50.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.106 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.577 0.704 . . . . 0.0 110.887 -179.999 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 97.5 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.938 0.399 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.09 131.33 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 279' ' ' ALA . 0.0 OUTLIER -129.56 116.83 19.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.485 ' O ' HD23 ' A' ' 300' ' ' LEU . 66.3 mt -148.07 138.82 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.139 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.734 HD12 ' CE1' ' A' ' 273' ' ' PHE . 76.8 mt -126.9 111.09 13.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.837 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 72.6 t80 -93.34 128.46 39.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.969 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 297' ' ' GLU . 16.8 t -112.02 129.06 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.112 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.461 ' HG3' ' N ' ' A' ' 237' ' ' ASN . 13.5 tpt180 -120.57 161.3 21.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.461 ' N ' ' HG3' ' A' ' 236' ' ' ARG . 9.0 t30 74.87 35.22 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 42.2 mt -85.24 124.82 32.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.858 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 3.6 mmt -62.82 133.6 54.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 266' ' ' ARG . 58.2 mt -59.46 -12.74 6.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 20.7 m -98.2 15.56 24.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 38.8 m -102.62 129.88 49.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.133 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.0 m -97.16 145.86 25.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 247' ' ' ILE . 45.7 mt-10 -42.03 -48.29 4.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.886 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -42.14 -38.77 1.8 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 10.8 mtt -66.05 -39.56 90.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 244' ' ' GLU . 44.9 mt -72.64 -34.97 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.468 ' HG2' ' ND2' ' A' ' 252' ' ' ASN . 25.9 tt0 -73.75 -46.62 44.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 13.7 ptmt -60.54 -45.14 94.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.576 ' HG3' HD11 ' A' ' 291' ' ' LEU . 25.3 mm-40 -61.76 -58.26 8.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.789 ' CD2' HG11 ' A' ' 271' ' ' VAL . 7.6 m-85 -55.81 -46.42 78.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.468 ' ND2' ' HG2' ' A' ' 248' ' ' GLU . 79.6 m-20 -66.02 -23.42 66.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.845 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -51.98 -37.31 52.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 14.5 mm -65.71 -52.57 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -142.71 133.48 12.58 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.609 0.719 . . . . 0.0 110.885 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 137.78 36.21 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.257 . . . . 0.0 112.32 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.93 41.04 96.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.534 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -106.63 -45.62 4.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 111.11 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 76.5 t -68.26 126.24 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -83.3 -60.59 2.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -147.85 150.15 33.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.824 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 85.7 t -127.68 110.82 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.16 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -100.78 110.07 22.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -79.49 147.86 32.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.804 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.0 mt -137.1 172.11 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.103 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.66 ' H ' HG22 ' A' ' 265' ' ' ILE . 23.5 mmt180 -31.32 -71.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.45 ' OD1' ' C ' ' A' ' 266' ' ' ARG . 1.0 OUTLIER -127.86 16.52 6.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.804 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -143.59 176.32 9.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.42 158.33 13.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.061 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.485 ' CD2' HD11 ' A' ' 265' ' ' ILE . 98.3 m-85 -117.86 146.61 43.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.789 HG11 ' CD2' ' A' ' 251' ' ' PHE . 21.0 t -130.41 119.64 46.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -98.2 147.51 24.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.734 ' CE1' HD12 ' A' ' 233' ' ' LEU . 38.5 m-85 -126.15 171.74 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.4 ' C ' ' OD1' ' A' ' 275' ' ' ASN . 13.2 t -79.13 -41.58 28.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.403 ' O ' ' OD1' ' A' ' 278' ' ' ASP . 5.9 m-20 -135.48 170.25 16.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.902 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 280' ' ' VAL . 3.8 ttp85 -74.36 -36.05 63.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 278' ' ' ASP . 12.1 pt-20 -53.04 -52.5 58.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.433 ' N ' ' HG3' ' A' ' 277' ' ' GLU . 7.4 p-10 -70.07 -47.32 62.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.585 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -51.14 -49.67 60.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.122 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 276' ' ' ARG . 84.4 t -65.45 -52.93 45.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.093 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -47.19 -41.69 18.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.834 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.46 -40.05 77.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.0 ttp -50.37 -54.2 23.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -68.45 -42.1 79.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.883 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -51.18 -54.38 26.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.064 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.569 HD13 ' CE1' ' A' ' 251' ' ' PHE . 42.1 mt -78.4 -41.53 32.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 286' ' ' LEU . 9.5 t30 -35.99 109.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 98.15 34.26 5.44 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 38.3 mmtt -112.63 147.33 36.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 89.6 t -114.39 97.92 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.576 HD11 ' HG3' ' A' ' 250' ' ' GLU . 41.6 mt -96.06 153.72 17.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.2 t0 42.97 24.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 75.66 38.0 38.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 33.1 p -146.43 133.93 10.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.659 0.742 . . . . 0.0 110.877 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 92.78 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.476 HD13 HD12 ' A' ' 291' ' ' LEU . 6.9 pt -81.32 146.2 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.121 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.403 ' O ' HG13 ' A' ' 235' ' ' VAL . 27.3 tt0 -112.19 156.59 22.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 20.8 t -143.77 115.1 2.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.12 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 29.4 p -138.5 172.94 12.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 232' ' ' ILE . 6.8 mt -88.88 100.34 13.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.837 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -70.61 137.68 50.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.109 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.584 0.707 . . . . 0.0 110.921 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 42.0 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.917 0.389 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.22 129.62 62.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.156 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' A' ' 276' ' ' ARG . 1.6 pttm -131.35 116.79 18.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 96.8 mt -147.92 142.32 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.149 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.766 HD12 ' CE1' ' A' ' 273' ' ' PHE . 92.3 mt -127.08 111.72 14.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.721 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 35.1 t80 -91.98 132.36 36.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.619 HG11 HD21 ' A' ' 238' ' ' LEU . 55.6 t -116.24 142.39 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.136 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -132.35 170.34 15.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 295' ' ' PRO . 28.1 t-20 62.31 49.21 4.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.619 HD21 HG11 ' A' ' 235' ' ' VAL . 39.4 mt -102.95 115.39 30.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.93 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 6.2 mtt -56.67 122.91 13.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 266' ' ' ARG . 38.6 mt -45.16 -33.12 2.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.939 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 13.3 t -63.22 -39.27 94.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.842 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 52.1 m -58.46 142.47 48.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.166 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 49.8 m -111.71 168.0 9.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.852 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 244' ' ' GLU . 1.2 mp0 -56.25 -46.87 79.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.911 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -43.31 -37.09 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.5 mmt -70.37 -45.03 66.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.856 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 48.9 mt -65.02 -40.18 88.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -67.51 -60.91 2.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 8.1 ptpt -45.85 -46.23 15.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.467 ' HG3' HD21 ' A' ' 291' ' ' LEU . 23.0 mm-40 -59.38 -69.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.486 ' CE1' HD13 ' A' ' 286' ' ' LEU . 16.1 m-85 -49.34 -24.19 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 253' ' ' ASN . 3.6 m-20 -73.3 -44.82 58.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 249' ' ' LYS . 6.8 m120 -36.36 -49.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.913 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 45.2 mm -47.95 -62.43 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -139.51 135.02 16.63 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.539 0.685 . . . . 0.0 110.934 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 127.44 14.63 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.684 2.256 . . . . 0.0 112.386 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 67.23 38.89 92.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.52 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -104.04 -43.67 5.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 251' ' ' PHE . 21.7 t -72.62 112.57 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -70.55 -64.61 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 262' ' ' VAL . 0.5 OUTLIER -140.83 165.05 28.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' A' ' 261' ' ' ARG . 40.3 t -140.2 113.98 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -101.53 107.4 18.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -79.83 143.28 34.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.758 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.3 mt -133.97 172.41 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.663 ' H ' HG22 ' A' ' 265' ' ' ILE . 12.7 mmm180 -31.34 -73.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -125.36 18.8 8.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.758 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -148.03 177.75 9.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.72 174.05 9.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.116 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -130.69 143.6 50.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.483 HG11 ' CD2' ' A' ' 251' ' ' PHE . 70.0 t -127.07 123.03 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -102.47 155.42 18.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.766 ' CE1' HD12 ' A' ' 233' ' ' LEU . 37.8 m-85 -132.65 177.67 7.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.418 ' C ' ' HE3' ' A' ' 231' ' ' LYS . 78.8 p -89.11 -14.14 36.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.822 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.427 ' N ' ' HD2' ' A' ' 231' ' ' LYS . 11.1 p30 -162.03 147.19 12.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.473 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 27.5 ttt180 -55.25 -45.83 76.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.889 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -40.82 -56.29 2.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -63.78 -48.32 77.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.435 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -48.25 -45.52 34.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.2 -59.1 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -46.74 -43.91 18.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.0 -34.56 73.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 59.4 ttp -53.33 -66.4 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -62.61 -37.76 87.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -46.47 -55.85 6.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.06 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.486 HD13 ' CE1' ' A' ' 251' ' ' PHE . 46.7 mt -80.61 -36.61 32.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 286' ' ' LEU . 22.9 t-20 -36.88 103.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 104.91 31.33 4.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -111.79 156.65 21.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.836 0.35 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.09 96.36 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.139 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 1.047 HD12 HD13 ' A' ' 296' ' ' ILE . 32.2 mt -90.33 153.96 20.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 291' ' ' LEU . 7.7 t70 37.48 39.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.868 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 61.98 43.97 98.45 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.493 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 291' ' ' LEU . 1.8 m -152.42 138.26 11.6 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.661 0.743 . . . . 0.0 110.841 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.401 ' O ' ' OD1' ' A' ' 237' ' ' ASN . 53.4 Cg_endo -69.8 100.78 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 1.047 HD13 HD12 ' A' ' 291' ' ' LEU . 8.3 pt -93.62 145.46 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -117.79 157.27 26.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 6.3 t -146.05 121.77 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 82.6 p -144.05 175.27 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 232' ' ' ILE . 8.7 mt -87.11 102.6 14.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.954 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.721 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -66.27 138.61 57.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.072 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 24.1 tttm . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.613 0.72 . . . . 0.0 110.902 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 57.3 m . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.939 0.399 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.54 132.55 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.428 ' HD3' ' C ' ' A' ' 275' ' ' ASN . 0.1 OUTLIER -131.22 116.91 18.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.613 ' O ' HD23 ' A' ' 233' ' ' LEU . 55.0 mt -147.86 141.33 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.098 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 232' ' ' ILE . 15.4 mt -124.25 105.09 9.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.831 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 6.5 t80 -91.21 125.12 35.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.402 ' CG1' HD11 ' A' ' 238' ' ' LEU . 23.4 t -106.35 135.75 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 234' ' ' TYR . 21.8 ptt180 -128.66 170.88 12.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 295' ' ' PRO . 6.9 t30 62.84 43.46 7.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.402 HD11 ' CG1' ' A' ' 235' ' ' VAL . 15.3 mt -100.83 140.81 34.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . 0.408 ' CE ' ' HB2' ' A' ' 294' ' ' SER . 20.3 mmt -80.14 141.07 36.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 266' ' ' ARG . 37.1 mt -53.72 -28.54 34.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.929 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.4 m -66.88 -25.31 66.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.923 HG23 ' SD ' ' A' ' 246' ' ' MET . 39.6 m -65.82 144.11 57.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.106 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.3 t -128.77 150.92 50.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.42 ' CG ' ' HB2' ' A' ' 264' ' ' LYS . 79.2 mt-10 -46.89 -20.82 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.861 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -66.7 -68.77 0.35 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.923 ' SD ' HG23 ' A' ' 242' ' ' THR . 20.2 ptm -53.12 -37.08 61.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 77.8 mt -61.44 -50.87 78.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.112 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.472 ' HG2' ' ND2' ' A' ' 252' ' ' ASN . 3.4 tt0 -59.37 -64.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.486 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 13.9 pttt -39.47 -46.09 1.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.486 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 33.6 mm-40 -57.82 -51.81 68.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.862 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.866 ' CE2' HG21 ' A' ' 271' ' ' VAL . 4.8 m-85 -61.76 -56.12 22.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.472 ' ND2' ' HG2' ' A' ' 248' ' ' GLU . 5.7 m-80 -54.32 -40.07 67.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -48.04 -31.35 5.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.548 HD12 ' HB1' ' A' ' 285' ' ' ALA . 29.2 mm -68.76 -54.24 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.157 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -142.27 120.3 7.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.58 0.705 . . . . 0.0 110.894 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 121.91 8.61 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.367 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 84.25 37.82 10.68 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -118.13 -43.84 2.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.336 . . . . 0.0 111.05 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 41.5 t -74.73 136.65 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.153 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . 0.408 ' HB3' ' NH1' ' A' ' 261' ' ' ARG . 65.1 mm-40 -100.08 -62.02 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . 0.475 ' CD ' ' HB2' ' A' ' 272' ' ' HIS . 0.1 OUTLIER -143.67 153.59 42.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.9 t -122.65 147.35 26.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -136.18 110.74 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.919 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . 0.42 ' HB2' ' CG ' ' A' ' 244' ' ' GLU . 11.0 tptm -87.58 144.8 26.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.815 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.7 mt -136.12 172.35 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.148 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.663 ' H ' HG22 ' A' ' 265' ' ' ILE . 18.9 mmt180 -31.55 -72.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.08 14.13 7.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.815 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -140.82 176.88 8.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.14 179.1 7.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.11 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.466 ' CE2' ' HB2' ' A' ' 234' ' ' TYR . 95.7 m-85 -144.29 148.94 35.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.866 HG21 ' CE2' ' A' ' 251' ' ' PHE . 3.1 t -135.54 123.12 36.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.141 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . 0.475 ' HB2' ' CD ' ' A' ' 261' ' ' ARG . 3.9 m-70 -97.8 150.74 20.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -126.92 176.87 6.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.895 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.8 t -97.52 -25.93 14.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.428 ' C ' ' HD3' ' A' ' 231' ' ' LYS . 7.6 m-80 -144.83 135.19 24.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 277' ' ' GLU . 14.0 ttt180 -45.53 -54.33 7.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 276' ' ' ARG . 62.9 mm-40 -37.01 -56.03 0.9 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.51 -47.89 83.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.94 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -54.86 -40.59 69.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.58 -42.99 90.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -65.39 -51.52 59.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.84 -38.72 79.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.075 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 47.4 ttp -52.23 -66.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.424 ' HA ' ' CB ' ' A' ' 287' ' ' ASN . 40.1 mtmt -58.79 -48.75 80.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.548 ' HB1' HD12 ' A' ' 254' ' ' ILE . . . -36.53 -52.65 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.684 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 73.4 mt -85.75 -29.24 24.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . 0.424 ' CB ' ' HA ' ' A' ' 284' ' ' LYS . 19.1 t-20 -42.53 95.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 112.08 29.63 3.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.494 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -108.52 155.9 20.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.828 0.347 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 75.5 t -118.02 109.59 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.548 ' HB3' ' HE1' ' A' ' 246' ' ' MET . 26.9 mt -106.54 153.24 22.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 42.53 29.16 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 71.99 42.55 51.75 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.506 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.408 ' HB2' ' CE ' ' A' ' 239' ' ' MET . 10.9 t -153.78 140.03 12.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.626 0.727 . . . . 0.0 110.866 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.491 ' O ' ' ND2' ' A' ' 237' ' ' ASN . 53.6 Cg_endo -69.78 98.56 0.7 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.727 2.285 . . . . 0.0 112.306 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.488 HD13 HD12 ' A' ' 291' ' ' LEU . 8.1 pt -86.14 147.45 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.126 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -121.77 153.33 38.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.423 HG21 ' HB2' ' A' ' 286' ' ' LEU . 8.4 t -135.32 119.2 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.174 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 16.3 p -137.8 168.11 20.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 232' ' ' ILE . 11.1 mt -83.87 100.1 10.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.831 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -71.11 138.45 49.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.079 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 15.5 pttm . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.596 0.712 . . . . 0.0 110.891 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.949 0.404 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.1 132.39 60.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.131 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.42 ' HD2' ' N ' ' A' ' 275' ' ' ASN . 4.3 pttm -131.49 117.02 18.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.638 ' O ' HD23 ' A' ' 300' ' ' LEU . 92.2 mt -147.93 138.88 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.149 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.665 HD12 ' CE1' ' A' ' 273' ' ' PHE . 68.6 mt -122.8 108.93 13.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.686 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 14.3 t80 -92.37 124.22 36.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.98 143.29 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.123 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -134.6 165.62 24.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 72.16 39.97 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.7 mt -99.15 115.87 30.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.4 mtt -56.21 130.78 45.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.662 HD23 ' O ' ' A' ' 266' ' ' ARG . 46.1 mt -44.68 -39.05 4.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 30.9 m -56.98 -36.77 70.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 24.6 m -60.86 137.4 58.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.177 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.7 m -113.9 170.39 8.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.834 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 247' ' ' ILE . 25.8 mt-10 -53.68 -52.59 59.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -40.03 -47.83 2.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.4 mtt -60.24 -37.94 81.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 244' ' ' GLU . 55.7 mt -73.75 -36.43 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.11 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.498 ' O ' ' ND2' ' A' ' 252' ' ' ASN . 16.8 tt0 -70.66 -46.77 62.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.477 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 4.6 ptmm? -62.91 -47.98 80.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.917 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.484 ' OE1' HD21 ' A' ' 291' ' ' LEU . 25.8 mm-40 -56.08 -54.8 40.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.546 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 10.2 m-85 -63.28 -47.47 82.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 248' ' ' GLU . 1.1 m-80 -54.73 -46.9 74.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -38.1 -48.35 1.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.861 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.436 HD12 ' HB1' ' A' ' 285' ' ' ALA . 48.2 mm -48.35 -57.95 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.121 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -141.06 128.19 11.87 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.564 0.697 . . . . 0.0 110.902 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 120.19 7.01 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.717 2.278 . . . . 0.0 112.311 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 76.39 34.54 45.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.515 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -104.32 -34.23 8.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 0.0 111.102 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 74.4 t -80.75 149.04 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -106.42 -59.21 1.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 261' ' ' ARG . 4.8 ptp180 -151.73 155.62 38.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.879 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.21 152.28 37.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.106 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -140.78 109.79 6.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 11.4 tptp -79.68 141.76 36.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.764 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.5 mt -132.33 172.52 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.115 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.673 ' H ' HG22 ' A' ' 265' ' ' ILE . 13.9 mmm180 -31.39 -72.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 0.5 OUTLIER -126.8 17.26 7.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.764 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -145.14 176.13 9.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -165.87 158.95 15.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.135 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.449 ' CD2' HD11 ' A' ' 265' ' ' ILE . 96.8 m-85 -117.57 151.53 36.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 57.8 t -139.44 134.4 39.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.121 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -113.57 157.99 21.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.824 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.665 ' CE1' HD12 ' A' ' 233' ' ' LEU . 30.4 m-85 -132.86 173.37 11.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.403 ' O ' ' ND2' ' A' ' 275' ' ' ASN . 43.4 t -81.49 -18.4 45.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.825 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.42 ' N ' ' HD2' ' A' ' 231' ' ' LYS . 4.8 m120 -157.12 159.4 37.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -61.73 -48.31 81.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -48.21 -44.25 32.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -65.28 -51.42 60.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . 0.547 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -56.04 -39.02 71.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.087 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.446 ' CG1' ' HE3' ' A' ' 284' ' ' LYS . 77.8 t -67.87 -47.94 77.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -59.08 -48.12 82.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.0 -34.82 76.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.2 ttp -60.38 -58.92 6.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.446 ' HE3' ' CG1' ' A' ' 280' ' ' VAL . 84.4 mttt -63.62 -28.35 69.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.436 ' HB1' HD12 ' A' ' 254' ' ' ILE . . . -65.42 -49.59 68.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.546 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 55.1 mt -85.21 -17.48 36.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.957 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -57.01 109.55 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 97.32 32.79 6.21 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.523 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -112.0 154.81 24.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.909 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 87.4 t -117.81 96.61 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.586 HD12 HD13 ' A' ' 296' ' ' ILE . 25.3 mt -92.73 152.0 19.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 41.77 25.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.21 43.52 25.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.499 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.1 t -154.75 137.62 10.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.692 0.758 . . . . 0.0 110.852 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 97.45 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.699 2.266 . . . . 0.0 112.329 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.586 HD13 HD12 ' A' ' 291' ' ' LEU . 7.9 pt -85.96 144.07 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.152 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -115.59 141.95 47.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' A' ' 286' ' ' LEU . 3.1 t -128.92 111.3 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 63.8 p -132.92 178.97 6.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 232' ' ' ILE . 10.2 mt -95.79 110.22 22.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.686 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -65.79 145.78 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 121.566 0.698 . . . . 0.0 110.916 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 93.4 p . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.899 0.381 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.1 130.46 68.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.135 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.428 ' HD2' ' CA ' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -130.47 116.64 18.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.915 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.419 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 56.8 mt -147.9 125.19 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.177 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 16.1 mt -115.6 112.09 21.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.638 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 51.3 t80 -91.88 121.45 33.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.585 HG11 HD21 ' A' ' 238' ' ' LEU . 34.3 t -108.67 121.9 62.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.163 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.424 ' HB2' ' CE2' ' A' ' 234' ' ' TYR . 28.3 ttt180 -115.64 160.31 20.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.42 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 28.8 t-20 71.55 48.35 0.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.585 HD21 HG11 ' A' ' 235' ' ' VAL . 19.8 mt -102.08 124.32 47.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 8.0 mmt -60.17 141.5 55.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 266' ' ' ARG . 26.3 mt -65.55 -24.09 67.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 34.2 m -82.99 16.0 2.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 23.0 m -102.83 141.36 35.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.124 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 67.7 m -111.11 147.68 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -43.52 -46.75 7.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -39.88 -46.24 1.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 12.1 mtt -62.6 -43.45 98.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 59.2 mt -64.52 -36.76 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.143 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -68.49 -57.29 6.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.911 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 18.6 pttt -52.33 -46.86 66.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.51 ' O ' ' ND2' ' A' ' 253' ' ' ASN . 19.3 mm-40 -55.99 -51.29 68.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.889 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.489 ' CE2' HG21 ' A' ' 271' ' ' VAL . 8.2 m-85 -72.7 -20.3 61.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -90.65 -11.03 41.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 250' ' ' GLU . 16.9 p30 -72.47 -17.92 61.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.547 ' H ' HD12 ' A' ' 254' ' ' ILE . 4.9 mp -79.47 -55.9 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.108 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -143.56 125.66 8.5 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.538 0.685 . . . . 0.0 110.903 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 120.23 7.05 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 87.09 33.41 12.11 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.423 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -108.74 -54.95 2.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 111.081 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.57 142.42 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -102.94 -61.79 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -144.92 152.99 41.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.68 127.85 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -119.08 104.7 10.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . 0.417 ' HZ3' HD13 ' A' ' 238' ' ' LEU . 9.9 tptp -79.4 145.14 33.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.759 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.3 mt -135.86 172.43 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.158 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.668 ' H ' HG22 ' A' ' 265' ' ' ILE . 39.9 mmm-85 -31.34 -74.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 8.4 p-10 -125.36 22.25 7.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.759 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.4 OUTLIER -151.52 177.01 10.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.9 171.37 14.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.093 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -135.58 134.51 39.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.891 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.489 HG21 ' CE2' ' A' ' 251' ' ' PHE . 39.4 t -120.16 129.82 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -104.85 155.34 19.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.412 ' C ' ' HG3' ' A' ' 231' ' ' LYS . 43.7 m-85 -136.41 -176.02 4.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.924 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 30.8 t -88.89 -31.86 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.428 ' CA ' ' HD2' ' A' ' 231' ' ' LYS . 2.7 m120 -152.17 144.65 24.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.988 ' O ' HG23 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -50.07 -29.46 8.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -54.42 -62.7 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -59.77 -39.11 83.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -64.11 -35.89 82.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.102 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.988 HG23 ' O ' ' A' ' 276' ' ' ARG . 97.2 t -68.55 -39.59 80.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.194 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -68.46 -51.4 43.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.7 -40.48 72.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.09 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.1 ttp -60.8 -45.78 93.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -75.02 -19.26 60.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -78.39 -39.15 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 41.3 mt -95.82 -21.27 18.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -48.67 96.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 113.79 30.84 2.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.444 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -107.48 160.16 15.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.809 0.338 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 58.6 t -123.46 107.92 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.107 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.428 HD11 ' HG3' ' A' ' 250' ' ' GLU . 34.7 mt -102.86 153.25 20.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 41.83 26.62 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.76 38.52 49.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.476 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 291' ' ' LEU . 23.7 p -146.4 137.39 12.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.687 0.756 . . . . 0.0 110.833 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.42 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.5 Cg_endo -69.8 101.79 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.718 2.279 . . . . 0.0 112.323 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 12.0 pt -90.65 147.75 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.36 133.42 52.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 28.2 t -115.36 116.77 53.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.111 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 28.7 p -131.16 169.23 16.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 10.9 mt -88.71 99.98 12.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.638 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -68.98 137.49 53.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 23.9 pttt . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 121.546 0.688 . . . . 0.0 110.913 179.974 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 79.3 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.945 0.402 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.5 p -110.8 137.91 41.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.164 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -135.14 116.88 15.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.488 ' O ' HD23 ' A' ' 233' ' ' LEU . 36.0 mt -147.98 136.55 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.121 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 232' ' ' ILE . 11.5 mt -120.64 108.11 13.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.786 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 17.9 t80 -91.18 129.04 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.2 135.76 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.128 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -129.26 163.04 26.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.834 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 7.9 t30 70.91 48.07 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 21.2 mt -103.28 123.09 46.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.1 mmt -60.88 123.33 17.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 266' ' ' ARG . 38.1 mt -45.73 -29.03 1.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 9.9 t -65.21 -37.6 87.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.449 HG22 ' N ' ' A' ' 243' ' ' SER . 35.1 m -58.82 156.35 11.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.127 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.449 ' N ' HG22 ' A' ' 242' ' ' THR . 58.3 m -128.8 167.9 16.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 247' ' ' ILE . 7.5 mp0 -54.42 -54.26 43.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 244' ' ' GLU . 41.6 tp10 -37.95 -39.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 5.8 mtt -71.18 -40.39 71.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 244' ' ' GLU . 44.3 mt -68.05 -40.46 83.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.122 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 18.8 tt0 -70.27 -56.23 7.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 0.0 OUTLIER -49.21 -46.55 45.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.904 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.485 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 39.2 mm-40 -60.74 -51.35 69.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 5.3 m-85 -65.86 -25.46 67.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 22.6 m120 -70.06 -46.47 64.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.868 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 252' ' ' ASN . 74.8 m-20 -36.2 -41.87 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 26.0 mm -56.44 -63.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.489 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 4.2 tppt? -141.89 136.42 15.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.6 0.714 . . . . 0.0 110.898 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.489 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 53.6 Cg_endo -69.78 132.56 23.55 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.715 2.277 . . . . 0.0 112.326 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 61.83 37.02 93.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.52 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 255' ' ' LYS . . . -99.16 -43.72 6.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.838 0.351 . . . . 0.0 111.162 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.416 HG11 ' CG2' ' A' ' 262' ' ' VAL . 96.6 t -70.14 118.33 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.108 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -78.53 -57.58 3.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -144.14 149.45 36.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.425 HG22 HG13 ' A' ' 271' ' ' VAL . 69.0 t -133.13 111.57 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.125 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -107.32 117.63 34.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -86.53 142.19 28.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.8 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.5 mt -131.12 172.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.685 ' H ' HG22 ' A' ' 265' ' ' ILE . 70.9 mtm-85 -30.1 -73.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.82 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.48 0.15 8.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.8 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -124.25 176.47 6.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -160.52 172.99 16.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.18 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.558 ' CE2' HD11 ' A' ' 265' ' ' ILE . 68.1 m-85 -136.37 135.4 38.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.544 HG11 ' CD2' ' A' ' 251' ' ' PHE . 8.1 t -130.16 126.08 61.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -103.36 159.3 15.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.415 ' HE1' HD12 ' A' ' 233' ' ' LEU . 34.9 m-85 -133.53 168.18 19.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.826 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.1 t -75.72 -39.2 57.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.467 ' N ' ' OD1' ' A' ' 275' ' ' ASN . 4.6 p-10 -139.58 149.07 43.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.938 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' A' ' 277' ' ' GLU . 15.2 ttt180 -51.35 -55.14 20.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.848 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 276' ' ' ARG . 5.8 mp0 -35.12 -60.28 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -55.75 -52.53 63.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -48.28 -45.62 34.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.094 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.613 HG12 ' HE2' ' A' ' 284' ' ' LYS . 86.6 t -59.21 -51.83 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.25 -54.1 41.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.89 -30.86 68.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . 0.445 ' O ' ' CB ' ' A' ' 287' ' ' ASN . 66.0 ttp -65.78 -57.33 8.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.613 ' HE2' HG12 ' A' ' 280' ' ' VAL . 42.8 mtmt -68.78 -32.68 72.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -62.08 -56.51 18.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.084 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.633 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 35.0 mt -76.17 -35.83 58.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 283' ' ' MET . 6.1 t-20 -41.81 106.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 100.59 37.5 3.72 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.473 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -114.17 153.19 30.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.856 0.36 . . . . 0.0 110.893 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 81.9 t -117.93 94.51 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.144 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.455 HD12 HD13 ' A' ' 296' ' ' ILE . 37.9 mt -94.46 153.59 17.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 41.88 25.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.84 38.51 36.16 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.542 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 291' ' ' LEU . 31.8 p -146.34 133.12 9.89 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.661 0.744 . . . . 0.0 110.821 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 86.19 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.687 2.258 . . . . 0.0 112.333 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.455 HD13 HD12 ' A' ' 291' ' ' LEU . 6.9 pt -72.95 149.63 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.141 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -118.82 156.43 29.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 20.2 t -143.6 118.51 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 60.6 p -143.55 162.79 34.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.187 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 9.3 mt -77.39 100.05 5.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.786 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -67.66 112.86 5.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.077 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 27.1 mttp . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 121.621 0.724 . . . . 0.0 110.923 179.963 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 96.0 p . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.931 0.396 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.473 ' O ' ' CD ' ' A' ' 276' ' ' ARG . 0.9 OUTLIER -119.68 139.8 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.123 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.452 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -133.56 116.73 16.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.4 mt -147.94 132.35 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.106 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 12.2 mt -115.48 109.13 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.888 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.538 ' CE2' ' HB3' ' A' ' 236' ' ' ARG . 12.9 t80 -91.49 134.12 34.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.42 HG11 HD21 ' A' ' 238' ' ' LEU . 22.7 t -120.91 131.07 73.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.18 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.538 ' HB3' ' CE2' ' A' ' 234' ' ' TYR . 14.6 ptt180 -123.47 163.39 20.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.4 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 38.6 t-20 69.84 50.79 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.439 HD12 ' CA ' ' A' ' 268' ' ' TYR . 11.8 mt -108.52 121.54 45.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.944 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 24.2 mtt -60.2 134.86 57.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 266' ' ' ARG . 19.5 mt -53.94 -26.84 27.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 64.0 p -65.03 -40.31 94.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . 0.441 ' O ' ' NZ ' ' A' ' 264' ' ' LYS . 52.1 m -59.46 147.9 34.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 59.5 m -121.17 164.19 17.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 247' ' ' ILE . 35.2 mt-10 -52.95 -54.38 35.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 244' ' ' GLU . 27.3 tt0 -36.81 -43.42 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.427 ' HA ' ' NZ ' ' A' ' 249' ' ' LYS . 9.5 mtp -63.63 -45.93 88.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 244' ' ' GLU . 28.4 mt -64.07 -29.39 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.149 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -71.27 -54.4 11.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 4.4 ptpp? -58.29 -41.82 85.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 17.4 mm-40 -61.94 -54.0 47.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.516 ' CE1' HD13 ' A' ' 286' ' ' LEU . 6.8 m-85 -68.21 -28.27 67.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.879 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . 0.445 ' OD1' HG21 ' A' ' 259' ' ' VAL . 4.6 m-20 -81.76 -23.9 36.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -59.97 -31.44 69.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.628 HD12 ' HB1' ' A' ' 285' ' ' ALA . 13.2 mm -66.44 -56.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.146 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -142.84 131.88 11.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.549 0.69 . . . . 0.0 110.934 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 133.65 26.07 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.717 2.278 . . . . 0.0 112.306 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 65.61 39.83 95.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.475 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -110.72 -27.04 9.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.756 0.312 . . . . 0.0 111.048 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.445 HG21 ' OD1' ' A' ' 252' ' ' ASN . 75.8 t -91.77 128.75 43.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.134 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -89.23 -54.66 4.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 30.5 ptt85 -151.11 150.74 31.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.87 138.44 54.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 33.4 tttp -132.95 115.96 15.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . 0.441 ' NZ ' ' O ' ' A' ' 242' ' ' THR . 17.0 tptm -86.48 146.73 26.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.82 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.7 mt -134.28 172.08 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.142 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.66 ' H ' HG22 ' A' ' 265' ' ' ILE . 21.7 mmm180 -31.96 -72.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -125.82 15.71 8.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.82 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -143.33 177.75 8.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.95 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -165.14 167.05 18.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.062 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.514 ' CD2' HD11 ' A' ' 265' ' ' ILE . 89.9 m-85 -130.6 143.68 50.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 40.5 t -135.11 126.61 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -102.24 153.89 19.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -125.83 -177.66 4.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.0 t -91.89 -31.62 15.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.869 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -144.51 156.51 44.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.473 ' CD ' ' O ' ' A' ' 230' ' ' VAL . 1.5 tpp85 -52.62 -67.06 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 276' ' ' ARG . 67.7 mm-40 -35.6 -57.84 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -47.93 -52.23 20.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -58.98 -46.67 87.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.99 -48.49 84.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.113 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.44 -53.51 57.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.63 -31.97 71.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 58.2 ttp -59.59 -53.96 51.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 285' ' ' ALA . 85.5 mttt -68.68 -53.23 23.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.628 ' HB1' HD12 ' A' ' 254' ' ' ILE . . . -36.55 -43.53 0.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.106 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.516 HD13 ' CE1' ' A' ' 251' ' ' PHE . 49.0 mt -90.56 -39.95 12.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.859 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 286' ' ' LEU . 20.7 t-20 -36.3 113.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 93.28 33.62 7.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.476 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -109.95 160.79 16.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 25.3 t -122.42 101.73 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.074 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.82 HD12 HD13 ' A' ' 296' ' ' ILE . 29.8 mt -99.1 154.2 18.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.8 p30 39.59 28.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 71.98 40.85 56.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.486 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 291' ' ' LEU . 1.9 m -149.23 137.5 11.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.681 0.753 . . . . 0.0 110.877 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . 0.4 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.8 Cg_endo -69.81 99.19 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.82 HD13 HD12 ' A' ' 291' ' ' LEU . 7.2 pt -90.69 147.85 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -118.62 155.89 30.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.1 119.54 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.169 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 80.4 p -139.85 174.63 10.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.83 118.28 26.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.46 151.69 39.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 16.0 pttp . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.586 0.708 . . . . 0.0 110.86 -179.973 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.86 0.362 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.457 ' O ' ' CD ' ' A' ' 276' ' ' ARG . 1.1 p -121.72 132.72 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.147 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 116.9 18.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.626 ' O ' HD23 ' A' ' 300' ' ' LEU . 69.9 mt -147.92 151.23 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.166 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.799 HD12 ' CE1' ' A' ' 273' ' ' PHE . 85.9 mt -136.8 110.12 7.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.558 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 23.9 t80 -91.18 129.42 37.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.1 126.96 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.11 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.538 ' HB3' ' CE2' ' A' ' 234' ' ' TYR . 23.6 ptt85 -120.17 169.72 9.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 63.94 47.77 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 64.3 mt -104.43 131.93 51.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . 0.494 ' CB ' ' OD2' ' A' ' 292' ' ' ASP . 8.7 mmt -71.25 132.09 44.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 266' ' ' ARG . 62.8 mt -50.27 -29.11 8.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.951 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 72.7 m -63.71 -33.26 75.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.86 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 87.4 m -66.5 138.04 57.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.103 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.2 m -117.77 164.77 14.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.825 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 245' ' ' GLU . 17.4 mt-10 -44.49 -60.47 1.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 244' ' ' GLU . 30.7 tt0 -34.86 -62.23 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 25.9 mmm -40.33 -56.96 1.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 250' ' ' GLU . 36.8 mt -62.94 -65.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -39.55 -34.4 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.835 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -77.99 -38.94 43.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 247' ' ' ILE . 21.4 mm-40 -66.08 -48.5 70.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.465 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 15.1 m-85 -67.24 -42.13 84.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -61.88 -40.67 96.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -42.74 -42.17 3.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 31.9 mm -55.64 -58.7 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.427 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 10.6 tppt? -142.82 135.03 13.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.585 0.707 . . . . 0.0 110.889 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.427 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 54.3 Cg_endo -69.73 133.64 26.1 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.673 2.249 . . . . 0.0 112.354 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 65.9 39.02 94.8 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.507 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -103.33 -55.23 2.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.855 0.36 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 251' ' ' PHE . 58.0 t -69.6 114.98 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.085 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -74.2 -55.97 5.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -150.61 144.22 25.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.2 t -121.84 119.41 58.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -105.77 108.87 20.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -79.42 143.44 35.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.737 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.7 mt -135.66 172.8 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.117 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.676 ' H ' HG22 ' A' ' 265' ' ' ILE . 21.1 mmt180 -30.17 -72.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 4.4 p-10 -128.29 20.35 6.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' TYR . . . . . 0.737 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -148.37 173.08 13.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -160.92 163.09 32.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' PHE . . . . . 0.471 ' CD2' HD11 ' A' ' 265' ' ' ILE . 92.6 m-85 -122.81 136.42 54.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.868 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.456 HG13 HG13 ' A' ' 259' ' ' VAL . 42.3 t -123.13 129.04 75.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.098 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -102.43 159.21 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.799 ' CE1' HD12 ' A' ' 233' ' ' LEU . 29.7 m-85 -137.19 -178.62 5.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.7 m -98.65 -28.28 13.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.841 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -145.95 147.68 31.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.891 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.579 HH21 HD22 ' A' ' 300' ' ' LEU . 1.3 tpt180 -50.52 -61.72 2.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 276' ' ' ARG . 27.8 mt-10 -36.62 -50.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.83 -57.83 10.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -54.83 -37.6 66.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.701 HG12 ' HE2' ' A' ' 284' ' ' LYS . 76.7 t -65.77 -47.26 86.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.171 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.21 -50.4 73.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.26 -26.2 68.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.081 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.0 ttp -64.01 -67.64 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.701 ' HE2' HG12 ' A' ' 280' ' ' VAL . 26.7 mtmt -59.79 -29.29 68.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -56.31 -55.67 30.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.085 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.465 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 60.7 mt -81.54 -30.64 33.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -40.31 104.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 105.52 20.54 9.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -97.48 154.9 17.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.339 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 98.3 t -122.09 98.17 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.104 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.402 HD12 HD13 ' A' ' 296' ' ' ILE . 32.1 mt -94.57 153.69 17.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.494 ' OD2' ' CB ' ' A' ' 239' ' ' MET . 25.0 t0 42.33 26.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.33 38.21 53.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.484 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 291' ' ' LEU . 22.4 p -146.34 134.04 10.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.63 0.729 . . . . 0.0 110.856 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 102.35 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 2.237 . . . . 0.0 112.38 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.402 HD13 HD12 ' A' ' 291' ' ' LEU . 11.4 pt -89.49 148.22 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -121.87 136.1 54.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.4 t -119.09 121.92 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.124 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 68.4 p -139.73 168.34 20.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.112 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 232' ' ' ILE . 11.7 mt -86.92 101.89 13.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -64.25 161.63 16.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.061 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' LYS . . . . . 0.409 ' HD2' ' C ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 121.569 0.699 . . . . 0.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 20.0 m -76.08 156.86 33.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 0.0 110.865 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.4 m -43.46 -50.34 7.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 108.68 -77.73 0.23 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.45 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 1.2 t -123.02 134.01 54.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 110.852 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 27.4 t -87.69 -34.5 18.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 89.46 87.69 1.27 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.491 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -174.97 173.78 2.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.717 0.294 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -130.06 108.07 9.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -76.14 -50.29 15.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 5.6 m -124.09 104.23 8.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.147 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 12.3 ptp -65.73 -34.01 77.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 2.8 m -108.82 85.34 2.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.7 p -93.59 110.27 21.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.866 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.7 p -122.48 132.99 70.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.125 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.51 116.85 18.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.503 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 63.2 mt -147.9 145.32 18.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.766 HD12 ' HE1' ' A' ' 273' ' ' PHE . 88.4 mt -133.26 109.21 9.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -91.71 133.28 35.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 23.1 t -114.58 137.44 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.106 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 32.0 ttp85 -129.78 156.13 44.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.888 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 73.83 44.28 0.28 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 25.0 mt -93.69 131.61 38.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 10.6 mmt -67.16 123.3 19.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 266' ' ' ARG . 26.0 mt -48.27 -32.01 6.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 9.5 t -66.72 -35.75 80.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 39.2 m -59.62 141.72 54.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.135 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 4.3 m -110.61 166.15 11.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 247' ' ' ILE . 29.7 mt-10 -52.27 -52.03 55.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -41.49 -43.52 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 21.2 mmm -63.99 -36.25 83.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 244' ' ' GLU . 43.0 mt -74.8 -38.31 44.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.123 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -71.13 -43.97 66.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 16.4 ptmt -63.89 -47.88 78.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.489 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 31.7 mm-40 -58.29 -46.95 85.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -72.57 -34.05 67.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.926 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -69.03 -32.22 71.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.874 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -47.02 -29.98 2.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 25.0 mm -68.2 -53.28 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -143.78 137.31 14.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.554 0.692 . . . . 0.0 110.936 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 126.24 13.11 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.682 2.255 . . . . 0.0 112.388 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 60.9 39.5 97.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.512 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -101.08 -45.13 5.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 111.12 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.24 109.93 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.14 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -61.37 -57.68 11.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . 0.4 ' HB3' ' NH1' ' A' ' 261' ' ' ARG . 1.1 ptp180 -153.34 158.05 40.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 91.1 t -132.41 115.89 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -110.31 106.95 16.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.933 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.424 ' HD3' ' CD1' ' A' ' 247' ' ' ILE . 14.7 tptm -79.51 148.56 31.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.787 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.1 mt -137.36 172.19 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.161 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.661 ' H ' HG22 ' A' ' 265' ' ' ILE . 20.1 mmt180 -31.86 -70.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.29 17.76 6.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.787 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -146.08 177.93 8.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -170.14 165.02 9.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.109 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -127.59 142.18 51.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.38 123.44 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.143 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -99.96 157.59 16.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.766 ' HE1' HD12 ' A' ' 233' ' ' LEU . 41.3 m-85 -135.0 170.83 15.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 2.4 t -84.3 -34.24 23.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -138.67 144.66 39.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.662 ' O ' HG23 ' A' ' 280' ' ' VAL . 26.4 ttt180 -55.07 -42.51 72.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -46.49 -55.26 7.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -60.32 -51.31 70.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -51.17 -42.48 60.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 276' ' ' ARG . 91.8 t -61.54 -48.57 88.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.13 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -58.33 -55.58 33.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.69 -26.72 64.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.078 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 51.2 ttp -65.5 -60.24 3.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 285' ' ' ALA . 6.1 mtmp? -65.26 -55.21 19.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.907 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 284' ' ' LYS . . . -36.4 -47.85 0.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.091 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 287' ' ' ASN . 34.3 mt -84.46 -39.71 18.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.9 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 286' ' ' LEU . 31.9 t30 -37.1 104.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 98.97 38.24 3.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.478 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -114.35 159.17 20.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.786 0.327 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 98.8 t -121.51 97.4 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.127 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.86 HD12 HD13 ' A' ' 296' ' ' ILE . 60.4 mt -92.99 153.15 18.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 291' ' ' LEU . 23.7 m-20 37.73 28.91 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.828 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 74.0 44.61 29.54 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.493 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 291' ' ' LEU . 8.2 t -155.02 134.7 7.96 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.669 0.747 . . . . 0.0 110.81 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 102.08 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.367 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.86 HD13 HD12 ' A' ' 291' ' ' LEU . 7.8 pt -93.89 144.37 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -116.66 154.71 30.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.8 t -141.26 119.4 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.162 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 76.9 p -137.88 169.44 17.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.151 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 232' ' ' ILE . 8.0 mt -83.78 108.49 16.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.503 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -66.1 140.75 58.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.35 90.55 7.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.625 0.726 . . . . 0.0 110.882 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 140.67 43.04 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.34 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 9.9 p -76.14 138.3 21.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.14 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -163.66 162.33 24.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.912 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -135.29 131.83 37.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -40.92 115.54 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 39.7 p -60.81 141.17 57.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.844 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 28.4 p -96.2 129.04 43.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -153.09 -172.56 21.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.483 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 114.72 3.8 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.717 2.278 . . . . 0.0 112.348 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 3.3 t -56.83 -50.3 72.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.852 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 66.1 m -96.03 88.24 4.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.886 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.458 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 68.5 m -90.29 169.65 10.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.909 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 25.2 t -91.82 -56.6 3.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.874 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 142.74 60.96 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.465 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 67.9 m -142.88 114.3 7.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 110.875 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 74.2 m -66.53 -34.77 78.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 66.89 150.59 0.15 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.498 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 43.56 41.93 3.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.767 0.317 . . . . 0.0 110.846 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -58.16 102.94 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.865 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -148.69 161.4 41.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 32.9 p -123.04 43.72 2.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.146 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 42.1 ttp -80.71 -50.35 10.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.849 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 3.2 m -164.76 148.14 8.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.876 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 50.9 m -71.55 98.57 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.851 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.93 134.85 60.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.2 116.58 17.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.54 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 37.6 mt -147.89 131.98 9.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 232' ' ' ILE . 15.7 mt -117.46 111.16 18.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.538 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 21.6 t80 -91.31 122.53 34.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.968 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.537 HG11 HD21 ' A' ' 238' ' ' LEU . 21.9 t -102.23 128.87 54.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.116 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 15.9 ttp85 -122.4 160.5 25.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.463 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 32.8 t-20 65.8 53.32 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.537 HD21 HG11 ' A' ' 235' ' ' VAL . 89.6 mt -106.16 131.31 53.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.906 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.9 mmt -66.33 136.99 56.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.855 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 266' ' ' ARG . 72.3 mt -56.4 -24.2 43.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 11.4 t -75.1 -26.4 59.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.429 ' HB ' ' NZ ' ' A' ' 264' ' ' LYS . 49.3 m -68.15 139.48 56.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.1 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 37.0 m -115.36 170.46 8.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.857 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 247' ' ' ILE . 48.8 mt-10 -50.95 -54.22 26.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -40.85 -48.06 3.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 2.9 mmt -55.98 -36.13 67.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 244' ' ' GLU . 40.6 mt -78.55 -46.72 24.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.115 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -60.22 -37.5 80.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 5.8 ptmt -73.47 -47.2 43.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.481 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 49.6 mm-40 -65.19 -22.78 66.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.613 ' CE1' HD13 ' A' ' 286' ' ' LEU . 7.3 m-85 -94.51 -26.32 16.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.44 ' OD1' ' CG2' ' A' ' 259' ' ' VAL . 78.6 m-20 -84.66 -18.99 33.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -59.6 -23.3 62.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 13.7 mm -75.7 -56.03 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -139.52 134.61 16.41 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.524 0.678 . . . . 0.0 110.923 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 138.09 37.09 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.679 2.253 . . . . 0.0 112.359 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 56.08 41.09 84.82 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.496 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -105.07 -53.06 2.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.86 0.362 . . . . 0.0 111.073 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.44 ' CG2' ' OD1' ' A' ' 252' ' ' ASN . 96.9 t -61.15 114.61 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.154 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -72.02 -62.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.926 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -149.07 151.45 34.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.498 HG22 HG13 ' A' ' 271' ' ' VAL . 58.0 t -128.86 151.71 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -141.47 116.2 9.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.429 ' NZ ' ' HB ' ' A' ' 242' ' ' THR . 30.1 tptt -84.88 145.94 27.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.773 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.3 mt -133.88 172.18 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.123 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.655 ' H ' HG22 ' A' ' 265' ' ' ILE . 14.4 mmm180 -31.51 -72.04 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -126.88 19.13 7.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.773 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -148.4 177.85 9.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -163.98 170.55 16.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -133.35 146.24 51.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.498 HG13 HG22 ' A' ' 262' ' ' VAL . 16.6 t -133.55 134.2 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.136 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -112.41 152.34 28.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -129.2 -177.82 4.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 41.8 t -95.45 -22.01 17.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.45 151.4 31.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.575 ' O ' HG23 ' A' ' 280' ' ' VAL . 16.2 ttt180 -62.44 -37.39 85.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -48.24 -63.49 1.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.92 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -44.88 94.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.847 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.98 -47.15 61.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 276' ' ' ARG . 85.9 t -63.87 -42.67 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -60.87 -49.26 78.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.829 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.0 -29.93 71.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.125 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 53.6 ttp -70.42 -50.37 39.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -69.97 -30.09 67.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.59 -45.1 84.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.613 HD13 ' CE1' ' A' ' 251' ' ' PHE . 41.5 mt -87.28 -27.6 22.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.436 ' OD1' ' C ' ' A' ' 287' ' ' ASN . 23.4 t-20 -48.8 108.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 97.62 33.74 5.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.505 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -113.95 151.13 32.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.932 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 86.3 t -110.05 103.47 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.162 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 1.018 HD12 HD13 ' A' ' 296' ' ' ILE . 25.1 mt -102.4 147.11 27.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 44.97 24.96 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.847 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 77.97 41.31 18.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.49 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 3.0 t -153.81 135.16 8.71 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.681 0.753 . . . . 0.0 110.836 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.463 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 54.3 Cg_endo -69.72 93.94 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 1.018 HD13 HD12 ' A' ' 291' ' ' LEU . 11.4 pt -76.64 146.51 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.114 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.629 ' OE1' HG23 ' A' ' 299' ' ' THR . 0.2 OUTLIER -122.12 135.11 54.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.908 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.79 118.21 54.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.154 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . 0.629 HG23 ' OE1' ' A' ' 297' ' ' GLU . 18.9 p -132.45 166.29 22.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.153 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.2 mt -83.77 102.87 12.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.54 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -71.16 157.33 38.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.115 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -106.71 140.93 21.83 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.586 0.708 . . . . 0.0 110.908 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 143.55 51.27 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.678 2.252 . . . . 0.0 112.34 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 90.8 t -108.85 110.42 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -156.54 134.58 11.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.852 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.76 135.22 33.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.911 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -59.2 105.22 0.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 4.6 m -73.97 154.94 39.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 59.0 p -95.45 -44.77 7.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 125.24 146.75 6.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 136.14 32.1 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.661 2.241 . . . . 0.0 112.345 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 34.0 p -71.78 -58.65 3.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 1.8 t 66.84 42.22 2.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 37.3 p -83.48 101.04 11.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.861 0.362 . . . . 0.0 110.851 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 45.6 m -88.69 -45.69 9.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.861 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 121.87 142.08 6.23 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 51.9 p -88.9 138.29 31.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 16.9 m -80.56 -29.34 37.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 101.8 -94.28 1.2 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -115.22 130.7 56.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.787 0.327 . . . . 0.0 110.896 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.44 ' N ' ' CD ' ' A' ' 224' ' ' GLU . 1.4 pm0 -142.53 174.17 10.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -128.27 102.27 6.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 82.6 p -83.34 45.3 1.02 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -97.76 -48.24 5.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 96.6 p -148.8 126.99 12.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.855 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 43.7 m -86.91 102.56 14.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.843 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.2 p -113.68 132.03 63.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.133 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.449 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -133.95 117.03 16.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.627 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 98.6 mt -147.73 139.14 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.107 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 232' ' ' ILE . 12.1 mt -121.09 107.63 12.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.751 ' CD1' ' CE1' ' A' ' 270' ' ' PHE . 33.3 t80 -91.46 121.32 33.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.19 132.23 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -119.69 155.78 31.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.409 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 38.6 t-20 70.68 52.62 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.865 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.23 126.62 52.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 22.8 mtt -71.49 139.98 49.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.622 HD23 ' O ' ' A' ' 266' ' ' ARG . 39.9 mt -55.96 -18.74 9.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.3 t -75.89 -28.59 58.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.833 HG23 ' SD ' ' A' ' 246' ' ' MET . 42.8 m -64.5 146.66 54.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 44.1 m -120.63 165.71 14.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.805 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 264' ' ' LYS . 49.0 mt-10 -64.5 -16.37 62.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -69.59 -64.02 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.833 ' SD ' HG23 ' A' ' 242' ' ' THR . 13.0 ptp -54.7 -30.87 56.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.854 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 73.1 mt -69.81 -45.13 78.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -65.53 -53.56 40.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.484 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 0.7 OUTLIER -53.32 -49.48 66.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.484 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 61.4 mm-40 -52.92 -53.46 49.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.615 ' CE2' HG21 ' A' ' 271' ' ' VAL . 5.8 m-85 -61.83 -58.49 7.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 253' ' ' ASN . 2.3 m120 -47.12 -49.1 22.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.952 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 252' ' ' ASN . 29.8 m-20 -36.65 -46.77 0.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.905 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.61 HD12 ' HB1' ' A' ' 285' ' ' ALA . 43.1 mm -51.64 -56.79 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.124 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.475 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 0.1 OUTLIER -143.95 137.06 13.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.548 0.689 . . . . 0.0 110.932 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.475 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 53.0 Cg_endo -69.82 136.75 33.64 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.63 2.22 . . . . 0.0 112.309 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 60.12 36.42 90.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -99.43 -39.15 8.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 111.13 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.5 t -90.99 132.99 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.171 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.424 ' OE1' ' N ' ' A' ' 260' ' ' GLU . 0.7 OUTLIER -94.37 -52.17 4.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . 0.481 ' HD3' ' N ' ' A' ' 262' ' ' VAL . 0.1 OUTLIER -151.23 161.75 42.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.481 ' N ' ' HD3' ' A' ' 261' ' ' ARG . 32.5 t -131.63 138.89 51.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.154 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 6.6 tppt? -123.99 113.6 18.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.839 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.409 ' HB2' ' CG ' ' A' ' 244' ' ' GLU . 13.9 tptp -87.66 143.31 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.754 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.7 mt -133.61 172.93 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.13 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.683 ' H ' HG22 ' A' ' 265' ' ' ILE . 20.4 mmt180 -30.66 -73.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.99 15.92 7.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.754 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -142.49 172.39 12.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.943 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -159.28 165.54 33.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.08 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.751 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 86.8 m-85 -128.35 149.6 50.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.615 HG21 ' CE2' ' A' ' 251' ' ' PHE . 19.8 t -132.56 123.78 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.115 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -97.15 144.24 27.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.835 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -120.4 177.52 5.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.845 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 33.4 t -90.86 -33.4 15.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.84 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -143.15 161.38 38.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 277' ' ' GLU . 11.1 ttp180 -64.49 -61.77 2.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 276' ' ' ARG . 16.1 mt-10 -35.99 -49.11 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -64.19 -50.73 66.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -53.4 -47.3 69.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.646 HG12 ' HD2' ' A' ' 284' ' ' LYS . 83.5 t -59.69 -43.12 90.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.84 -56.39 17.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.09 -38.24 67.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.124 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 65.0 ttp -60.32 -47.71 84.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.872 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.646 ' HD2' HG12 ' A' ' 280' ' ' VAL . 2.9 mtpm? -70.08 -37.6 75.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.61 ' HB1' HD12 ' A' ' 254' ' ' ILE . . . -55.19 -47.96 74.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.091 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.503 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 64.8 mt -84.6 -36.65 21.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 286' ' ' LEU . 11.3 t30 -36.74 93.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 113.03 33.82 1.93 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.475 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -110.79 157.88 19.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.806 0.336 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 91.3 t -119.8 96.13 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.837 HD12 HD13 ' A' ' 296' ' ' ILE . 31.3 mt -92.9 147.29 22.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.4 ' OD1' ' SD ' ' A' ' 246' ' ' MET . 3.2 m-20 46.64 30.47 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 69.91 43.05 67.4 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.459 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.9 m -155.05 137.35 9.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.693 0.759 . . . . 0.0 110.856 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.409 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.3 Cg_endo -69.79 108.74 2.15 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.627 2.218 . . . . 0.0 112.365 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.837 HD13 HD12 ' A' ' 291' ' ' LEU . 10.1 pt -97.54 141.72 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -112.34 143.9 42.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.847 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.07 117.84 51.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 10.5 p -132.84 167.57 19.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.209 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 9.3 mt -85.91 113.18 21.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.627 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -66.23 139.01 58.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.125 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.0 141.77 59.1 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.586 0.708 . . . . 0.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 141.7 45.69 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.701 2.267 . . . . 0.0 112.297 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 91.4 t -104.32 99.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -82.3 51.24 1.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.83 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -44.17 117.42 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.92 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -62.81 134.59 56.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 60.2 p -107.92 132.63 53.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.874 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 2.7 m -115.55 136.52 53.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 114.79 148.21 9.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.487 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 91.61 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.656 2.237 . . . . 0.0 112.352 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 7.4 t -156.93 125.2 5.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.862 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 3.5 m -58.08 176.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.907 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.526 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 74.3 m -101.05 97.73 8.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.887 0.375 . . . . 0.0 110.844 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 18.2 p -126.28 161.07 28.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.847 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 104.87 40.78 2.08 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.509 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 96.6 p -116.33 149.83 38.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.881 0.372 . . . . 0.0 110.87 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 43.9 m -101.0 -35.15 9.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 156.39 -156.1 26.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.509 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.38 118.96 33.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.748 0.309 . . . . 0.0 110.902 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -78.81 85.25 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.92 167.01 8.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 9.4 t -164.08 158.93 19.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.117 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 11.0 mmt -75.37 -51.77 12.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.936 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 24.4 m -83.17 93.18 7.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 80.1 p -109.62 107.75 17.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -116.25 132.69 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.112 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.405 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -130.72 116.9 18.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.883 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 68.5 mt -147.91 136.42 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.129 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 23.4 mt -118.57 110.16 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.595 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 28.2 t80 -93.47 125.74 38.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.907 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.472 HG11 HD21 ' A' ' 238' ' ' LEU . 21.3 t -108.83 142.52 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.089 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 7.3 ttt-85 -134.87 157.23 47.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 295' ' ' PRO . 12.2 t30 71.92 47.95 0.3 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.472 HD21 HG11 ' A' ' 235' ' ' VAL . 31.0 mt -100.99 125.34 47.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 14.3 mtt -63.75 125.73 25.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.836 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 266' ' ' ARG . 20.3 mt -50.93 -23.95 3.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.934 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 7.2 m -68.87 -33.32 73.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.529 HG23 ' SD ' ' A' ' 246' ' ' MET . 24.9 m -63.56 144.9 56.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.196 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 19.6 m -112.17 165.81 11.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.855 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.57 -46.69 80.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -45.17 -36.65 3.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.529 ' SD ' HG23 ' A' ' 242' ' ' THR . 27.5 mtt -69.53 -42.02 75.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.879 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 46.0 mt -68.89 -39.92 80.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.452 ' OE1' ' CG2' ' A' ' 262' ' ' VAL . 4.3 tp10 -64.69 -43.79 92.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.864 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 1.7 ptmm? -72.54 -46.27 55.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.528 ' CD ' HD21 ' A' ' 291' ' ' LEU . 62.3 mm-40 -56.82 -33.51 66.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.915 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.639 ' CE2' HG21 ' A' ' 271' ' ' VAL . 8.0 m-85 -87.93 -30.61 19.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -76.42 -26.91 55.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -52.72 -23.84 7.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 16.0 mm -78.19 -52.82 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -144.14 134.0 11.76 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.587 0.708 . . . . 0.0 110.924 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 142.53 48.28 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.71 2.273 . . . . 0.0 112.348 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 55.13 26.23 41.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.519 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -90.52 -53.72 4.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.333 . . . . 0.0 111.08 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.5 t -62.25 114.42 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -73.98 -60.02 2.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -150.2 146.2 26.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.87 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.452 ' CG2' ' OE1' ' A' ' 248' ' ' GLU . 61.3 t -116.92 128.84 74.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.13 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -115.63 108.41 16.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -85.22 142.17 29.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.771 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.7 mt -133.86 172.41 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.66 ' H ' HG22 ' A' ' 265' ' ' ILE . 15.6 mmt180 -31.11 -72.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.82 15.84 8.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.85 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.771 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -143.37 175.27 10.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -163.79 160.32 22.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.052 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.441 ' CD2' HD11 ' A' ' 265' ' ' ILE . 86.4 m-85 -124.56 138.15 54.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.639 HG21 ' CE2' ' A' ' 251' ' ' PHE . 3.1 t -123.12 129.58 74.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.11 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -106.69 151.74 24.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.865 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -129.73 174.62 9.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 25.4 t -80.96 -38.41 27.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.878 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -144.28 153.31 41.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 277' ' ' GLU . 21.5 ttt180 -50.87 -56.17 13.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.876 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 276' ' ' ARG . 4.9 mm-40 -35.76 -54.76 0.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -59.63 -49.93 75.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.813 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -53.05 -50.18 64.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 48.9 t -53.75 -48.9 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.121 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -59.01 -59.93 4.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.844 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.28 -18.64 6.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 56.9 ttp -78.01 -57.67 3.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -66.89 -29.56 69.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -62.42 -56.99 12.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.095 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.631 ' CD1' ' CD1' ' A' ' 251' ' ' PHE . 55.2 mt -76.71 -40.19 49.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.945 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -39.87 121.14 1.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 90.63 27.33 20.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.525 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -110.37 161.78 15.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.369 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.406 HG13 ' C ' ' A' ' 294' ' ' SER . 72.9 t -123.85 95.11 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.078 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.758 HD12 HD13 ' A' ' 296' ' ' ILE . 33.1 mt -87.07 148.01 25.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 40.6 t0 41.47 41.54 1.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.902 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 59.58 45.85 94.94 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.406 ' C ' HG13 ' A' ' 290' ' ' VAL . 2.0 t -154.62 136.59 9.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.683 0.754 . . . . 0.0 110.883 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.425 ' O ' ' ND2' ' A' ' 237' ' ' ASN . 53.6 Cg_endo -69.76 110.9 2.67 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.712 2.275 . . . . 0.0 112.306 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.758 HD13 HD12 ' A' ' 291' ' ' LEU . 10.8 pt -101.33 144.38 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.176 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -115.45 151.79 34.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 8.8 t -140.43 113.52 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 51.2 p -134.35 167.65 20.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.163 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 10.9 mt -81.54 108.87 15.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.595 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -68.92 137.41 53.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.42 90.49 5.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 0.0 110.942 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 133.41 25.54 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.661 2.241 . . . . 0.0 112.384 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 29.1 m -82.96 143.2 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.141 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -158.81 111.46 2.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.28 -44.06 53.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -50.54 110.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 309' ' ' SER . 11.2 t -72.19 120.94 18.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 308' ' ' SER . 47.3 p -37.32 108.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.836 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -174.18 83.85 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.514 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 163.88 36.59 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.656 2.237 . . . . 0.0 112.352 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 68.9 m -70.0 167.25 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 51.2 m -58.86 168.92 1.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.886 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.508 -179.926 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 39.7 t -68.24 -54.49 17.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.893 0.378 . . . . 0.0 110.877 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 2.7 t -46.74 153.14 0.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -168.87 -66.6 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 43.1 m -82.95 145.69 29.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.891 0.377 . . . . 0.0 110.863 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.6 t -62.7 -14.79 48.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.832 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 122.55 -101.81 0.75 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.509 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -135.69 124.88 24.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 110.828 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -119.4 -45.82 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 6.5 t70 57.34 30.84 19.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 9.9 t -68.61 137.94 54.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.094 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 3.9 ttp -72.87 -30.26 63.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 30.2 t -81.79 110.13 16.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 94.6 p -70.29 105.77 3.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.19 136.5 51.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.112 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.451 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -137.61 116.88 12.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.682 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 77.0 mt -147.91 140.29 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.055 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 11.4 mt -120.83 111.87 18.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.921 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.517 ' CE2' ' HB2' ' A' ' 236' ' ' ARG . 16.2 t80 -92.08 129.72 37.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.843 HG11 HD21 ' A' ' 238' ' ' LEU . 17.4 t -115.18 133.82 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.517 ' HB2' ' CE2' ' A' ' 234' ' ' TYR . 30.3 ttp85 -129.31 161.17 30.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 71.26 35.84 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.843 HD21 HG11 ' A' ' 235' ' ' VAL . 11.5 mt -91.76 122.6 34.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.496 ' CB ' ' OD2' ' A' ' 292' ' ' ASP . 4.7 mmt -57.43 139.66 52.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.495 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 40.4 mt -63.34 -7.66 6.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.885 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 37.6 m -97.44 16.64 19.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.615 HG23 ' SD ' ' A' ' 246' ' ' MET . 49.2 m -99.02 145.33 27.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 2.3 m -119.05 155.07 32.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -56.1 -15.04 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.835 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -72.58 -66.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.615 ' SD ' HG23 ' A' ' 242' ' ' THR . 13.2 ptp -55.64 -29.08 58.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.88 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 63.4 mt -75.77 -45.84 37.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.134 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.434 ' HG2' ' ND2' ' A' ' 252' ' ' ASN . 17.9 tt0 -63.1 -44.28 96.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 16.2 ptmt -64.61 -47.58 78.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.595 ' HG3' HD21 ' A' ' 291' ' ' LEU . 21.6 mm-40 -57.25 -34.72 68.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -81.89 -32.16 31.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.434 ' ND2' ' HG2' ' A' ' 248' ' ' GLU . 59.2 m-20 -79.86 -14.6 58.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.431 ' OD1' HD13 ' A' ' 254' ' ' ILE . 34.7 p-10 -60.17 -18.48 48.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.431 HD13 ' OD1' ' A' ' 253' ' ' ASN . 10.0 mm -79.86 -60.21 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -136.67 135.32 20.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.556 0.693 . . . . 0.0 110.959 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 137.45 35.56 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.727 2.285 . . . . 0.0 112.317 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.57 40.43 94.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.511 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -102.56 -56.41 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.854 0.359 . . . . 0.0 111.112 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.2 t -59.76 136.13 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -93.91 -55.77 3.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -152.74 149.32 28.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 19.2 t -122.41 137.85 54.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -128.31 109.1 11.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -80.35 140.62 36.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.954 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.704 HG22 ' H ' ' A' ' 266' ' ' ARG . 6.2 mt -130.82 173.33 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.083 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.704 ' H ' HG22 ' A' ' 265' ' ' ILE . 22.0 mmt180 -28.66 -75.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.879 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -125.0 14.26 8.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.746 ' HA ' HD12 ' A' ' 238' ' ' LEU . 0.1 OUTLIER -140.58 171.67 13.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.944 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -157.87 154.88 28.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -116.07 146.06 42.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.892 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 18.1 t -134.49 125.35 46.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.145 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -98.9 154.68 17.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.889 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -131.85 167.88 18.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.6 t -77.18 -33.78 56.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -146.63 153.13 39.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 277' ' ' GLU . 5.8 ttt-85 -54.04 -55.95 22.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 276' ' ' ARG . 77.8 mt-10 -34.91 -59.79 0.47 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.885 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -56.84 -49.11 76.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.83 -53.33 33.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.66 -37.0 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.159 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -65.41 -49.4 69.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.97 -21.17 65.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 51.2 ttp -71.3 -58.45 3.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -66.16 -30.02 70.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -60.66 -55.67 30.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 42.8 mt -79.49 -31.29 42.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -40.65 115.3 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 93.08 32.92 7.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -109.83 157.46 19.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.802 0.334 . . . . 0.0 110.954 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 76.5 t -118.79 96.19 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.152 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.936 HD12 HD13 ' A' ' 296' ' ' ILE . 30.6 mt -95.0 152.81 18.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.496 ' OD2' ' CB ' ' A' ' 239' ' ' MET . 34.2 t70 41.86 26.51 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.83 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.7 43.84 34.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.516 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 2.0 m -154.39 137.88 10.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.62 0.724 . . . . 0.0 110.897 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 91.93 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.685 2.257 . . . . 0.0 112.352 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.936 HD13 HD12 ' A' ' 291' ' ' LEU . 17.2 pt -78.35 144.97 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -120.44 140.06 51.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.91 134.61 66.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 41.0 p -147.32 176.43 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.189 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 232' ' ' ILE . 15.5 mt -95.64 105.78 17.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.682 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -71.78 145.01 48.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -94.65 143.97 27.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.582 0.706 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 150.78 68.59 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.717 2.278 . . . . 0.0 112.32 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 304' ' ' VAL . 9.3 p -90.29 121.24 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.13 147.31 35.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.822 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -133.51 136.27 44.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -72.65 84.98 1.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 8.5 t -59.09 127.28 31.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.839 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 18.2 m -123.3 164.82 18.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.884 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 105.31 83.03 1.63 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.429 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 159.13 54.54 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.665 2.244 . . . . 0.0 112.375 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 22.1 p -139.58 138.68 36.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 40.0 t -55.75 124.66 18.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.7 t -131.91 167.57 19.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.87 0.367 . . . . 0.0 110.876 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 31.3 t -85.6 136.1 33.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 86.12 51.64 3.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.491 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 88.1 p -138.84 121.73 16.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.382 . . . . 0.0 110.86 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 10.4 t -116.94 -34.69 4.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.895 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -166.63 84.71 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.513 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.401 ' HB2' HG22 ' A' ' 226' ' ' THR . 2.6 p30 -92.31 140.5 29.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.745 0.307 . . . . 0.0 110.851 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -119.64 86.45 2.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.891 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 46.86 39.81 8.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 226' ' ' THR . 10.1 t -104.46 116.14 31.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.134 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 17.4 ptm -96.41 -45.37 6.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 87.8 p -79.36 129.93 34.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 69.0 m -61.75 103.65 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.859 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.42 130.5 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.116 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.32 116.85 18.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.518 ' O ' HD23 ' A' ' 300' ' ' LEU . 40.6 mt -148.05 136.5 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.114 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.612 HD12 ' HE1' ' A' ' 273' ' ' PHE . 36.0 mt -124.04 108.57 12.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.891 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 22.8 t80 -92.02 126.27 37.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.873 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 24.3 t -108.0 144.49 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.134 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -136.98 157.81 45.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 295' ' ' PRO . 15.1 t30 72.9 53.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 14.8 mt -111.14 134.46 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 3.8 mtt -70.51 137.47 50.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 266' ' ' ARG . 70.3 mt -53.95 -18.65 3.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 36.7 m -75.09 -31.36 61.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.554 HG23 ' HB2' ' A' ' 246' ' ' MET . 50.6 m -67.5 127.27 32.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.151 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.1 t -107.08 157.4 17.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -43.34 -28.04 0.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -60.55 -42.55 96.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.554 ' HB2' HG23 ' A' ' 242' ' ' THR . 7.3 mmt -63.82 -42.47 97.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.478 ' HB ' HG11 ' A' ' 262' ' ' VAL . 69.1 mt -67.12 -36.9 78.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.439 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 19.3 tt0 -70.34 -49.12 52.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 4.8 ptmt -63.23 -46.77 85.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.584 ' HG3' HD21 ' A' ' 291' ' ' LEU . 27.7 mm-40 -59.79 -56.29 23.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.865 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.592 ' CE2' HG21 ' A' ' 271' ' ' VAL . 7.4 m-85 -62.33 -41.77 98.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.439 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 5.8 m-20 -62.03 -42.35 99.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -38.49 -42.62 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 44.2 mm -53.99 -58.95 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.445 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 26.6 tptt -141.05 136.81 16.32 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.538 0.685 . . . . 0.0 110.909 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.445 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 53.4 Cg_endo -69.77 131.28 20.89 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.677 2.251 . . . . 0.0 112.325 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 62.82 39.52 98.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.509 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -103.94 -45.11 4.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 0.0 111.069 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.409 ' CG2' ' OD1' ' A' ' 252' ' ' ASN . 93.8 t -71.62 117.89 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.64 -60.32 2.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -145.52 152.96 40.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.478 HG11 ' HB ' ' A' ' 247' ' ' ILE . 92.2 t -127.8 130.74 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -118.94 109.65 16.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -86.66 143.61 27.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.902 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.689 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.5 mt -133.95 172.65 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.687 ' H ' HG22 ' A' ' 265' ' ' ILE . 22.7 mmt180 -30.89 -70.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.879 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -125.62 -1.11 7.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.689 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -124.45 177.54 5.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.96 164.94 16.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.101 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 265' ' ' ILE . 97.8 m-85 -127.21 142.81 51.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.592 HG21 ' CE2' ' A' ' 251' ' ' PHE . 5.2 t -129.99 122.65 54.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -105.74 133.38 50.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.817 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.612 ' HE1' HD12 ' A' ' 233' ' ' LEU . 30.9 m-85 -108.02 175.71 5.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.449 ' O ' ' ND2' ' A' ' 275' ' ' ASN . 17.3 t -86.5 -28.46 23.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 274' ' ' SER . 5.3 m120 -146.92 149.52 33.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -52.48 -49.19 65.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 278' ' ' ASP . 13.8 pt-20 -44.35 -51.85 8.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.425 ' N ' ' HG3' ' A' ' 277' ' ' GLU . 2.5 m-20 -60.62 -50.53 73.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.844 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.463 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -52.44 -49.79 63.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.06 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 77.9 t -53.77 -54.97 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -53.56 -59.83 4.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.431 ' CB ' ' CZ ' ' A' ' 273' ' ' PHE . . . -54.33 -29.36 47.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 62.2 ttp -68.84 -57.14 5.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -63.67 -51.62 64.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -45.12 -51.97 9.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.074 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.532 HD13 ' CE1' ' A' ' 251' ' ' PHE . 81.4 mt -79.13 -29.15 42.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.914 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.402 ' O ' ' ND2' ' A' ' 287' ' ' ASN . 2.7 t30 -49.52 91.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 115.88 31.49 1.91 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.458 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.411 ' HB2' HD11 ' A' ' 296' ' ' ILE . 3.7 mmpt? -106.5 163.2 13.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 110.931 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 51.9 t -125.53 96.59 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.106 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.584 HD21 ' HG3' ' A' ' 250' ' ' GLU . 72.0 mt -89.92 152.67 21.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.899 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 291' ' ' LEU . 1.6 m-20 34.94 36.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 66.62 46.99 71.51 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.477 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 291' ' ' LEU . 5.2 t -154.77 136.25 9.22 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.667 0.746 . . . . 0.0 110.86 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.448 ' O ' ' ND2' ' A' ' 237' ' ' ASN . 54.1 Cg_endo -69.68 106.05 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.719 2.279 . . . . 0.0 112.367 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.475 HD13 HD12 ' A' ' 291' ' ' LEU . 7.9 pt -94.09 145.28 8.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.16 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -118.6 146.83 44.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.0 117.81 39.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 33.9 p -135.67 170.31 16.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.518 HD23 ' O ' ' A' ' 232' ' ' ILE . 22.3 mt -86.89 102.2 14.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.934 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -72.41 114.16 10.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -79.31 143.99 61.35 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.537 0.684 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 141.48 45.41 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.67 2.247 . . . . 0.0 112.334 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 91.6 t -103.22 97.28 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.129 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -139.5 135.67 33.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -63.64 153.58 35.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.35 123.92 23.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 21.9 p -82.31 155.31 24.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 60.3 p -100.06 151.92 20.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.866 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 178.72 -178.15 48.64 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.493 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 135.69 31.25 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.707 2.272 . . . . 0.0 112.321 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 70.6 m -96.28 -55.71 2.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.86 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 1.9 t -112.39 107.38 16.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.836 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.479 -179.982 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 7.3 t 52.25 41.53 30.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 110.831 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 31.5 t -109.76 103.24 12.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 109.97 57.21 0.52 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.473 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 93.4 p -114.5 42.26 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.875 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.3 t -112.25 -34.5 5.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 80.68 -100.96 1.99 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.458 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -50.01 104.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.766 0.317 . . . . 0.0 110.838 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -74.21 94.47 2.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -55.97 -47.11 78.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 42.1 p 40.1 41.1 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 33.8 mtt -95.4 -46.06 6.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 42.9 m -159.41 148.73 18.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.9 m -65.66 99.35 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.884 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.88 133.11 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.139 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.34 116.84 19.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.44 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 20.0 mt -147.95 130.93 7.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.09 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 279' ' ' ALA . 15.2 mt -117.49 112.49 20.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.914 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -91.85 128.99 37.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.09 128.74 73.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.127 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -125.23 159.55 31.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 7.0 t30 71.88 51.23 0.23 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 41.5 mt -107.83 119.09 38.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 7.0 mmt -54.3 125.39 19.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.705 HD23 ' O ' ' A' ' 266' ' ' ARG . 65.1 mt -44.44 -30.17 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 36.0 t -59.92 -40.53 89.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.449 ' HA ' ' CE ' ' A' ' 246' ' ' MET . 30.9 m -60.56 155.16 19.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.153 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.42 ' N ' HG22 ' A' ' 242' ' ' THR . 43.2 m -134.64 168.28 19.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.838 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 245' ' ' GLU . 54.3 mt-10 -47.43 -57.74 4.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 244' ' ' GLU . 38.0 tt0 -35.68 -59.73 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.449 ' CE ' ' HA ' ' A' ' 242' ' ' THR . 6.9 mtt -47.52 -51.66 19.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.0 -34.02 47.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.118 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -64.66 -51.38 62.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 1.6 ptpp? -65.81 -44.34 85.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.888 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.554 ' HG3' HD21 ' A' ' 291' ' ' LEU . 52.0 mm-40 -61.0 -28.8 69.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.668 ' CE2' HG21 ' A' ' 271' ' ' VAL . 7.2 m-85 -95.24 -23.19 17.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.77 -35.7 32.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 250' ' ' GLU . 0.6 OUTLIER -42.56 -29.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.88 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 15.5 mm -68.76 -66.79 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.143 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -131.35 131.96 23.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.519 0.676 . . . . 0.0 110.887 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 121.83 8.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 72.9 33.25 60.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.522 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -101.34 -39.71 7.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 78.8 t -73.16 113.75 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.061 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -66.84 -65.0 0.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.907 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . 0.476 ' CD ' ' HB2' ' A' ' 272' ' ' HIS . 0.0 OUTLIER -146.86 162.62 38.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.877 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 48.1 t -133.53 137.57 52.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . 0.423 ' C ' ' HD3' ' A' ' 263' ' ' LYS . 9.4 tmtm? -127.06 105.2 8.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.429 ' CB ' ' HG3' ' A' ' 244' ' ' GLU . 11.4 tptp -79.67 145.17 33.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.836 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.8 mt -133.6 172.05 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.148 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.705 ' O ' HD23 ' A' ' 240' ' ' LEU . 51.9 mtt85 -32.01 -71.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.64 15.57 7.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.836 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -142.56 177.37 8.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -167.6 164.74 14.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.075 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.442 ' CD2' HD11 ' A' ' 265' ' ' ILE . 98.3 m-85 -130.94 142.9 50.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.668 HG21 ' CE2' ' A' ' 251' ' ' PHE . 21.4 t -124.47 125.51 70.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.107 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . 0.476 ' HB2' ' CD ' ' A' ' 261' ' ' ARG . 3.5 m-70 -105.3 137.55 42.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -117.03 -177.51 3.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.83 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.3 t -99.45 -24.99 14.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -144.78 144.17 31.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.865 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 277' ' ' GLU . 9.6 ttp180 -54.4 -54.17 44.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 276' ' ' ARG . 4.8 mm-40 -35.64 -54.64 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.42 -51.72 67.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.417 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -46.48 -46.88 19.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.057 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.453 ' CG1' ' HD2' ' A' ' 284' ' ' LYS . 51.6 t -65.69 -54.47 27.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.084 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -50.13 -47.61 54.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.49 -31.37 68.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 67.6 ttp -66.82 -53.58 31.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.453 ' HD2' ' CG1' ' A' ' 280' ' ' VAL . 30.0 mtpt -65.92 -39.75 90.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.885 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -53.85 -53.83 47.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.475 HD13 ' CE1' ' A' ' 251' ' ' PHE . 35.2 mt -77.06 -35.49 56.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -41.15 95.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 114.83 32.53 1.87 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.524 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -113.66 160.35 18.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 0.0 110.863 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 95.8 t -123.23 103.59 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.612 HD12 HD13 ' A' ' 296' ' ' ILE . 22.4 mt -95.64 150.85 19.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 41.92 24.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 77.32 38.17 29.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 291' ' ' LEU . 23.6 p -145.59 135.68 11.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.645 0.736 . . . . 0.0 110.908 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 102.41 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.7 2.267 . . . . 0.0 112.328 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.612 HD13 HD12 ' A' ' 291' ' ' LEU . 7.3 pt -90.43 147.2 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.11 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -122.96 140.69 52.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.895 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.24 122.33 65.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 81.9 p -137.84 172.79 12.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.122 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 11.4 mt -90.22 110.02 21.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.44 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -71.43 153.42 42.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.105 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.35 142.45 24.57 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.578 0.704 . . . . 0.0 110.893 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 152.76 69.48 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.669 2.246 . . . . 0.0 112.373 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.42 135.68 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.092 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -104.16 126.07 50.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -156.15 120.42 4.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.2 84.44 7.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.862 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 19.4 t -78.49 161.99 26.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 15.8 t -69.55 155.13 40.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -40.6 160.81 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -17.47 37.44 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.671 2.247 . . . . 0.0 112.317 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 92.1 p -78.07 114.92 17.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.851 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 3.9 m -77.7 137.74 38.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.839 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.543 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 218' ' ' SER . 58.1 m -123.81 131.04 53.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.927 0.394 . . . . 0.0 110.854 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 217' ' ' SER . 1.8 t 37.85 42.08 0.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.876 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -84.02 -58.19 2.26 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 75.6 m -105.28 83.24 1.94 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 110.883 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.3 p -86.35 -35.0 20.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.852 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 175.86 -148.35 9.26 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.528 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -172.17 120.58 0.43 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.802 0.334 . . . . 0.0 110.875 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.78 143.73 46.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.915 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -99.3 156.13 17.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 27.2 m -62.48 -52.81 62.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.17 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 81.8 mtp -63.48 -53.98 43.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.853 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 1.9 m -87.23 92.92 9.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.842 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 88.9 p -101.35 109.81 21.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.836 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.54 131.98 62.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.138 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.21 116.83 17.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.525 ' O ' HD23 ' A' ' 233' ' ' LEU . 21.9 mt -147.94 140.77 18.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.592 HD12 ' CE1' ' A' ' 273' ' ' PHE . 39.5 mt -126.28 106.89 9.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.731 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 38.9 t80 -91.38 123.95 35.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.96 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.482 HG11 HD21 ' A' ' 238' ' ' LEU . 20.8 t -104.45 148.36 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.107 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.527 ' HG3' ' CE2' ' A' ' 234' ' ' TYR . 24.0 mtp180 -138.72 160.31 39.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.46 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 26.7 t-20 67.72 53.03 0.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.672 HD13 HD11 ' A' ' 247' ' ' ILE . 27.0 mt -109.46 120.63 43.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 8.4 mmt -54.97 133.64 48.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.849 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.507 HD23 ' O ' ' A' ' 266' ' ' ARG . 54.4 mt -51.91 -25.01 7.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 61.5 m -70.79 -32.3 69.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.52 HG23 ' HB2' ' A' ' 246' ' ' MET . 93.9 m -65.82 139.95 58.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.1 t -121.11 164.11 17.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.83 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -47.92 -22.04 0.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -65.69 -45.3 83.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.52 ' HB2' HG23 ' A' ' 242' ' ' THR . 2.3 mmt -67.59 -44.53 77.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.672 HD11 HD13 ' A' ' 238' ' ' LEU . 79.2 mt -65.97 -37.65 80.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.442 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 13.9 tt0 -71.62 -57.75 4.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 5.8 ptmt -49.34 -45.98 46.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.488 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 23.6 mm-40 -61.99 -58.21 8.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.531 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 6.0 m-85 -54.57 -27.53 39.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 16.2 m120 -71.77 -44.57 63.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.955 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -38.78 -40.76 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 17.0 mm -56.47 -64.24 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -139.48 131.75 15.16 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.58 0.705 . . . . 0.0 110.908 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 136.67 33.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.617 2.211 . . . . 0.0 112.39 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 63.37 33.32 86.93 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.445 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -100.75 -51.04 3.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.353 . . . . 0.0 111.108 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.73 135.9 24.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.123 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -96.89 -64.33 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -146.06 142.41 28.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 66.6 t -120.92 136.55 57.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.154 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -129.66 110.13 11.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 265' ' ' ILE . 23.4 tptp -79.49 144.63 33.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.927 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.693 HG22 ' H ' ' A' ' 266' ' ' ARG . 6.5 mt -132.3 173.1 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.141 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.693 ' H ' HG22 ' A' ' 265' ' ' ILE . 20.3 mmm180 -29.4 -68.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -132.42 15.08 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.649 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -142.86 173.38 11.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.928 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -162.18 158.98 25.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.086 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 95.3 m-85 -118.62 148.86 42.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.427 HG11 ' CD2' ' A' ' 251' ' ' PHE . 21.3 t -134.81 124.43 43.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.162 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -100.68 146.82 26.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.592 ' CE1' HD12 ' A' ' 233' ' ' LEU . 22.7 m-85 -126.84 167.59 15.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.887 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 45.8 m -74.79 -39.17 61.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -142.87 153.34 43.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.857 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.443 ' O ' ' C ' ' A' ' 277' ' ' GLU . 10.0 ttt85 -54.4 -57.7 10.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 276' ' ' ARG . 4.6 mp0 -34.36 -50.25 0.41 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -63.67 -53.65 48.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.57 ' HB1' HD21 ' A' ' 233' ' ' LEU . . . -51.86 -53.31 41.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.429 HG12 ' NZ ' ' A' ' 284' ' ' LYS . 56.1 t -52.74 -44.8 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.173 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.62 -51.83 67.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.15 -14.57 63.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.107 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -76.6 -60.8 2.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.429 ' NZ ' HG12 ' A' ' 280' ' ' VAL . 19.0 mtmm -64.22 -37.48 87.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -51.46 -54.7 24.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.111 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.531 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 50.5 mt -76.08 -40.16 53.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 286' ' ' LEU . 2.0 t30 -36.29 97.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 109.51 33.91 2.58 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.522 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -114.86 164.2 14.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.769 0.318 . . . . 0.0 110.953 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.413 HG13 ' N ' ' A' ' 294' ' ' SER . 56.8 t -124.64 110.79 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.114 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 293' ' ' GLY . 26.9 mt -102.96 146.38 28.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 39.62 29.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.59 47.55 12.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.469 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.413 ' N ' HG13 ' A' ' 290' ' ' VAL . 1.8 m -154.52 134.68 8.11 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.678 0.751 . . . . 0.0 110.852 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.46 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.4 Cg_endo -69.76 94.78 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.695 2.263 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 10.1 pt -83.61 148.31 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 298' ' ' VAL . 4.5 tp10 -122.79 148.41 45.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 286' ' ' LEU . 4.2 t -130.97 117.88 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.156 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 24.7 p -134.78 160.57 37.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.175 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 232' ' ' ILE . 8.8 mt -83.88 100.61 11.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.731 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -66.73 124.52 23.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.069 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.469 ' CD ' ' H ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -75.12 143.44 77.23 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.583 0.706 . . . . 0.0 110.918 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 162.8 40.67 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.69 2.26 . . . . 0.0 112.321 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.77 135.26 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -72.09 139.17 48.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -171.75 117.14 0.4 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.919 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -105.6 103.62 13.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.874 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 82.9 p -79.72 140.6 36.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 35.3 t -108.26 122.97 48.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -177.66 146.08 7.44 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -175.28 1.1 Allowed 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.683 2.255 . . . . 0.0 112.345 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 79.2 p -114.52 93.65 4.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.871 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 2.7 m -129.83 156.76 43.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.481 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 38.1 m -115.03 116.6 28.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 0.0 110.849 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 4.0 t -84.41 -56.83 3.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.854 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 142.18 -157.24 26.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 24.6 p -64.63 153.47 39.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.886 0.374 . . . . 0.0 110.882 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.9 t -101.31 -34.9 9.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 86.49 107.92 0.8 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.502 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -141.78 144.0 33.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.765 0.317 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -50.22 135.28 21.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . 0.401 ' O ' ' CG ' ' A' ' 225' ' ' ASP . 15.1 p-10 -50.22 97.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.825 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 23.8 m -90.88 137.8 32.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.171 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 23.0 ttt -84.19 -46.6 11.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 32.4 t -76.8 109.54 10.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.838 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 92.5 p -64.13 103.7 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.831 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -106.83 131.02 57.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.131 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.64 116.42 18.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.49 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 80.9 mt -147.9 142.66 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.139 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.796 HD12 ' HE1' ' A' ' 273' ' ' PHE . 81.7 mt -128.94 106.0 8.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.638 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 32.6 t80 -91.31 128.52 37.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.9 t -109.56 150.64 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.149 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 -138.81 157.98 45.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 71.8 54.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 23.6 mt -107.04 113.14 26.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.45 ' CG ' ' OD2' ' A' ' 292' ' ' ASP . 13.4 mmt -53.89 128.15 28.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.443 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 25.7 mt -49.09 -30.38 6.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.906 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 97.8 p -64.49 -33.36 75.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.444 ' O ' ' NZ ' ' A' ' 264' ' ' LYS . 7.8 m -58.96 150.05 25.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.146 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 3.4 m -118.02 159.79 22.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -54.19 -41.62 68.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -54.84 -32.34 60.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.6 mtt -70.74 -37.25 73.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 25.9 mt -74.72 -39.81 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.156 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -68.81 -45.97 69.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.476 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 0.0 OUTLIER -62.35 -48.38 80.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.907 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.476 ' N ' ' CG ' ' A' ' 249' ' ' LYS . 52.8 mm-40 -56.35 -50.11 72.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.467 ' CD2' HG11 ' A' ' 271' ' ' VAL . 7.2 m-85 -65.74 -23.56 66.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -75.49 -41.38 55.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -37.37 -46.96 0.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 49.7 mm -49.59 -63.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -141.17 129.38 12.29 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.596 0.712 . . . . 0.0 110.934 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 114.96 3.88 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.672 2.248 . . . . 0.0 112.324 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 90.36 38.23 6.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -114.35 -43.62 3.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 111.084 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.61 118.4 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -80.25 -67.99 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -144.76 150.92 38.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 93.7 t -127.22 130.1 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.12 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -115.54 106.26 13.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 242' ' ' THR . 15.6 tptm -80.09 140.94 36.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.768 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.1 mt -132.26 172.42 16.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.668 ' H ' HG22 ' A' ' 265' ' ' ILE . 30.7 mmt180 -31.78 -72.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 7.7 p-10 -126.51 17.48 7.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.768 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -146.25 178.01 8.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -169.22 165.78 10.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.104 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.575 ' CE1' ' CD1' ' A' ' 234' ' ' TYR . 96.3 m-85 -126.89 145.4 50.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 251' ' ' PHE . 66.6 t -129.79 134.54 62.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.117 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -113.99 156.29 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.796 ' HE1' HD12 ' A' ' 233' ' ' LEU . 44.9 m-85 -134.37 179.95 5.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 62.5 p -83.26 -34.68 25.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.821 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -147.49 153.18 39.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.872 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 277' ' ' GLU . 8.5 ttt85 -53.79 -54.57 36.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 276' ' ' ARG . 44.7 mt-10 -34.48 -56.52 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.81 -50.78 72.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.05 -54.23 21.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.038 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 71.6 t -53.39 -47.89 57.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.088 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -56.0 -58.45 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.879 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.19 -30.87 51.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.091 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 63.6 ttp -68.07 -55.74 11.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -68.6 -14.94 63.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -79.29 -52.73 7.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.082 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 287' ' ' ASN . 59.5 mt -82.69 -35.16 27.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 286' ' ' LEU . 2.3 t-20 -38.28 99.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 107.68 34.37 2.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.504 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -113.59 159.66 19.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.824 0.345 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 86.7 t -121.32 93.6 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.173 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.475 HD12 HD13 ' A' ' 296' ' ' ILE . 27.7 mt -92.08 153.86 19.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.901 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.45 ' OD2' ' CG ' ' A' ' 239' ' ' MET . 3.2 p-10 42.15 25.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.1 38.29 40.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.51 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 291' ' ' LEU . 68.1 p -147.05 134.9 10.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.637 0.732 . . . . 0.0 110.887 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 92.0 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.629 2.22 . . . . 0.0 112.323 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.475 HD13 HD12 ' A' ' 291' ' ' LEU . 7.5 pt -82.85 148.38 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -125.87 143.71 50.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.6 t -123.86 127.22 73.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 25.7 p -137.43 171.76 13.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 232' ' ' ILE . 5.4 mt -94.74 100.15 12.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.638 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -65.5 151.72 45.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 17.0 mmtm -107.24 142.79 25.84 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.596 0.713 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 145.38 56.98 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.704 2.27 . . . . 0.0 112.351 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 89.5 t -109.14 124.05 65.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.104 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -143.68 171.99 13.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -158.66 141.81 14.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -39.41 122.77 1.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 79.9 p -77.86 157.45 29.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 29.5 m -109.83 101.55 10.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -138.13 -157.44 7.46 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 160.08 51.01 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.687 2.258 . . . . 0.0 112.34 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 22.4 t 67.24 36.26 4.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.848 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 19.8 m -101.88 131.96 47.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.473 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 19.7 m -89.83 81.11 6.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.909 0.385 . . . . 0.0 110.877 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 77.4 p -59.11 153.62 17.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.83 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 141.82 -80.7 0.25 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.508 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 63.8 p -91.93 40.53 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.38 . . . . 0.0 110.809 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.4 t -62.79 -35.18 79.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.843 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 148.13 92.82 0.11 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.505 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.14 110.71 0.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.791 0.329 . . . . 0.0 110.857 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -46.71 -45.82 19.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -37.57 -56.62 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.813 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 37.5 m -119.85 127.07 52.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -84.73 -52.95 5.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 1.9 t -145.18 134.44 22.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.871 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 57.7 p -60.61 100.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -103.15 137.68 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.132 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.476 ' HE2' ' CA ' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -136.71 116.99 13.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.923 179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.618 ' O ' HD23 ' A' ' 233' ' ' LEU . 70.2 mt -147.95 137.05 15.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.174 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 232' ' ' ILE . 10.7 mt -122.07 110.96 16.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.922 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 236' ' ' ARG . 22.5 t80 -91.43 132.92 35.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.938 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.42 ' CG1' HD11 ' A' ' 238' ' ' LEU . 16.5 t -120.08 133.08 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.089 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 234' ' ' TYR . 9.7 ptm180 -129.59 161.98 29.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.419 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 35.2 t-20 71.79 38.79 0.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.42 HD11 ' CG1' ' A' ' 235' ' ' VAL . 26.2 mt -96.71 126.95 42.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 14.6 mmt -59.0 131.92 52.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.477 ' CD2' ' O ' ' A' ' 266' ' ' ARG . 53.5 mt -51.35 -38.16 51.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 29.8 t -59.03 -24.43 62.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.874 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.463 HG22 ' N ' ' A' ' 243' ' ' SER . 30.9 m -60.38 157.09 14.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.177 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.463 ' N ' HG22 ' A' ' 242' ' ' THR . 64.9 m -134.6 153.89 51.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.845 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -44.94 -50.62 10.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -43.91 -41.71 5.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 9.5 mtt -65.7 -38.14 88.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 72.0 mt -72.42 -34.08 47.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 24.5 tt0 -75.32 -48.5 22.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 14.3 ptmt -57.96 -48.07 81.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.97 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.474 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 26.1 mm-40 -62.34 -59.48 4.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -59.15 -23.83 62.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.448 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 6.8 m-20 -80.99 -37.63 28.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -45.12 -45.11 11.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 42.8 mm -50.72 -63.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -134.87 127.07 18.18 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.527 0.68 . . . . 0.0 110.943 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 125.35 12.07 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.672 2.248 . . . . 0.0 112.341 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 75.84 33.7 50.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.487 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -105.17 -45.33 4.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 111.073 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 51.5 t -69.24 118.65 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -77.75 -60.7 2.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -146.78 154.56 41.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 94.4 t -126.58 142.69 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -134.85 109.61 8.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -82.71 146.68 28.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.814 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.8 mt -135.44 172.19 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.092 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.652 ' H ' HG22 ' A' ' 265' ' ' ILE . 21.4 mmt85 -31.71 -72.08 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.82 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.73 15.41 7.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.814 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -142.27 176.72 8.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.918 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.13 166.91 16.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.113 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -130.6 144.26 51.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 18.3 t -129.85 117.26 40.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -93.4 154.75 17.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.475 ' HE1' HD12 ' A' ' 233' ' ' LEU . 45.6 m-85 -130.86 179.7 5.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.418 ' O ' ' ND2' ' A' ' 275' ' ' ASN . 3.8 m -102.28 -23.09 14.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.845 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.476 ' CA ' ' HE2' ' A' ' 231' ' ' LYS . 1.7 m120 -142.33 133.35 25.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.41 ' N ' ' CE ' ' A' ' 231' ' ' LYS . 6.0 ttp-105 -49.87 -46.58 51.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -46.99 -48.84 21.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.89 -57.63 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.426 ' HB1' HD21 ' A' ' 233' ' ' LEU . . . -48.59 -49.47 36.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.077 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 64.6 t -55.74 -52.98 42.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.137 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -57.81 -47.84 81.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.91 -26.69 68.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 9.6 tmm? -72.14 -50.13 30.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -70.38 -35.25 73.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -57.2 -57.96 10.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.108 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 47.9 mt -74.24 -32.81 63.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -41.93 99.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 109.3 29.9 3.8 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.474 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -109.14 161.19 15.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 0.0 110.873 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 71.8 t -123.59 93.87 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.105 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.606 HD12 HD13 ' A' ' 296' ' ' ILE . 31.8 mt -87.11 153.43 21.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 291' ' ' LEU . 3.9 p30 35.43 34.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 68.12 46.39 65.69 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.479 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 291' ' ' LEU . 5.6 t -155.07 133.65 7.16 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.651 0.738 . . . . 0.0 110.852 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.419 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.9 Cg_endo -69.75 101.27 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.682 2.254 . . . . 0.0 112.363 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.606 HD13 HD12 ' A' ' 291' ' ' LEU . 7.5 pt -89.44 145.37 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.152 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -120.92 137.64 54.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.52 122.26 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.072 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 69.5 p -140.46 163.35 33.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.4 mt -77.61 114.15 16.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.543 ' HB3' ' CG2' ' A' ' 232' ' ' ILE . . . -68.42 155.77 39.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.086 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 303' ' ' PRO . 0.6 OUTLIER -112.93 90.5 15.72 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.554 0.693 . . . . 0.0 110.919 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 302' ' ' LYS . 54.0 Cg_endo -69.72 133.11 24.85 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.696 2.264 . . . . 0.0 112.327 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.79 152.96 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.15 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -172.04 119.11 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.49 148.15 29.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -119.83 131.88 55.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.84 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 309' ' ' SER . 92.4 p -78.36 132.69 37.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 308' ' ' SER . 2.0 m -37.61 152.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 171.61 83.43 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.466 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 89.51 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.654 2.236 . . . . 0.0 112.312 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 38.4 t -101.78 142.89 32.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 94.4 p -98.18 149.1 22.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.889 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.454 -179.968 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 96.0 p -163.75 111.76 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 0.0 110.861 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 42.1 p -128.89 140.2 51.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.894 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 116.83 -149.79 18.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.533 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 67.9 m -118.72 145.54 45.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 0.0 110.81 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 69.1 p -84.9 -33.37 22.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.891 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 107.36 136.95 8.26 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.43 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.33 -58.82 1.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.779 0.323 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -46.78 121.67 3.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.923 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -57.65 89.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 4.1 p -124.68 110.14 14.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 2.8 ttt -82.34 -44.58 16.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 25.0 p -75.43 108.69 8.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.842 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 93.1 p -77.35 103.27 7.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.842 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -110.75 135.38 50.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.116 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.93 116.78 17.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.553 ' O ' HD23 ' A' ' 300' ' ' LEU . 19.7 mt -147.96 138.2 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.524 HD12 ' CE1' ' A' ' 273' ' ' PHE . 34.6 mt -123.85 110.63 15.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.62 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 52.9 t80 -92.56 127.76 38.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.577 HG11 HD21 ' A' ' 238' ' ' LEU . 51.5 t -110.39 139.88 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.087 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -135.34 162.97 31.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.412 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 35.0 t-20 67.56 47.45 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.577 HD21 HG11 ' A' ' 235' ' ' VAL . 64.9 mt -104.45 137.42 42.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.1 mmt -69.51 129.9 40.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 266' ' ' ARG . 27.5 mt -50.28 -35.63 28.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.0 t -63.39 -26.92 68.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 93.5 m -64.83 140.44 58.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.8 m -113.94 167.68 10.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.872 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 247' ' ' ILE . 5.4 mp0 -53.17 -50.08 65.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.857 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -41.27 -42.29 2.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 3.1 mmt -65.81 -34.62 78.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 244' ' ' GLU . 21.6 mt -75.58 -40.69 41.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -65.45 -45.21 84.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.496 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 2.3 ptmm? -64.93 -49.15 71.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.892 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.528 ' HG3' HD11 ' A' ' 291' ' ' LEU . 44.4 mm-40 -56.9 -35.09 68.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.463 ' CD2' HG11 ' A' ' 271' ' ' VAL . 5.4 m-85 -87.85 -21.5 24.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -88.83 -8.7 53.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -75.6 -18.22 59.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.642 ' H ' HD12 ' A' ' 254' ' ' ILE . 3.7 mp -85.28 -52.58 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -140.39 129.32 13.13 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.56 0.695 . . . . 0.0 110.877 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 123.27 9.93 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.695 2.263 . . . . 0.0 112.343 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 73.18 39.35 52.96 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -104.0 -43.44 5.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 111.112 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 251' ' ' PHE . 24.2 t -72.5 121.9 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -82.84 -58.65 2.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -145.56 151.67 38.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 97.9 t -126.11 135.43 63.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.146 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -127.25 106.04 8.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 tptt -79.56 146.24 32.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.752 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.9 mt -137.28 172.46 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.668 ' H ' HG22 ' A' ' 265' ' ' ILE . 30.5 mmt180 -30.77 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -127.0 20.2 6.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.872 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.752 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.3 OUTLIER -148.81 175.93 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.962 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.03 168.86 18.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.427 ' CD2' HD11 ' A' ' 265' ' ' ILE . 92.7 m-85 -130.57 137.81 49.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.463 HG11 ' CD2' ' A' ' 251' ' ' PHE . 18.0 t -127.56 122.69 59.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.134 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -98.85 155.72 17.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.524 ' CE1' HD12 ' A' ' 233' ' ' LEU . 16.2 m-85 -129.43 179.58 5.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.3 t -98.69 -19.05 17.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.809 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.449 ' OD1' ' CG ' ' A' ' 278' ' ' ASP . 47.2 p30 -154.25 142.1 20.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -51.0 -47.39 61.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -41.02 -65.31 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.449 ' CG ' ' OD1' ' A' ' 275' ' ' ASN . 72.1 m-20 -52.5 -50.2 63.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.23 -44.6 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.609 HG12 ' HE3' ' A' ' 284' ' ' LYS . 54.2 t -60.97 -47.82 91.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -59.82 -60.98 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -53.2 -28.08 24.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.111 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.486 ' O ' ' CB ' ' A' ' 287' ' ' ASN . 65.9 ttp -68.18 -54.39 18.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.609 ' HE3' HG12 ' A' ' 280' ' ' VAL . 6.4 mtmp? -78.86 -15.62 58.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.402 ' HB3' HG12 ' A' ' 254' ' ' ILE . . . -75.02 -29.95 60.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.103 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.527 HD11 ' O ' ' A' ' 250' ' ' GLU . 46.6 mt -111.95 -28.6 7.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.915 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 283' ' ' MET . 9.2 t-20 -55.99 106.12 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 114.26 4.57 22.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.464 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 289' ' ' LYS . 12.7 mptt -98.35 153.76 18.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 110.89 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 294' ' ' SER . 59.0 t -107.09 96.97 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.692 HD12 HD13 ' A' ' 296' ' ' ILE . 22.1 mt -83.64 146.62 28.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.917 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 292' ' ' ASP . 26.3 t70 36.3 40.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.839 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 65.19 44.56 93.71 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.477 ' N ' HG13 ' A' ' 290' ' ' VAL . 8.4 t -154.32 132.01 6.36 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.624 0.726 . . . . 0.0 110.886 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.412 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.6 Cg_endo -69.79 105.79 1.55 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.637 2.225 . . . . 0.0 112.348 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.692 HD13 HD12 ' A' ' 291' ' ' LEU . 19.3 pt -95.76 140.64 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -117.15 134.44 54.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 4.1 t -123.28 112.79 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.138 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 58.6 p -128.28 165.34 20.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 232' ' ' ILE . 16.7 mt -82.59 102.47 11.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -66.88 141.6 57.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -98.72 137.87 20.65 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.572 0.701 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 146.0 59.01 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.659 2.239 . . . . 0.0 112.332 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 305' ' ' ASP . 9.5 p -87.04 155.5 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.134 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.403 ' N ' HG22 ' A' ' 304' ' ' VAL . 25.4 t0 -41.68 111.87 0.27 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.882 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -147.89 111.5 5.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -125.24 116.29 21.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.864 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 24.7 p -72.68 162.01 30.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 2.1 t -90.54 56.87 3.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.842 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -115.43 83.47 0.34 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.537 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -36.63 10.42 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.678 2.252 . . . . 0.0 112.349 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 12.7 m -170.87 158.18 5.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 26.2 m -121.01 87.78 2.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.844 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.47 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 7.0 m -66.46 134.71 53.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 0.0 110.843 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 14.2 t -165.88 149.5 7.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.882 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -135.02 -132.12 3.13 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.472 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 19.1 t -152.22 139.71 19.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 110.867 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 6.7 t -78.03 -34.39 50.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.846 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 147.27 60.81 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.89 121.51 21.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.332 . . . . 0.0 110.837 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.73 114.1 27.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.47 157.76 26.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 50.7 p -77.01 129.63 36.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.189 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 19.7 ttp -65.35 -38.36 89.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 7.4 t -120.22 91.8 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.862 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.2 t -76.26 103.51 6.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.41 129.24 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.148 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -130.92 116.68 18.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.474 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 75.1 mt -147.91 132.89 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.107 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 232' ' ' ILE . 10.8 mt -117.17 109.28 16.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.911 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.535 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 24.3 t80 -91.67 132.71 36.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.26 140.53 41.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.123 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -137.63 166.71 23.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.833 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 38.5 t30 69.15 44.62 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 26.2 mt -101.52 154.34 18.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 4.4 mtt -83.38 133.96 34.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.862 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 266' ' ' ARG . 63.9 mt -56.53 -13.91 2.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.947 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 2.0 m -90.14 9.03 29.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 98.6 m -100.88 135.16 42.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.135 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 21.4 p -106.57 171.21 7.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -64.61 -18.67 65.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -69.52 -44.2 71.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.888 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 9.7 mtt -64.96 -39.05 92.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.872 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 35.8 mt -70.97 -40.04 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -68.0 -50.77 53.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 2.4 ptmm? -56.81 -47.35 80.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.499 ' O ' ' ND2' ' A' ' 253' ' ' ASN . 54.0 mm-40 -56.87 -65.55 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.623 ' CE1' HD13 ' A' ' 286' ' ' LEU . 8.0 m-85 -52.43 -22.48 4.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.886 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -79.84 -43.73 21.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.63 ' OD1' HD13 ' A' ' 254' ' ' ILE . 0.7 OUTLIER -46.82 -28.91 1.71 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.63 HD13 ' OD1' ' A' ' 253' ' ' ASN . 14.8 mm -74.8 -51.04 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.536 ' HG2' ' HB2' ' A' ' 258' ' ' ALA . 34.8 tptt -139.16 112.16 7.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.557 0.694 . . . . 0.0 110.9 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 125.93 12.7 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.685 2.256 . . . . 0.0 112.335 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 74.96 28.86 61.75 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.492 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.536 ' HB2' ' HG2' ' A' ' 255' ' ' LYS . . . -106.97 -48.03 3.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 111.093 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.3 131.63 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.159 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -89.78 -62.64 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -147.76 158.46 44.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.505 HG22 HG13 ' A' ' 271' ' ' VAL . 90.1 t -137.93 142.83 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.2 116.01 19.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -81.53 139.52 35.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.825 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.2 mt -129.13 172.41 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.151 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.669 ' H ' HG22 ' A' ' 265' ' ' ILE . 18.2 mmm180 -31.32 -75.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.63 19.45 8.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.825 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -146.79 174.9 11.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.81 167.37 18.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.111 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -126.67 151.09 48.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.53 HG11 ' CD2' ' A' ' 251' ' ' PHE . 15.1 t -138.03 117.46 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.074 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -94.76 158.15 15.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -133.45 178.69 6.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 85.7 p -95.45 -14.95 23.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.865 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -160.0 145.85 15.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 280' ' ' VAL . 18.4 ttt-85 -55.22 -41.69 72.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -45.67 -58.39 3.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -60.95 -46.44 90.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -50.58 -51.21 50.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.101 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 276' ' ' ARG . 66.2 t -58.53 -49.83 81.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.167 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -55.4 -57.3 12.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.66 -33.96 61.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.102 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 53.5 ttp -59.87 -68.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -61.29 -20.28 62.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -67.0 -56.97 7.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.623 HD13 ' CE1' ' A' ' 251' ' ' PHE . 26.4 mt -79.93 -30.37 39.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -40.55 112.3 0.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 95.4 32.3 7.07 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.471 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -109.74 158.94 17.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.806 0.336 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 83.1 t -118.79 96.26 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.12 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.728 HD12 HD13 ' A' ' 296' ' ' ILE . 38.0 mt -92.72 153.47 18.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 61.7 t0 40.96 28.31 0.05 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 72.97 41.46 48.48 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.446 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 291' ' ' LEU . 1.8 m -154.3 138.7 11.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.674 0.749 . . . . 0.0 110.908 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 105.99 1.58 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 0.0 112.381 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.728 HD13 HD12 ' A' ' 291' ' ' LEU . 9.8 pt -93.54 151.36 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -123.22 148.38 45.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 11.1 t -133.36 124.72 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.108 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 67.7 p -141.06 165.02 28.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 6.9 mt -81.48 106.63 13.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -71.24 139.81 50.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.106 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -75.68 137.54 70.38 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.577 0.704 . . . . 0.0 110.887 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 151.56 68.81 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.642 2.228 . . . . 0.0 112.323 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 304' ' ' VAL . 9.0 p -85.93 124.29 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.114 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -58.92 128.6 38.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.865 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.8 154.05 47.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -53.85 118.47 4.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 31.0 m -88.37 131.22 34.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.6 t -131.59 107.2 8.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -159.03 70.55 0.24 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.511 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 148.63 65.74 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.657 2.238 . . . . 0.0 112.397 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 4.8 t -96.72 140.79 30.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 92.2 p -131.63 131.43 43.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.89 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 -179.968 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 25.7 m -90.24 155.54 18.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 0.0 110.912 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.4 t -72.03 130.36 40.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 42.62 -153.18 0.2 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.488 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 27.1 t -144.32 148.59 34.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.86 0.362 . . . . 0.0 110.862 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 86.5 p -103.41 -34.81 8.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -112.54 100.5 1.13 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.455 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -129.35 98.15 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.813 0.34 . . . . 0.0 110.875 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.93 175.29 14.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -100.65 95.46 6.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 84.9 m -89.37 106.19 18.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.169 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 12.1 ptp -85.99 -8.04 58.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 19.6 m -106.57 79.94 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 97.5 p -56.71 103.01 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.09 131.33 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 279' ' ' ALA . 0.0 OUTLIER -129.56 116.83 19.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.485 ' O ' HD23 ' A' ' 300' ' ' LEU . 66.3 mt -148.07 138.82 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.139 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.734 HD12 ' CE1' ' A' ' 273' ' ' PHE . 76.8 mt -126.9 111.09 13.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.927 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.837 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 72.6 t80 -93.34 128.46 39.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.969 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 297' ' ' GLU . 16.8 t -112.02 129.06 68.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.112 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.461 ' HG3' ' N ' ' A' ' 237' ' ' ASN . 13.5 tpt180 -120.57 161.3 21.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.461 ' N ' ' HG3' ' A' ' 236' ' ' ARG . 9.0 t30 74.87 35.22 0.65 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 42.2 mt -85.24 124.82 32.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.858 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 3.6 mmt -62.82 133.6 54.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 266' ' ' ARG . 58.2 mt -59.46 -12.74 6.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 20.7 m -98.2 15.56 24.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 38.8 m -102.62 129.88 49.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.133 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 16.0 m -97.16 145.86 25.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.844 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 247' ' ' ILE . 45.7 mt-10 -42.03 -48.29 4.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.886 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -42.14 -38.77 1.8 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 10.8 mtt -66.05 -39.56 90.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 244' ' ' GLU . 44.9 mt -72.64 -34.97 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.468 ' HG2' ' ND2' ' A' ' 252' ' ' ASN . 25.9 tt0 -73.75 -46.62 44.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.489 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 13.7 ptmt -60.54 -45.14 94.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.576 ' HG3' HD11 ' A' ' 291' ' ' LEU . 25.3 mm-40 -61.76 -58.26 8.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.789 ' CD2' HG11 ' A' ' 271' ' ' VAL . 7.6 m-85 -55.81 -46.42 78.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.468 ' ND2' ' HG2' ' A' ' 248' ' ' GLU . 79.6 m-20 -66.02 -23.42 66.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.845 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -51.98 -37.31 52.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 14.5 mm -65.71 -52.57 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -142.71 133.48 12.58 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.609 0.719 . . . . 0.0 110.885 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 137.78 36.21 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.686 2.257 . . . . 0.0 112.32 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.93 41.04 96.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.534 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -106.63 -45.62 4.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 111.11 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 76.5 t -68.26 126.24 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -83.3 -60.59 2.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -147.85 150.15 33.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.824 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 85.7 t -127.68 110.82 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.16 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -100.78 110.07 22.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -79.49 147.86 32.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.804 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.0 mt -137.1 172.11 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.103 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.66 ' H ' HG22 ' A' ' 265' ' ' ILE . 23.5 mmt180 -31.32 -71.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.45 ' OD1' ' C ' ' A' ' 266' ' ' ARG . 1.0 OUTLIER -127.86 16.52 6.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.892 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.804 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -143.59 176.32 9.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.42 158.33 13.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.061 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.485 ' CD2' HD11 ' A' ' 265' ' ' ILE . 98.3 m-85 -117.86 146.61 43.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.789 HG11 ' CD2' ' A' ' 251' ' ' PHE . 21.0 t -130.41 119.64 46.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -98.2 147.51 24.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.734 ' CE1' HD12 ' A' ' 233' ' ' LEU . 38.5 m-85 -126.15 171.74 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.4 ' C ' ' OD1' ' A' ' 275' ' ' ASN . 13.2 t -79.13 -41.58 28.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.876 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.403 ' O ' ' OD1' ' A' ' 278' ' ' ASP . 5.9 m-20 -135.48 170.25 16.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.902 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 280' ' ' VAL . 3.8 ttp85 -74.36 -36.05 63.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.433 ' HG3' ' N ' ' A' ' 278' ' ' ASP . 12.1 pt-20 -53.04 -52.5 58.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.433 ' N ' ' HG3' ' A' ' 277' ' ' GLU . 7.4 p-10 -70.07 -47.32 62.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.585 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -51.14 -49.67 60.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.122 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 276' ' ' ARG . 84.4 t -65.45 -52.93 45.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.093 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -47.19 -41.69 18.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.834 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.46 -40.05 77.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.141 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.0 ttp -50.37 -54.2 23.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -68.45 -42.1 79.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.883 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -51.18 -54.38 26.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.064 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.569 HD13 ' CE1' ' A' ' 251' ' ' PHE . 42.1 mt -78.4 -41.53 32.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.947 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 286' ' ' LEU . 9.5 t30 -35.99 109.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 98.15 34.26 5.44 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.474 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 38.3 mmtt -112.63 147.33 36.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 89.6 t -114.39 97.92 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.576 HD11 ' HG3' ' A' ' 250' ' ' GLU . 41.6 mt -96.06 153.72 17.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.2 t0 42.97 24.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 75.66 38.0 38.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 33.1 p -146.43 133.93 10.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.659 0.742 . . . . 0.0 110.877 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 92.78 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.476 HD13 HD12 ' A' ' 291' ' ' LEU . 6.9 pt -81.32 146.2 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.121 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.403 ' O ' HG13 ' A' ' 235' ' ' VAL . 27.3 tt0 -112.19 156.59 22.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 20.8 t -143.77 115.1 2.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.12 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 29.4 p -138.5 172.94 12.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 232' ' ' ILE . 6.8 mt -88.88 100.34 13.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.837 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -70.61 137.68 50.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.109 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -95.0 139.24 22.02 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.584 0.707 . . . . 0.0 110.921 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 164.24 35.22 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.679 2.253 . . . . 0.0 112.388 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 304' ' ' VAL . 35.1 m -85.71 121.33 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.122 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 304' ' ' VAL . 27.0 m-20 -36.15 114.21 0.27 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.837 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -147.83 109.59 4.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -105.83 135.89 46.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 8.5 t -72.8 136.65 45.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 14.9 t -135.81 113.82 11.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 165.12 148.32 5.44 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.447 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 169.01 19.89 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.658 2.239 . . . . 0.0 112.385 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 3.6 m -91.79 157.89 16.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.864 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 58.2 m -102.95 170.42 7.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.504 179.965 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 89.6 p -140.83 171.7 13.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 0.0 110.865 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 80.6 p -165.64 163.83 19.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.837 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -72.77 -173.28 23.31 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.437 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 29.6 t -89.73 117.55 28.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 110.82 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 7.2 t -119.47 -33.71 4.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.26 85.94 0.26 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.513 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -66.34 140.84 58.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.76 0.314 . . . . 0.0 110.887 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -104.89 163.66 12.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -64.91 114.07 4.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 63.8 p -96.04 113.11 24.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.182 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -54.39 -45.32 72.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.6 m -95.03 124.53 39.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.869 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 42.0 p -87.66 98.38 11.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.3 p -108.22 129.62 62.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.156 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.473 ' HD3' ' N ' ' A' ' 276' ' ' ARG . 1.6 pttm -131.35 116.79 18.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 96.8 mt -147.92 142.32 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.149 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.766 HD12 ' CE1' ' A' ' 273' ' ' PHE . 92.3 mt -127.08 111.72 14.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.721 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 35.1 t80 -91.98 132.36 36.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.619 HG11 HD21 ' A' ' 238' ' ' LEU . 55.6 t -116.24 142.39 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.136 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -132.35 170.34 15.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 295' ' ' PRO . 28.1 t-20 62.31 49.21 4.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.619 HD21 HG11 ' A' ' 235' ' ' VAL . 39.4 mt -102.95 115.39 30.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.93 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 6.2 mtt -56.67 122.91 13.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 266' ' ' ARG . 38.6 mt -45.16 -33.12 2.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.939 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 13.3 t -63.22 -39.27 94.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.842 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 52.1 m -58.46 142.47 48.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.166 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 49.8 m -111.71 168.0 9.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.852 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 244' ' ' GLU . 1.2 mp0 -56.25 -46.87 79.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.911 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -43.31 -37.09 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.5 mmt -70.37 -45.03 66.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.856 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 48.9 mt -65.02 -40.18 88.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -67.51 -60.91 2.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 8.1 ptpt -45.85 -46.23 15.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.467 ' HG3' HD21 ' A' ' 291' ' ' LEU . 23.0 mm-40 -59.38 -69.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.486 ' CE1' HD13 ' A' ' 286' ' ' LEU . 16.1 m-85 -49.34 -24.19 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.849 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 253' ' ' ASN . 3.6 m-20 -73.3 -44.82 58.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 249' ' ' LYS . 6.8 m120 -36.36 -49.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.913 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 45.2 mm -47.95 -62.43 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -139.51 135.02 16.63 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.539 0.685 . . . . 0.0 110.934 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 127.44 14.63 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.684 2.256 . . . . 0.0 112.386 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 67.23 38.89 92.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.52 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -104.04 -43.67 5.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 251' ' ' PHE . 21.7 t -72.62 112.57 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -70.55 -64.61 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 262' ' ' VAL . 0.5 OUTLIER -140.83 165.05 28.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' A' ' 261' ' ' ARG . 40.3 t -140.2 113.98 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -101.53 107.4 18.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -79.83 143.28 34.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.758 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.3 mt -133.97 172.41 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.663 ' H ' HG22 ' A' ' 265' ' ' ILE . 12.7 mmm180 -31.34 -73.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -125.36 18.8 8.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.758 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -148.03 177.75 9.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -166.72 174.05 9.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.116 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -130.69 143.6 50.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.483 HG11 ' CD2' ' A' ' 251' ' ' PHE . 70.0 t -127.07 123.03 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -102.47 155.42 18.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.766 ' CE1' HD12 ' A' ' 233' ' ' LEU . 37.8 m-85 -132.65 177.67 7.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.418 ' C ' ' HE3' ' A' ' 231' ' ' LYS . 78.8 p -89.11 -14.14 36.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.822 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.427 ' N ' ' HD2' ' A' ' 231' ' ' LYS . 11.1 p30 -162.03 147.19 12.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.473 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 27.5 ttt180 -55.25 -45.83 76.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.889 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -40.82 -56.29 2.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -63.78 -48.32 77.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.435 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -48.25 -45.52 34.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.2 -59.1 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -46.74 -43.91 18.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.0 -34.56 73.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 59.4 ttp -53.33 -66.4 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -62.61 -37.76 87.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -46.47 -55.85 6.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.06 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.486 HD13 ' CE1' ' A' ' 251' ' ' PHE . 46.7 mt -80.61 -36.61 32.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 286' ' ' LEU . 22.9 t-20 -36.88 103.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 104.91 31.33 4.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -111.79 156.65 21.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.836 0.35 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.09 96.36 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.139 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 1.047 HD12 HD13 ' A' ' 296' ' ' ILE . 32.2 mt -90.33 153.96 20.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 291' ' ' LEU . 7.7 t70 37.48 39.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.868 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 61.98 43.97 98.45 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.493 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 291' ' ' LEU . 1.8 m -152.42 138.26 11.6 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.661 0.743 . . . . 0.0 110.841 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.401 ' O ' ' OD1' ' A' ' 237' ' ' ASN . 53.4 Cg_endo -69.8 100.78 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.68 2.253 . . . . 0.0 112.323 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 1.047 HD13 HD12 ' A' ' 291' ' ' LEU . 8.3 pt -93.62 145.46 7.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -117.79 157.27 26.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 6.3 t -146.05 121.77 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 82.6 p -144.05 175.27 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 232' ' ' ILE . 8.7 mt -87.11 102.6 14.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.954 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.721 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -66.27 138.61 57.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.072 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -96.04 117.41 66.32 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.613 0.72 . . . . 0.0 110.902 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 150.05 67.53 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.663 2.242 . . . . 0.0 112.39 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 90.1 t -109.09 125.92 66.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.08 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.86 163.71 29.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -94.94 120.09 34.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -87.75 130.6 34.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.84 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 72.9 m -89.24 111.6 22.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.852 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 17.1 m -70.92 121.4 18.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.873 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 122.61 -98.32 0.61 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.463 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 143.08 49.85 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.693 2.262 . . . . 0.0 112.365 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 18.4 m -114.86 -51.15 2.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 74.4 p -52.9 110.49 0.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.851 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.474 179.992 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.431 -0.268 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.4 t -168.02 134.12 1.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.389 . . . . 0.0 110.845 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 45.3 m -43.19 114.28 0.6 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.866 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -106.19 -93.0 2.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.494 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 77.7 p -136.96 120.15 16.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 110.9 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 57.8 m -88.07 -35.4 17.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.842 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 89.0 167.09 42.76 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.512 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.64 118.7 20.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.767 0.317 . . . . 0.0 110.877 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -173.87 154.89 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -125.75 79.38 1.82 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 88.6 m -134.72 125.72 27.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.187 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 17.7 tpp -65.34 -54.8 23.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 60.6 p -46.19 134.6 8.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.878 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 57.3 m -81.26 102.38 10.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.54 132.55 60.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.123 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.428 ' HD3' ' C ' ' A' ' 275' ' ' ASN . 0.1 OUTLIER -131.22 116.91 18.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.613 ' O ' HD23 ' A' ' 233' ' ' LEU . 55.0 mt -147.86 141.33 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.098 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 232' ' ' ILE . 15.4 mt -124.25 105.09 9.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.831 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 6.5 t80 -91.21 125.12 35.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.402 ' CG1' HD11 ' A' ' 238' ' ' LEU . 23.4 t -106.35 135.75 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.091 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 234' ' ' TYR . 21.8 ptt180 -128.66 170.88 12.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 295' ' ' PRO . 6.9 t30 62.84 43.46 7.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.866 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.402 HD11 ' CG1' ' A' ' 235' ' ' VAL . 15.3 mt -100.83 140.81 34.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.408 ' CE ' ' HB2' ' A' ' 294' ' ' SER . 20.3 mmt -80.14 141.07 36.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 266' ' ' ARG . 37.1 mt -53.72 -28.54 34.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.929 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 6.4 m -66.88 -25.31 66.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.923 HG23 ' SD ' ' A' ' 246' ' ' MET . 39.6 m -65.82 144.11 57.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.106 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 1.3 t -128.77 150.92 50.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.42 ' CG ' ' HB2' ' A' ' 264' ' ' LYS . 79.2 mt-10 -46.89 -20.82 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.861 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -66.7 -68.77 0.35 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.923 ' SD ' HG23 ' A' ' 242' ' ' THR . 20.2 ptm -53.12 -37.08 61.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 77.8 mt -61.44 -50.87 78.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.112 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.472 ' HG2' ' ND2' ' A' ' 252' ' ' ASN . 3.4 tt0 -59.37 -64.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.486 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 13.9 pttt -39.47 -46.09 1.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.486 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 33.6 mm-40 -57.82 -51.81 68.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.862 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.866 ' CE2' HG21 ' A' ' 271' ' ' VAL . 4.8 m-85 -61.76 -56.12 22.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.472 ' ND2' ' HG2' ' A' ' 248' ' ' GLU . 5.7 m-80 -54.32 -40.07 67.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -48.04 -31.35 5.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.548 HD12 ' HB1' ' A' ' 285' ' ' ALA . 29.2 mm -68.76 -54.24 21.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.157 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -142.27 120.3 7.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.58 0.705 . . . . 0.0 110.894 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 121.91 8.61 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.367 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 84.25 37.82 10.68 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -118.13 -43.84 2.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.336 . . . . 0.0 111.05 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 41.5 t -74.73 136.65 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.153 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.408 ' HB3' ' NH1' ' A' ' 261' ' ' ARG . 65.1 mm-40 -100.08 -62.02 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . 0.475 ' CD ' ' HB2' ' A' ' 272' ' ' HIS . 0.1 OUTLIER -143.67 153.59 42.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.9 t -122.65 147.35 26.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -136.18 110.74 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.919 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.42 ' HB2' ' CG ' ' A' ' 244' ' ' GLU . 11.0 tptm -87.58 144.8 26.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.815 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.7 mt -136.12 172.35 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.148 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.663 ' H ' HG22 ' A' ' 265' ' ' ILE . 18.9 mmt180 -31.55 -72.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.08 14.13 7.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.815 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -140.82 176.88 8.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.14 179.1 7.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.11 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.466 ' CE2' ' HB2' ' A' ' 234' ' ' TYR . 95.7 m-85 -144.29 148.94 35.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.884 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.866 HG21 ' CE2' ' A' ' 251' ' ' PHE . 3.1 t -135.54 123.12 36.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.141 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . 0.475 ' HB2' ' CD ' ' A' ' 261' ' ' ARG . 3.9 m-70 -97.8 150.74 20.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -126.92 176.87 6.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.895 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.8 t -97.52 -25.93 14.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.428 ' C ' ' HD3' ' A' ' 231' ' ' LYS . 7.6 m-80 -144.83 135.19 24.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.875 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 277' ' ' GLU . 14.0 ttt180 -45.53 -54.33 7.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 276' ' ' ARG . 62.9 mm-40 -37.01 -56.03 0.9 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.51 -47.89 83.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.94 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -54.86 -40.59 69.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.58 -42.99 90.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -65.39 -51.52 59.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.84 -38.72 79.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.075 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 47.4 ttp -52.23 -66.78 0.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.424 ' HA ' ' CB ' ' A' ' 287' ' ' ASN . 40.1 mtmt -58.79 -48.75 80.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.548 ' HB1' HD12 ' A' ' 254' ' ' ILE . . . -36.53 -52.65 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.684 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 73.4 mt -85.75 -29.24 24.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.424 ' CB ' ' HA ' ' A' ' 284' ' ' LYS . 19.1 t-20 -42.53 95.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 286' ' ' LEU . . . 112.08 29.63 3.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.494 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -108.52 155.9 20.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.828 0.347 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 75.5 t -118.02 109.59 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.548 ' HB3' ' HE1' ' A' ' 246' ' ' MET . 26.9 mt -106.54 153.24 22.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 42.53 29.16 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 71.99 42.55 51.75 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.506 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.408 ' HB2' ' CE ' ' A' ' 239' ' ' MET . 10.9 t -153.78 140.03 12.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.626 0.727 . . . . 0.0 110.866 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.491 ' O ' ' ND2' ' A' ' 237' ' ' ASN . 53.6 Cg_endo -69.78 98.56 0.7 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.727 2.285 . . . . 0.0 112.306 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.488 HD13 HD12 ' A' ' 291' ' ' LEU . 8.1 pt -86.14 147.45 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.126 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -121.77 153.33 38.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.423 HG21 ' HB2' ' A' ' 286' ' ' LEU . 8.4 t -135.32 119.2 25.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.174 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 16.3 p -137.8 168.11 20.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 232' ' ' ILE . 11.1 mt -83.87 100.1 10.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.937 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.831 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -71.11 138.45 49.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.079 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 15.5 pttm -81.47 143.2 51.08 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.596 0.712 . . . . 0.0 110.891 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 168.5 21.44 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.745 2.297 . . . . 0.0 112.324 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.56 ' O ' HG23 ' A' ' 304' ' ' VAL . 34.9 m -90.5 115.57 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.129 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 304' ' ' VAL . 2.7 t70 -34.42 141.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 307' ' ' ASP . 49.4 tttt -172.76 117.04 0.32 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 306' ' ' LYS . 10.2 t0 -35.09 137.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 12.7 m -108.2 112.74 25.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.847 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.1 m -94.4 124.94 38.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.813 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -171.57 92.83 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.496 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 176.36 6.86 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.63 2.22 . . . . 0.0 112.382 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 9.0 t -135.16 167.88 20.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 41.2 p 42.66 42.44 2.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.857 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.456 -179.973 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 4.7 t -97.97 91.45 5.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.372 . . . . 0.0 110.838 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 4.3 m -123.65 136.45 54.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.838 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -111.97 88.41 0.5 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.507 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 70.3 m -77.86 85.33 4.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.889 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 52.5 m -107.56 23.17 14.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.83 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -134.61 79.04 0.33 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.522 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.18 111.33 14.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.743 0.306 . . . . 0.0 110.861 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -50.43 119.8 4.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -84.11 81.63 8.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 45.7 p -121.74 130.71 53.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 3.3 mmt -67.51 -42.16 83.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 68.1 m -82.1 88.94 6.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 56.9 m -62.51 98.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.809 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.1 132.39 60.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.131 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.42 ' HD2' ' N ' ' A' ' 275' ' ' ASN . 4.3 pttm -131.49 117.02 18.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.638 ' O ' HD23 ' A' ' 300' ' ' LEU . 92.2 mt -147.93 138.88 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.149 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.665 HD12 ' CE1' ' A' ' 273' ' ' PHE . 68.6 mt -122.8 108.93 13.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.686 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 14.3 t80 -92.37 124.22 36.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.98 143.29 20.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.123 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -134.6 165.62 24.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 72.16 39.97 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 44.7 mt -99.15 115.87 30.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.4 mtt -56.21 130.78 45.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.662 HD23 ' O ' ' A' ' 266' ' ' ARG . 46.1 mt -44.68 -39.05 4.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 30.9 m -56.98 -36.77 70.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 24.6 m -60.86 137.4 58.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.177 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 15.7 m -113.9 170.39 8.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.834 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 247' ' ' ILE . 25.8 mt-10 -53.68 -52.59 59.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -40.03 -47.83 2.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.4 mtt -60.24 -37.94 81.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 244' ' ' GLU . 55.7 mt -73.75 -36.43 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.11 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.498 ' O ' ' ND2' ' A' ' 252' ' ' ASN . 16.8 tt0 -70.66 -46.77 62.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.477 ' CG ' ' N ' ' A' ' 250' ' ' GLU . 4.6 ptmm? -62.91 -47.98 80.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.917 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.484 ' OE1' HD21 ' A' ' 291' ' ' LEU . 25.8 mm-40 -56.08 -54.8 40.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.546 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 10.2 m-85 -63.28 -47.47 82.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 248' ' ' GLU . 1.1 m-80 -54.73 -46.9 74.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -38.1 -48.35 1.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.861 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.436 HD12 ' HB1' ' A' ' 285' ' ' ALA . 48.2 mm -48.35 -57.95 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.121 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -141.06 128.19 11.87 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.564 0.697 . . . . 0.0 110.902 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 120.19 7.01 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.717 2.278 . . . . 0.0 112.311 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 76.39 34.54 45.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.515 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -104.32 -34.23 8.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 0.0 111.102 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 74.4 t -80.75 149.04 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -106.42 -59.21 1.82 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 261' ' ' ARG . 4.8 ptp180 -151.73 155.62 38.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.879 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.21 152.28 37.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.106 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -140.78 109.79 6.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 11.4 tptp -79.68 141.76 36.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.764 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.5 mt -132.33 172.52 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.115 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.673 ' H ' HG22 ' A' ' 265' ' ' ILE . 13.9 mmm180 -31.39 -72.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 0.5 OUTLIER -126.8 17.26 7.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.764 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -145.14 176.13 9.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -165.87 158.95 15.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.135 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.449 ' CD2' HD11 ' A' ' 265' ' ' ILE . 96.8 m-85 -117.57 151.53 36.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 57.8 t -139.44 134.4 39.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.121 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -113.57 157.99 21.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.824 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.665 ' CE1' HD12 ' A' ' 233' ' ' LEU . 30.4 m-85 -132.86 173.37 11.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.403 ' O ' ' ND2' ' A' ' 275' ' ' ASN . 43.4 t -81.49 -18.4 45.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.825 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.42 ' N ' ' HD2' ' A' ' 231' ' ' LYS . 4.8 m120 -157.12 159.4 37.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -61.73 -48.31 81.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -48.21 -44.25 32.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -65.28 -51.42 60.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . 0.547 ' O ' HD11 ' A' ' 233' ' ' LEU . . . -56.04 -39.02 71.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.087 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.446 ' CG1' ' HE3' ' A' ' 284' ' ' LYS . 77.8 t -67.87 -47.94 77.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -59.08 -48.12 82.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.0 -34.82 76.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.2 ttp -60.38 -58.92 6.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.446 ' HE3' ' CG1' ' A' ' 280' ' ' VAL . 84.4 mttt -63.62 -28.35 69.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.436 ' HB1' HD12 ' A' ' 254' ' ' ILE . . . -65.42 -49.59 68.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.546 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 55.1 mt -85.21 -17.48 36.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.957 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -57.01 109.55 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 97.32 32.79 6.21 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.523 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -112.0 154.81 24.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.909 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 87.4 t -117.81 96.61 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.586 HD12 HD13 ' A' ' 296' ' ' ILE . 25.3 mt -92.73 152.0 19.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 41.77 25.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.21 43.52 25.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.499 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 8.1 t -154.75 137.62 10.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.692 0.758 . . . . 0.0 110.852 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 97.45 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.699 2.266 . . . . 0.0 112.329 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.586 HD13 HD12 ' A' ' 291' ' ' LEU . 7.9 pt -85.96 144.07 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.152 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -115.59 141.95 47.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' A' ' 286' ' ' LEU . 3.1 t -128.92 111.3 22.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 63.8 p -132.92 178.97 6.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 232' ' ' ILE . 10.2 mt -95.79 110.22 22.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.686 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -65.79 145.78 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.37 124.26 80.6 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.566 0.698 . . . . 0.0 110.916 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 144.79 54.77 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 0.0 112.329 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 8.2 p -84.11 131.36 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.142 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -117.01 160.46 20.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.812 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -147.68 150.7 34.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -38.06 99.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.904 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 83.6 p -84.32 126.22 32.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.874 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 61.5 p -58.59 -52.35 66.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.864 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 122.89 79.51 0.47 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.514 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -12.3 32.62 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.709 2.273 . . . . 0.0 112.315 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 90.1 p -40.79 161.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 29.5 m -41.4 136.25 1.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.506 179.987 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 10.6 t -155.25 107.35 2.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.852 0.358 . . . . 0.0 110.821 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 2.8 t -109.49 -59.28 1.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 116.95 -109.81 1.98 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.523 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 64.3 m -46.32 129.95 10.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.891 0.377 . . . . 0.0 110.868 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.2 t -95.66 -34.55 11.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -152.64 117.99 0.85 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.492 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -79.62 120.9 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.806 0.336 . . . . 0.0 110.837 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -62.57 139.58 58.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -119.8 104.31 10.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 31.0 p -90.51 171.9 9.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.11 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 45.2 mtt -64.13 -46.5 83.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 4.1 m -86.98 146.63 26.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 93.4 p -85.05 98.43 10.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.824 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.1 130.46 68.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.135 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.428 ' HD2' ' CA ' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -130.47 116.64 18.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.915 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.419 ' CG2' ' HB3' ' A' ' 301' ' ' ALA . 56.8 mt -147.9 125.19 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.177 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 16.1 mt -115.6 112.09 21.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.638 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 51.3 t80 -91.88 121.45 33.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.585 HG11 HD21 ' A' ' 238' ' ' LEU . 34.3 t -108.67 121.9 62.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.163 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.424 ' HB2' ' CE2' ' A' ' 234' ' ' TYR . 28.3 ttt180 -115.64 160.31 20.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.42 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 28.8 t-20 71.55 48.35 0.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.585 HD21 HG11 ' A' ' 235' ' ' VAL . 19.8 mt -102.08 124.32 47.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 8.0 mmt -60.17 141.5 55.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 266' ' ' ARG . 26.3 mt -65.55 -24.09 67.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 34.2 m -82.99 16.0 2.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 23.0 m -102.83 141.36 35.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.124 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 67.7 m -111.11 147.68 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -43.52 -46.75 7.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -39.88 -46.24 1.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 12.1 mtt -62.6 -43.45 98.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . . . . . . . . . 59.2 mt -64.52 -36.76 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.143 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -68.49 -57.29 6.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.911 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 18.6 pttt -52.33 -46.86 66.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.51 ' O ' ' ND2' ' A' ' 253' ' ' ASN . 19.3 mm-40 -55.99 -51.29 68.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.889 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.489 ' CE2' HG21 ' A' ' 271' ' ' VAL . 8.2 m-85 -72.7 -20.3 61.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -90.65 -11.03 41.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 250' ' ' GLU . 16.9 p30 -72.47 -17.92 61.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.547 ' H ' HD12 ' A' ' 254' ' ' ILE . 4.9 mp -79.47 -55.9 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.108 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -143.56 125.66 8.5 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.538 0.685 . . . . 0.0 110.903 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 120.23 7.05 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 87.09 33.41 12.11 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.423 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -108.74 -54.95 2.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 111.081 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.57 142.42 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -102.94 -61.79 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -144.92 152.99 41.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.68 127.85 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -119.08 104.7 10.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.417 ' HZ3' HD13 ' A' ' 238' ' ' LEU . 9.9 tptp -79.4 145.14 33.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.759 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.3 mt -135.86 172.43 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.158 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.668 ' H ' HG22 ' A' ' 265' ' ' ILE . 39.9 mmm-85 -31.34 -74.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 8.4 p-10 -125.36 22.25 7.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.759 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.4 OUTLIER -151.52 177.01 10.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -164.9 171.37 14.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.093 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -135.58 134.51 39.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.891 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.489 HG21 ' CE2' ' A' ' 251' ' ' PHE . 39.4 t -120.16 129.82 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -104.85 155.34 19.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.412 ' C ' ' HG3' ' A' ' 231' ' ' LYS . 43.7 m-85 -136.41 -176.02 4.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.924 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 30.8 t -88.89 -31.86 18.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.428 ' CA ' ' HD2' ' A' ' 231' ' ' LYS . 2.7 m120 -152.17 144.65 24.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.988 ' O ' HG23 ' A' ' 280' ' ' VAL . 0.0 OUTLIER -50.07 -29.46 8.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -54.42 -62.7 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -59.77 -39.11 83.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -64.11 -35.89 82.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.102 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.988 HG23 ' O ' ' A' ' 276' ' ' ARG . 97.2 t -68.55 -39.59 80.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.194 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -68.46 -51.4 43.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -55.7 -40.48 72.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.09 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.1 ttp -60.8 -45.78 93.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -75.02 -19.26 60.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -78.39 -39.15 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 41.3 mt -95.82 -21.27 18.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -48.67 96.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 113.79 30.84 2.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.444 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -107.48 160.16 15.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.809 0.338 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 58.6 t -123.46 107.92 19.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.107 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.428 HD11 ' HG3' ' A' ' 250' ' ' GLU . 34.7 mt -102.86 153.25 20.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 41.83 26.62 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.76 38.52 49.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.476 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 291' ' ' LEU . 23.7 p -146.4 137.39 12.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.687 0.756 . . . . 0.0 110.833 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.42 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.5 Cg_endo -69.8 101.79 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.718 2.279 . . . . 0.0 112.323 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 12.0 pt -90.65 147.75 5.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.36 133.42 52.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 28.2 t -115.36 116.77 53.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.111 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 28.7 p -131.16 169.23 16.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.183 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 10.9 mt -88.71 99.98 12.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.638 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -68.98 137.49 53.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -88.63 143.57 32.18 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.546 0.688 . . . . 0.0 110.913 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 141.78 46.29 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.679 2.252 . . . . 0.0 112.338 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 304' ' ' VAL . 34.9 m -93.02 127.21 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.101 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -88.04 96.14 10.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -145.91 120.58 9.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 12.8 t70 57.65 41.69 25.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.846 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 15.0 t -61.56 108.23 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 37.9 t 38.2 42.37 0.49 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -70.42 -67.05 2.01 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.525 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 120.63 7.39 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.718 2.279 . . . . 0.0 112.353 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 18.0 t -53.0 130.38 33.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.882 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 1.3 t -135.21 128.08 31.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.836 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.488 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 61.6 p -139.76 111.3 7.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 51.6 p -65.02 163.86 13.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.887 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -95.15 124.23 7.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.493 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 4.6 m -109.77 119.05 38.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.372 . . . . 0.0 110.864 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 1.1 t -76.4 -35.02 58.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.881 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 132.93 96.39 0.61 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.477 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -74.86 -64.44 1.04 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 110.866 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 46.37 41.07 8.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.907 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -111.83 81.84 1.52 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 43.0 p -121.62 116.48 24.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -49.12 -47.15 45.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 83.6 p -109.33 119.19 38.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 79.3 p -59.73 104.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.852 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 1.5 p -110.8 137.91 41.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.164 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -135.14 116.88 15.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.488 ' O ' HD23 ' A' ' 233' ' ' LEU . 36.0 mt -147.98 136.55 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.121 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 232' ' ' ILE . 11.5 mt -120.64 108.11 13.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.786 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 17.9 t80 -91.18 129.04 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.2 135.76 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.128 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -129.26 163.04 26.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.834 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 7.9 t30 70.91 48.07 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 21.2 mt -103.28 123.09 46.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.1 mmt -60.88 123.33 17.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 266' ' ' ARG . 38.1 mt -45.73 -29.03 1.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 9.9 t -65.21 -37.6 87.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.449 HG22 ' N ' ' A' ' 243' ' ' SER . 35.1 m -58.82 156.35 11.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.127 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.449 ' N ' HG22 ' A' ' 242' ' ' THR . 58.3 m -128.8 167.9 16.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 247' ' ' ILE . 7.5 mp0 -54.42 -54.26 43.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 244' ' ' GLU . 41.6 tp10 -37.95 -39.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 5.8 mtt -71.18 -40.39 71.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 244' ' ' GLU . 44.3 mt -68.05 -40.46 83.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.122 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 252' ' ' ASN . 18.8 tt0 -70.27 -56.23 7.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 0.0 OUTLIER -49.21 -46.55 45.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.904 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.485 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 39.2 mm-40 -60.74 -51.35 69.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 5.3 m-85 -65.86 -25.46 67.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.413 ' CG ' ' O ' ' A' ' 248' ' ' GLU . 22.6 m120 -70.06 -46.47 64.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.868 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 252' ' ' ASN . 74.8 m-20 -36.2 -41.87 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 26.0 mm -56.44 -63.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.086 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.489 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 4.2 tppt? -141.89 136.42 15.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.6 0.714 . . . . 0.0 110.898 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.489 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 53.6 Cg_endo -69.78 132.56 23.55 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.715 2.277 . . . . 0.0 112.326 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 61.83 37.02 93.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.52 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 255' ' ' LYS . . . -99.16 -43.72 6.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.838 0.351 . . . . 0.0 111.162 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.416 HG11 ' CG2' ' A' ' 262' ' ' VAL . 96.6 t -70.14 118.33 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.108 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -78.53 -57.58 3.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -144.14 149.45 36.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.425 HG22 HG13 ' A' ' 271' ' ' VAL . 69.0 t -133.13 111.57 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.125 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -107.32 117.63 34.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -86.53 142.19 28.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.8 HG21 ' CE2' ' A' ' 268' ' ' TYR . 6.5 mt -131.12 172.97 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.685 ' H ' HG22 ' A' ' 265' ' ' ILE . 70.9 mtm-85 -30.1 -73.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.82 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.48 0.15 8.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.8 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -124.25 176.47 6.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -160.52 172.99 16.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.18 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.558 ' CE2' HD11 ' A' ' 265' ' ' ILE . 68.1 m-85 -136.37 135.4 38.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.544 HG11 ' CD2' ' A' ' 251' ' ' PHE . 8.1 t -130.16 126.08 61.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -103.36 159.3 15.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.415 ' HE1' HD12 ' A' ' 233' ' ' LEU . 34.9 m-85 -133.53 168.18 19.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.826 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 1.1 t -75.72 -39.2 57.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.467 ' N ' ' OD1' ' A' ' 275' ' ' ASN . 4.6 p-10 -139.58 149.07 43.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.938 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' A' ' 277' ' ' GLU . 15.2 ttt180 -51.35 -55.14 20.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.848 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 276' ' ' ARG . 5.8 mp0 -35.12 -60.28 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -55.75 -52.53 63.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -48.28 -45.62 34.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.094 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.613 HG12 ' HE2' ' A' ' 284' ' ' LYS . 86.6 t -59.21 -51.83 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.25 -54.1 41.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.89 -30.86 68.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . 0.445 ' O ' ' CB ' ' A' ' 287' ' ' ASN . 66.0 ttp -65.78 -57.33 8.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.613 ' HE2' HG12 ' A' ' 280' ' ' VAL . 42.8 mtmt -68.78 -32.68 72.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -62.08 -56.51 18.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.084 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.633 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 35.0 mt -76.17 -35.83 58.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 283' ' ' MET . 6.1 t-20 -41.81 106.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 100.59 37.5 3.72 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.473 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -114.17 153.19 30.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.856 0.36 . . . . 0.0 110.893 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 81.9 t -117.93 94.51 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.144 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.455 HD12 HD13 ' A' ' 296' ' ' ILE . 37.9 mt -94.46 153.59 17.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 41.88 25.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 75.84 38.51 36.16 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.542 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 291' ' ' LEU . 31.8 p -146.34 133.12 9.89 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.661 0.744 . . . . 0.0 110.821 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 86.19 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.687 2.258 . . . . 0.0 112.333 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.455 HD13 HD12 ' A' ' 291' ' ' LEU . 6.9 pt -72.95 149.63 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.141 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -118.82 156.43 29.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 20.2 t -143.6 118.51 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 60.6 p -143.55 162.79 34.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.187 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 9.3 mt -77.39 100.05 5.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.786 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -67.66 112.86 5.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.077 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -80.5 137.83 51.6 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.621 0.724 . . . . 0.0 110.923 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 143.1 49.89 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.729 2.286 . . . . 0.0 112.366 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 92.1 t -104.61 108.41 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.145 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -163.62 151.64 13.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -95.28 166.43 11.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -114.93 130.41 56.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.862 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 9.3 t -88.79 137.45 32.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.837 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 5.7 t -92.36 135.3 34.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.849 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 135.26 92.28 0.39 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.488 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -9.09 25.25 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.635 2.223 . . . . 0.0 112.334 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 2.4 m -134.02 161.06 35.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 15.2 m -39.15 159.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.81 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 179.967 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 23.0 m -152.01 130.44 12.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.844 0.354 . . . . 0.0 110.834 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 41.2 t -127.24 155.21 43.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -132.14 -117.06 1.82 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 76.0 p -72.33 166.97 21.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.89 0.376 . . . . 0.0 110.857 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 55.4 m -110.49 -35.01 6.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.845 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -128.97 122.2 3.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.529 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -143.44 157.54 44.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 110.854 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -64.12 138.67 58.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.86 109.17 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 25.4 p -58.94 163.32 3.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 7.5 mtt -97.19 -53.94 3.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.895 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 56.7 m -40.93 125.12 2.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 96.0 p -74.12 100.84 3.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.473 ' O ' ' CD ' ' A' ' 276' ' ' ARG . 0.9 OUTLIER -119.68 139.8 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.123 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.452 ' N ' ' HD3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -133.56 116.73 16.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 6.4 mt -147.94 132.35 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.106 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 12.2 mt -115.48 109.13 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.888 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.538 ' CE2' ' HB3' ' A' ' 236' ' ' ARG . 12.9 t80 -91.49 134.12 34.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.42 HG11 HD21 ' A' ' 238' ' ' LEU . 22.7 t -120.91 131.07 73.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.18 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.538 ' HB3' ' CE2' ' A' ' 234' ' ' TYR . 14.6 ptt180 -123.47 163.39 20.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.4 ' ND2' ' HG2' ' A' ' 295' ' ' PRO . 38.6 t-20 69.84 50.79 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.901 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.439 HD12 ' CA ' ' A' ' 268' ' ' TYR . 11.8 mt -108.52 121.54 45.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.944 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 24.2 mtt -60.2 134.86 57.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 266' ' ' ARG . 19.5 mt -53.94 -26.84 27.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 64.0 p -65.03 -40.31 94.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.898 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . 0.441 ' O ' ' NZ ' ' A' ' 264' ' ' LYS . 52.1 m -59.46 147.9 34.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 59.5 m -121.17 164.19 17.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 247' ' ' ILE . 35.2 mt-10 -52.95 -54.38 35.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 244' ' ' GLU . 27.3 tt0 -36.81 -43.42 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.427 ' HA ' ' NZ ' ' A' ' 249' ' ' LYS . 9.5 mtp -63.63 -45.93 88.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 244' ' ' GLU . 28.4 mt -64.07 -29.39 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.149 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -71.27 -54.4 11.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 250' ' ' GLU . 4.4 ptpp? -58.29 -41.82 85.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 249' ' ' LYS . 17.4 mm-40 -61.94 -54.0 47.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.516 ' CE1' HD13 ' A' ' 286' ' ' LEU . 6.8 m-85 -68.21 -28.27 67.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.879 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . 0.445 ' OD1' HG21 ' A' ' 259' ' ' VAL . 4.6 m-20 -81.76 -23.9 36.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -59.97 -31.44 69.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.628 HD12 ' HB1' ' A' ' 285' ' ' ALA . 13.2 mm -66.44 -56.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.146 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -142.84 131.88 11.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.549 0.69 . . . . 0.0 110.934 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 133.65 26.07 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.717 2.278 . . . . 0.0 112.306 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 65.61 39.83 95.66 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.475 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -110.72 -27.04 9.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.756 0.312 . . . . 0.0 111.048 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.445 HG21 ' OD1' ' A' ' 252' ' ' ASN . 75.8 t -91.77 128.75 43.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.134 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -89.23 -54.66 4.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 30.5 ptt85 -151.11 150.74 31.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.87 138.44 54.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 33.4 tttp -132.95 115.96 15.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . 0.441 ' NZ ' ' O ' ' A' ' 242' ' ' THR . 17.0 tptm -86.48 146.73 26.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.82 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.7 mt -134.28 172.08 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.142 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.66 ' H ' HG22 ' A' ' 265' ' ' ILE . 21.7 mmm180 -31.96 -72.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -125.82 15.71 8.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.82 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.1 OUTLIER -143.33 177.75 8.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.95 -179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -165.14 167.05 18.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.062 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.514 ' CD2' HD11 ' A' ' 265' ' ' ILE . 89.9 m-85 -130.6 143.68 50.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 40.5 t -135.11 126.61 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -102.24 153.89 19.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -125.83 -177.66 4.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 5.0 t -91.89 -31.62 15.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.869 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -144.51 156.51 44.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.928 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.473 ' CD ' ' O ' ' A' ' 230' ' ' VAL . 1.5 tpp85 -52.62 -67.06 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 276' ' ' ARG . 67.7 mm-40 -35.6 -57.84 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -47.93 -52.23 20.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -58.98 -46.67 87.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.99 -48.49 84.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.113 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.44 -53.51 57.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.63 -31.97 71.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 58.2 ttp -59.59 -53.96 51.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 285' ' ' ALA . 85.5 mttt -68.68 -53.23 23.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.628 ' HB1' HD12 ' A' ' 254' ' ' ILE . . . -36.55 -43.53 0.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.106 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.516 HD13 ' CE1' ' A' ' 251' ' ' PHE . 49.0 mt -90.56 -39.95 12.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.859 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . 0.428 ' C ' ' O ' ' A' ' 286' ' ' LEU . 20.7 t-20 -36.3 113.43 0.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 93.28 33.62 7.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.476 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 36.0 mmtt -109.95 160.79 16.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 25.3 t -122.42 101.73 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.074 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.82 HD12 HD13 ' A' ' 296' ' ' ILE . 29.8 mt -99.1 154.2 18.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.8 p30 39.59 28.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 291' ' ' LEU . . . 71.98 40.85 56.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.486 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 291' ' ' LEU . 1.9 m -149.23 137.5 11.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.681 0.753 . . . . 0.0 110.877 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.4 ' HG2' ' ND2' ' A' ' 237' ' ' ASN . 53.8 Cg_endo -69.81 99.19 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.82 HD13 HD12 ' A' ' 291' ' ' LEU . 7.2 pt -90.69 147.85 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -118.62 155.89 30.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 2.9 t -144.1 119.54 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.169 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 80.4 p -139.85 174.63 10.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.83 118.28 26.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.46 151.69 39.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -105.23 121.55 45.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.586 0.708 . . . . 0.0 110.86 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 142.08 46.83 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.715 2.277 . . . . 0.0 112.325 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 304' ' ' VAL . 8.9 p -87.68 127.46 40.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.127 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -142.03 123.48 14.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -76.9 167.69 21.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.938 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 27.6 t70 44.63 39.09 3.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 3.6 m -79.29 145.54 33.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 33.2 t -120.17 138.24 53.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.817 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -119.48 67.6 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.507 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 158.26 57.7 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.69 2.26 . . . . 0.0 112.37 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 2.3 t -123.64 113.47 18.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 34.3 t -90.53 142.59 27.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.863 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.522 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 218' ' ' SER . 67.4 m -118.8 -178.99 3.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 110.829 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 217' ' ' SER . 55.5 p 34.73 43.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 106.23 -173.74 19.95 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.481 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 5.4 m -88.79 149.38 23.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.852 0.358 . . . . 0.0 110.889 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.7 t -103.59 -35.13 8.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.855 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -116.68 172.64 14.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.497 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -111.07 84.77 1.99 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.761 0.315 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -129.8 93.84 3.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -82.4 106.79 14.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 22.0 m -81.61 116.02 21.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.138 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' MET . . . . . . . . . . . . . 13.4 ttm -61.25 -47.67 84.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.887 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 1.2 t -75.53 129.16 36.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.8 m -71.4 98.41 1.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.893 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.457 ' O ' ' CD ' ' A' ' 276' ' ' ARG . 1.1 p -121.72 132.72 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.147 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 116.9 18.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.626 ' O ' HD23 ' A' ' 300' ' ' LEU . 69.9 mt -147.92 151.23 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.166 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.799 HD12 ' CE1' ' A' ' 273' ' ' PHE . 85.9 mt -136.8 110.12 7.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.558 ' HB2' ' HB2' ' A' ' 301' ' ' ALA . 23.9 t80 -91.18 129.42 37.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.1 126.96 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.11 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.538 ' HB3' ' CE2' ' A' ' 234' ' ' TYR . 23.6 ptt85 -120.17 169.72 9.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 63.94 47.77 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 64.3 mt -104.43 131.93 51.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.908 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.494 ' CB ' ' OD2' ' A' ' 292' ' ' ASP . 8.7 mmt -71.25 132.09 44.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 266' ' ' ARG . 62.8 mt -50.27 -29.11 8.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.951 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 72.7 m -63.71 -33.26 75.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.86 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' THR . . . . . . . . . . . . . 87.4 m -66.5 138.04 57.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.103 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 6.2 m -117.77 164.77 14.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.825 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.44 ' O ' ' C ' ' A' ' 245' ' ' GLU . 17.4 mt-10 -44.49 -60.47 1.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.915 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 244' ' ' GLU . 30.7 tt0 -34.86 -62.23 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 25.9 mmm -40.33 -56.96 1.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 250' ' ' GLU . 36.8 mt -62.94 -65.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -39.55 -34.4 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.835 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -77.99 -38.94 43.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 247' ' ' ILE . 21.4 mm-40 -66.08 -48.5 70.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.465 ' CE1' ' CD1' ' A' ' 286' ' ' LEU . 15.1 m-85 -67.24 -42.13 84.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -61.88 -40.67 96.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -42.74 -42.17 3.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 31.9 mm -55.64 -58.7 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.427 ' CD ' ' HD2' ' A' ' 256' ' ' PRO . 10.6 tppt? -142.82 135.03 13.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.585 0.707 . . . . 0.0 110.889 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.427 ' HD2' ' CD ' ' A' ' 255' ' ' LYS . 54.3 Cg_endo -69.73 133.64 26.1 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.673 2.249 . . . . 0.0 112.354 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 65.9 39.02 94.8 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.507 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ALA . . . . . . . . . . . . . . . -103.33 -55.23 2.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.855 0.36 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 251' ' ' PHE . 58.0 t -69.6 114.98 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.085 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -74.2 -55.97 5.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -150.61 144.22 25.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.2 t -121.84 119.41 58.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -105.77 108.87 20.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -79.42 143.44 35.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.737 HG21 ' CE2' ' A' ' 268' ' ' TYR . 5.7 mt -135.66 172.8 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.117 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.676 ' H ' HG22 ' A' ' 265' ' ' ILE . 21.1 mmt180 -30.17 -72.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 4.4 p-10 -128.29 20.35 6.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' TYR . . . . . 0.737 ' CE2' HG21 ' A' ' 265' ' ' ILE . 0.2 OUTLIER -148.37 173.08 13.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -160.92 163.09 32.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.471 ' CD2' HD11 ' A' ' 265' ' ' ILE . 92.6 m-85 -122.81 136.42 54.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.868 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.456 HG13 HG13 ' A' ' 259' ' ' VAL . 42.3 t -123.13 129.04 75.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.098 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -102.43 159.21 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.799 ' CE1' HD12 ' A' ' 233' ' ' LEU . 29.7 m-85 -137.19 -178.62 5.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 7.7 m -98.65 -28.28 13.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.841 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -145.95 147.68 31.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.891 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.579 HH21 HD22 ' A' ' 300' ' ' LEU . 1.3 tpt180 -50.52 -61.72 2.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 276' ' ' ARG . 27.8 mt-10 -36.62 -50.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.83 -57.83 10.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' ALA . . . . . . . . . . . . . . . -54.83 -37.6 66.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.701 HG12 ' HE2' ' A' ' 284' ' ' LYS . 76.7 t -65.77 -47.26 86.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.171 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.21 -50.4 73.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.26 -26.2 68.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.081 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' MET . . . . . . . . . . . . . 61.0 ttp -64.01 -67.64 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.701 ' HE2' HG12 ' A' ' 280' ' ' VAL . 26.7 mtmt -59.79 -29.29 68.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -56.31 -55.67 30.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.085 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.465 ' CD1' ' CE1' ' A' ' 251' ' ' PHE . 60.7 mt -81.54 -30.64 33.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -40.31 104.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.862 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' GLY . . . . . . . . . . . . . . . 105.52 20.54 9.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -97.48 154.9 17.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.339 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' VAL . . . . . . . . . . . . . 98.3 t -122.09 98.17 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.104 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.402 HD12 HD13 ' A' ' 296' ' ' ILE . 32.1 mt -94.57 153.69 17.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.494 ' OD2' ' CB ' ' A' ' 239' ' ' MET . 25.0 t0 42.33 26.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 73.33 38.21 53.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.484 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 291' ' ' LEU . 22.4 p -146.34 134.04 10.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.63 0.729 . . . . 0.0 110.856 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 102.35 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 2.237 . . . . 0.0 112.38 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.402 HD13 HD12 ' A' ' 291' ' ' LEU . 11.4 pt -89.49 148.22 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -121.87 136.1 54.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 3.4 t -119.09 121.92 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.124 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 68.4 p -139.73 168.34 20.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.112 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 232' ' ' ILE . 11.7 mt -86.92 101.89 13.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.558 ' HB2' ' HB2' ' A' ' 234' ' ' TYR . . . -64.25 161.63 16.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.061 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' LYS . . . . . 0.409 ' HD2' ' C ' ' A' ' 302' ' ' LYS . 0.0 OUTLIER -99.52 142.21 24.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.569 0.699 . . . . 0.0 110.889 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 141.65 46.01 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.647 2.231 . . . . 0.0 112.38 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 13.2 p -79.99 140.79 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.163 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -119.82 174.12 6.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.875 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -168.62 124.05 0.94 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -66.22 80.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . . . . . . . . . 4.7 t -97.0 142.6 28.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 14.1 m -113.12 117.24 31.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -129.14 147.05 17.56 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.519 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 112.75 3.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.635 2.223 . . . . 0.0 112.355 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' SER . . . . . . . . . . . . . 62.2 m -114.51 103.71 11.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 79.8 p -75.7 150.0 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.812 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.486 -179.995 . . . . . . . . 0 0 . 1 stop_ save_